0001906324-23-000058.txt : 20231102 0001906324-23-000058.hdr.sgml : 20231102 20231101180439 ACCESSION NUMBER: 0001906324-23-000058 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 81 CONFORMED PERIOD OF REPORT: 20231001 FILED AS OF DATE: 20231102 DATE AS OF CHANGE: 20231101 FILER: COMPANY DATA: COMPANY CONFORMED NAME: QuidelOrtho Corp CENTRAL INDEX KEY: 0001906324 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 874496285 FISCAL YEAR END: 0101 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-41409 FILM NUMBER: 231369445 BUSINESS ADDRESS: STREET 1: 9975 SUMMERS RIDGE ROAD CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: (858) 552-1100 MAIL ADDRESS: STREET 1: 9975 SUMMERS RIDGE ROAD CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: Coronado Topco, Inc. DATE OF NAME CHANGE: 20220124 10-Q 1 qdel-20231001.htm 10-Q qdel-20231001
000190632412/312023Q3falsehttp://fasb.org/us-gaap/2023#OtherLiabilitiesCurrenthttp://fasb.org/us-gaap/2023#OtherLiabilitiesCurrenthttp://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrenthttp://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrenthttp://fasb.org/us-gaap/2023#PrepaidExpenseAndOtherAssetsCurrenthttp://fasb.org/us-gaap/2023#PrepaidExpenseAndOtherAssetsCurrenthttp://fasb.org/us-gaap/2023#OtherAssetsNoncurrenthttp://fasb.org/us-gaap/2023#OtherAssetsNoncurrenthttp://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrenthttp://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrenthttp://fasb.org/us-gaap/2023#PrepaidExpenseAndOtherAssetsCurrenthttp://fasb.org/us-gaap/2023#PrepaidExpenseAndOtherAssetsCurrenthttp://fasb.org/us-gaap/2023#OtherLiabilitiesCurrenthttp://fasb.org/us-gaap/2023#OtherLiabilitiesCurrenthttp://fasb.org/us-gaap/2023#PrepaidExpenseAndOtherAssetsCurrenthttp://fasb.org/us-gaap/2023#PrepaidExpenseAndOtherAssetsCurrenthttp://fasb.org/us-gaap/2023#OtherLiabilitiesCurrenthttp://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent00019063242023-01-022023-10-0100019063242023-10-25xbrli:shares00019063242023-10-01iso4217:USD00019063242023-01-01iso4217:USDxbrli:shares00019063242023-07-032023-10-0100019063242022-07-042022-10-0200019063242022-01-032022-10-020001906324us-gaap:CommonStockMember2023-01-010001906324us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2023-01-010001906324us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-01-010001906324us-gaap:RetainedEarningsMember2023-01-010001906324us-gaap:CommonStockMember2023-01-022023-04-020001906324us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2023-01-022023-04-0200019063242023-01-022023-04-020001906324us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-01-022023-04-020001906324us-gaap:RetainedEarningsMember2023-01-022023-04-020001906324us-gaap:CommonStockMember2023-04-020001906324us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2023-04-020001906324us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-04-020001906324us-gaap:RetainedEarningsMember2023-04-0200019063242023-04-020001906324us-gaap:CommonStockMember2023-04-032023-07-020001906324us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2023-04-032023-07-0200019063242023-04-032023-07-020001906324us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-04-032023-07-020001906324us-gaap:RetainedEarningsMember2023-04-032023-07-020001906324us-gaap:CommonStockMember2023-07-020001906324us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2023-07-020001906324us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-07-020001906324us-gaap:RetainedEarningsMember2023-07-0200019063242023-07-020001906324us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2023-07-032023-10-010001906324us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-07-032023-10-010001906324us-gaap:RetainedEarningsMember2023-07-032023-10-010001906324us-gaap:CommonStockMember2023-10-010001906324us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2023-10-010001906324us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-10-010001906324us-gaap:RetainedEarningsMember2023-10-010001906324us-gaap:CommonStockMember2022-01-020001906324us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2022-01-020001906324us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-01-020001906324us-gaap:RetainedEarningsMember2022-01-0200019063242022-01-020001906324us-gaap:CommonStockMember2022-01-032022-04-030001906324us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2022-01-032022-04-0300019063242022-01-032022-04-030001906324us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-01-032022-04-030001906324us-gaap:RetainedEarningsMember2022-01-032022-04-030001906324us-gaap:CommonStockMember2022-04-030001906324us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2022-04-030001906324us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-04-030001906324us-gaap:RetainedEarningsMember2022-04-0300019063242022-04-030001906324us-gaap:CommonStockMember2022-04-042022-07-030001906324us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2022-04-042022-07-0300019063242022-04-042022-07-030001906324us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-04-042022-07-030001906324us-gaap:RetainedEarningsMember2022-04-042022-07-030001906324us-gaap:CommonStockMember2022-07-030001906324us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2022-07-030001906324us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-07-030001906324us-gaap:RetainedEarningsMember2022-07-0300019063242022-07-030001906324us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2022-07-042022-10-020001906324us-gaap:CommonStockMember2022-07-042022-10-020001906324us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-07-042022-10-020001906324us-gaap:RetainedEarningsMember2022-07-042022-10-020001906324us-gaap:CommonStockMember2022-10-020001906324us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2022-10-020001906324us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-10-020001906324us-gaap:RetainedEarningsMember2022-10-0200019063242022-10-020001906324us-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMemberqdel:RetailCustomersMember2023-01-022023-10-01xbrli:pure0001906324qdel:OrthoMember2022-05-262022-05-260001906324qdel:OrthoMember2022-05-260001906324qdel:OrthoMember2022-07-042022-10-020001906324qdel:OrthoMember2021-07-052021-10-030001906324qdel:OrthoMember2022-01-032022-10-020001906324qdel:OrthoMember2021-01-042021-10-030001906324us-gaap:StockCompensationPlanMember2023-07-032023-10-010001906324us-gaap:StockCompensationPlanMember2023-01-022023-10-010001906324us-gaap:StockCompensationPlanMember2022-07-042022-10-020001906324us-gaap:StockCompensationPlanMember2022-01-032022-10-020001906324us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember2023-10-010001906324us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember2023-01-010001906324qdel:Customer1Member2023-10-010001906324qdel:Customer1Member2023-01-010001906324us-gaap:PrepaidExpensesAndOtherCurrentAssetsMemberqdel:ExpectedValueContractCustomersMember2023-10-010001906324us-gaap:PrepaidExpensesAndOtherCurrentAssetsMemberqdel:ExpectedValueContractCustomersMember2023-01-010001906324qdel:Customer2Member2023-10-010001906324qdel:Customer2Member2023-01-010001906324us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember2023-07-032023-10-010001906324us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember2023-01-022023-10-010001906324us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember2022-07-042022-10-020001906324us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember2022-01-032022-10-020001906324us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementAndThirdPartyMember2023-07-032023-10-010001906324us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementAndThirdPartyMember2023-01-022023-10-010001906324us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementAndThirdPartyMember2022-07-042022-10-020001906324us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementAndThirdPartyMember2022-01-032022-10-020001906324qdel:LabsMember2023-07-032023-10-010001906324qdel:LabsMember2022-07-042022-10-020001906324qdel:LabsMember2023-01-022023-10-010001906324qdel:LabsMember2022-01-032022-10-020001906324qdel:TransfusionMedicineMember2023-07-032023-10-010001906324qdel:TransfusionMedicineMember2022-07-042022-10-020001906324qdel:TransfusionMedicineMember2023-01-022023-10-010001906324qdel:TransfusionMedicineMember2022-01-032022-10-020001906324qdel:PointOfCareMember2023-07-032023-10-010001906324qdel:PointOfCareMember2022-07-042022-10-020001906324qdel:PointOfCareMember2023-01-022023-10-010001906324qdel:PointOfCareMember2022-01-032022-10-020001906324qdel:MolecularDiagnosticsMember2023-07-032023-10-010001906324qdel:MolecularDiagnosticsMember2022-07-042022-10-020001906324qdel:MolecularDiagnosticsMember2023-01-022023-10-010001906324qdel:MolecularDiagnosticsMember2022-01-032022-10-020001906324qdel:CustomerAMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:SalesMember2022-01-032022-10-020001906324us-gaap:CustomerConcentrationRiskMemberus-gaap:SalesMemberqdel:CustomerBMember2022-01-032022-10-020001906324us-gaap:CustomerConcentrationRiskMemberus-gaap:AccountsReceivableMemberqdel:CustomersWithBalancesDueInExcessOf10OfAccountsReceivableMember2023-10-010001906324us-gaap:CustomerConcentrationRiskMemberus-gaap:AccountsReceivableMemberqdel:CustomersWithBalancesDueInExcessOf10OfAccountsReceivableMember2023-01-010001906324us-gaap:ProductConcentrationRiskMemberqdel:RespiratoryMemberus-gaap:SalesRevenueNetMember2023-07-032023-10-010001906324us-gaap:ProductConcentrationRiskMemberqdel:RespiratoryMemberus-gaap:SalesRevenueNetMember2023-01-022023-10-010001906324us-gaap:ProductConcentrationRiskMemberqdel:RespiratoryMemberus-gaap:SalesRevenueNetMember2022-07-042022-10-020001906324us-gaap:ProductConcentrationRiskMemberqdel:RespiratoryMemberus-gaap:SalesRevenueNetMember2022-01-032022-10-020001906324qdel:NorthAmericaSegmentMember2023-07-032023-10-010001906324qdel:NorthAmericaSegmentMember2022-07-042022-10-020001906324qdel:NorthAmericaSegmentMember2023-01-022023-10-010001906324qdel:NorthAmericaSegmentMember2022-01-032022-10-020001906324qdel:EMEASegmentMember2023-07-032023-10-010001906324qdel:EMEASegmentMember2022-07-042022-10-020001906324qdel:EMEASegmentMember2023-01-022023-10-010001906324qdel:EMEASegmentMember2022-01-032022-10-020001906324qdel:ChinaMember2023-07-032023-10-010001906324qdel:ChinaMember2022-07-042022-10-020001906324qdel:ChinaMember2023-01-022023-10-010001906324qdel:ChinaMember2022-01-032022-10-020001906324qdel:OtherMember2023-07-032023-10-010001906324qdel:OtherMember2022-07-042022-10-020001906324qdel:OtherMember2023-01-022023-10-010001906324qdel:OtherMember2022-01-032022-10-020001906324us-gaap:ShortTermInvestmentsMemberus-gaap:CorporateDebtSecuritiesMember2023-10-010001906324us-gaap:ShortTermInvestmentsMemberus-gaap:CorporateDebtSecuritiesMember2023-01-010001906324us-gaap:ShortTermInvestmentsMemberus-gaap:AssetBackedSecuritiesMember2023-10-010001906324us-gaap:ShortTermInvestmentsMemberus-gaap:AssetBackedSecuritiesMember2023-01-010001906324us-gaap:ShortTermInvestmentsMemberus-gaap:USGovernmentDebtSecuritiesMember2023-10-010001906324us-gaap:ShortTermInvestmentsMemberus-gaap:USGovernmentDebtSecuritiesMember2023-01-010001906324us-gaap:ShortTermInvestmentsMemberqdel:AgencyBondsMember2023-10-010001906324us-gaap:ShortTermInvestmentsMemberqdel:AgencyBondsMember2023-01-010001906324us-gaap:ShortTermInvestmentsMemberus-gaap:ForeignGovernmentDebtSecuritiesMember2023-10-010001906324us-gaap:ShortTermInvestmentsMemberus-gaap:ForeignGovernmentDebtSecuritiesMember2023-01-010001906324us-gaap:OtherDebtSecuritiesMemberus-gaap:ShortTermInvestmentsMember2023-10-010001906324us-gaap:OtherDebtSecuritiesMemberus-gaap:ShortTermInvestmentsMember2023-01-010001906324us-gaap:ShortTermInvestmentsMember2023-10-010001906324us-gaap:ShortTermInvestmentsMember2023-01-010001906324qdel:LongTermInvestmentsMemberus-gaap:CorporateDebtSecuritiesMember2023-10-010001906324qdel:LongTermInvestmentsMemberus-gaap:CorporateDebtSecuritiesMember2023-01-010001906324qdel:LongTermInvestmentsMemberus-gaap:AssetBackedSecuritiesMember2023-10-010001906324qdel:LongTermInvestmentsMemberus-gaap:AssetBackedSecuritiesMember2023-01-010001906324qdel:LongTermInvestmentsMemberqdel:AgencyBondsMember2023-10-010001906324qdel:LongTermInvestmentsMemberqdel:AgencyBondsMember2023-01-010001906324qdel:NorthAmericaSegmentMember2023-01-010001906324qdel:EMEASegmentMember2023-01-010001906324qdel:ChinaMember2023-01-010001906324qdel:OtherMember2023-01-010001906324qdel:NorthAmericaSegmentMember2023-10-010001906324qdel:EMEASegmentMember2023-10-010001906324qdel:ChinaMember2023-10-010001906324qdel:OtherMember2023-10-010001906324us-gaap:SecuredDebtMemberqdel:BankOfAmericaCreditFacilityMemberus-gaap:LineOfCreditMember2023-10-010001906324us-gaap:SecuredDebtMemberqdel:BankOfAmericaCreditFacilityMemberus-gaap:LineOfCreditMember2023-01-010001906324us-gaap:SecuredDebtMemberqdel:BankOfAmericaCreditFacilityMemberus-gaap:LineOfCreditMember2022-05-270001906324qdel:BankOfAmericaCreditFacilityMemberus-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMember2022-08-040001906324us-gaap:LetterOfCreditMemberqdel:BankOfAmericaCreditFacilityMemberus-gaap:LineOfCreditMember2023-01-022023-10-010001906324qdel:BankOfAmericaCreditFacilityMemberus-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMember2023-10-010001906324us-gaap:SecuredDebtMemberqdel:BankOfAmericaCreditFacilityMemberus-gaap:LineOfCreditMember2023-01-022023-10-010001906324qdel:VoluntaryPrepaymentMemberus-gaap:SecuredDebtMemberqdel:BankOfAmericaCreditFacilityMemberus-gaap:LineOfCreditMember2023-01-022023-10-01qdel:covenant0001906324qdel:EndingAfterTheClosingDateOfTheCreditAgreementMemberqdel:BankOfAmericaCreditFacilityMemberus-gaap:LineOfCreditMember2023-10-010001906324qdel:EndingAfterInitialMeasurementPeriodMemberqdel:BankOfAmericaCreditFacilityMemberus-gaap:LineOfCreditMember2023-10-010001906324us-gaap:LineOfCreditMemberqdel:BankOfAmericaCreditFacilityMember2023-10-010001906324us-gaap:SecuredDebtMemberqdel:BankOfAmericaCreditFacilityMemberus-gaap:LineOfCreditMember2023-07-032023-10-010001906324us-gaap:SecuredDebtMemberqdel:BankOfAmericaCreditFacilityMemberus-gaap:LineOfCreditMember2022-07-042022-10-020001906324us-gaap:SecuredDebtMemberqdel:BankOfAmericaCreditFacilityMemberus-gaap:LineOfCreditMember2022-01-032022-10-020001906324qdel:BankOfAmericaCreditFacilityMemberus-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMember2023-07-032023-10-010001906324qdel:BankOfAmericaCreditFacilityMemberus-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMember2022-07-042022-10-020001906324qdel:BankOfAmericaCreditFacilityMemberus-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMember2023-01-022023-10-010001906324qdel:BankOfAmericaCreditFacilityMemberus-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMember2022-01-032022-10-020001906324us-gaap:CostOfSalesMember2023-07-032023-10-010001906324us-gaap:CostOfSalesMember2022-07-042022-10-020001906324us-gaap:CostOfSalesMember2023-01-022023-10-010001906324us-gaap:CostOfSalesMember2022-01-032022-10-020001906324us-gaap:ResearchAndDevelopmentExpenseMember2023-07-032023-10-010001906324us-gaap:ResearchAndDevelopmentExpenseMember2022-07-042022-10-020001906324us-gaap:ResearchAndDevelopmentExpenseMember2023-01-022023-10-010001906324us-gaap:ResearchAndDevelopmentExpenseMember2022-01-032022-10-020001906324us-gaap:SellingAndMarketingExpenseMember2023-07-032023-10-010001906324us-gaap:SellingAndMarketingExpenseMember2022-07-042022-10-020001906324us-gaap:SellingAndMarketingExpenseMember2023-01-022023-10-010001906324us-gaap:SellingAndMarketingExpenseMember2022-01-032022-10-020001906324us-gaap:AcquisitionRelatedCostsMember2023-07-032023-10-010001906324us-gaap:AcquisitionRelatedCostsMember2022-07-042022-10-020001906324us-gaap:AcquisitionRelatedCostsMember2023-01-022023-10-010001906324us-gaap:AcquisitionRelatedCostsMember2022-01-032022-10-020001906324us-gaap:EmployeeStockOptionMember2023-10-010001906324us-gaap:EmployeeStockOptionMember2023-01-022023-10-010001906324srt:MaximumMember2023-01-022023-10-010001906324us-gaap:RestrictedStockUnitsRSUMember2023-01-022023-10-010001906324us-gaap:RestrictedStockUnitsRSUMember2022-01-032022-10-020001906324us-gaap:RestrictedStockUnitsRSUMember2023-10-010001906324us-gaap:FairValueInputsLevel1Member2023-10-010001906324us-gaap:FairValueInputsLevel2Member2023-10-010001906324us-gaap:FairValueInputsLevel3Member2023-10-010001906324us-gaap:FairValueInputsLevel1Member2023-01-010001906324us-gaap:FairValueInputsLevel2Member2023-01-010001906324us-gaap:FairValueInputsLevel3Member2023-01-010001906324qdel:BNPBusinessMember2023-04-300001906324us-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-10-010001906324qdel:InterestRateSwapOneMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-10-010001906324qdel:InterestRateSwapTwoMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-10-010001906324qdel:InterestRateSwapThreeMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-10-010001906324qdel:InterestRateSwapFourMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-10-010001906324qdel:InterestRateSwapFiveMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-10-010001906324srt:ScenarioForecastMemberus-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-12-290001906324us-gaap:ForeignExchangeContractMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-10-010001906324us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMember2023-10-010001906324us-gaap:SalesMemberus-gaap:ForeignExchangeForwardMember2023-07-032023-10-010001906324us-gaap:ForeignExchangeForwardMemberus-gaap:CostOfSalesMember2023-07-032023-10-010001906324us-gaap:InterestRateSwapMemberus-gaap:InterestExpenseMember2023-07-032023-10-010001906324us-gaap:SalesMemberus-gaap:ForeignExchangeForwardMember2023-01-022023-10-010001906324us-gaap:ForeignExchangeForwardMemberus-gaap:CostOfSalesMember2023-01-022023-10-010001906324us-gaap:InterestRateSwapMemberus-gaap:InterestExpenseMember2023-01-022023-10-010001906324us-gaap:SalesMemberus-gaap:ForeignExchangeForwardMember2022-07-042022-10-020001906324us-gaap:ForeignExchangeForwardMemberus-gaap:CostOfSalesMember2022-07-042022-10-020001906324us-gaap:InterestRateSwapMemberus-gaap:InterestExpenseMember2022-07-042022-10-020001906324us-gaap:SalesMemberus-gaap:ForeignExchangeForwardMember2022-01-032022-10-020001906324us-gaap:ForeignExchangeForwardMemberus-gaap:CostOfSalesMember2022-01-032022-10-020001906324us-gaap:InterestRateSwapMemberus-gaap:InterestExpenseMember2022-01-032022-10-020001906324us-gaap:OtherNonoperatingIncomeExpenseMemberus-gaap:ForeignExchangeForwardMember2023-07-032023-10-010001906324us-gaap:OtherNonoperatingIncomeExpenseMemberus-gaap:ForeignExchangeForwardMember2023-01-022023-10-010001906324us-gaap:OtherNonoperatingIncomeExpenseMemberus-gaap:ForeignExchangeForwardMember2022-07-042022-10-020001906324us-gaap:OtherNonoperatingIncomeExpenseMemberus-gaap:ForeignExchangeForwardMember2022-01-032022-10-020001906324us-gaap:OtherNonoperatingIncomeExpenseMemberus-gaap:InterestRateSwapMember2022-07-042022-10-020001906324us-gaap:OtherNonoperatingIncomeExpenseMemberus-gaap:InterestRateSwapMember2022-01-032022-10-020001906324us-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-01-010001906324us-gaap:ForeignExchangeContractMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-01-010001906324us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMember2023-01-010001906324us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2023-07-020001906324us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember2023-07-020001906324us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember2023-07-020001906324us-gaap:AccumulatedTranslationAdjustmentMember2023-07-020001906324us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2023-07-032023-10-010001906324us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember2023-07-032023-10-010001906324us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember2023-07-032023-10-010001906324us-gaap:AccumulatedTranslationAdjustmentMember2023-07-032023-10-010001906324us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2023-10-010001906324us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember2023-10-010001906324us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember2023-10-010001906324us-gaap:AccumulatedTranslationAdjustmentMember2023-10-010001906324us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2023-01-010001906324us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember2023-01-010001906324us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember2023-01-010001906324us-gaap:AccumulatedTranslationAdjustmentMember2023-01-010001906324us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2023-01-022023-10-010001906324us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember2023-01-022023-10-010001906324us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember2023-01-022023-10-010001906324us-gaap:AccumulatedTranslationAdjustmentMember2023-01-022023-10-010001906324us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember2022-07-030001906324us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember2022-07-030001906324us-gaap:AccumulatedTranslationAdjustmentMember2022-07-030001906324us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember2022-07-042022-10-020001906324us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember2022-07-042022-10-020001906324us-gaap:AccumulatedTranslationAdjustmentMember2022-07-042022-10-020001906324us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember2022-10-020001906324us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember2022-10-020001906324us-gaap:AccumulatedTranslationAdjustmentMember2022-10-020001906324us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember2022-01-020001906324us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember2022-01-020001906324us-gaap:AccumulatedTranslationAdjustmentMember2022-01-020001906324us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember2022-01-032022-10-020001906324us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember2022-01-032022-10-020001906324us-gaap:AccumulatedTranslationAdjustmentMember2022-01-032022-10-02

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 ____________________________________________________________________________
FORM 10-Q
  ____________________________________________________________________________
(Mark One)
☒QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended October 1, 2023
or
☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from                      to                     
Commission File Number: 001-41409
 ____________________________________________________________________________ 
QUIDELORTHO CORPORATION
(Exact name of registrant as specified in its charter)
  ____________________________________________________________________________
Delaware 87-4496285
(State or other jurisdiction of
incorporation or organization)		 (I.R.S. Employer
Identification No.)
9975 Summers Ridge Road, San Diego, California
92121
(Address of principal executive offices)
(zip code)
(858) 552-1100
(Registrant’s telephone number, including area code)
Not Applicable
(Former name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, $0.001 Par ValueQDELThe Nasdaq Stock Market
____________________________________________________________________________ 
Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  ☒    No  ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes  ☒    No  ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer
☒
Accelerated filer☐
Non-accelerated filer☐Smaller reporting company☐
Emerging growth company☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  ☐   No  ☒
As of October 25, 2023, 66,818,718 shares of the registrant’s common stock were outstanding.



INDEX
 

2

PART I    FINANCIAL INFORMATION
 
ITEM 1.    Financial Statements
QUIDELORTHO CORPORATION
CONSOLIDATED BALANCE SHEETS
(Unaudited)
(In millions, except par value)
October 1, 2023January 1, 2023
ASSETS
Current assets:
Cash and cash equivalents$149.3 $292.9 
Marketable securities43.9 52.1 
Accounts receivable, net331.2 453.9 
Inventories551.7 524.1 
Prepaid expenses and other current assets295.2 252.1 
Total current assets1,371.3 1,575.1 
Property, plant and equipment, net1,369.4 1,339.0 
Marketable securities11.9 21.0 
Right-of-use assets172.2 181.0 
Goodwill2,442.9 2,476.8 
Intangible assets, net2,976.5 3,123.8 
Deferred tax asset15.7 16.4 
Other assets179.2 122.7 
Total assets$8,539.1 $8,855.8 
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable$253.0 $283.3 
Accrued payroll and related expenses106.8 139.2 
Income tax payable1.8 51.6 
Current portion of borrowings193.0 207.5 
Other current liabilities305.4 325.4 
Total current liabilities860.0 1,007.0 
Operating lease liabilities175.9 186.4 
Long-term borrowings2,274.6 2,430.8 
Deferred tax liability196.5 213.2 
Other liabilities65.4 83.8 
Total liabilities3,572.4 3,921.2 
Commitments and contingencies (Note 10)
Stockholders’ equity:
Preferred stock, $0.001 par value per share; 5.0 shares authorized; none issued or outstanding at October 1, 2023 and January 1, 2023
— — 
Common stock, $0.001 par value per share; 126.2 shares authorized; 66.8 and 66.4 shares issued and outstanding at October 1, 2023 and January 1, 2023, respectively
0.1 — 
Additional paid-in capital2,839.0 2,804.3 
Accumulated other comprehensive loss(53.2)(67.6)
Retained earnings2,180.8 2,197.9 
Total stockholders’ equity4,966.7 4,934.6 
Total liabilities and stockholders’ equity$8,539.1 $8,855.8 
See accompanying notes.
3

QUIDELORTHO CORPORATION
CONSOLIDATED STATEMENTS OF (LOSS) INCOME
(Unaudited)
(In millions, except per share data)
 
 Three Months EndedNine Months Ended
October 1, 2023October 2, 2022October 1, 2023October 2, 2022
Total revenues$744.0 $783.8 $2,255.2 $2,399.5 
Cost of sales, excluding amortization of intangibles375.9 376.3 1,142.1 912.5 
Selling, marketing and administrative194.1 204.2 575.6 407.4 
Research and development62.4 65.6 187.5 126.2 
Amortization of intangible assets51.4 50.5 153.6 78.6 
Acquisition and integration costs26.5 26.4 80.4 109.6 
Other operating expenses7.4 4.0 17.0 8.0 
Operating income26.3 56.8 99.0 757.2 
Interest expense, net37.7 29.7 110.9 41.0 
Loss on extinguishment of debt— — — 24.0 
Other expense (income), net4.1 (4.2)8.0 (2.6)
(Loss) income before income taxes(15.5)31.3 (19.9)694.8 
(Benefit from) provision for income taxes(2.8)12.1 (2.8)176.4 
Net (loss) income$(12.7)$19.2 $(17.1)$518.4 
Basic (loss) earnings per share$(0.19)$0.29 $(0.26)$9.67 
Diluted (loss) earnings per share$(0.19)$0.28 $(0.26)$9.56 
Weighted-average shares outstanding - basic66.9 66.9 66.8 53.6 
Weighted-average shares outstanding - diluted66.9 67.5 66.8 54.2 

See accompanying notes.

4

QUIDELORTHO CORPORATION
CONSOLIDATED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME
(Unaudited)
(In millions)
 
 Three Months EndedNine Months Ended
 October 1, 2023October 2, 2022October 1, 2023October 2, 2022
Net (loss) income$(12.7)$19.2 $(17.1)$518.4 
Other comprehensive (loss) income
Changes in cumulative translation adjustment, net of tax(55.3)(92.9)(17.2)(158.9)
Changes in unrealized gains (losses) from investments, net of tax0.2 — 0.3 (0.6)
Changes in unrealized gains (losses) from cash flow hedges, net of tax:
Net unrealized gains on derivative instruments24.5 9.3 47.6 13.9 
Reclassification of net realized (gains) losses on derivative instruments included in net (loss) income(6.3)(0.2)(16.3)0.7 
Total change in unrealized gains from cash flow hedges, net of tax18.2 9.1 31.3 14.6 
Comprehensive (loss) income$(49.6)$(64.6)$(2.7)$373.5 

See accompanying notes.

5

QUIDELORTHO CORPORATION
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY
(Unaudited)
(In millions)
Common StockAdditional
paid-in
capital		Accumulated
other
comprehensive
(loss) income 		Retained
earnings 		Total
stockholders’
equity
SharesPar
Balance at January 1, 202366.4 $— $2,804.3 $(67.6)$2,197.9 $4,934.6 
Issuance of common stock under equity compensation plans0.3 0.1 3.8 — — 3.9 
Stock-based compensation expense— — 10.4 — — 10.4 
Tax withholdings related to vesting of stock-based awards(0.1)— (9.5)— — (9.5)
Other comprehensive income, net of tax— — — 8.3 — 8.3 
Net income— — — — 48.8 48.8 
Balance at April 2, 202366.6 0.1 2,809.0 (59.3)2,246.7 4,996.5 
Issuance of common stock under equity compensation plans0.2 — 5.5 — — 5.5 
Stock-based compensation expense— — 13.7 — — 13.7 
Tax withholdings related to vesting of stock-based awards— — (3.0)— — (3.0)
Other comprehensive income, net of tax— — — 43.0 — 43.0 
Net loss— — — — (53.2)(53.2)
Balance at July 2, 202366.8 0.1 2,825.2 (16.3)2,193.5 5,002.5 
Issuance of common stock under equity compensation plans— — 0.8 — — 0.8 
Stock-based compensation expense— — 13.5 — — 13.5 
Tax withholdings related to vesting of stock-based awards— — (0.5)— — (0.5)
Other comprehensive loss, net of tax— — — (36.9)— (36.9)
Net loss— — — — (12.7)(12.7)
Balance at October 1, 202366.8 $0.1 $2,839.0 $(53.2)$2,180.8 $4,966.7 
.
6

Common StockAdditional
paid-in
capital		Accumulated
other
comprehensive
income (loss)		Retained
earnings		Total
stockholders’
equity
SharesPar
Balance at January 2, 202241.7 $— $279.8 $0.4 $1,649.2 $1,929.4 
Issuance of common stock under equity compensation plans0.2 — 6.4 — — 6.4 
Stock-based compensation expense— — 6.2 — — 6.2 
Tax withholdings related to vesting of stock-based awards(0.1)— (6.8)— — (6.8)
Other comprehensive loss, net of tax— — — (0.2)— (0.2)
Net income— — — — 479.9 479.9 
Balance at April 3, 202241.8 — 285.6 0.2 2,129.1 2,414.9 
Issuance of common stock under equity compensation plans0.1 — 0.8 — — 0.8 
Stock-based compensation expense— — 14.7 — — 14.7 
Issuance of shares in connection with the Combinations25.1 — 2,495.4 — — 2,495.4 
Issuance of equity replacement awards in connection with the Combinations— — 36.1 — — 36.1 
Tax withholdings related to vesting of stock-based awards— — (0.7)— — (0.7)
Other comprehensive loss, net of tax— — — (60.9)— (60.9)
Net income— — — — 19.3 19.3 
Balance at July 3, 202267.0 — 2,831.9 (60.7)2,148.4 4,919.6 
Issuance of common stock under equity compensation and benefit plans— — 2.6 — — 2.6 
Stock-based compensation expense— — 12.6 — — 12.6 
Tax withholdings related to vesting of stock-based awards— — (0.6)— — (0.6)
Repurchases of common stock(1.0)— (74.3)— — (74.3)
Other comprehensive loss, net of tax— — — (83.8)— (83.8)
Net income— — — — 19.2 19.2 
Balance at October 2, 202266.0 $— $2,772.2 $(144.5)$2,167.6 $4,795.3 

See accompanying notes.
7

QUIDELORTHO CORPORATION
CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
(In millions)
 Nine Months Ended
 October 1, 2023October 2, 2022
OPERATING ACTIVITIES
Net (loss) income$(17.1)$518.4 
Adjustments to reconcile net (loss) income to net cash provided by operating activities:
Depreciation and amortization341.8 167.0 
Stock-based compensation expense39.3 36.6 
Net change in operating lease right-of-use assets and liabilities0.1 9.9 
Payment of accreted interest on contingent and deferred consideration(9.7)(10.4)
Loss on extinguishment of debt— 24.0 
Unwind inventory fair value adjustment— 46.6 
Other non-cash, net(4.9)(3.7)
Changes in assets and liabilities:
Accounts receivable124.1 181.6 
Inventories(146.0)(97.9)
Prepaid expenses and other current and non-current assets(35.1)(41.3)
Accounts payable(6.3)9.2 
Accrued payroll and related expenses(31.0)(3.6)
Income taxes payable(51.3)(9.2)
Other current and non-current liabilities(4.1)(111.3)
Net cash provided by operating activities199.8 715.9 
INVESTING ACTIVITIES
Acquisitions of property, plant, equipment, investments and intangibles(160.7)(79.2)
Acquisition of businesses, net of cash and restricted cash acquired— (1,511.4)
Proceeds from government assistance allocated to fixed assets10.5 15.8 
Purchases of marketable securities(50.6)(49.4)
Proceeds from sale of marketable securities68.3 39.3 
Net cash used for investing activities(132.5)(1,584.9)
FINANCING ACTIVITIES
Proceeds from issuance of common stock8.1 5.2 
Short-term borrowings, net2.9 — 
Proceeds from long-term borrowings, net of debt issuance costs— 2,734.5 
Payments on long-term borrowings and extinguishment costs(175.7)(2,336.1)
Payments of tax withholdings related to vesting of stock-based awards(13.0)(8.0)
Repurchases of common stock— (74.3)
Principal payments of acquisition contingent consideration— (4.2)
Principal payments of deferred consideration(30.3)(33.4)
Net cash (used for) provided by financing activities(208.0)283.7 
Effect of exchange rates on cash(3.3)(4.3)
Net decrease in cash, cash equivalents and restricted cash(144.0)(589.6)
Cash, cash equivalents and restricted cash at beginning of period293.9 802.8 
Cash, cash equivalents and restricted cash at end of period$149.9 $213.2 
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION
Purchase of property, equipment and intangibles by incurring current liabilities$11.4 $17.4 
Capital expenditures to be reimbursed under a government contract$3.0 $— 
Transfer of instrument inventories to fixed assets$105.8 $48.6 
Reduction of other current liabilities upon issuance of restricted share units$1.9 $4.6 
See accompanying notes.
8

QuidelOrtho Corporation
Notes to Consolidated Financial Statements
(Unaudited)
Note 1. Basis of Presentation and Summary of Significant Accounting Policies
Basis of Presentation
The accompanying unaudited Consolidated Financial Statements of QuidelOrtho Corporation and its subsidiaries (the “Company” or “QuidelOrtho”) have been prepared in accordance with generally accepted accounting principles in the U.S. (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation (consisting of normal recurring accruals) have been included.
The information at October 1, 2023, and for the three and nine months ended October 1, 2023 and October 2, 2022, is unaudited. For further information, refer to the Company’s Consolidated Financial Statements and notes thereto for the fiscal year ended January 1, 2023 included in QuidelOrtho’s 2022 Annual Report on Form 10-K. Operating results for any quarter are historically seasonal in nature and are not necessarily indicative of the results expected for the full year.
The Company follows the concept of a fiscal year that ends on the Sunday nearest to the end of the month of December, and fiscal quarters that end on the Sunday nearest to the end of the months of March, June and September. For 2023 and 2022, the Company’s fiscal year will end or has ended on December 31, 2023 and January 1, 2023, respectively. For 2023 and 2022, the Company’s third quarter ended on October 1, 2023 and October 2, 2022, respectively. The three and nine months ended October 1, 2023 and October 2, 2022 each included 13 and 39 weeks, respectively.
Use of Estimates
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses and the related disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
Significant Accounting Policies
During the nine months ended October 1, 2023, there have been no changes to the Company’s significant accounting policies as described in the Company’s 2022 Annual Report on Form 10-K, except for the following policy, which was the result of a change in accounting estimates:
Revenue Recognition
The Company generates a portion of its revenue from sales of the QuickVue At-Home OTC COVID-19 tests to retail customers. The Company estimates the transaction price for revenue from sales to retail customers based on historical experience and current trends to evaluate when uncertainties related to right of return provisions are resolved. In prior periods, due to a lack of history on which to base an estimate of products to be returned from retailers, the Company established a reserve based on an estimate of total inventory remaining at our retailers that was subject to return.
During the three months ended October 1, 2023, the Company concluded that it had developed sufficient historical experience regarding the pattern in customer returns to be able to estimate the amount of consideration to which we expect to be entitled, excluding consideration for the products expected to be returned. Amounts received or receivable that are expected to be returned are recognized as a refund liability, which is included in Other current liabilities. The refund liability is estimated utilizing historical sale and return rates over the period during which customers have a right of return, taking into account available information on competitive products and contract changes. The refund liability is remeasured at each reporting period to reflect changes in assumptions about expected returns. Revenue from sales to retail customers amounted to approximately 3% of Total revenues for the nine months ended October 1, 2023. This change in estimate did not have a material impact on the Company’s Consolidated Financial Statements.
Recent Accounting Pronouncements
There have been no accounting pronouncements issued or adopted during the nine months ended October 1, 2023 that are expected to have a material impact on the Company’s Consolidated Financial Statements.
9

Note 2. Business Combination
On May 27, 2022, pursuant to a Business Combination Agreement entered into as of December 22, 2021 (the “BCA”), by and among Quidel Corporation (“Quidel”), Ortho Clinical Diagnostics Holdings plc (“Ortho”), QuidelOrtho (formerly Coronado Topco, Inc.), Orca Holdco, Inc., Laguna Merger Sub, Inc. and Orca Holdco 2, Inc., Quidel and Ortho consummated a business combination (the “Combinations”) and each of Quidel and Ortho became a wholly owned subsidiary of QuidelOrtho. As a result of the Combinations, QuidelOrtho became the successor issuer to Quidel. The Combinations enhance the Company’s revenue profile and expand the Company’s geographic footprint and product diversity.
The Combinations were completed for a total consideration of approximately $4.3 billion, which included the fair value of equity issued based on the May 26, 2022 closing price of $99.60 per share of Quidel common stock. Former Ortho shareholders received $7.14 in cash and 0.1055 shares of QuidelOrtho common stock for each Ortho ordinary share. The Company funded the cash portion of the purchase price with cash on its balance sheet and a portion of the Term Loan proceeds from the Financing (each as defined in Note 8).
The Combinations have been accounted for as a business combination, which requires that assets acquired and liabilities assumed be recognized at their fair value as of the date of the consummation of the Combinations, with Quidel considered the accounting and the legal acquirer. The assessment of the fair value of assets acquired and liabilities assumed was finalized in the second quarter of 2023. Measurement period adjustments in fiscal year 2023 decreased goodwill by $23.9 million, reflecting (i) a decrease of $22.3 million to deferred tax liability, (ii) a decrease of $2.9 million to income tax payable and (iii) a decrease of $1.3 million in deferred tax asset. The related impact to net earnings that would have been recognized in previous periods if the adjustments were recognized as of the date of the consummation of the Combinations is immaterial to the Company’s Consolidated Financial Statements.
The following unaudited supplemental pro forma financial information shows the combined results of operations of the Company as if the Combinations had occurred on January 4, 2021, the beginning of the periods presented:
Three Months EndedNine Months Ended
(In millions)October 2, 2022October 3, 2021October 2, 2022October 3, 2021
Pro forma total revenues$783.8 $1,032.3 $3,184.7 $2,583.5 
Pro forma net income50.2 225.2 549.5 340.2 
This unaudited supplemental pro forma financial information is presented for informational purposes only and is not indicative of the results of operations that would have been achieved had the Combinations been completed at the beginning of fiscal year 2021. In addition, the unaudited supplemental pro forma financial information is not a projection of the Company’s future results of operations, nor does it reflect the expected realization of any synergies or cost savings associated with the Combinations. The unaudited supplemental pro forma financial information includes adjustments for:
•incremental intangible assets amortization expense based on the preliminary fair values of the identifiable intangible assets acquired;
•incremental cost of sales related to the fair value step-up of inventory;
•decreases in interest expense associated with the issuance of debt to finance the Combinations and to repay Ortho’s then-outstanding indebtedness, including the net impact of the removal of the amortization of the discount on Ortho’s indebtedness and the change in amortization of deferred financing fees;
•the removal of loss on extinguishment of debt from Ortho’s results in fiscal year 2021 and the reclassification of loss on extinguishment of debt in fiscal years 2021 and 2022;
•the reclassification of expense related to the accelerated vesting of certain stock awards of Ortho’s former chief executive officer; and
•tax impacts related to the above adjustments.
Note 3. Computation of Earnings Per Share
Basic earnings per share (“EPS”) is computed by dividing Net (loss) income by the weighted-average number of shares of common stock outstanding. Diluted EPS is computed based on the sum of the weighted-average number of shares of common stock and potentially dilutive shares of common stock outstanding during the period. Potentially dilutive shares of common stock consist of shares issuable from stock options and unvested restricted stock units (“RSUs”). Potentially dilutive shares of common stock from outstanding stock options and unvested RSUs are determined using the average share price for each period under the treasury stock method.
10

The following table presents the calculation of the weighted-average shares used in computing basic and diluted EPS:
Three Months EndedNine Months Ended
(In millions)October 1, 2023October 2, 2022October 1, 2023October 2, 2022
Basic weighted-average shares of common stock outstanding66.9 66.9 66.8 53.6 
Dilutive potential shares issuable from stock options and RSUs(1)
— 0.6 — 0.6 
Diluted weighted-average shares of common stock outstanding66.9 67.5 66.8 54.2 
(1) In the three and nine months ended October 1, 2023, all potential shares of common stock issuable for stock options and RSUs were excluded from the dilutive calculations above because the effect of including them would have been anti-dilutive. The dilutive effect of potential shares of common stock issuable for stock options and RSUs on the weighted-average number of shares of common stock outstanding would have been as follows:
Three Months EndedNine Months Ended
(In millions)October 1, 2023October 1, 2023
Basic weighted-average shares of common stock outstanding66.9 66.8 
Dilutive potential shares issuable from stock options and RSUs0.4 0.5 
Diluted weighted-average shares of common stock outstanding67.3 67.3 
Stock options and RSUs where the combined exercise price and unrecognized stock-based compensation was greater than the average market price for the Company’s common stock were not included in the computations of diluted weighted-average shares because the effect would have been anti-dilutive. These stock options and RSUs represented 1.7 million and 1.6 million shares of common stock for the three and nine months ended October 1, 2023, respectively, and 1.0 million shares of common stock for each of the three and nine months ended October 2, 2022.
Note 4. Revenue
Contract Balances
Timing of revenue recognition may differ from timing of invoicing to customers. The Company records an asset when revenue is recognized prior to invoicing a customer (a “contract asset”). Contract assets are included within Prepaid expenses and other current assets in the Company’s Consolidated Balance Sheets and are transferred to accounts receivable when the right to payment becomes unconditional. The balance of contract assets recorded in the Company’s Consolidated Balance Sheets as of October 1, 2023 and January 1, 2023 was $53.5 million and $49.6 million, respectively.
The contract asset balance consisted of the following components, all of which related to agreements acquired by the Company in connection with the Combinations:
•a customer supply agreement under which the difference between the timing of invoicing and revenue recognition resulted in a contract asset of $3.8 million and $6.8 million as of October 1, 2023 and January 1, 2023, respectively;
•contractual arrangements with certain customers under which the Company invoices the customers based on reportable results generated by its reagents; however, control of the goods transfers to the customers upon shipment or delivery of the products, as determined under the terms of the contract. Using the expected value method, the Company estimates the number of reagents that will generate a reportable result. The Company records the revenue upon shipment and an associated contract asset, and relieves the contract asset upon completion of the invoicing. The balance of the contract asset related to these arrangements was $42.4 million and $38.5 million as of October 1, 2023 and January 1, 2023, respectively; and
•one of the Company’s contract manufacturing agreements that recognizes revenue as the products are manufactured resulted in a contract asset of $7.3 million and $4.3 million as of October 1, 2023 and January 1, 2023, respectively.
The Company reviews contract assets for expected credit losses resulting from the collectability of customer accounts. Expected losses are established based on historical losses, customer mix and credit policies, current economic conditions in customers’ country or industry, and expectations associated with reasonable and supportable forecasts. No credit losses related to contract assets were recognized during the three and nine months ended October 1, 2023.
The Company recognizes a contract liability when a customer pays an invoice prior to the Company transferring control of the goods or services (“contract liabilities”). The Company’s contract liabilities consist of deferred revenue primarily related to customer service contracts. The Company classifies deferred revenue as current or non-current based on the timing of the transfer of control or performance of the service. The balance of the Company’s current deferred revenue was $34.6 million as
11

of October 1, 2023 and $76.4 million as of January 1, 2023. The Company has one arrangement with a customer where the revenue is expected to be recognized beyond one year. The balance of the deferred revenue included in long-term liabilities was $13.5 million and $9.4 million as of October 1, 2023 and January 1, 2023, respectively, and was included in Other liabilities in the Consolidated Balance Sheets. The amount of deferred revenue as of January 1, 2023 that was recorded in Total revenues during the three and nine months ended October 1, 2023 was $2.4 million and $70.9 million, respectively.
Joint Business with Grifols
In connection with the Combinations, the Company acquired the ongoing collaboration arrangement (the “Joint Business”) between Ortho and Grifols Diagnostic Solutions, Inc. (“Grifols”), under which Ortho and Grifols agreed to pursue a collaboration relating to Ortho’s Hepatitis and HIV diagnostics business. The governance of the Joint Business is shared through a supervisory board made up of equal representation by Ortho and Grifols, which is responsible for all significant decisions relating to the Joint Business that are not exclusively assigned to either Ortho or Grifols, as defined in the Joint Business agreement. The Company’s portion of the pre-tax net profit shared under the Joint Business was $8.9 million and $38.6 million during the three and nine months ended October 1, 2023, respectively, and $7.9 million and $13.5 million during the three and nine months ended October 2, 2022, respectively. These amounts included the Company’s portion of the pre-tax net profit of $7.3 million and $14.0 million during the three and nine months ended October 1, 2023, respectively, and $5.2 million and $8.8 million during the three and nine months ended October 2, 2022, respectively, on sales transactions with third parties where the Company is the principal. The Company recognized revenues, cost of sales, excluding amortization of intangibles, and operating expenses, on a gross basis on these sales transactions in their respective lines in the Consolidated Statements of (Loss) Income. The Company’s portion of the pre-tax net profit also included revenue from collaboration and royalty agreements of $1.6 million and $24.6 million during the three and nine months ended October 1, 2023, respectively, and $2.7 million and $4.7 million during the three and nine months ended October 2, 2022, respectively, which is presented on a net basis within Total revenues.
Disaggregation of Revenue
The following table summarizes Total revenues by business unit:
Three Months EndedNine Months Ended
(In millions)October 1, 2023October 2, 2022October 1, 2023October 2, 2022
Labs$341.4 $334.8 $1,073.5 $505.5 
Transfusion Medicine163.9 163.1 483.1 231.3 
Point of Care233.1 270.5 675.4 1,580.6 
Molecular Diagnostics5.6 15.4 23.2 82.1 
Total revenues$744.0 $783.8 $2,255.2 $2,399.5 
Concentration of Revenue and Credit Risk
For the nine months ended October 1, 2023, no customers individually accounted for more than 10% of Total revenues. For the nine months ended October 2, 2022, one customer and one distributor represented 27% and 10%, respectively, of Total revenues.
As of October 1, 2023 and January 1, 2023, customers with a balance due in excess of 10% of Accounts receivable, net totaled $99.4 million and $161.9 million, respectively. Revenue related to our respiratory products accounted for 25% and 24% of Total revenues for the three and nine months ended October 1, 2023, respectively, and 30% and 63% for the three and nine months ended October 2, 2022, respectively.
12

Note 5. Segment and Geographic Information
Total revenues by reportable segment are as follows:
Three Months EndedNine Months Ended
(In millions)October 1, 2023October 2, 2022October 1, 2023October 2, 2022
North America$465.2 $517.6 $1,426.8 $1,917.3 
EMEA74.5 73.7 236.4 131.0 
China81.1 80.8 233.0 163.1 
Other123.2 111.7 359.0 188.1 
Total revenues$744.0 $783.8 $2,255.2 $2,399.5 
In the fourth quarter of 2022, the Company revised the internal allocation of certain global costs primarily between the North America segment and Corporate to better align costs that impact the Company as a whole. Prior periods have been revised to align with the current period presentation. The following table sets forth Adjusted EBITDA by segment and the reconciliations to (Loss) income before income taxes for the three and nine months ended October 1, 2023 and October 2, 2022:
Three Months EndedNine Months Ended
(In millions)October 1, 2023October 2, 2022October 1, 2023October 2, 2022
North America$253.4 $293.5 $708.1 $1,246.1 
EMEA10.2 17.2 22.7 33.4 
China37.3 45.0 96.0 84.2 
Other31.2 29.8 89.3 64.1 
Total segment Adjusted EBITDA332.1 385.5 916.1 1,427.8 
Corporate (1)
(162.9)(158.7)(388.3)(341.9)
Interest expense, net(37.7)(29.7)(110.9)(41.0)
Depreciation and amortization(113.1)(104.2)(341.8)(167.0)
Acquisition and integration costs(26.5)(26.4)(80.4)(109.6)
Amortization of deferred cloud computing
   implementation costs
(2.8)(1.6)(5.9)(3.9)
Impairment of long-lived assets(2.2)— (3.2)— 
Loss on investments(1.0)— (1.2)(0.8)
EU medical device regulation transition costs (2)
(0.4)(0.6)(1.9)(1.0)
Unwind inventory fair value adjustment— (35.4)— (46.6)
Employee compensation charges— (1.0)— (1.5)
Loss on extinguishment of debt— — — (24.0)
Derivative mark-to-market gain— 3.4 — 4.4 
Tax indemnification income0.1 0.3 0.2 0.3 
Other adjustments(1.1)(0.3)(2.6)(0.4)
(Loss) income before income taxes$(15.5)$31.3 $(19.9)$694.8 
(1) Primarily consists of costs related to executive and staff functions, including certain finance, human resources, manufacturing and information technology (“IT”) functions, which benefit the Company as a whole. These costs are primarily related to the general management of these functions on a corporate level and the design and development of programs, policies and procedures that are then implemented in the individual segments, with each segment bearing its own cost of implementation. The Company’s corporate function also includes debt and stock-based compensation associated with all employee stock-based awards.
(2) Represents incremental consulting costs and research and development (“R&D”) manufacturing site costs to align compliance of the Company’s existing, on-market products that were previously registered under the European In Vitro Diagnostics Directive regulatory framework with the requirements under the EU’s In Vitro Diagnostic Regulation, which generally apply from May 2022 onwards.
13

The chief operating decision maker does not review capital expenditures, total depreciation and amortization or assets by segment, and therefore this information has been excluded as it does not comprise part of management’s key performance metrics.
Note 6. Income Taxes
The Company calculates its interim income tax provision in accordance with ASC 270, Interim Reporting, and ASC 740, Accounting for Income Taxes. At the end of each interim period, the Company estimates its annual effective tax rate and applies that rate to its ordinary quarterly earnings to calculate the tax related to ordinary income. The tax effects for other items that are excluded from ordinary income are discretely calculated and recognized in the period in which they occur.
For the three months ended October 1, 2023, the Company recognized an income tax benefit of $2.8 million in relation to loss before income taxes of $15.5 million, resulting in an effective benefit tax rate of 18.1%. For the three months ended October 2, 2022, the Company recognized a provision for income taxes of $12.1 million in relation to income before income taxes of $31.3 million, resulting in an effective tax rate of 38.7%. For the three months ended October 1, 2023, the effective tax rate differed from the U.S. federal statutory rate primarily due to operating losses in certain subsidiaries not being benefited due to the establishment of valuation allowances and Global Intangible Low-Tax Income, partially offset by non-U.S. earnings being taxed at rates that are different than the U.S. statutory rate, R&D credits, foreign tax credits and foreign exchange losses. For the three months ended October 2, 2022, the effective tax rate was impacted primarily by income taxes owed in certain U.S. states.
For the nine months ended October 1, 2023, the Company recognized an income tax benefit of $2.8 million in relation to loss before income taxes of $19.9 million, resulting in an effective benefit tax rate of 14.1%. For the nine months ended October 2, 2022, the Company recognized a provision for income taxes of $176.4 million in relation to income before income taxes of $694.8 million, resulting in an effective tax rate of 25.4%. For the nine months ended October 1, 2023, the effective tax rate differed from the U.S. federal statutory rate primarily due to net operating losses in certain subsidiaries not being benefited due to the establishment of valuation allowances and Global Intangible Low-Tax Income, partially offset by non-U.S. earnings being taxed at rates that are different than the U.S. statutory rate, R&D credits, foreign tax credits and foreign exchange losses. For the nine months ended October 2, 2022, the effective tax rate was primarily impacted by incomes taxes owed in certain U.S. states.
The balance of unrecognized tax benefits at October 1, 2023, not including interest and penalties, was $38.7 million, of which $27.5 million could affect the effective income tax rate in future periods, if recognized. The Company also recognizes interest and penalties related to unrecognized tax benefits in tax expense. At October 1, 2023, the Company had approximately $8.5 million of interest and penalties accrued related to unrecognized tax benefits. The Company estimates that within the next 12 months, its uncertain tax positions, excluding interest, will decrease by $14.2 million.
The Company is subject to periodic audits by domestic and foreign tax authorities. Due to the carryforward of unutilized credits, the Company’s federal tax years from 2012 and onwards are subject to examination by the U.S. authorities. The Company’s state and foreign tax years for 2001 and onwards are subject to examination by applicable tax authorities. The Company believes that it has appropriate support for the income tax positions taken on its tax returns and that its accruals for tax liabilities are adequate for all open years based on an assessment of many factors, including past experience and interpretations of tax laws applied to the facts of each matter.
Indemnification Assets
On January 16, 2014, Ortho entered into a stock and asset purchase agreement of (i) certain assets and liabilities and (ii) all of the equity interests and substantially all of the assets and liabilities of certain entities, which, together with their subsidiaries, comprised the Ortho business from Johnson & Johnson. The agreement generally provided that Johnson & Johnson retained all income tax liabilities accrued as of the date of the acquisition, including reserves for unrecognized tax benefits. The indemnification receivable from Johnson & Johnson totaled $16.4 million and $16.8 million as of October 1, 2023 and January 1, 2023, respectively, and is included as a component of Prepaid expenses and other current assets and Other assets on the Consolidated Balance Sheets. The Company recorded $0.3 million and $1.0 million of interest and penalties during the three and nine months ended October 1, 2023, respectively, and $0.3 million and $0.4 million during the three and nine months ended October 2, 2022, respectively.
14

Note 7. Balance Sheet Account Details
Cash, Cash Equivalents and Restricted Cash
(In millions)October 1, 2023January 1, 2023
Cash and cash equivalents$149.3 $292.9 
Restricted cash included in Other assets0.6 1.0 
Cash, cash equivalents and restricted cash$149.9 $293.9 
Marketable Securities
The following table is a summary of marketable securities:
October 1, 2023January 1, 2023
(In millions)Amortized CostGross Unrealized LossesFair ValueAmortized CostGross Unrealized LossesFair Value
Corporate bonds$32.8 $(0.2)$32.6 $40.5 $(0.5)$40.0 
Corporate asset-backed securities7.8 — 7.8 6.7 — 6.7 
U.S. government securities— — — 2.0 — 2.0 
Agency bonds1.5 — 1.5 1.0 — 1.0 
Sovereign government bonds2.0 — 2.0 1.9 — 1.9 
Foreign and other— — — 0.5 — 0.5 
Total marketable securities, current44.1 (0.2)43.9 52.6 (0.5)52.1 
Corporate bonds, non-current8.8 (0.1)8.7 13.3 (0.1)13.2 
Corporate asset-backed securities, non-current3.2 — 3.2 7.9 (0.1)7.8 
Agency bonds, non-current— — — — — — 
Total marketable securities$56.1 $(0.3)$55.8 $73.8 $(0.7)$73.1 
Accounts Receivable, Net
Accounts receivables primarily consisted of trade accounts receivables with maturities of one year or less and are presented net of reserves:
(In millions)October 1, 2023January 1, 2023
Accounts receivable$419.1 $543.0 
Allowance for contract rebates and discounts(75.2)(77.1)
Allowance for doubtful accounts(12.7)(12.0)
Total accounts receivable, net$331.2 $453.9 
15

Inventories
Inventories are stated at the lower of cost (first-in, first-out) or net realizable value. Inventories consisted of the following:
(In millions)October 1, 2023January 1, 2023
Raw materials$197.9 $185.2 
Work-in-process (materials, labor and overhead)104.7 82.7 
Finished goods (materials, labor and overhead)295.5 295.1 
Total inventories (1)
$598.1 $563.0 
Inventories$551.7 $524.1 
Other assets (2)
46.4 38.9 
Total inventories$598.1 $563.0 
(1) Includes adjustment of approximately $39 million in the nine months ended October 1, 2023 due to changes in estimates to decrease inventory obsolescence reserves from the prior period.
(2) Other assets includes inventory expected to remain on hand beyond one year.
Prepaid Expenses and Other Current Assets
Prepaid expenses and other current assets consisted of the following:
(In millions)October 1, 2023January 1, 2023
Income taxes and other tax receivables$93.1 $38.6 
Prepaid expenses92.2 96.7 
Contract assets53.5 49.6 
Other receivables42.4 44.3 
Derivatives10.9 22.0 
Other3.1 0.9 
Total prepaid expenses and other current assets$295.2 $252.1 
Goodwill
Changes in goodwill were as follows:
(In millions)North AmericaEMEAChinaOtherTotal
Balance at January 1, 2023$1,547.7 $358.6 $118.1 $452.4 $2,476.8 
Purchase accounting adjustments(13.4)(4.1)(1.3)(5.1)(23.9)
Foreign currency translation(0.1)(4.1)(6.4)0.6 (10.0)
Balance at October 1, 2023$1,534.2 $350.4 $110.4 $447.9 $2,442.9 
16

Other Current Liabilities
Other current liabilities consisted of the following:
(In millions)October 1, 2023January 1, 2023
Accrued commissions, rebates and returns$51.5 $57.5 
Accrued other taxes payable39.7 9.3 
Deferred revenue34.6 76.4 
Accrued interest32.2 1.4 
Operating lease liabilities26.3 24.4 
Derivatives6.7 19.7 
Deferred consideration— 39.3 
Other114.4 97.4 
Total other current liabilities$305.4 $325.4 
Note 8. Borrowings
The components of borrowings were as follows:
(In millions)October 1, 2023January 1, 2023
Term Loan$2,472.2 $2,646.9 
Financing lease obligation 0.5 0.8 
Other short-term borrowings2.9 — 
Other long-term borrowings0.7 1.2 
Unamortized deferred financing costs(8.7)(10.6)
Total borrowings2,467.6 2,638.3 
Less: current portion(193.0)(207.5)
Long-term borrowings$2,274.6 $2,430.8 
The credit agreement, dated May 27, 2022, by and among the Company, as borrower, Bank of America, N.A., as administrative agent and swing line lender, and the other lenders and L/C issuers party thereto (the “Credit Agreement”) consists of a $2,750.0 million senior secured term loan facility (the “Term Loan”) and an $800.0 million revolving credit facility (the “Revolving Credit Facility” and with the Term Loan, the “Financing”). As of October 1, 2023 and January 1, 2023, there were no amounts outstanding under the Revolving Credit Facility. As of October 1, 2023, letters of credit issued under the Revolving Credit Facility totaled $12.9 million, which reduced the available amount under the Revolving Credit Facility to $787.1 million. During the nine months ended October 1, 2023, the Company made $174.7 million in payments on the Term Loan, including a voluntary prepayment of $20.0 million.
The Credit Agreement contains affirmative and negative covenants that are customary for credit agreements of this nature. The negative covenants include, among other things, limitations on asset sales, mergers, indebtedness, liens, investments and transactions with affiliates. The Credit Agreement contains two financial covenants: (i) a maximum Consolidated Leverage Ratio (as defined in the Credit Agreement) as of the last day of each fiscal quarter of (a) 4.50 to 1.00 for the first four fiscal quarters ending after the closing date of the Credit Agreement (the “Initial Measurement Period”), (b) 4.00 to 1.00 for the first four fiscal quarters ending after the Initial Measurement Period and (c) 3.50 to 1.00 for each fiscal quarter thereafter; and (ii) a minimum Consolidated Interest Coverage Ratio (as defined in the Credit Agreement) of 3.00 to 1.00 as of the end of any fiscal quarter for the most recently completed four fiscal quarters. The Company was in compliance with the financial covenants as of October 1, 2023.
17

The following table provides the detailed amounts within Interest expense, net for the three and nine months ended October 1, 2023 and October 2, 2022:
Three Months EndedNine Months Ended
(In millions)October 1, 2023October 2, 2022October 1, 2023October 2, 2022
Term Loan$45.7 $27.9 $130.8 $36.3 
Revolving Credit Facility0.9 0.6 1.9 1.0 
Amortization of deferred financing costs0.9 0.9 2.5 1.2 
Derivative instruments and other(8.5)0.6 (20.2)3.5 
Interest income(1.3)(0.3)(4.1)(1.0)
Interest expense, net$37.7 $29.7 $110.9 $41.0 
Note 9. Stock-based Compensation
Stock-based compensation expense was as follows:
Three Months EndedNine Months Ended
(In millions)October 1, 2023October 2, 2022October 1, 2023October 2, 2022
Cost of sales$1.2 $0.8 $3.3 $2.0 
Research and development1.6 1.3 4.2 3.8 
Selling, marketing and administrative
10.3 7.2 27.5 20.5 
Acquisition and integration costs4.0 6.9 13.1 24.2 
Total stock-based compensation expense$17.1 $16.2 $48.1 $50.5 
The table above includes compensation expense related to liability-classified awards of $3.0 million and $8.8 million for the three and nine months ended October 1, 2023, respectively, and $3.0 million and $13.9 million for the three and nine months ended October 2, 2022, respectively, which has been or is expected to be settled in cash. These awards primarily represent the $7.14 per share cash-settled portion of the replacement awards issued in connection with the Combinations.
The Company granted 253 thousand stock options during the nine months ended October 1, 2023. As of October 1, 2023, total unrecognized compensation expense related to stock options was approximately $20.0 million and the related weighted-average period over which it is expected to be recognized is approximately 2.0 years. The maximum contractual term of the Company’s stock options is ten years.
The estimated fair value of each stock option was determined on the date of grant using the Black-Scholes option valuation model with the following weighted-average assumptions for the option grants:
Nine Months Ended
October 1, 2023October 2, 2022
Risk-free interest rate3.52 %1.99 %
Expected option life (in years)5.534.89
Volatility rate57 %58 %
Dividend rate0 %0 %
Weighted-average grant date fair value$48.17$50.86
In January 2023, the Compensation Committee of the Company’s Board of Directors approved a modification to the vesting terms of certain stock options that were previously granted by Ortho to certain Ortho employees, such that the stock options will vest on December 31, 2023. The modification resulted in an additional $2.9 million and $8.0 million of stock-based compensation expense recognized during the three and nine months ended October 1, 2023, respectively. The total unrecognized expense relating to unvested shares for these stock options as of October 1, 2023 was $3.1 million and will be recognized through December 31, 2023.
18

The Company granted 609 thousand RSUs during the nine months ended October 1, 2023. The fair value of RSUs is determined based on the closing market price of the Company’s common stock on the grant date. The weighted-average fair value of RSUs granted during the nine months ended October 1, 2023 and October 2, 2022 was $87.14 and $97.52, respectively. The total amount of unrecognized compensation expense related to non-vested RSUs as of October 1, 2023 was approximately $78.4 million, which is expected to be recognized over a weighted-average period of approximately 2.2 years.
Note 10. Commitments and Contingencies
From time to time, the Company is involved in litigation and other legal proceedings, including matters related to product liability claims, commercial disputes and intellectual property claims, as well as regulatory, employment, and other claims related to its business. The Company accrues for legal claims when, and to the extent that, amounts associated with the claims become probable and are reasonably estimable. If the reasonable estimate of a known or probable loss is a range, and no amount within the range is a better estimate than any other, the minimum amount of the range is accrued. When determining the estimated loss or range of loss, significant judgment is required to estimate the amount and timing of a loss to be recorded. Estimates of probable losses resulting from these matters are inherently difficult to predict. The actual costs of resolving legal claims may be substantially higher or lower than the amounts accrued for those claims. For those matters as to which the Company is not able to estimate a possible loss or range of loss, the Company is not able to determine whether the loss will have a material adverse effect on its business, financial condition, results of operations or liquidity.
Management believes that all such current legal actions, in the aggregate, are not expected to have a material adverse effect on the Company. However, the resolution of, or increase in any accruals for, one or more matters may have a material adverse effect on the Company’s results of operations and cash flows.
Note 11. Fair Value Measurements
The following table presents the Company’s hierarchy for its assets and liabilities measured at fair value on a recurring basis as of the following periods:
 October 1, 2023January 1, 2023
(In millions)Level 1Level 2Level 3TotalLevel 1Level 2Level 3Total
Assets:
Cash equivalents$2.0 $— $— $2.0 $0.6 $2.1 $— $2.7 
Marketable securities— 55.8 — 55.8 2.0 71.1 — 73.1 
Derivative assets— 49.9 — 49.9 — 22.0 — 22.0 
Total assets measured at fair value$2.0 $105.7 $— $107.7 $2.6 $95.2 $— $97.8 
Liabilities:
Derivative liabilities$— $6.7 $— $6.7 $— $21.8 $— $21.8 
Contingent consideration— — 0.1 0.1 — — 0.1 0.1 
Deferred consideration— — — — — 39.3 — 39.3 
Total liabilities measured at fair value$— $6.7 $0.1 $6.8 $— $61.1 $0.1 $61.2 
There were no transfers of assets or liabilities into or out of Level 3 of the fair value hierarchy during the three and nine months ended October 1, 2023 and fiscal year 2022.
Cash equivalents consist of funds held in money market accounts that are valued using quoted prices in active markets for identical instruments and highly liquid corporate debt securities with maturities within three months from purchase. Marketable securities consist of investment-grade corporate and government debt securities, corporate asset-backed securities and commercial paper. Derivative financial instruments are based on observable inputs that are corroborated by market data. Observable inputs include broker quotes, daily market foreign currency rates and forward pricing curves.
In connection with the acquisition of the B-type Natriuretic Peptide assay business run on Beckman Coulter analyzers from Alere Inc., the Company paid its last annual installment of $40.0 million during the nine months ended October 1, 2023.
Financial Instruments Not Measured at Fair Value
The estimated fair value of the Company’s borrowings under the Term Loan was $2,444.4 million at October 1, 2023, compared to the carrying amount, excluding debt issuance costs, of $2,472.2 million. The estimated fair value of the Company’s borrowings under the Term Loan was $2,630.3 million at January 1, 2023, compared to the carrying amount,
19

excluding debt issuance costs, of $2,646.9 million. The estimate of fair value is generally based on the quoted market prices for similar issuances of long-term debt with the same maturities, which is classified as a Level 2 input.
Note 12. Derivative Instruments and Hedging Activities
The Company selectively uses derivative and non-derivative instruments to manage market risk associated with changes in interest rates and foreign currency exchange rates. The use of derivatives is intended for hedging purposes only, and the Company does not enter into derivative transactions for speculative purposes.
Credit risk represents the Company’s gross exposure to potential accounting loss on derivative instruments that are outstanding or unsettled if all counterparties failed to perform according to the terms of the contract. The Company generally enters into master netting arrangements that reduce credit risk by permitting net settlement of transactions with the same counterparty. The Company does not have any derivative instruments with credit-risk related contingent features that would require it to post collateral.
Interest Rate Hedging Instruments
The Company’s interest rate risk relates primarily to interest rate exposures on variable rate debt, including the Revolving Credit Facility and Term Loan. See Note 8 for additional information on the currently outstanding components of the Revolving Credit Facility and Term Loan. The Company entered into interest rate swap agreements to hedge the related risk of the variability to the Company’s cash flows due to the rates specified for these credit facilities.
The Company designates its interest rate swaps as cash flow hedges. The Company records gains and losses due to changes in fair value of the derivatives within Other comprehensive (loss) income (“OCI”) and reclassifies these amounts to Interest expense, net in the same period or periods for which the underlying hedged transaction affects earnings. In the event the Company determines the hedged transaction is no longer probable to occur or concludes the hedge relationship is no longer effective, the hedge is prospectively de-designated. Pre-tax unrealized gains of $29.0 million as of October 1, 2023 are expected to be reclassified from OCI to earnings in the next 12 months.
The following table summarizes the Company’s interest rate derivative agreements as of October 1, 2023, all of which were interest rate swaps:
Notional Amount
(In millions) (1)
DescriptionHedge DesignationEffective DateExpiration Date
$500.0 
Pay 1.58% fixed, receive floating rate
(1-month USD-SOFR)
Designated cash flow hedgeMay 29, 2022December 31, 2023
$397.2 
Pay 3.765% fixed, receive floating rate
(1-month USD-SOFR)
Designated cash flow hedgeDecember 30, 2022May 27, 2027
$144.4 
Pay 3.7725% fixed, receive floating rate
(1-month USD-SOFR)
Designated cash flow hedgeDecember 30, 2022May 27, 2027
$216.7 
Pay 3.7675% fixed, receive floating rate
(1-month USD-SOFR)
Designated cash flow hedgeDecember 30, 2022May 27, 2027
$288.9 
Pay 3.7575% fixed, receive floating rate
(1-month USD-SOFR)
Designated cash flow hedgeDecember 30, 2022May 27, 2027
$252.8 
Pay 3.7725% fixed, receive floating rate
(1-month USD-SOFR)
Designated cash flow hedgeDecember 30, 2022May 27, 2027
(1) The notional value of interest rate swap contracts with an effective date of December 30, 2022 is expected to increase to $1.8 billion on December 29, 2023.
Currency Hedging Instruments
The Company has currency risk exposures relating primarily to foreign currency denominated monetary assets and liabilities and forecasted foreign currency denominated intercompany and third-party transactions. The Company uses foreign currency forward contracts and may use option contracts and cross currency swaps to manage its currency risk exposures. The Company’s foreign currency forward contracts are denominated primarily in Australian Dollar, Brazilian Real, British Pound, Canadian Dollar, Chilean Peso, Chinese Yuan/Renminbi, Colombian Peso, Euro, Indian Rupee, Japanese Yen, Mexican Peso, Philippine Peso, South Korean Won, Swiss Franc and the Thai Baht.
The Company designates certain foreign currency forward contracts as cash flow hedges. The Company records gains and losses due to changes in fair value of the derivatives within OCI and reclassifies these amounts to Total revenues and Cost of sales, excluding amortization of intangibles in the same period or periods for which the underlying hedged transaction affects
20

earnings. In the event the Company determines the hedged transaction is no longer probable to occur or concludes the hedge relationship is no longer effective, the hedge is prospectively de-designated. Pre-tax unrealized loss of $2.0 million as of October 1, 2023 is expected to be reclassified from OCI to earnings in the next 12 months.
The Company also enters into foreign currency forward contracts that are not part of designated hedging relationships and which are intended to mitigate exchange rate risk of monetary assets and liabilities and related forecasted transactions. The Company records these non-designated derivatives at mark-to-market with gains and losses recognized in earnings within Other expense (income), net.
The following table provides details of the currency hedging instruments outstanding as of October 1, 2023:
DescriptionNotional Amount
(In millions)		Hedge Designation
Foreign currency forward contracts$127.0 Cash Flow Hedge
Foreign currency forward contracts$616.9 Non-designated
The following table summarizes pre-tax gains and losses from designated derivative and non-derivative instruments within Accumulated other comprehensive (loss) income (“AOCI”) for the three and nine months ended October 1, 2023 and October 2, 2022:
Designated Hedging Instruments
(In millions)Amount of Loss (Gain) Recognized in OCI on HedgesLocation of Amounts Reclassified From AOCI Into IncomeAmount of Loss (Gain) Reclassified From AOCI Into Income
Three Months Ended October 1, 2023
Foreign currency forward contracts (sales)$(1.0)Total revenues$1.8 
Foreign currency forward contracts (purchases)$(0.1)Cost of sales, excluding amortization of intangibles$0.4 
Interest rate derivatives$(28.0)Interest expense, net$(8.5)
Nine Months Ended October 1, 2023
Foreign currency forward contracts (sales)$0.7 Total revenues$2.7 
Foreign currency forward contracts (purchases)$(2.2)Cost of sales, excluding amortization of intangibles$2.1 
Interest rate derivatives$(54.1)Interest expense, net$(21.1)
Three Months Ended October 2, 2022
Foreign currency forward contracts (sales)$(2.6)Total revenues$(0.7)
Foreign currency forward contracts (purchases)$(0.6)Cost of sales, excluding amortization of intangibles$(0.1)
Interest rate derivatives$(7.9)Interest expense, net$0.4 
Nine Months Ended October 2, 2022
Foreign currency forward contracts (sales)$(5.0)Total revenues$(0.9)
Foreign currency forward contracts (purchases)$(0.8)Cost of sales, excluding amortization of intangibles$(0.1)
Interest rate derivatives$(11.0)Interest expense, net$1.7 
Fair value (gains) and losses on foreign currency forward contracts, as determined using Level 2 inputs, that do not qualify for hedge accounting treatment are recorded in Other expense (income), net. Fair value losses were $0.2 million for the three months ended October 1, 2023 and fair value gains were $0.3 million for the nine months ended October 1, 2023. Fair value losses on foreign currency forward contracts, as determined using Level 2 inputs, that do not qualify for hedge accounting treatment are recorded in Other expense (income), net and were $2.7 million and $3.0 million for the three and nine months ended October 2, 2022, respectively.
21

Fair value gains on interest rate derivatives, as determined using Level 2 inputs, that do not qualify for hedge accounting treatment are recorded in Other expense (income), net and were $3.4 million and $4.4 million for the three and nine months ended October 2, 2022, respectively.
The following table summarizes the fair value of designated and non-designated hedging instruments recognized within the Consolidated Balance Sheets as of October 1, 2023 and January 1, 2023:
(In millions)October 1, 2023January 1, 2023
Designated cash flow hedges
Interest rate derivatives:
Prepaid expenses and other current assets$4.9 $15.9 
Other assets$39.0 $— 
Other liabilities$— $2.1 
Foreign currency forward contracts:
Prepaid expenses and other current assets$2.1 $4.6 
Other current liabilities$3.4 $14.3 
Non-designated hedging instruments
Foreign currency forward contracts:
Prepaid expenses and other current assets$3.9 $1.5 
Other current liabilities$3.3 $5.4 
Note 13. Related Party Transactions
Quotient Limited
As a result of the consummation of the Combinations, the Company acquired Ortho’s Letter Agreement (the “Letter Agreement”), entered into in September 2020 with Quotient Limited (“Quotient”), in which Ortho partnered with Quotient to commercialize, when approved, Quotient’s next generation product in immunohematology, a transfusion diagnostic patient immunohematology microarray intended for use with Quotient’s MosaiQ® instruments. Under the Letter Agreement, the Company was required to make certain milestone payments to Quotient as specified milestones and benchmarks were achieved. Quotient subsequently revised its business strategy to pause development and commercialization of its MosaiQ testing solutions in immunohematology and infectious disease immunoassay screening. On January 10, 2023, Quotient filed a voluntary petition for relief under Chapter 11 of Title 11 of the United States Code in the United States Bankruptcy Court for the Southern District of Texas (the “Bankruptcy Proceeding”). Following the completion of the Bankruptcy Proceeding, the Company’s equity interests in Quotient were canceled for no consideration. Quotient is no longer considered a related party of the Company.
22

Note 14. Accumulated Other Comprehensive Loss
The following table summarizes the changes in Accumulated other comprehensive loss by component:
Three Months Ended October 1, 2023
(In millions)Pension and Other Post-
Employment Benefits		Cash Flow HedgesAvailable-for-Sale InvestmentsUnrealized Foreign Currency Translation AdjustmentsAccumulated Other Comprehensive (Loss) Income
Balance at July 2, 2023$0.7 $14.6 $(0.4)$(31.2)$(16.3)
Current period deferrals (1)
— 24.5 0.2 (55.3)(30.6)
Amounts reclassified to net income— (6.3)— — (6.3)
Net change— 18.2 0.2 (55.3)(36.9)
Balance at October 1, 2023$0.7 $32.8 $(0.2)$(86.5)$(53.2)
Nine Months Ended October 1, 2023
Pension and Other Post-
Employment Benefits		Cash Flow HedgesAvailable-for-Sale InvestmentsUnrealized Foreign Currency Translation AdjustmentsAccumulated Other Comprehensive (Loss) Income
Balance at January 1, 2023$0.7 $1.5 $(0.5)$(69.3)$(67.6)
Current period deferrals (1)
— 47.6 0.3 (17.2)30.7 
Amounts reclassified to net income— (16.3)— — (16.3)
Net change— 31.3 0.3 (17.2)14.4 
Balance at October 1, 2023$0.7 $32.8 $(0.2)$(86.5)$(53.2)
Three Months Ended October 2, 2022
(In millions)Cash Flow HedgesAvailable-for-Sale InvestmentsUnrealized Foreign Currency Translation AdjustmentsAccumulated Other Comprehensive Income (Loss)
Balance at July 3, 2022$5.5 $(0.7)$(65.5)$(60.7)
Current period deferrals (2)
9.3 — (92.9)(83.6)
Amounts reclassified to net income(0.2)— — (0.2)
Net change9.1 — (92.9)(83.8)
Balance at October 2, 2022$14.6 $(0.7)$(158.4)$(144.5)
Nine Months Ended October 2, 2022
Cash Flow HedgesAvailable-for-Sale InvestmentsUnrealized Foreign Currency Translation AdjustmentsAccumulated Other Comprehensive Income (Loss)
Balance at January 2, 2022$— $(0.1)$0.5 $0.4 
Current period deferrals (2)
13.9 (0.6)(158.9)(145.6)
Amounts reclassified to net income0.7 — — 0.7 
Net change14.6 (0.6)(158.9)(144.9)
Balance at October 2, 2022$14.6 $(0.7)$(158.4)$(144.5)
(1) Includes tax impact of $4.6 million and $8.0 million related to cash flow hedges for the three and nine months ended October 1, 2023, respectively.
(2) Includes tax impact of $1.7 million and $2.8 million related to cash flow hedges for the three and nine months ended October 2, 2022, respectively.
23

ITEM 2.    Management’s Discussion and Analysis of Financial Condition and Results of Operations
In this Quarterly Report on Form 10-Q (the “Quarterly Report”), all references to “we,” “our” and “us” refer to QuidelOrtho Corporation and its subsidiaries.
Future Uncertainties and Forward-Looking Statements
This Quarterly Report contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). These statements include any statement contained herein that is not strictly historical, including, but not limited to, certain statements under Part I, Item 2, “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and located elsewhere herein regarding our commercial and other strategic goals, industry prospects, our expected results of operations or financial position, and future plans, objectives, strategies, expectations and intentions. Without limiting the foregoing, the words “may,” “will,” “would,” “should,” “might,” “expect,” “anticipate,” “believe,” “estimate,” “plan,” “intend,” “goal,” “project,” “strategy,” “future,” “continue” or similar words, expressions or the negative of such terms or other comparable terminology are intended to identify forward-looking statements. Such statements are based on the beliefs and expectations of our management as of the date of this Quarterly Report and are subject to significant known and unknown risks and uncertainties. Actual results or outcomes may differ significantly from those set forth or implied in the forward-looking statements. The following factors, among others, could cause actual results to differ from those set forth or implied in the forward-looking statements: the challenges and costs of integrating, restructuring and achieving anticipated synergies as a result of the Combinations (as defined in this Quarterly Report); supply chain, production, logistics, distribution and labor disruptions and challenges; and other macroeconomic, geopolitical, market, business, competitive and/or regulatory factors affecting our business generally, including those discussed under Part II, Item 1A, “Risk Factors” of this Quarterly Report and Part I, Item 1A, “Risk Factors” of our Annual Report on Form 10-K for the fiscal year ended January 1, 2023. Investors should not rely on forward-looking statements as predictions of future events because these statements are based on assumptions that may not come true and are speculative by their nature. All forward-looking statements are based on information currently available to us and speak only as of the date of this Quarterly Report. We undertake no obligation to update any of the forward-looking information or time-sensitive information included in this Quarterly Report, whether as a result of new information, future events, changed expectations or otherwise, except as required by law.
Information Available on Our Website
This Quarterly Report and each of our other periodic and current reports, including any amendments thereto, are available, free of charge, on our website, www.quidelortho.com, as soon as reasonably practicable after such material is electronically filed with or furnished to the Securities and Exchange Commission (the “SEC”). From time to time, we may use our website as a channel of distribution of material information related to the Company. Financial and other material information regarding the Company is routinely posted on and accessible at https://ir.quidelortho.com/. The information contained on or connected to our website is provided for convenience and is not deemed to be incorporated by reference into this Quarterly Report or filed with or furnished to the SEC and should not be considered part of this Quarterly Report.
Overview
Our vision is to advance diagnostics to power a healthier future. With our expertise in immunoassay and molecular testing, clinical chemistry and transfusion medicine, we aim to provide clarity to clinicians and patients to help create better health outcomes. Our global infrastructure and commercial reach support our customers across more than 130 countries and territories with quality diagnostics, a broad test portfolio and market-leading service. We operate globally with manufacturing facilities in the U.S. and U.K. and with sales centers, administrative offices and warehouses located throughout the world.
We currently sell our products directly to end users through a direct sales force and through a network of distributors, for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, leading universities, retail clinics, pharmacies, wellness screening centers, other point-of-care settings, blood banks and donor centers, as well as for individual, non-professional, over-the-counter use. We reached new markets as we introduced our QuickVue At-Home OTC COVID-19 test for at-home consumer use, school districts, health departments and many other locations.
We manage our business geographically to better align with the market dynamics of the specific geographic regions in which we operate, with our reportable segments being North America; Europe, the Middle East and Africa (“EMEA”); and China. Latin America, Japan and Asia Pacific are immaterial operating segments that are not considered reportable segments and are included in “Other.” We generate our revenue primarily in the following business units: Labs, Transfusion Medicine, Point of Care and Molecular Diagnostics.
24

On May 27, 2022, pursuant to the BCA, Quidel and Ortho consummated the Combinations and each of Quidel and Ortho became a wholly owned subsidiary of QuidelOrtho. For additional information about the Combinations, see Note 2 to the Consolidated Financial Statements.
For the nine months ended October 1, 2023, Total revenues decreased by 6% to $2,255.2 million as compared to the same period in the prior year. Currency exchange rates had a favorable impact of 100 basis points on our growth rate. Our revenues can be highly concentrated over a small number of products, including certain of our respiratory products. For the nine months ended October 1, 2023 and October 2, 2022, revenues related to our respiratory products accounted for approximately 24% and 63% of our Total revenues, respectively, primarily driven by sales of our COVID-19 products. For the nine months ended October 1, 2023, no customers individually accounted for more than 10% of our Total revenues. For the nine months ended October 2, 2022, one customer and one distributor each represented 10% or more of our Total revenues.
COVID-19 Pandemic
The healthcare challenge and other impacts surrounding the SARS-CoV-2 virus that emerged in late 2019 and the global pandemic that followed presented significant business uncertainty and had a dramatic impact on businesses globally, including ours. On April 10, 2023, H.J.Res. 7 was signed into law, which ended the national emergency in the U.S. related to the COVID-19 pandemic. As the COVID-19 pandemic transitions to an endemic state, the degree to which it will continue to impact our business operations, strategy, financial condition and results of operations depends on future developments that are uncertain and difficult to predict.
Supply Chains
During the last few years, as a result of the COVID-19 pandemic and other macroeconomic and geopolitical conditions—including inflationary pressures, general economic slowdown or a recession, rising interest rates, foreign exchange rate volatility and changes in monetary policy—we have experienced shortages and delays in receiving certain raw materials and other components for our products and have experienced logistics and distribution challenges, as well as challenges in labor availability and rising labor costs, all of which have affected our ability to fulfill customer orders, including instrument placements, on a timely basis. While we have made notable improvements throughout 2023, these supply, production, logistics, distribution and labor disruptions and challenges have impacted, and we expect will continue for some period of time to impact, our operations.
Some of our raw materials are available from a limited number of sources. During 2022 and through the third quarter of 2023, we have encountered some increasing pressures on raw material pricing. To mitigate these supply chain challenges, we continue to (i) partner with suppliers to invest in additional capacity and raw material inventory, (ii) diversify our supply base, where possible, to minimize reliance on a single source of supply for key raw materials and components and (iii) create redundancy in our global supply chain. In addition, we routinely evaluate our supply chain for potential gaps and continue to take other steps intended to help address continuity. In our distribution operations, we have been investing in and implementing automation capabilities to help improve accuracy and timeliness of customer shipments.
We continue to monitor these developments, as well as other international developments, including the Russia-Ukraine conflict and localization efforts, and the impact of such factors on our business. We cannot currently predict the frequency, duration or scope of these supply, production, logistics, distribution and labor disruptions and challenges. However, we proactively work with our suppliers, manufacturers, distributors, industry partners and government agencies to address these challenges in our efforts to meet the needs of our customers. Despite our mitigation efforts, such disruptions and challenges have materially affected and could further materially affect our ability to timely manufacture and distribute our products and could unfavorably impact our results of operations depending on the nature and duration of such disruptions and challenges.
Outlook
Our financial performance and results of operations will depend on future developments and other factors that are highly uncertain, continuously evolving and unpredictable, including the occurrence, spread, severity, duration and emergence of new variants of respiratory diseases, including flu, strep, respiratory syncytial virus (“RSV”) and COVID-19, as well as the ongoing supply, production and logistics challenges.
Demand for our respiratory products, which includes our COVID-19 products, declined during the first nine months of 2023 compared to prior periods due to the end of the U.S. public health emergency regarding COVID-19 and the transition of COVID-19 from a pandemic to an endemic environment. For the remainder of the year, we expect demand for our respiratory products to continue to fluctuate and pricing pressures on certain products to persist as a result of a number of factors, including increased supply, emergence and spread of new variants, and the seasonal demands of the cold, flu and RSV seasons, which are typically more prevalent during the fall and winter.
With respect to our core products, excluding respiratory products, we anticipate revenue growth for the remainder of 2023.
25

Because our business environment is highly competitive, our long-term growth and profitability will depend in part on our ability to retain and grow our current customers and attract new customers through developing and delivering new and improved products and services that meet our customers’ needs and expectations, including with respect to product performance, product offerings, cost, automation and other work-flow efficiency. As a result, we expect to continue to maintain our emphasis on R&D investments for longer term growth, including for our next generation platforms and assays, as well as additional assays to be launched on our current platforms. In addition, we expect to continue to evaluate strategic opportunities to expand our product lines and services, production capabilities, technologies and geographic footprint and address other business challenges and opportunities.
While we expect the revenues and financial results from our respiratory products to be affected by the seasonal demands of the cold, flu and RSV seasons, we intend to continue our focus on prudently managing our business and delivering improved financial results, while at the same time striving to introduce new products and services into the market.
Results of Operations
Revenues
The following table compares Total revenues by business unit for the three and nine months ended October 1, 2023 and October 2, 2022:
Three Months EndedNine Months Ended
(Dollars in millions)October 1, 2023October 2, 2022% ChangeOctober 1, 2023October 2, 2022% Change
Labs$341.4 $334.8 2 %$1,073.5 $505.5 112 %
Transfusion Medicine163.9 163.1 — %483.1 231.3 109 %
Point of Care233.1 270.5 (14)%675.4 1,580.6 (57)%
Molecular Diagnostics5.6 15.4 (64)%23.2 82.1 (72)%
Total revenues$744.0 $783.8 (5)%$2,255.2 $2,399.5 (6)%
For the three months ended October 1, 2023, Total revenues decreased to $744.0 million from $783.8 million for the same period in the prior year. Labs and Transfusion Medicine revenue increased 1% compared to the prior year. The decrease in Point of Care revenue of $37.4 million was driven primarily by lower demand for QuickVue SARS Antigen assays, partially offset by an increase in sales of Sofia SARS Antigen assays. Molecular Diagnostics sales decreased by $9.8 million, primarily driven by decreased demand for the Lyra SARS Antigen assay. Currency exchange rates did not significantly impact the growth rate for the three months ended October 1, 2023.
For the nine months ended October 1, 2023, Total revenues decreased to $2,255.2 million from $2,399.5 million for the same period in the prior year. The increases in Labs and Transfusion Medicine revenue were primarily related to incremental revenues from the Combinations. Additionally, the increase in Labs revenue also included a $19.2 million settlement award from a third party related to one of our collaboration agreements. The Point of Care business unit contributed to revenue decline, driven by decreases of $783.0 million in sales of QuickVue SARS Antigen assays and $121.2 million in sales of Sofia SARS Antigen assays. Molecular Diagnostics sales decreased by $58.9 million, driven primarily by lower demand for the Lyra SARS Antigen assay. Currency exchange rates had a favorable impact of approximately 100 basis points on the growth rate for the nine months ended October 1, 2023.
Cost of Sales, Excluding Amortization of Intangible Assets
Cost of sales, excluding amortization of intangible assets, decreased to $375.9 million, or 50.5% of Total revenues, for the three months ended October 1, 2023, compared to $376.3 million, or 48.0% of Total revenues, for the three months ended October 2, 2022. Cost of sales, excluding amortization of intangible assets, was impacted by revenue decline and a shift in product mix. During the three months ended October 2, 2022, we recorded $35.4 million of expense related to the unwind of the inventory fair value adjustment related to the Combinations.
Cost of sales, excluding amortization of intangible assets, increased to $1,142.1 million, or 50.6% of Total revenues, for the nine months ended October 1, 2023, compared to $912.5 million, or 38.0% of Total revenues, for the nine months ended October 2, 2022. The increase in cost of sales, excluding amortization of intangible assets, was driven primarily by incremental revenues in the Labs and Transfusion Medicine business units as a result of the Combinations, partially offset by decreases in sales of QuickVue and Sofia SARS Antigen assays as well as decreases in other indirect manufacturing costs. We also recorded $46.6 million of expense related to the unwind of the inventory fair value adjustment related to the Combinations during the nine months ended October 2, 2022.
26

Operating Expenses
The following table summarizes operating expenses for the three and nine months ended October 1, 2023 and October 2, 2022:
Three Months EndedNine Months Ended
(Dollars in millions)October 1, 2023% of
Total Revenues		October 2, 2022% of
Total Revenues		October 1, 2023% of
Total Revenues		October 2, 2022% of
Total Revenues
Selling, marketing and
   administrative		$194.1 26.1 %$204.2 26.1 %$575.6 25.5 %$407.4 17.0 %
Research and development62.4 8.4 %65.6 8.4 %187.5 8.3 %126.2 5.3 %
Amortization of intangible assets51.4 6.9 %50.5 6.4 %153.6 6.8 %78.6 3.3 %
Acquisition and integration costs26.5 3.6 %26.4 3.4 %80.4 3.6 %109.6 4.6 %
Other operating expense, net7.4 1.0 %4.0 0.5 %17.0 0.8 %8.0 0.3 %
Selling, Marketing and Administrative Expenses
Selling, marketing and administrative expenses for the three months ended October 1, 2023 decreased by $10.1 million, or 4.9%, to $194.1 million from $204.2 million for the same period in the prior year, primarily due to employee compensation costs.
Selling, marketing and administrative expenses for the nine months ended October 1, 2023 increased by $168.2 million, or 41.3%, to $575.6 million from $407.4 million for the same period in the prior year, primarily due to the incremental impact of the Combinations, partially offset by freight expense due to lower sales and shipment volume and employee compensation costs.
Research and Development Expense
Research and development expense for the three months ended October 1, 2023 decreased by $3.2 million, or 4.9%, to $62.4 million from $65.6 million for the same period in the prior year, primarily due to lower costs related to outside services.
Research and development expense for the nine months ended October 1, 2023 increased by $61.3 million, or 48.6%, to $187.5 million from $126.2 million for the same period in the prior year, primarily due to the incremental impact of the Combinations, as well as increased costs related to the development of our Savanna, QuickVue OTC assays and Sofia products.
Amortization of Intangible Assets
Amortization of intangible assets was $51.4 million and $153.6 million for the three and nine months ended October 1, 2023, respectively, and $50.5 million and $78.6 million for the three and nine months ended October 2, 2022, respectively. The increase in amortization expense in the nine months ended October 1, 2023 compared to the prior year period was primarily due to the Combinations.
Acquisition and Integration Costs
Acquisition and integration costs were $26.5 million and $80.4 million for the three and nine months ended October 1, 2023, respectively, and $26.4 million and $109.6 million for the three and nine months ended October 2, 2022, respectively. The decrease in costs in the nine months ended October 1, 2023 compared to the prior year period was primarily due to acquisition costs attributable to the Combinations.
Other Operating Expense, Net
Other operating expense, net was $7.4 million and $17.0 million for the three and nine months ended October 1, 2023, respectively, and $4.0 million and $8.0 million for the three and nine months ended October 2, 2022, respectively. Other operating expense, net was primarily related to the profit share expense for our Joint Business with Grifols, which we acquired in connection with the Combinations.
Non-operating Expenses
Interest Expense, Net
Interest expense, net was $37.7 million and $29.7 million for the three months ended October 1, 2023 and October 2, 2022, respectively. Interest expense, net was $110.9 million and $41.0 million for the nine months ended October 1, 2023 and October 2, 2022, respectively. The increase in interest expense, net in the three and nine months ended October 1, 2023
27

compared to the prior year periods was primarily related to the Term Loan under the Credit Agreement entered into in connection with the Combinations. See Note 8 to the Consolidated Financial Statements for more information related to our Term Loan.
Loss on Extinguishment of Debt
Loss on extinguishment of debt was $24.0 million for the nine months ended October 2, 2022, and was related to the satisfaction and discharge of the senior notes and termination of the former term loans and revolving credit facility of Ortho, which occurred in connection with the consummation of the Combinations.
Other Expense (Income), Net
Other expense (income), net was an expense of $4.1 million and $8.0 million for the three and nine months ended October 1, 2023, respectively, and income of $4.2 million and $2.6 million for the three and nine months ended October 2, 2022, respectively. Other expense (income), net in the three and nine months ended October 1, 2023 and October 2, 2022 was primarily related to net foreign currency losses.
Income Taxes
For the three months ended October 1, 2023, we recognized an income tax benefit of $2.8 million in relation to loss before income taxes of $15.5 million, resulting in an effective benefit tax rate of 18.1%. For the three months ended October 2, 2022, we recognized a provision for income taxes of $12.1 million in relation to income before income taxes of $31.3 million, resulting in an effective tax rate of 38.7%. For the three months ended October 1, 2023, the effective tax rate differed from the U.S. federal statutory rate primarily due to operating losses in certain subsidiaries not being benefited due to the establishment of valuation allowances and Global Intangible Low-Tax Income, partially offset by non-U.S. earnings being taxed at rates that are different than the U.S. statutory rate, R&D credits, foreign tax credits and foreign exchange losses. For the three months ended October 2, 2022, the effective tax rate was impacted primarily by income taxes owed in certain U.S. states.
For the nine months ended October 1, 2023, we recognized an income tax benefit of $2.8 million in relation to loss before income taxes of $19.9 million, resulting in an effective benefit tax rate of 14.1%. For the nine months ended October 2, 2022, the Company recognized a provision for income taxes of $176.4 million in relation to income before income taxes of $694.8 million, resulting in an effective tax rate of 25.4%. For the nine months ended October 1, 2023, the effective tax rate differed from the U.S. federal statutory rate primarily due to net operating losses in certain subsidiaries not being benefited due to the establishment of valuation allowances and Global Intangible Low-Tax Income, partially offset by non-U.S. earnings being taxed at rates that are different than the U.S. statutory rate, R&D credits, foreign tax credits and foreign exchange losses. For the nine months ended October 2, 2022, the effective tax rate was primarily impacted by income taxes owed in certain U.S. states.
Segment Results
We operate under three geographically-based reportable segments: North America; EMEA; and China. Our operations in Latin America, Japan and Asia Pacific are immaterial operating segments that are not considered reportable segments and are included in “Other.” In the fourth quarter of 2022, we revised the internal allocation of certain global costs primarily between the North America segment and Corporate to better align costs that impact the Company as a whole. Prior periods have been revised to align with the current period presentation.
The key indicators that we monitor are as follows:
•Total revenues — This measure is discussed in the section entitled “Results of Operations.”
•Adjusted EBITDA — Adjusted EBITDA by reportable segment is used by our management to measure and evaluate the internal operating performance of our reportable segments. It is also the basis for calculating certain management incentive compensation programs. We believe that this measurement is useful to investors as a way to analyze the underlying trends in our core business, including at the segment level, consistently across the periods presented and to evaluate performance under management incentive compensation programs. Adjusted EBITDA consists of Net (loss) income before Interest expense, net, (Benefit from) provision for income taxes and depreciation and amortization and eliminates (i) certain non-operating income or expense items, and (ii) impacts of certain noncash, unusual or other items that are included in Net (loss) income and that we do not consider indicative of our ongoing operating performance. See Note 5 to the Consolidated Financial Statements for a reconciliation of Adjusted EBITDA by reportable segment to (Loss) income before income taxes.
28

North America
Total revenues and Adjusted EBITDA for North America were as follows:
Three Months EndedNine Months Ended
(Dollars in millions)October 1, 2023October 2, 2022% ChangeOctober 1, 2023October 2, 2022% Change
Total revenues$465.2 $517.6 (10)%$1,426.8 $1,917.3 (26)%
Adjusted EBITDA$253.4 $293.5 (14)%$708.1 $1,246.1 (43)%
Total revenues were $465.2 million for the three months ended October 1, 2023, compared to Total revenues of $517.6 million for the three months ended October 2, 2022. The decrease was primarily driven by lower demand for QuickVue and Lyra SARS Antigen assays, partially offset by increased sales of Sofia SARS Antigen assays.
Total revenues were $1,426.8 million for the nine months ended October 1, 2023, compared to Total revenues of $1,917.3 million for the nine months ended October 2, 2022. The decrease was primarily driven by lower demand for QuickVue and Sofia SARS Antigen assays, partially offset by incremental revenues of $433.8 million from the Combinations.
Adjusted EBITDA was $253.4 million for the three months ended October 1, 2023, compared to Adjusted EBITDA of $293.5 million for the three months ended October 2, 2022. The decrease was primarily driven by lower demand for QuickVue SARS Antigen assays, partially offset by decreased distribution and selling costs.
Adjusted EBITDA was $708.1 million for the nine months ended October 1, 2023, compared to Adjusted EBITDA of $1,246.1 million for the nine months ended October 2, 2022. The decrease was primarily driven by lower demand for QuickVue SARS Antigen assays, partially offset by decreased distribution and selling costs and approximately $160 million of incremental impact of the Combinations.
EMEA
Total revenues and Adjusted EBITDA for EMEA were as follows:
Three Months EndedNine Months Ended
(Dollars in millions)October 1, 2023October 2, 2022% ChangeOctober 1, 2023October 2, 2022% Change
Total revenues$74.5 $73.7 1 %$236.4 $131.0 80 %
Adjusted EBITDA$10.2 $17.2 (41)%$22.7 $33.4 (32)%
Total revenues were $74.5 million for the three months ended October 1, 2023, which increased slightly compared to Total revenues of $73.7 million for the three months ended October 2, 2022.
Total revenues were $236.4 million for the nine months ended October 1, 2023, compared to Total revenues of $131.0 million for the nine months ended October 2, 2022. The increase was primarily driven by incremental revenues of $110.1 million from the Combinations, partially offset by a decrease in Point of Care revenue.
Adjusted EBITDA was $10.2 million for the three months ended October 1, 2023, compared to Adjusted EBITDA of $17.2 million for the three months ended October 2, 2022. The decrease was primarily driven by lower Point of Care revenue.
Adjusted EBITDA was $22.7 million for the nine months ended October 1, 2023, compared to Adjusted EBITDA of $33.4 million for the nine months ended October 2, 2022. The decrease was primarily driven by lower Point of Care revenue.
China
Total revenues and Adjusted EBITDA for China were as follows:
Three Months EndedNine Months Ended
(Dollars in millions)October 1, 2023October 2, 2022% ChangeOctober 1, 2023October 2, 2022% Change
Total revenues$81.1 $80.8 — %$233.0 $163.1 43 %
Adjusted EBITDA$37.3 $45.0 (17)%$96.0 $84.2 14 %
Total revenues were $81.1 million for the three months ended October 1, 2023, which increased slightly compared to Total revenues of $80.8 million for the three months ended October 2, 2022.
Total revenues were $233.0 million for the nine months ended October 1, 2023, compared to Total revenues of $163.1 million for the nine months ended October 2, 2022. The increase was primarily driven by incremental revenues of $95.0 million from
29

the Combinations, partially offset by lower Point of Care revenue, primarily related to decreased demand for QuickVue SARS Antigen assays.
Adjusted EBITDA was $37.3 million for the three months ended October 1, 2023, compared to Adjusted EBITDA of $45.0 million for the three months ended October 2, 2022. The decrease was primarily driven by a shift in product mix.
Adjusted EBITDA was $96.0 million for the nine months ended October 1, 2023, compared to Adjusted EBITDA of $84.2 million for the nine months ended October 2, 2022. The increase was primarily driven by approximately $29 million of incremental impact of the Combinations, partially offset by lower Point of Care revenue and a shift in product mix.
Other
Total revenues and Adjusted EBITDA for Other, which includes our Latin America, Japan and Asia Pacific operating segments, were as follows:
Three Months EndedNine Months Ended
(Dollars in millions)October 1, 2023October 2, 2022% ChangeOctober 1, 2023October 2, 2022% Change
Total revenues$123.2 $111.7 10 %$359.0 $188.1 91 %
Adjusted EBITDA$31.2 $29.8 5 %$89.3 $64.1 39 %
Total revenues were $123.2 million for the three months ended October 1, 2023, compared to Total revenues of $111.7 million for the three months ended October 2, 2022. The increase was primarily driven by higher Labs revenue.
Total revenues were $359.0 million for the nine months ended October 1, 2023, compared to Total revenues of $188.1 million for the nine months ended October 2, 2022. The increase was primarily driven by incremental revenues of $177.1 million from the Combinations, partially offset by lower Point of Care revenue.
Adjusted EBITDA was $31.2 million for the three months ended October 1, 2023, compared to Adjusted EBITDA of $29.8 million for the three months ended October 2, 2022. The increase was primarily driven by higher Labs revenue.
Adjusted EBITDA was $89.3 million for the nine months ended October 1, 2023, compared to Adjusted EBITDA of $64.1 million for the nine months ended October 2, 2022. The increase was primarily driven by approximately $37 million of incremental impact of the Combinations, partially offset by lower Point of Care revenue.
Liquidity and Capital Resources
As of October 1, 2023 and January 1, 2023, our principal sources of liquidity consisted of the following:
(Dollars in millions)October 1, 2023January 1, 2023
Cash and cash equivalents$149.3 $292.9 
Marketable securities, current43.9 52.1 
Marketable securities, non-current11.9 21.0 
Total cash, cash equivalents and marketable securities$205.1 $366.0 
Amount available to borrow under the Revolving Credit Facility$787.1 $786.9 
Working capital including cash and cash equivalents and marketable securities, current$511.3 $568.1 
As of October 1, 2023, we had $149.3 million in Cash and cash equivalents, a $143.6 million decrease from January 1, 2023. Our cash requirements fluctuate as a result of numerous factors, including cash generated from operations, progress in R&D, capital expansion projects and acquisition and business development activities. We believe our organizational structure allows us the necessary flexibility to move funds throughout our subsidiaries to meet our operational working capital needs.
Debt Capitalization
Our Credit Agreement consists of a $2,750.0 million Term Loan and an $800.0 million Revolving Credit Facility. As of October 1, 2023 and January 1, 2023, there were no amounts outstanding under the Revolving Credit Facility. As of October 1, 2023, letters of credit issued under the Revolving Credit Facility totaled $12.9 million, which reduced the available amount under the Revolving Credit Facility to $787.1 million.
The Term Loan is subject to quarterly amortization of the principal amount on the last business day of each of our fiscal quarters. The required quarterly payments are 1.875% of the aggregate initial principal amount of the Term Loan through the fiscal second quarter of 2024, and 1.250% thereafter. The final remaining principal installment is due on the maturity date. The
30

Term Loan and the Revolving Credit Facility will mature on May 27, 2027. We must prepay loans outstanding under the Credit Agreement in an amount equal to the Net Cash Proceeds from (i) certain property dispositions and (ii) the receipt of certain other amounts not in the ordinary course of business, such as certain insurance proceeds and condemnation awards, in each case, if not reinvested within a specified time period as contemplated in the Credit Agreement.
During the nine months ended October 1, 2023, we made $174.7 million in payments on our Term Loan, including a voluntary prepayment of $20.0 million.
The Credit Agreement contains affirmative and negative covenants that are customary for credit agreements of this nature. The negative covenants include, among other things, limitations on asset sales, mergers, indebtedness, liens, investments and transactions with affiliates. The Credit Agreement contains two financial covenants: (i) a maximum Consolidated Leverage Ratio (as defined in the Credit Agreement) as of the last day of each fiscal quarter of (a) 4.50 to 1.00 for the Initial Measurement Period, (b) 4.00 to 1.00 for the first four fiscal quarters ending after the Initial Measurement Period and (c) 3.50 to 1.00 for each fiscal quarter thereafter; and (ii) a minimum Consolidated Interest Coverage Ratio (as defined in the Credit Agreement) of 3.00 to 1.00 as of the end of any fiscal quarter for the most recently completed four fiscal quarters. We were in compliance with the financial covenants as of October 1, 2023.
On March 31, 2023, we entered into an amendment to our existing receivables purchase agreement (the “RPA”), by and among Ortho-Clinical Diagnostics US FinanceCo I, LLC (“Ortho FinanceCo I”), as Seller, our wholly owned receivables financing subsidiary, Wells Fargo Bank, N.A., as administrative agent (the “Agent”), Ortho-Clinical Diagnostics, Inc., as the Master Servicer and as an Originator (“Ortho Inc.”), Quidel Corporation, as an Originator, and certain Purchasers. Under the RPA, as amended, Ortho FinanceCo I may sell receivables in amounts up to a $150.0 million limit, subject to certain conditions, including that, at any date of determination, the aggregate capital paid to Ortho FinanceCo I does not exceed a “capital coverage amount,” equal to an adjusted net receivables pool balance minus a required reserve. Ortho FinanceCo I has guaranteed the prompt payment of the sold receivables, and to secure the prompt payment and performance of such guaranteed obligations, Ortho FinanceCo I has granted a security interest to the Agent, for the benefit of the Purchasers, in all assets of Ortho FinanceCo I. Ortho Inc., in its capacity as Master Servicer under the RPA, is responsible for administering and collecting the receivables and has made customary representations, warranties, covenants and indemnities. We have also provided a performance guaranty for the benefit of Ortho FinanceCo I to cause the due and punctual performance by Ortho Inc. of its obligations as Master Servicer.
Cash Flow Summary
Nine Months Ended
(In millions)October 1, 2023October 2, 2022
Net cash provided by operating activities$199.8 $715.9 
Net cash used for investing activities(132.5)(1,584.9)
Net cash (used for) provided by financing activities(208.0)283.7 
Effect of exchange rates on cash(3.3)(4.3)
Net decrease in cash, cash equivalents and restricted cash$(144.0)$(589.6)
Nine Months Ended October 1, 2023
Cash provided by operating activities was $199.8 million for the nine months ended October 1, 2023, and reflected a net loss of $17.1 million and non-cash adjustments of $366.6 million, primarily associated with depreciation and amortization, stock-based compensation expense and accretion of interest on deferred consideration. In addition, we benefited from collections on accounts receivables, which contributed $124.1 million to Cash provided by operating activities, offset by other changes in working capital, including $146.0 million cash outflows for inventories.
Cash used for investing activities was $132.5 million for the nine months ended October 1, 2023, and was primarily related to $160.7 million in purchases of property, plant, equipment, investments and intangibles. We also purchased $50.6 million and sold $68.3 million of marketable securities.
Cash used for financing activities was $208.0 million for the nine months ended October 1, 2023, and was primarily related to payments on long-term borrowings of $175.7 million, payments for deferred consideration of $30.3 million and payments of tax withholdings related to vesting of stock-based awards of $13.0 million.
Nine Months Ended October 2, 2022
Cash provided by operating activities was $715.9 million for the nine months ended October 2, 2022, and reflected net income of $518.4 million and non-cash adjustments of $270.0 million, primarily associated with depreciation and amortization, stock-
31

based compensation expense, net change in operating lease right-of-use assets and liabilities, accretion of interest on contingent and deferred consideration, loss on extinguishment of debt and amortization of the inventory fair value step up initially recorded in connection with the Combinations. In addition, we benefited from collections on accounts receivables, which contributed $181.6 million to Cash provided by operating activities, partially offset by net cash outflows related to inventories, accounts payable and other current and non-current liabilities.
Cash used for investing activities was $1,584.9 million for the nine months ended October 2, 2022, and was primarily related to the Combinations. Additionally, we purchased $79.2 million of property, equipment, investments and intangibles and received $15.8 million of proceeds from government assistance allocated to fixed assets. We also purchased $49.4 million and sold $39.3 million of marketable securities.
Cash provided by financing activities was $283.7 million for the nine months ended October 2, 2022, and was primarily related to proceeds from long-term borrowings, net of debt issuance costs of $2,734.5 million, payments on long-term borrowings and extinguishment costs of $2,336.1 million, repurchases of common stock of $74.3 million and payments of $37.6 million for contingent and deferred consideration.
Liquidity Outlook
Short-term Liquidity Outlook
Our primary source of liquidity, other than our holdings of Cash and cash equivalents, has been cash flows from operations. Cash generated from operations provides us with the financial flexibility we need to meet normal operating, investing and financing needs. We anticipate that our current Cash and cash equivalents, together with cash provided by operating activities and amounts available under our Revolving Credit Facility, will be sufficient to fund our near-term capital and operating needs for at least the next 12 months.
Normal operating needs include the planned costs to operate our business, including amounts required to fund working capital, R&D and capital expenditures. Our primary short-term needs for capital, which are subject to change, include expenditures related to:
•interest on and repayments of our long-term borrowings, deferred consideration, contingent consideration and lease obligations;
•acquisitions of property, equipment and other fixed assets in support of our manufacturing facility expansions;
•the continued advancement of R&D efforts;
•our integration of the Ortho business arising from the Combinations;
•support of commercialization efforts related to our current and future products, including support of our direct sales force and field support resources; and
•potential strategic acquisitions and investments.
Due to the risks inherent in the product development process, we are unable to estimate with meaningful certainty the costs we will incur in the continued development of our product candidates for commercialization. Our R&D costs may be substantial as we move product candidates into preclinical and clinical trials and advance our existing product candidates into later stages of development.
The primary purposes of our capital expenditures are to invest in manufacturing capacity expansion, acquire certain of our instruments, acquire scientific equipment, purchase or develop IT and implement facility improvements. We plan to fund the capital expenditures with the cash on our balance sheet.
We are focused on expanding the number of instruments placed in the field and solidifying long-term contractual relationships with customers. In order to achieve this goal, in certain jurisdictions where it is permitted, we have leveraged a reagent rental model that has been recognized as more attractive to certain customers. In this model, we lease, rather than sell, instruments to our customers. Over the term of the contract, the purchase price of the instrument is embedded in the price of the assays and reagents. Going forward, we intend to increase the number of reagent rental placements in developed markets, a strategy that we believe is beneficial to our commercial goals because it lowers our customers’ upfront capital costs and therefore allows purchasing decisions to be made at the lab manager level. For these same reasons, the reagent rental model also benefits our commercial strategy in emerging markets. We believe that the shift in our sales strategy will grow our installed base, thereby increasing sales of higher-margin assays, reagents and other consumables over the life of the customer contracts and enhancing our recurring revenue and cash flows. During the nine months ended October 1, 2023, we transferred $105.8 million of instrument inventories from Inventories to Property, plant and equipment, net, further increasing our investment in property, plant and equipment.
32

Long-term Liquidity Outlook
Our future capital requirements and the adequacy of our available funds to service any long-term debt outstanding and to fund working capital expenditures and business development efforts will depend on many factors, including:
•our ability to successfully integrate the recently acquired Ortho business and realize cross-selling revenue synergies;
•our ability to realize revenue growth from our new technologies and create innovative products in our markets;
•outstanding debt and covenant restrictions;
•our ability to leverage our operating expenses to realize operating profits as we grow revenue;
•competing technological and market developments; and
•our entry into strategic collaborations with other companies or acquisitions of other companies or technologies to enhance or complement our product and service offerings.
In January 2023, we entered into a lease for warehouse space that has not yet commenced, with total lease payments of approximately $36 million. This lease is expected to commence during the fourth quarter of 2023 or the first quarter of 2024 with a lease term of five years.
Seasonality
Sales of our respiratory products are subject to, and significantly affected by, the seasonal demands of the cold, flu and RSV seasons, which are typically more prevalent during the fall and winter. Historically, sales of our influenza products have varied from year to year based, in large part, on the severity, length and timing of the onset of the cold, flu and RSV seasons.
Recent Accounting Pronouncements
There have been no accounting pronouncements issued or adopted during the nine months ended October 1, 2023 that are expected to have a material impact on the Company’s financial statements.
Critical Accounting Estimates
Our discussion and analysis of our financial condition and results of operations are based on our Consolidated Financial Statements, which have been prepared in accordance with GAAP. The preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. On an on-going basis, we evaluate our estimates, including those related to reserve for contractual rebates, returns, goodwill and intangible assets and income taxes. We base our estimates on historical experience and on various other assumptions that we believe are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.
A comprehensive discussion of our critical accounting estimates is included in “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our Annual Report on Form 10-K for the fiscal year ended January 1, 2023. Other than the change in accounting estimates described in Note 1 to our Consolidated Financial Statements, there were no material changes to our critical accounting estimates during the nine months ended October 1, 2023.
ITEM 3.    Quantitative and Qualitative Disclosures About Market Risk
Our business and financial results are affected by fluctuations in world financial markets, including interest rates and currency exchange rates. We manage these risks through normal operating and financing activities and, when deemed appropriate, through the use of derivative financial instruments. We have policies governing our use of derivative instruments, and we do not enter into financial instruments for trading or speculative purposes.
Interest Rate Risk
We are subject to interest rate risk in connection with our long-term debt. Our principal interest exposure relates to outstanding amounts under our Credit Agreement. Our Credit Agreement provides for variable rate borrowings of up to $2,750.0 million under the Term Loan and $800.0 million under the Revolving Credit Facility. Assuming facilities under the Credit Agreement are fully drawn, each one-eighth percentage point increase or decrease in the applicable interest rates would correspondingly change our interest expense on our outstanding borrowings under the Credit Agreement by approximately $4.1 million per year before considering the impact of derivative instruments. For further discussion of the risks related to our Credit Agreement, see “Risk Factors—Risks Relating to Corporate Finance—Our indebtedness could adversely affect our financial condition, limit
33

our ability to raise additional capital to fund our operations and prevent us from fulfilling our obligations under our indebtedness” in Part I, Item 1A, “Risk Factors” of our Annual Report on Form 10-K for the fiscal year ended January 1, 2023.
We selectively use derivative instruments to reduce market risk associated with changes in interest rates. The use of derivatives is intended for hedging purposes only, and we do not enter into derivative instruments for speculative purposes.
We entered into an interest rate swap agreement, commencing on May 29, 2022, which fixed a portion of the variable interest due on our variable rate debt. Under the terms of the agreement, we will pay a fixed rate of 1.58% and receive a variable rate of interest based on the USD-SOFR rate from the counterparty, which is reset every month through December 31, 2023. As of October 1, 2023, the notional amount of the interest rate swap was $500.0 million. We also entered into interest rate swap contracts, commencing on December 30, 2022, with a total notional value of $1.3 billion, which is expected to increase to $1.8 billion on December 29, 2023, to hedge future interest rate exposures on variable rate debt, including the Revolving Credit Facility and Term Loan.
Our current investment policy with respect to our cash and cash equivalents focuses on maintaining acceptable levels of interest rate risk and liquidity. Although we continue to evaluate our investments, our cash equivalents as of October 1, 2023 consisted primarily of government money market funds and other high credit quality debt securities. These funds provide daily liquidity and may be subject to interest rate risk and decrease in value if market interest rates increase. We do not expect our operating results or cash flows to be affected to any significant degree by a sudden change in market interest rates.
Foreign Currency Exchange Risk
We are exposed to foreign currency exchange risk by virtue of our international operations. These risks include the translation of local currency balances of foreign subsidiaries, transaction gains and losses associated with intercompany balances with foreign subsidiaries and transactions denominated in currencies other than the functional currency of the local jurisdiction. We derived approximately 39% and 38% of our Total revenues for the three and nine months ended October 1, 2023, respectively, from operations outside the U.S. For translation of operations in non-U.S. Dollar currencies, the local currency of most entities is the functional currency. Foreign exchange effects from the translation of our balance sheet resulted in a comprehensive loss of $55.3 million and $17.2 million for the three and nine months ended October 1, 2023, respectively. Foreign exchange effects from the translation of our balance sheet resulted in a comprehensive loss of $92.9 million and $158.9 million for the three and nine months ended October 2, 2022, respectively. Adjustments resulting from the re-measurement of transactions denominated in foreign currencies other than the functional currency of our subsidiaries are expensed as incurred.
In the majority of our jurisdictions, we earn revenue and incur costs in the currency used in such jurisdiction. We incur significant costs in foreign currencies, including Australian Dollar, Brazilian Real, British Pound, Canadian Dollar, Chilean Peso, Chinese Yuan/Renminbi, Colombian Peso, Euro, Indian Rupee, Japanese Yen, Mexican Peso, Philippine Peso, South Korean Won, Swiss Franc and the Thai Baht. As a result, movements in exchange rates cause our revenue and expenses to fluctuate, impacting our profitability and cash flows. Future business operations and opportunities, including the continued expansion of our business outside North America, may further increase the risk that cash flows resulting from these activities may be adversely affected by changes in currency exchange rates.
Like many multi-national companies, we have exposure to the British Pound. We are negatively impacted by a lower British Pound exchange rate from translation impact when compared to the U.S. Dollar, but we also benefit from expenses denominated in British Pound, as well as some cross-border transactions at a lower exchange rate. The magnitude of the impact is dependent on our level of operations and business volumes in the U.K., forward contract hedge positions, cross currency volume and the exchange rate.
Additionally, in order to fund the purchase price for the assets and capital stock of certain non-U.S. entities, a combination of equity contributions and intercompany loans were utilized to capitalize certain non-U.S. subsidiaries. In many instances, the intercompany loans are denominated in currencies other than the functional currency of the affected subsidiaries. Where intercompany loans are not a component of permanently invested capital of the affected subsidiaries, increases or decreases in the value of the subsidiaries’ functional currency against other currencies can affect our results of operations. During the three and nine months ended October 1, 2023, we recorded net foreign currency exchange losses of $1.8 million and $4.8 million, respectively. During the three and nine months ended October 2, 2022, we recorded net foreign currency exchange gains of $0.2 million and losses of $2.2 million, respectively. The foreign currency gains/losses in each period primarily consist of unrealized gains/losses related to intercompany loans denominated in currencies other than the functional currency of the affected subsidiaries. We have entered into and may continue to enter into derivative instruments to manage our foreign currency exposure on these intercompany loans in the future.
We have entered into foreign currency forward contracts to manage our foreign currency exposures on foreign currency denominated firm commitments and forecasted foreign currency denominated intercompany and third-party transactions. We had forward contracts outstanding with a total notional amount of $743.9 million as of October 1, 2023, with maturity dates through December 2023. Foreign currency forward contracts that qualified and were designated for hedge accounting are
34

recorded at their fair value as of October 1, 2023 and the pre-tax unrealized loss of $2.0 million is reported as a component of Other comprehensive (loss) income, all of which is expected to be reclassified to earnings in the next 12 months. Actual gains (losses) upon settlement will be recognized in earnings, within the line item impacted, during the estimated time in which the transactions are incurred. Actual losses upon settlement recognized in earnings during the three and nine months ended October 1, 2023 were $2.2 million and $4.8 million, respectively. Actual gains upon settlement recognized in earnings during the three and nine months ended October 2, 2022 were $0.8 million and $1.0 million, respectively.
See Note 12 to the Consolidated Financial Statements for additional information related to such forward contracts, which information is incorporated herein by reference.
ITEM 4.    Controls and Procedures
Evaluation of disclosure controls and procedures: We have performed an evaluation under the supervision and with the participation of our management, including our Chief Executive Officer (“CEO”) and Chief Financial Officer (“CFO”), of the effectiveness of our disclosure controls and procedures, as defined in Exchange Act Rules 13a-15(e) and 15d-15(e). Based on that evaluation, our CEO and CFO concluded that our disclosure controls and procedures were effective as of October 1, 2023 at a reasonable assurance level to ensure that information required to be disclosed by us in the reports filed or submitted by us under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the SEC. Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives and management necessarily applies its judgment in evaluating the cost benefit relationship of possible controls and procedures.
Changes in internal control over financial reporting: There were no changes in our internal control over financial reporting during the fiscal quarter ended October 1, 2023 that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

35


PART II OTHER INFORMATION
ITEM 1.    Legal Proceedings
The information set forth in Note 10 to the Consolidated Financial Statements is incorporated herein by reference.
ITEM 1A.    Risk Factors
There has been no material change in our risk factors as previously disclosed in our Annual Report on Form 10-K for the fiscal year ended January 1, 2023. For a detailed description of our risk factors, refer to Part I, Item IA, “Risk Factors” of our Annual Report on Form 10-K for the fiscal year ended January 1, 2023.
ITEM 2.    Unregistered Sales of Equity Securities and Use of Proceeds
Issuer Purchases of Equity Securities
The table below sets forth information regarding repurchases of our common stock by us during the three months ended October 1, 2023.
Period
Total Number of Shares Purchased (1)
Average Price Paid per ShareTotal Number of Shares Purchased as Part of Publicly Announced Plans or Programs
Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs (2)
July 3, 2023 - July 30, 20231,235 $86.16 — $225,677,460 
July 31, 2023 - August 27, 20232,900 77.53 — 225,677,460 
August 28, 2023 - October 1, 20232,785 75.84 — 225,677,460 
Total6,920 $78.39 — $225,677,460 
(1) Represents shares surrendered to the Company to satisfy the payment of minimum tax withholding obligations.
(2) On August 17, 2022, the Company’s Board of Directors authorized a stock repurchase program, allowing the Company to repurchase up to $300.0 million of its common stock through August 17, 2024.
ITEM 3.    Defaults Upon Senior Securities
None.
ITEM 4.    Mine Safety Disclosures
Not applicable.
ITEM 5.    Other Information
(a)None.
(b)None.
(c)During the last fiscal quarter, no director or officer (as defined in Exchange Act Rule 16a-1(f)) adopted or terminated any Rule 10b5-1 trading arrangement or non-Rule 10b5-1 trading arrangement.
36

ITEM 6.    Exhibits
Exhibit Number
3.1
3.2
3.3
4.1
31.1*
31.2*
32.1**
101The following financial statements, formatted in Inline XBRL: (i) Consolidated Balance Sheets, (ii) Consolidated Statements of (Loss) Income, (iii) Consolidated Statements of Comprehensive (Loss) Income, (iv) Consolidated Statements of Stockholders’ Equity, (v) Consolidated Statements of Cash Flows, and (vi) Notes to Consolidated Financial Statements, tagged as blocks of text and including detailed tags
104The cover page, formatted in Inline XBRL (included as Exhibit 101)
_________________________
*    Filed herewith.
**    Furnished herewith.
37

SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
Date: November 1, 2023QUIDELORTHO CORPORATION
/s/ DOUGLAS C. BRYANT
Douglas C. Bryant
President and Chief Executive Officer
(Principal Executive Officer)
/s/ JOSEPH M. BUSKY
Joseph M. Busky
Chief Financial Officer
(Principal Financial and Accounting Officer)

38
 EX-31.1 2 ex31110012023.htm EX-31.1 Document

Exhibit 31.1
CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER
PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, Douglas C. Bryant, certify that:
1.    I have reviewed this quarterly report on Form 10-Q of QuidelOrtho Corporation;
2.    Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.    Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.    The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.    The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
Date: November 1, 2023
 
/s/ DOUGLAS C. BRYANT
Douglas C. Bryant
President and Chief Executive Officer
(Principal Executive Officer)


 EX-31.2 3 ex31210012023.htm EX-31.2 Document

Exhibit 31.2
CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER
PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, Joseph M. Busky, certify that:
 
1.    I have reviewed this quarterly report on Form 10-Q of QuidelOrtho Corporation;
2.    Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.    Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.    The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.    The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
Date: November 1, 2023
 
/s/ JOSEPH M. BUSKY
Joseph M. Busky
Chief Financial Officer
(Principal Financial Officer)


 EX-32.1 4 ex32110012023.htm EX-32.1 Document

Exhibit 32.1
Certifications by the Principal Executive Officer and Principal Financial Officer of Registrant Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
Each of the undersigned hereby certifies, in his capacity as an officer of QuidelOrtho Corporation, a Delaware corporation (the “Company”), for purposes of 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of his knowledge:
 
•the Company’s Quarterly Report on Form 10-Q for the period ended October 1, 2023 (the “Report”), as filed with the Securities and Exchange Commission on the date hereof, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
•the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Dated: November 1, 2023
 
/s/ DOUGLAS C. BRYANT
Douglas C. Bryant
President and Chief Executive Officer
(Principal Executive Officer)
/s/ JOSEPH M. BUSKY
Joseph M. Busky
Chief Financial Officer
(Principal Financial Officer)


 EX-101.SCH 5 qdel-20231001.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0000001 - Document - Cover Page link:presentationLink link:calculationLink link:definitionLink 0000002 - Statement - Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 0000003 - Statement - Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 0000004 - Statement - Consolidated Statements of Income link:presentationLink link:calculationLink link:definitionLink 0000005 - Statement - Consolidated Statements of Comprehensive Income (Loss) link:presentationLink link:calculationLink link:definitionLink 0000006 - Statement - Consolidated Statements of Stockholders' Equity Statement link:presentationLink link:calculationLink link:definitionLink 0000007 - Statement - Consolidated Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 0000008 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 0000009 - Disclosure - Business Combination link:presentationLink link:calculationLink link:definitionLink 0000010 - Disclosure - Computation of Earnings Per Share link:presentationLink link:calculationLink link:definitionLink 0000011 - Disclosure - Revenue link:presentationLink link:calculationLink link:definitionLink 0000012 - Disclosure - Segment and Geographic Information link:presentationLink link:calculationLink link:definitionLink 0000013 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 0000014 - Disclosure - Balance Sheet Account Details link:presentationLink link:calculationLink link:definitionLink 0000015 - Disclosure - Borrowings link:presentationLink link:calculationLink link:definitionLink 0000016 - Disclosure - Stock-Based Compensation link:presentationLink link:calculationLink link:definitionLink 0000017 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 0000018 - Disclosure - Fair Value Measurements link:presentationLink link:calculationLink link:definitionLink 0000019 - Disclosure - Derivative Instruments and Hedging Activities link:presentationLink link:calculationLink link:definitionLink 0000020 - Disclosure - Related Party Transactions link:presentationLink link:calculationLink link:definitionLink 0000021 - Disclosure - Accumulated Other Comprehensive Loss link:presentationLink link:calculationLink link:definitionLink 9954471 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 9954472 - Disclosure - Business Combination (Tables) link:presentationLink link:calculationLink link:definitionLink 9954473 - Disclosure - Computation of Earnings Per Share (Tables) link:presentationLink link:calculationLink link:definitionLink 9954474 - Disclosure - Revenue (Tables) link:presentationLink link:calculationLink link:definitionLink 9954475 - Disclosure - Segment and Geographic Information (Tables) link:presentationLink link:calculationLink link:definitionLink 9954476 - Disclosure - Balance Sheet Account Details (Tables) link:presentationLink link:calculationLink link:definitionLink 9954477 - Disclosure - Borrowings (Tables) link:presentationLink link:calculationLink link:definitionLink 9954478 - Disclosure - Stock-Based Compensation (Tables) link:presentationLink link:calculationLink link:definitionLink 9954479 - Disclosure - Fair Value Measurements (Tables) link:presentationLink link:calculationLink link:definitionLink 9954480 - Disclosure - Derivative Instruments and Hedging Activities (Tables) link:presentationLink link:calculationLink link:definitionLink 9954481 - Disclosure - Accumulated Other Comprehensive Loss (Tables) link:presentationLink link:calculationLink link:definitionLink 9954482 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954483 - Disclosure - Business Combination - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954484 - Disclosure - Business Combination - Pro Forma Information (Details) link:presentationLink link:calculationLink link:definitionLink 9954485 - Disclosure - Computation of Earnings Per Share - Calculation of Basic and Diluted Earnings Per Share (Details) link:presentationLink link:calculationLink link:definitionLink 9954486 - Disclosure - Computation of Earnings Per Share - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954487 - Disclosure - Revenue - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954488 - Disclosure - Revenue - Disaggregation of Revenue (Details) link:presentationLink link:calculationLink link:definitionLink 9954489 - Disclosure - Segment and Geographic Information - Total Revenues by Reportable Segment (Details) link:presentationLink link:calculationLink link:definitionLink 9954490 - Disclosure - Segment and Geographic Information - Reconciliation to Income (Details) link:presentationLink link:calculationLink link:definitionLink 9954491 - Disclosure - Income Taxes (Detail) link:presentationLink link:calculationLink link:definitionLink 9954492 - Disclosure - Balance Sheet Account Details Cash, Cash Equivalents and Restricted Cash (Details) link:presentationLink link:calculationLink link:definitionLink 9954493 - Disclosure - Balance Sheet Account Details Marketable Securities (Details) link:presentationLink link:calculationLink link:definitionLink 9954494 - Disclosure - Balance Sheet Account Details Accounts Receivable (Details) link:presentationLink link:calculationLink link:definitionLink 9954495 - Disclosure - Balance Sheet Account Details Inventories (Details) link:presentationLink link:calculationLink link:definitionLink 9954495 - Disclosure - Balance Sheet Account Details Inventories (Details) link:presentationLink link:calculationLink link:definitionLink 9954496 - Disclosure - Balance Sheet Account Details Prepaid expenses and other current assets (Details) link:presentationLink link:calculationLink link:definitionLink 9954497 - Disclosure - Balance Sheet Account Details - Goodwill Rollforward (Details) link:presentationLink link:calculationLink link:definitionLink 9954498 - Disclosure - Balance Sheet Account Details Other Current Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 9954499 - Disclosure - Borrowings - Schedule of Borrowings (Details) link:presentationLink link:calculationLink link:definitionLink 9954499 - Disclosure - Borrowings - Schedule of Borrowings (Details) link:presentationLink link:calculationLink link:definitionLink 9954500 - Disclosure - Borrowings - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954501 - Disclosure - Borrowings - Interest Expense (Details) link:presentationLink link:calculationLink link:definitionLink 9954502 - Disclosure - Stock-Based Compensation - Compensation Expense Related to Stock-Based Compensation Plans (Details) link:presentationLink link:calculationLink link:definitionLink 9954503 - Disclosure - Stock-Based Compensation - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954504 - Disclosure - Stock-Based Compensation - Estimated Fair Value of Each Stock Option Award (Details) link:presentationLink link:calculationLink link:definitionLink 9954505 - Disclosure - Fair Value Measurements - Assets and Liabilities Measured at Fair Value on Recurring Basis (Details) link:presentationLink link:calculationLink link:definitionLink 9954506 - Disclosure - Fair Value Measurements - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954507 - Disclosure - Derivative Instruments and Hedging Activities - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954508 - Disclosure - Derivative Instruments and Hedging Activities - Schedule of Interest Rate Derivatives (Details) link:presentationLink link:calculationLink link:definitionLink 9954509 - Disclosure - Derivative Instruments and Hedging Activities - Schedule of Currency Hedging Instruments (Details) link:presentationLink link:calculationLink link:definitionLink 9954510 - Disclosure - Derivative Instruments and Hedging Activities - Schedule of Gain (Loss) (Details) link:presentationLink link:calculationLink link:definitionLink 9954511 - Disclosure - Derivative Instruments and Hedging Activities - Schedule of Fair Value (Details) link:presentationLink link:calculationLink link:definitionLink 9954512 - Disclosure - Accumulated Other Comprehensive Loss (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 6 qdel-20231001_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 7 qdel-20231001_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 8 qdel-20231001_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Stock Appreciation Rights (SARs) Stock Appreciation Rights (SARs) [Member] Pay vs Performance Disclosure [Line Items] Statistical Measurement [Domain] Statistical Measurement [Domain] Line of credit, maximum borrowing capacity Line of Credit Facility, Maximum Borrowing Capacity Research and development Research and Development Expense Changes in assets and liabilities: Increase (Decrease) in Operating Capital [Abstract] Underlying Security Market Price Change Underlying Security Market Price Change, Percent Interest income Interest Income, Other Award Type [Domain] Award Type [Domain] Fair Value as of Grant Date Award Grant Date Fair Value Borrowings Debt Disclosure [Text Block] Collaborative Arrangement, Transaction with Party to Collaborative Arrangement Collaborative Arrangement, Transaction with Party to Collaborative Arrangement [Member] Additional paid-in capital Common Stock Including Additional Paid in Capital [Member] Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Revolving Credit Facility Revolving Credit Facility [Member] Effect of exchange rates on cash Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations Deferred tax liability Deferred Income Tax Liabilities, Net MNPI Disclosure Timed for Compensation Value MNPI Disclosure Timed for Compensation Value [Flag] Corporate Corporate Adjusted EBITDA Corporate Adjusted EBITDA Accounts payable Accounts Payable, Current Prepaid expenses and other current assets Prepaid Expenses and Other Current Assets [Member] Restatement Determination Date: Restatement Determination Date [Axis] Corporate bonds Corporate Debt Securities [Member] Commitments and contingencies (Note 10) Commitments and Contingencies Insider Trading Policies and Procedures [Line Items] Rule 10b5-1 Arrangement Terminated Rule 10b5-1 Arrangement Terminated [Flag] Credit Agreement Bank Of America Credit Facility [Member] Bank Of America Credit Facility Derivatives Derivative Asset, Current Derivative Asset, Current Disaggregation of Revenue [Line Items] Disaggregation of Revenue [Line Items] Deferred revenue, current Deferred revenue Deferred Revenue, Current Restatement does not require Recovery Restatement Does Not Require Recovery [Text Block] Proceeds from issuance of common stock Proceeds from Issuance of Common Stock Schedule of Goodwill [Table] Schedule of Goodwill [Table] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Income Taxes Income Tax Disclosure [Text Block] Dividend rate Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate Capital expenditures to be reimbursed under a government contract Consideration Received for Capital Expenditures Paid but Not yet Incurred Consideration Received for Capital Expenditures Paid but Not yet Incurred Long-Term Investments Long-Term Investments [Member] Long-Term Investments Other adjustments Other adjustments Other adjustments Customer [Axis] Customer [Axis] Current liabilities: Liabilities, Current [Abstract] Preferred stock, par value per share (in dollars per share) Preferred Stock, Par or Stated Value Per Share Preferred stock, $0.001 par value per share; 5.0 shares authorized; none issued or outstanding at October 1, 2023 and January 1, 2023 Preferred Stock, Value, Issued Unamortized deferred financing costs Debt Issuance Costs, Noncurrent, Net Business Acquisition [Line Items] Business Acquisition [Line Items] Principal payments of acquisition contingent consideration Payment for Contingent Consideration Liability, Financing Activities Diluted (loss) earnings per share Earnings Per Share, Diluted Increase to share based compensation from modification of vesting awards Share-Based Compensation Expense, Increase From Modification Of Vesting Share-Based Compensation Expense, Increase From Modification Of Vesting PEO Total Compensation Amount PEO Total Compensation Amount Accounts receivable, net Total accounts receivable, net Accounts Receivable, after Allowance for Credit Loss, Current Goodwill [Roll Forward] Goodwill [Roll Forward] Reclassification of net realized (gains) losses on derivative instruments included in net (loss) income Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax Closing price of Quidel Common Stock (in usd per share) Business Acquisition, Share Price Trading Arrangements, by Individual Trading Arrangements, by Individual [Table] Level 3 Fair Value, Inputs, Level 3 [Member] Line of Credit Line of Credit [Member] Trading Symbol Trading Symbol Non-PEO NEO Average Compensation Actually Paid Amount Non-PEO NEO Average Compensation Actually Paid Amount Prepaid Expenses and Other Current Assets Schedule of Other Current Assets [Table Text Block] Long-Term Debt, Fair Value Long-Term Debt, Fair Value Weighted-average grant date fair value of stock options granted (in USD per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Net (loss) income Net (loss) income Net (loss) income Net Income (Loss) Total current liabilities Liabilities, Current Derivative Contract [Domain] Derivative Contract [Domain] Fair Value Disclosures [Abstract] Fair Value Disclosures [Abstract] Changed Peer Group, Footnote Changed Peer Group, Footnote [Text Block] Company Selected Measure Name Company Selected Measure Name Cash, Cash Equivalents and Restricted Cash Schedule of Cash and Cash Equivalents [Table Text Block] Long-term borrowings Debt and Lease Obligation LIABILITIES AND STOCKHOLDERS’ EQUITY Liabilities and Equity [Abstract] Repurchases of common stock Stock Repurchased During Period, Value EMEA EMEA Segment [Member] EMEA Segment Stockholders’ equity: Equity, Attributable to Parent [Abstract] Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax Concentration Risk Benchmark [Domain] Concentration Risk Benchmark [Domain] Amount of Loss (Gain) Recognized in OCI on Hedges Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax Schedule of Earnings Per Share, Basic and Diluted Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Executive Category: Executive Category [Axis] Foreign Exchange Contract Foreign Exchange Contract [Member] Level 1 Fair Value, Inputs, Level 1 [Member] Name Measure Name Marketable securities Marketable Securities, Current Name Forgone Recovery, Individual Name Principal payments of deferred consideration Payment On Acquisition Deferred Consideration Payment On Acquisition Deferred Consideration Goodwill Goodwill, Beginning Balance Goodwill, Ending Balance Goodwill Equity Components [Axis] Equity Components [Axis] Fair Value, Option, Eligible Item or Group Financial Instruments [Domain] Additional 402(v) Disclosure Additional 402(v) Disclosure [Text Block] Segment Reconciliation [Abstract] Segment Reconciliation [Abstract] Stock options granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross Underlying Securities Award Underlying Securities Amount Proceeds from government assistance allocated to fixed assets Proceeds from Contribution in Aid of Construction Entity Small Business Entity Small Business Number of financial covenants Number Of Financial Covenants Number Of Financial Covenants Accumulated Other Comprehensive Loss Comprehensive Income (Loss) Note [Text Block] Local Phone Number Local Phone Number Accounts receivable Increase (Decrease) in Accounts Receivable Recovery of Erroneously Awarded Compensation Disclosure [Line Items] Forecast Forecast [Member] Letter of Credit Letter of Credit [Member] Short-term borrowings, net Proceeds from (Repayments of) Short-Term Debt, Maturing in Three Months or Less Derivative, Notional Amount Derivative, Notional Amount Accounts Receivable Accounts Receivable [Member] Changes in unrealized gains (losses) from investments, net of tax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax Molecular Diagnostics Molecular Diagnostics [Member] Molecular Diagnostics Other long-term borrowings Other Long-Term Debt, Noncurrent Operating lease liabilities Operating Lease, Liability, Noncurrent RSUs Restricted Stock Units (RSUs) [Member] Forgone Recovery due to Violation of Home Country Law, Amount Forgone Recovery due to Violation of Home Country Law, Amount Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Tax indemnification income Tax Indemnification Income (Expense) Tax Indemnification Income (Expense) Marketable Securities Marketable Securities [Table Text Block] Income Statement Location [Axis] Income Statement Location [Axis] Schedule of Debt Schedule of Long-Term Debt Instruments [Table Text Block] Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Inventory Adjustments Inventory Adjustments Tax withholdings related to vesting of stock-based awards Share-Based Payment Arrangement, Decrease for Tax Withholding Obligation Foreign Exchange Forward Foreign Exchange Forward [Member] Goodwill adjustment, decrease to deferred tax liabilities Goodwill, Purchase Accounting Adjustment, Decrease To Deferred Tax Liabilities Goodwill, Purchase Accounting Adjustment, Decrease To Deferred Tax Liabilities Total revenues Revenues Income tax payable Accrued Income Taxes, Current Product and Service [Domain] Product and Service [Domain] Other Performance Measure, Amount Other Performance Measure, Amount Interest expense, debt Interest Expense, Debt Ending after the closing date of the credit agreement Ending After The Closing Date Of The Credit Agreement [Member] Ending After The Closing Date Of The Credit Agreement Proceeds from long-term borrowings, net of debt issuance costs Proceeds from Debt, Net of Issuance Costs Aggregate Available Trading Arrangement, Securities Aggregate Available Amount Leverage ratio, minimum Debt instrument, Covenant, Leverage Ratio, Minimum Debt instrument, Covenant, Leverage Ratio, Minimum Inventories Increase (Decrease) in Inventories Research and development Research and Development Expense [Member] INVESTING ACTIVITIES Net Cash Provided by (Used in) Investing Activities [Abstract] Insider Trading Policies and Procedures Not Adopted Insider Trading Policies and Procedures Not Adopted [Text Block] Acquisition and integration costs Acquisition and integration costs Business Combination, Acquisition Related Costs Award Type [Axis] Award Type [Axis] Potentially dilutive shares excluded from calculation due to anti-dilutive effect Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Derivative Instruments and Hedging Activities Disclosure [Abstract] Derivative Instruments and Hedging Activities Disclosure [Abstract] RSUs granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period Document Quarterly Report Document Quarterly Report Debt prepayment cost Payment for Debt Extinguishment or Debt Prepayment Cost Income taxes and other tax receivables Income Taxes Receivable, Current Unrecognized compensation expense Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Loss on extinguishment of debt Loss on extinguishment of debt Gain (Loss) on Extinguishment of Debt Hedging Designation [Axis] Hedging Designation [Axis] Goodwill [Line Items] Goodwill [Line Items] Trading Arrangement: Trading Arrangement [Axis] Related Party Transactions Related Party Transactions Disclosure [Text Block] Schedule of Interest Expense Interest Income and Interest Expense Disclosure [Table Text Block] Reclassification [Line Items] Reclassification [Line Items] Use of Estimates Use of Estimates, Policy [Policy Text Block] PEO Actually Paid Compensation Amount PEO Actually Paid Compensation Amount Purchase of property, equipment and intangibles by incurring current liabilities Noncash or Part Noncash Acquisition, Fixed Assets Acquired Long-term Debt, Type [Domain] Long-Term Debt, Type [Domain] Entity File Number Entity File Number Assets: Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract] Statement [Table] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Operating lease liabilities Operating Lease, Liability, Current Prepaid expenses Prepaid Expense, Current Customer A Customer A [Member] Customer A Debt Payment Terms [Axis] Debt Payment Terms [Axis] Debt Payment Terms Deferred revenue, noncurrent Deferred Revenue, Noncurrent Leverage ratio maximum Debt Instrument, Covenant, Leverage Ratio, Maximum Debt Instrument, Covenant, Leverage Ratio, Maximum Amortization of intangible assets Amortization of Intangible Assets Entity Shell Company Entity Shell Company Business Acquisition, Acquiree [Domain] Business Acquisition, Acquiree [Domain] Risk-free interest rate Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum Recent Accounting Pronouncements New Accounting Pronouncements, Policy [Policy Text Block] Restatement Determination Date Restatement Determination Date Income taxes payable Increase (Decrease) in Income Taxes Payable Other current and non-current liabilities Increase (Decrease) in Other Operating Liabilities Rule 10b5-1 Arrangement Adopted Rule 10b5-1 Arrangement Adopted [Flag] Cash, cash equivalents and restricted cash at beginning of period Cash, cash equivalents and restricted cash at end of period Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Net change in operating lease right-of-use assets and liabilities Change in operating lease right-of-use assets and liabilities Change in operating lease right-of-use assets and liabilities Stock Price or TSR Estimation Method Stock Price or TSR Estimation Method [Text Block] Common stock, shares issued (in shares) Common Stock, Shares, Issued Gross Profit Gross Profit Business Combination, Consideration Transferred Business Combination, Consideration Transferred Estimated Fair Value of Each Stock Option Award Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Collaborative Arrangement, Transaction with Party to Collaborative Arrangement and Third Party Collaborative Arrangement, Transaction with Party to Collaborative Arrangement and Third Party [Member] Security Exchange Name Security Exchange Name Total assets measured at fair value Assets, Fair Value Disclosure Selling, marketing and administrative Selling, General and Administrative Expense Accumulated other comprehensive loss Accumulated Other Comprehensive Income (Loss), Net of Tax Current period deferrals Other Comprehensive Income (Loss), before Reclassifications, Net of Tax Unrealized Foreign Currency Translation Adjustments Accumulated Foreign Currency Adjustment Attributable to Parent [Member] Stock Options Employee Stock Option [Member] Derivative Instruments and Hedging Activities Derivative Instruments and Hedging Activities Disclosure [Text Block] Expected weighted-average period of recognition for unrecognized compensation expense Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Maximum Maximum [Member] Comprehensive (loss) income Comprehensive Income (Loss), Net of Tax, Attributable to Parent Unrecognized share based compensation expense relating to unvested shares Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount Schedule of Interest Rate Derivatives Schedule of Interest Rate Derivatives [Table Text Block] Document Type Document Type Amortization of deferred financing costs Debt Related Commitment Fees and Debt Issuance Costs Issuance of equity replacement awards in connection with the Combinations Stock Issued During Period, Value, Equity Replacement Awards, Acquisitions Stock Issued During Period, Value, Equity Replacement Awards, Acquisitions North America North America Segment [Member] North America Segment Tabular List, Table Tabular List [Table Text Block] Issuance of shares in connection with the Combinations Stock Issued During Period, Value, Acquisitions Entity Address, Address Line One Entity Address, Address Line One Marketable securities Marketable Securities, Noncurrent Cost of sales, excluding amortization of intangibles Cost of Goods and Service, Excluding Depreciation, Depletion, and Amortization Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] Derivatives Derivative Liability, Current Derivative Liability, Current Stock-Based Compensation Share-Based Payment Arrangement [Text Block] Derivative Asset, Noncurrent, Statement of Financial Position [Extensible Enumeration] Derivative Asset, Noncurrent, Statement of Financial Position [Extensible Enumeration] Basis of Presentation Basis of Accounting, Policy [Policy Text Block] Business Acquisition [Axis] Business Acquisition [Axis] Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] Derivative [Table] Derivative [Table] Restricted Cash, Noncurrent Restricted Cash, Noncurrent Customer Concentration Risk Customer Concentration Risk [Member] Other current liabilities Total other current liabilities Other Liabilities, Current Income Statement [Abstract] Income Statement [Abstract] Raw materials Inventory, Raw Materials, Net of Reserves Revenue Revenue from Contract with Customer, Including Assessed Tax Title of 12(b) Security Title of 12(b) Security Insider Trading Policies and Procedures Adopted Insider Trading Policies and Procedures Adopted [Flag] Business Combination Business Combination Disclosure [Text Block] Derivative liabilities Derivative Liability Aggregate Erroneous Compensation Not Yet Determined Aggregate Erroneous Compensation Not Yet Determined [Text Block] Pro forma net income Business Acquisition, Pro Forma Net Income (Loss) Other Other Assets, Current Issuance of common stock under equity compensation plans Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture Income Tax Disclosure [Abstract] Income Tax Disclosure [Abstract] Derivative, Fixed Interest Rate Derivative, Fixed Interest Rate Forgone Recovery due to Expense of Enforcement, Amount Forgone Recovery due to Expense of Enforcement, Amount Entity Tax Identification Number Entity Tax Identification Number Foreign currency translation Goodwill, Foreign Currency Translation Gain (Loss) Inventories Inventory, Net Purchases of marketable securities Payments to Acquire Marketable Securities Statistical Measurement [Axis] Statistical Measurement [Axis] Inventory, Noncurrent Inventory, Noncurrent Business Acquisition, Pro Forma Information, Nonrecurring Adjustment [Line Items] Business Acquisition, Pro Forma Information, Nonrecurring Adjustment [Line Items] Eligible Item or Group for Fair Value Option Financial Instrument [Axis] Balance Sheet Location [Domain] Balance Sheet Location [Domain] Entity Interactive Data Current Entity Interactive Data Current Disaggregation of Revenue [Table] Disaggregation of Revenue [Table] Deferred consideration Deferred Consideration, Current Deferred Consideration, Current Total Shareholder Return Amount Total Shareholder Return Amount Repurchases of common stock Payments for Repurchase of Common Stock Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Adjustment To PEO Compensation, Footnote Adjustment To PEO Compensation, Footnote [Text Block] Segments [Domain] Segments [Domain] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Retained earnings Retained Earnings (Accumulated Deficit) Measure: Measure [Axis] Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Abstract] Name Outstanding Recovery, Individual Name Revenue Recognition Revenue from Contract with Customer [Policy Text Block] Foreign and other Other Debt Obligations [Member] Document And Entity Information [Abstract] Document And Entity Information [Abstract] Document and Entity Information [Abstract] Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Current assets: Assets, Current [Abstract] Accounts receivable Accounts Receivable, before Allowance for Credit Loss, Current Entity Address, State or Province Entity Address, State or Province Compensation Actually Paid vs. Total Shareholder Return Compensation Actually Paid vs. Total Shareholder Return [Text Block] OPERATING ACTIVITIES Net Cash Provided by (Used in) Operating Activities [Abstract] Statement [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Schedule of Derivative Assets at Fair Value Schedule of Derivative Assets at Fair Value [Table Text Block] Other Other [Member] Other nonreportable segments Common stock, shares outstanding (in shares) Common Stock, Shares, Outstanding PEO PEO [Member] Other operating expenses Other Cost and Expense, Operating Allowance for contract rebates and discounts Allowance for contract rebates and discounts Allowance for contract rebates and discounts Other non-cash, net Other Operating Activities, Cash Flow Statement Balance (in shares) Balance (in shares) Shares, Outstanding Accumulated Other Comprehensive Income (Loss) [Line Items] Accumulated Other Comprehensive Income (Loss) [Line Items] Retail Customers Retail Customers [Member] Retail Customers Other short-term borrowings Other Short-Term Borrowings Common stock, par value per share (in dollars per share) Common Stock, Par or Stated Value Per Share Net cash used for investing activities Net Cash Provided by (Used in) Investing Activities Customer [Domain] Customer [Domain] Amount of Loss (Gain) Reclassified From AOCI Into Income Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax Inventories Schedule of Inventory, Current [Table Text Block] Interest Rate Swap Interest Rate Swap [Member] Debt Instrument [Axis] Debt Instrument [Axis] Derivative Liability, Noncurrent Derivative Liability, Noncurrent Outstanding Aggregate Erroneous Compensation Amount Outstanding Aggregate Erroneous Compensation Amount Payments of term loan Repayments of Debt Effective income tax rate Effective Income Tax Rate Reconciliation, Percent Installment payment Business Combinations, Contingent Consideration, Installment Payment Made Business Combinations, Contingent Consideration, Installment Payment Made Credit Facility [Axis] Credit Facility [Axis] Total liabilities Liabilities Total Shareholder Return Vs Peer Group Total Shareholder Return Vs Peer Group [Text Block] Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Amortization of deferred cloud computing implementation costs Amortization of deferred cloud computing implementation costs Amortization of deferred cloud computing implementation costs Accumulated other comprehensive (loss) income AOCI Attributable to Parent [Member] Aggregate Erroneous Compensation Amount Aggregate Erroneous Compensation Amount All Executive Categories All Executive Categories [Member] Business Unit [Axis] Business Unit [Axis] Business Unit Accumulated Other Comprehensive Income (Loss) [Table] Accumulated Other Comprehensive Income (Loss) [Table] Non-Rule 10b5-1 Arrangement Adopted Non-Rule 10b5-1 Arrangement Adopted [Flag] Debt Disclosure [Abstract] Debt Disclosure [Abstract] Earnings Per Share [Abstract] Earnings Per Share [Abstract] Decrease in unrecognized tax benefits is reasonably possible Decrease in Unrecognized Tax Benefits is Reasonably Possible Common stock, $0.001 par value per share; 126.2 shares authorized; 66.8 and 66.4 shares issued and outstanding at October 1, 2023 and January 1, 2023, respectively Common Stock, Value, Issued U.S. government securities US Government Debt Securities [Member] Employee compensation charges Employee Benefits and Share-Based Compensation Business Unit [Domain] Business Unit [Domain] Business Unit [Domain] Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization, Consolidation and Presentation of Financial Statements [Abstract] Awards Close in Time to MNPI Disclosures, Table Awards Close in Time to MNPI Disclosures [Table Text Block] Total current assets Assets, Current Business Acquisition, Pro Forma Information, Nonrecurring Adjustments [Table] Business Acquisition, Pro Forma Information, Nonrecurring Adjustments [Table] Payments on long-term borrowings and extinguishment costs Finance Lease, Principal Payments Assets and Liabilities Measured at Fair Value on Recurring Basis Fair Value, Liabilities Measured on Recurring Basis [Table Text Block] Contingent consideration Business Combination, Contingent Consideration, Liability Revenue from Contract with Customer [Abstract] All Individuals All Individuals [Member] SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION Supplemental Cash Flow Information [Abstract] Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table] Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table] Unrecognized tax benefits, income tax interest and penalties accrued Unrecognized Tax Benefits, Income Tax Penalties Accrued Other expense (income), net Other Nonoperating Income (Expense) Entity Filer Category Entity Filer Category Derivative Liability, Current, Statement of Financial Position [Extensible Enumeration] Derivative Liability, Current, Statement of Financial Position [Extensible Enumeration] Non-PEO NEO Average Total Compensation Amount Non-PEO NEO Average Total Compensation Amount Expected Value Contract Customers Expected Value Contract Customers [Member] Expected Value Contract Customers Statement [Table] Statement [Table] Current Fiscal Year End Date Current Fiscal Year End Date Derivative Instruments and Hedging Activities Disclosures [Line Items] Derivative Instruments and Hedging Activities Disclosures [Line Items] Repurchases of common stock (in shares) Stock Repurchased During Period, Shares Unrecognized tax benefits Unrecognized Tax Benefits PEO Name PEO Name Volatility rate Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum Percentage of risk concentration Concentration Risk, Percentage Fair Value, by Balance Sheet Grouping [Table] Fair Value, by Balance Sheet Grouping [Table] Schedule of Accumulated Other Comprehensive Income (Loss) Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block] Preferred stock, shares authorized (in shares) Preferred Stock, Shares Authorized Weighted-Average Grant Date Fair Value, Granted (in USD per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Goodwill Schedule of Goodwill [Table Text Block] Preferred stock, shares outstanding (in shares) Preferred Stock, Shares Outstanding Corporate asset-backed securities Asset-Backed Securities [Member] Marketable Securities [Line Items] Marketable Securities [Line Items] Net cash provided by operating activities Net Cash Provided by (Used in) Operating Activities Foreign currency cash flow hedge, gain (loss) to be reclassified during next 12 months Foreign Currency Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months Erroneously Awarded Compensation Recovery Erroneously Awarded Compensation Recovery [Table] Other Other Accrued Liabilities, Current Industry And Geographic Information [Abstract] Industry And Geographic Information [Abstract] Industry and Geographic Information [Abstract] Product Concentration Risk Product Concentration Risk [Member] Depreciation and amortization Depreciation and amortization Depreciation, Depletion and Amortization Accrued interest Interest and Dividends Payable Labs Labs [Member] Labs Award Timing, How MNPI Considered Award Timing, How MNPI Considered [Text Block] Accrued payroll and related expenses Increase (Decrease) in Employee Related Liabilities Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] Unwind inventory fair value adjustment Unwind inventory fair value adjustment Unwind Inventory Fair Value Adjustment Unwind Inventory Fair Value Adjustment Business Combination and Asset Acquisition [Abstract] Total stockholders’ equity Balance Balance Equity, Attributable to Parent Covenant Period [Axis] Covenant Period [Axis] Covenant Period Deferred revenue, revenue recognized Deferred Revenue, Revenue Recognized Unrecognized tax benefits the could impact effective tax rate Unrecognized Tax Benefits that Would Impact Effective Tax Rate Pro forma total revenues Business Acquisition, Pro Forma Revenue Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Available-for-Sale Investments AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-Sale, Including Noncontrolling Interest [Member] Changes in cumulative translation adjustment, net of tax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Accrued commissions, rebates and returns Customer Incentive, Payable, Current Customer Incentive, Payable, Current Concentration Risk Type [Axis] Concentration Risk Type [Axis] Expected option life (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term Total borrowings Long-Term Debt and Lease Obligation (Loss) income before income taxes (Loss) income before income taxes Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Contract assets Unbilled Contracts Receivable Non-designated hedging instruments Not Designated as Hedging Instrument [Member] Preferred stock, shares issued (in shares) Preferred Stock, Shares Issued Hedging Designation [Domain] Hedging Designation [Domain] Level 2 Fair Value, Inputs, Level 2 [Member] Entity Emerging Growth Company Entity Emerging Growth Company Intangible assets, net Intangible Assets, Net (Excluding Goodwill) Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Named Executive Officers, Footnote Named Executive Officers, Footnote [Text Block] Transfer of instrument inventories to fixed assets Noncash of Part Noncash Acquisition, Fixed Assets transferred from inventories Noncash of Part Noncash Acquisition, Fixed Assets transferred from inventories Document Fiscal Period Focus (Q1,Q2,Q3,FY) Document Fiscal Period Focus Remaining borrowing capacity Line of Credit Facility, Remaining Borrowing Capacity Pay vs Performance Disclosure, Table Pay vs Performance [Table Text Block] Antidilutive Securities [Axis] Antidilutive Securities [Axis] Share-Based Payment Arrangement Share-Based Payment Arrangement [Member] Title Trading Arrangement, Individual Title Stock-based compensation expense Share-Based Payment Arrangement, Noncash Expense Share-based liabilities paid Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Share-Based Liabilities Paid Revenue from External Customers by Geographic Areas Revenue from External Customers by Geographic Areas [Table Text Block] Common Stock Common Stock [Member] Individual: Individual [Axis] BNP Business BNP Business [Member] BNP Business [Member] City Area Code City Area Code Entity Address, Postal Zip Code Entity Address, Postal Zip Code Product and Service [Axis] Product and Service [Axis] Computation of Earnings Per Share Earnings Per Share [Text Block] Income Statement Location [Domain] Income Statement Location [Domain] Derivative Asset, Noncurrent Derivative Asset, Noncurrent Interest Rate Swap One Interest Rate Swap One [Member] Interest Rate Swap One Document Fiscal Year Focus Document Fiscal Year Focus Beginning balance Ending balance Equity, Including Portion Attributable to Noncontrolling Interest Marketable Securities [Table] Marketable Securities [Table] Tax impact related to cash flow hedges Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax Penalties and interest expense Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense Property, plant and equipment, net Property, Plant and Equipment, Net Customer B Customer B [Member] Customer B Exercise Price Award Exercise Price Fair value gain (loss) on derivative instruments not designated as hedging instruments Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net Other comprehensive income (loss), net of tax Other Comprehensive Income (Loss), Net of Tax Interest Rate Swap Three Interest Rate Swap Three [Member] Interest Rate Swap Three Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Accrued other taxes payable Accrual for Taxes Other than Income Taxes, Current ASSETS Assets [Abstract] Award Timing MNPI Disclosure Award Timing MNPI Disclosure [Text Block] Cash paid to former Ortho stockholders per Ortho Share (in usd per share) Business Combination, Consideration Transferred, Equity Interests Issued and Issuable, Cash Paid Per Acquiree Share Business Combination, Consideration Transferred, Equity Interests Issued and Issuable, Cash Paid Per Acquiree Share Total liabilities measured at fair value Liabilities, Fair Value Disclosure Payments of tax withholdings related to vesting of stock-based awards Payment, Tax Withholding, Share-Based Payment Arrangement Net cash (used for) provided by financing activities Net Cash Provided by (Used in) Financing Activities Deferred tax asset Deferred Income Tax Assets, Net Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Retained earnings Retained Earnings [Member] Less: current portion Long-Term Debt, Current Maturities Compensation Expense Related to Stock-Based Compensation Plans Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] Adjustment to Non-PEO NEO Compensation Footnote Adjustment to Non-PEO NEO Compensation Footnote [Text Block] Total liabilities and stockholders’ equity Liabilities and Equity Debt Securities, Available-for-sale, Amortized Cost Debt Securities, Available-for-Sale, Amortized Cost Other assets Other Assets, Noncurrent Peer Group Total Shareholder Return Amount Peer Group Total Shareholder Return Amount Total change in unrealized gains from cash flow hedges, net of tax Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax Basic (loss) earnings per share Earnings Per Share, Basic Right-of-use assets Operating Lease, Right-of-Use Asset Schedule of Long-term Debt Instruments [Table] Schedule of Long-Term Debt Instruments [Table] Accounting Policies [Abstract] Accounting Policies [Abstract] Derivative Asset, Current, Statement of Financial Position [Extensible Enumeration] Derivative Asset, Current, Statement of Financial Position [Extensible Enumeration] Equity Valuation Assumption Difference, Footnote Equity Valuation Assumption Difference, Footnote [Text Block] Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Abstract] Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Abstract] Erroneous Compensation Analysis Erroneous Compensation Analysis [Text Block] Allowance for doubtful accounts Allowance for doubtful accounts Allowance for doubtful accounts Arrangement Duration Trading Arrangement Duration Entity Address, City or Town Entity Address, City or Town Award Timing MNPI Considered Award Timing MNPI Considered [Flag] Schedule of Segment Reporting Information, by Segment Schedule of Segment Reporting Information, by Segment [Table Text Block] Stock options, term (in years) Share-Based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Remaining Contractual Term Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration] Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration] Balance Sheet Account Details Supplemental Balance Sheet Disclosures [Text Block] Document Transition Report Document Transition Report Award Timing Predetermined Award Timing Predetermined [Flag] Measurement period adjustments of goodwill Purchase accounting adjustments Goodwill, Purchase Accounting Adjustments Interest expense, net Interest Expense [Member] Schedule of Business Acquisitions, by Acquisition [Table] Schedule of Business Acquisitions, by Acquisition [Table] Derivative Instruments and Hedging Activities Disclosures [Table] Derivative Instruments and Hedging Activities Disclosures [Table] Termination Date Trading Arrangement Termination Date Proceeds from sale of marketable securities Proceeds from Sale and Maturity of Marketable Securities Accounts payable Increase (Decrease) in Accounts Payable Common stock, shares authorized (in shares) Common Stock, Shares Authorized Derivative instruments and other Derivative instruments and other Derivative instruments and other China China [Member] China Indemnification receivable Indemnification Receivable Indemnification Receivable Short-term Investments Short-Term Investments [Member] Derivative Instrument [Axis] Derivative Instrument [Axis] Term Loan Long-Term Debt, Gross Adjustments to reconcile net (loss) income to net cash provided by operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Related Party Transactions [Abstract] All Trading Arrangements All Trading Arrangements [Member] Pre tax gain (loss) from reclassification Interest Rate Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net All Adjustments to Compensation All Adjustments to Compensation [Member] Derivative [Line Items] Derivative [Line Items] Award Timing Disclosures [Line Items] Compensation Amount Outstanding Recovery Compensation Amount Additional paid-in capital Additional Paid in Capital Goodwill adjustment, decrease to income taxes payable Goodwill, Purchase Accounting Adjustment, Decrease To Income Taxes Payable Goodwill, Purchase Accounting Adjustment, Decrease To Income Taxes Payable Reclassification [Table] Reclassification [Table] Other comprehensive (loss) income Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract] Derivative assets Derivative Asset Covenant Period [Domain] Covenant Period [Domain] Covenant Period [Domain] Statement of Comprehensive Income [Abstract] Statement of Comprehensive Income [Abstract] Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table] Current portion of borrowings Debt, Current Prepaid expenses and other current assets Total prepaid expenses and other current assets Prepaid Expense and Other Assets, Current Insider Trading Arrangements [Line Items] Debt Payment Terms [Domain] Debt Payment Terms [Domain] Debt Payment Terms [Domain] Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items] Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items] Issuance of common stock under equity compensation plans (in shares) Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture Entity Registrant Name Entity Registrant Name Material Terms of Trading Arrangement Material Terms of Trading Arrangement [Text Block] Award Timing Method Award Timing Method [Text Block] Dilutive potential shares issuable from stock options and RSUs Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements Customers With Balances Due In Excess of 10% Of Accounts Receivable Customers With Balances Due In Excess of 10% Of Accounts Receivable [Member] Customers With Balances Due In Excess of 10% Of Accounts Receivable Issuance of shares in connection with the Combinations (in shares) Stock Issued During Period, Shares, Acquisitions Adjustment to Compensation, Amount Adjustment to Compensation Amount Ortho Ortho [Member] Ortho Cost of sales Cost of Sales [Member] Deferred consideration Other Deferred Compensation Arrangements, Liability, Current and Noncurrent Reduction of other current liabilities upon issuance of restricted share units Receivable For Stock Option Exercises Receivable For Stock Option Exercises Document Period End Date Document Period End Date Proceeds from lines of credit Proceeds from Lines of Credit Compensation Actually Paid vs. Net Income Compensation Actually Paid vs. Net Income [Text Block] Adoption Date Trading Arrangement Adoption Date Peer Group Issuers, Footnote Peer Group Issuers, Footnote [Text Block] Total revenues Sales [Member] Financing lease obligation Finance Lease, Liability, Noncurrent Accounts Receivable, Net Accounts Receivable, Allowance for Credit Loss [Table Text Block] Pro Forma Financial Information Business Acquisition, Pro Forma Information [Table Text Block] Entity Central Index Key Entity Central Index Key Liabilities: Liabilities, Fair Value Disclosure [Abstract] Derivative mark-to-market gain Derivative, Gain (Loss) on Derivative, Net Basis of Presentation and Summary of Significant Accounting Policies Basis of Presentation and Significant Accounting Policies [Text Block] Total stock-based compensation expense Share-Based Payment Arrangement, Expense Non-Rule 10b5-1 Arrangement Terminated Non-Rule 10b5-1 Arrangement Terminated [Flag] (Benefit from) provision for income taxes Income Tax Expense (Benefit) Finished goods (materials, labor and overhead) Inventory, Finished Goods, Net of Reserves Schedule of Derivative Instruments, Effect on Other Comprehensive (Loss) Income Schedule of Derivative Instruments, Effect on Other Comprehensive Income (Loss) [Table Text Block] Designated cash flow hedges Designated as Hedging Instrument [Member] Accrued payroll and related expenses Employee-related Liabilities, Current Fair Value Measurements Fair Value Disclosures [Text Block] Cash Flow Hedges Accumulated Gain (Loss), Cash Flow Hedge, Including Noncontrolling Interest [Member] Interest Rate Swap Five Interest Rate Swap Five [Member] Interest Rate Swap Five Revenue Benchmark Revenue Benchmark [Member] Name Trading Arrangement, Individual Name Amounts reclassified to net income Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax Net change Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent Impairment of long-lived assets Impairment of Long-Lived Assets to be Disposed of Disaggregation of Revenue Disaggregation of Revenue [Table Text Block] Segment Adjusted EBITDA Segment Adjusted EBITDA Segment Adjusted EBITDA Equity [Abstract] Equity [Abstract] Ortho Exchange Ratio (in shares) Business Combination, Consideration Transferred, Equity Interests Issued and Issuable, Entity Shares Issued Per Acquiree Share Business Combination, Consideration Transferred, Equity Interests Issued and Issuable, Entity Shares Issued Per Acquiree Share Other receivables Other Receivables, Net, Current Compensation Actually Paid vs. Company Selected Measure Compensation Actually Paid vs. Company Selected Measure [Text Block] Long-term Debt, Type [Axis] Long-Term Debt, Type [Axis] Amendment Flag Amendment Flag Interest Rate Swap Four Interest Rate Swap Four [Member] Interest Rate Swap Four Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Acquisition of businesses, net of cash and restricted cash acquired Payments to Acquire Businesses, Net of Cash Acquired Tax withholdings related to vesting of stock-based awards (in shares) Share-Based Payment Arrangement, Shares Withheld for Tax Withholding Obligation Interest expense, net Interest expense, net Interest expense, net Interest Income (Expense), Net Credit Facility [Domain] Credit Facility [Domain] Compensation Actually Paid vs. Other Measure Compensation Actually Paid vs. Other Measure [Text Block] Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration] Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration] Selling, marketing and administrative Selling and Marketing Expense [Member] Weighted-average shares outstanding - diluted Diluted weighted-average shares of common stock outstanding Weighted Average Number of Shares Outstanding, Diluted Point of Care Point of Care [Member] Point of Care Prepaid expenses and other current and non-current assets Increase (Decrease) in Prepaid Expenses, Other Forgone Recovery, Explanation of Impracticability Forgone Recovery, Explanation of Impracticability [Text Block] Respiratory Respiratory [Member] Respiratory Ending after initial measurement period Ending After Initial Measurement Period [Member] Ending After Initial Measurement Period Derivative Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration] Derivative Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration] Cash equivalents Money Market Funds, at Carrying Value Revenue Revenue from Contract with Customer [Text Block] Goodwill adjustment, decrease to deferred tax assets Goodwill, Purchase Accounting Adjustment, DecreaseTo Deferred Tax Assets Goodwill, Purchase Accounting Adjustment, DecreaseTo Deferred Tax Assets Acquisitions of property, plant, equipment, investments and intangibles Payments to Acquire Property, Plant, and Equipment Company Selected Measure Amount Company Selected Measure Amount Net unrealized gains on derivative instruments Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax Transfusion Medicine Transfusion Medicine [Member] Transfusion Medicine Balance Sheet Location [Axis] Balance Sheet Location [Axis] Total assets Assets Name Awards Close in Time to MNPI Disclosures, Individual Name Loss on investments Income (Loss) from Equity Method Investments Customer 2 Customer 2 [Member] Customer 2 Stock-based compensation expense APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Pension and Other Post- Employment Benefits Accumulated Defined Benefit Plans Adjustment Including Portion Attributable to Noncontrolling Interest [Member] Other Current Liabilities Other Current Liabilities [Table Text Block] Other liabilities Other Liabilities, Noncurrent Non-NEOs Non-NEOs [Member] Other Nonoperating Income (Expense) Other Nonoperating Income (Expense) [Member] Acquisition and integration costs Acquisition-related Costs [Member] Payment of accreted interest on contingent and deferred consideration Payment Of Accreted Interest On Contingent Consideration Liability And Deferred Consideration, Operating Activities Payment Of Accreted Interest On Contingent Consideration Liability And Deferred Consideration, Operating Activities Segment and Geographic Information Segment Reporting Disclosure [Text Block] Sovereign government bonds Debt Security, Government, Non-US [Member] Net decrease in cash, cash equivalents and restricted cash Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect EU medical device regulation transition costs EU medical device regulation transition costs EU medical device regulation transition costs FINANCING ACTIVITIES Net Cash Provided by (Used in) Financing Activities [Abstract] Term Loan Secured Debt [Member] Non-PEO NEO Non-PEO NEO [Member] Total marketable securities Marketable securities Marketable Securities Equity Component [Domain] Equity Component [Domain] Adjustment to Compensation: Adjustment to Compensation [Axis] Work-in-process (materials, labor and overhead) Inventory, Work in Process, Net of Reserves Non-GAAP Measure Description Non-GAAP Measure Description [Text Block] Scenario [Axis] Scenario [Axis] Voluntary Prepayment Voluntary Prepayment [Member] Voluntary Prepayment Debt Instrument [Line Items] Debt Instrument [Line Items] Contract assets Contract with Customer, Asset, after Allowance for Credit Loss Customer 1 Customer 1 [Member] Customer 1 Weighted-average shares outstanding - basic Basic weighted-average shares of common stock outstanding Weighted Average Number of Shares Outstanding, Basic Entity Current Reporting Status Entity Current Reporting Status Inventories, including noncurrent portion, net Inventories, including noncurrent portion, net Inventories, including noncurrent portion, net Concentration Risk Type [Domain] Concentration Risk Type [Domain] Operating income Operating Income (Loss) PotentialWeightedAverageNumberOfDilutedSharesOutstandingDiluted weighted-average shares of common stock outstanding Potential Dilutive Effect On Weighted Average Number Of Shares Outstanding PotentialWeightedAverageNumberOfDilutedSharesOutstanding Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Axis] Interest Rate Swap Two Interest Rate Swap Two [Member] Interest Rate Swap Two Agency bonds Agency bonds [Member] Agency bonds Pay vs Performance Disclosure Pay vs Performance Disclosure [Table] Segments [Axis] Segments [Axis] Statement [Line Items] Statement [Line Items] Scenario [Domain] Scenario [Domain] Schedule of Currency Hedging Instruments Schedule of Derivative Instruments [Table Text Block] Forgone Recovery due to Disqualification of Tax Benefits, Amount Forgone Recovery due to Disqualification of Tax Benefits, Amount Awards Close in Time to MNPI Disclosures Awards Close in Time to MNPI Disclosures [Table] EX-101.PRE 9 qdel-20231001_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 10 R1.htm IDEA: XBRL DOCUMENT v3.23.3
Cover Page - shares
 9 Months Ended
Oct. 01, 2023
Oct. 25, 2023
Document And Entity Information [Abstract]    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Oct. 01, 2023  
Document Transition Report false  
Entity File Number 001-41409  
Entity Registrant Name QUIDELORTHO CORP  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 87-4496285  
Entity Address, Address Line One 9975 Summers Ridge Road  
Entity Address, City or Town San Diego  
Entity Address, State or Province CA  
Entity Address, Postal Zip Code 92121  
City Area Code 858  
Local Phone Number 552-1100  
Title of 12(b) Security Common Stock, $0.001 Par Value  
Trading Symbol QDEL  
Security Exchange Name NASDAQ  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Large Accelerated Filer  
Entity Small Business false  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   66,818,718
Entity Central Index Key 0001906324  
Current Fiscal Year End Date --12-31  
Document Fiscal Year Focus 2023  
Document Fiscal Period Focus (Q1,Q2,Q3,FY) Q3  
Amendment Flag false  
XML 11 R2.htm IDEA: XBRL DOCUMENT v3.23.3
Consolidated Balance Sheets - USD ($)
$ in Millions
Oct. 01, 2023
Jan. 01, 2023
Current assets:    
Cash and cash equivalents $ 149.3 $ 292.9
Marketable securities 43.9 52.1
Accounts receivable, net 331.2 453.9
Inventories 551.7 524.1
Prepaid expenses and other current assets 295.2 252.1
Total current assets 1,371.3 1,575.1
Property, plant and equipment, net 1,369.4 1,339.0
Marketable securities 11.9 21.0
Right-of-use assets 172.2 181.0
Goodwill 2,442.9 2,476.8
Intangible assets, net 2,976.5 3,123.8
Deferred tax asset 15.7 16.4
Other assets 179.2 122.7
Total assets 8,539.1 8,855.8
Current liabilities:    
Accounts payable 253.0 283.3
Accrued payroll and related expenses 106.8 139.2
Income tax payable 1.8 51.6
Current portion of borrowings 193.0 207.5
Other current liabilities 305.4 325.4
Total current liabilities 860.0 1,007.0
Operating lease liabilities 175.9 186.4
Long-term borrowings 2,274.6 2,430.8
Deferred tax liability 196.5 213.2
Other liabilities 65.4 83.8
Total liabilities 3,572.4 3,921.2
Commitments and contingencies (Note 10)
Stockholders’ equity:    
Preferred stock, $0.001 par value per share; 5.0 shares authorized; none issued or outstanding at October 1, 2023 and January 1, 2023 0.0 0.0
Common stock, $0.001 par value per share; 126.2 shares authorized; 66.8 and 66.4 shares issued and outstanding at October 1, 2023 and January 1, 2023, respectively 0.1 0.0
Additional paid-in capital 2,839.0 2,804.3
Accumulated other comprehensive loss (53.2) (67.6)
Retained earnings 2,180.8 2,197.9
Total stockholders’ equity 4,966.7 4,934.6
Total liabilities and stockholders’ equity $ 8,539.1 $ 8,855.8
XML 12 R3.htm IDEA: XBRL DOCUMENT v3.23.3
Consolidated Balance Sheets (Parenthetical) - $ / shares
Oct. 01, 2023
Jan. 01, 2023
Statement of Financial Position [Abstract]    
Preferred stock, par value per share (in dollars per share) $ 0.001 $ 0.001
Preferred stock, shares authorized (in shares) 5,000,000.0 5,000,000.0
Preferred stock, shares issued (in shares) 0 0
Preferred stock, shares outstanding (in shares) 0 0
Common stock, par value per share (in dollars per share) $ 0.001 $ 0.001
Common stock, shares authorized (in shares) 126,200,000 126,200,000
Common stock, shares issued (in shares) 66,800,000 66,400,000
Common stock, shares outstanding (in shares) 66,800,000 66,400,000
XML 13 R4.htm IDEA: XBRL DOCUMENT v3.23.3
Consolidated Statements of Income - USD ($)
shares in Millions, $ in Millions
 3 Months Ended 9 Months Ended
Oct. 01, 2023
Oct. 02, 2022
Oct. 01, 2023
Oct. 02, 2022
Income Statement [Abstract]        
Total revenues $ 744.0 $ 783.8 $ 2,255.2 $ 2,399.5
Cost of sales, excluding amortization of intangibles 375.9 376.3 1,142.1 912.5
Selling, marketing and administrative 194.1 204.2 575.6 407.4
Research and development 62.4 65.6 187.5 126.2
Amortization of intangible assets 51.4 50.5 153.6 78.6
Acquisition and integration costs 26.5 26.4 80.4 109.6
Other operating expenses 7.4 4.0 17.0 8.0
Operating income 26.3 56.8 99.0 757.2
Interest expense, net 37.7 29.7 110.9 41.0
Loss on extinguishment of debt 0.0 0.0 0.0 24.0
Other expense (income), net 4.1 (4.2) 8.0 (2.6)
(Loss) income before income taxes (15.5) 31.3 (19.9) 694.8
(Benefit from) provision for income taxes (2.8) 12.1 (2.8) 176.4
Net (loss) income $ (12.7) $ 19.2 $ (17.1) $ 518.4
Basic (loss) earnings per share $ (0.19) $ 0.29 $ (0.26) $ 9.67
Diluted (loss) earnings per share $ (0.19) $ 0.28 $ (0.26) $ 9.56
Weighted-average shares outstanding - basic 66.9 66.9 66.8 53.6
Weighted-average shares outstanding - diluted 66.9 67.5 66.8 54.2
XML 14 R5.htm IDEA: XBRL DOCUMENT v3.23.3
Consolidated Statements of Comprehensive Income (Loss) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Oct. 01, 2023
Oct. 02, 2022
Oct. 01, 2023
Oct. 02, 2022
Statement of Comprehensive Income [Abstract]        
Net (loss) income $ (12.7) $ 19.2 $ (17.1) $ 518.4
Other comprehensive (loss) income        
Changes in cumulative translation adjustment, net of tax (55.3) (92.9) (17.2) (158.9)
Changes in unrealized gains (losses) from investments, net of tax 0.2 0.0 0.3 (0.6)
Net unrealized gains on derivative instruments 24.5 9.3 47.6 13.9
Reclassification of net realized (gains) losses on derivative instruments included in net (loss) income (6.3) (0.2) (16.3) 0.7
Total change in unrealized gains from cash flow hedges, net of tax 18.2 9.1 31.3 14.6
Comprehensive (loss) income $ (49.6) $ (64.6) $ (2.7) $ 373.5
XML 15 R6.htm IDEA: XBRL DOCUMENT v3.23.3
Consolidated Statements of Stockholders' Equity Statement - USD ($)
shares in Millions, $ in Millions
Total
Common Stock
Additional paid-in capital
Accumulated other comprehensive (loss) income
Retained earnings
Balance (in shares) at Jan. 02, 2022   41.7      
Balance at Jan. 02, 2022 $ 1,929.4 $ 0.0 $ 279.8 $ 0.4 $ 1,649.2
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock under equity compensation plans (in shares)   0.2      
Issuance of common stock under equity compensation plans 6.4   6.4    
Stock-based compensation expense 6.2   6.2    
Tax withholdings related to vesting of stock-based awards (in shares)   (0.1)      
Tax withholdings related to vesting of stock-based awards (6.8)   (6.8)    
Other comprehensive income (loss), net of tax (0.2)     (0.2)  
Net (loss) income 479.9       479.9
Balance (in shares) at Apr. 03, 2022   41.8      
Balance at Apr. 03, 2022 2,414.9 $ 0.0 285.6 0.2 2,129.1
Balance (in shares) at Jan. 02, 2022   41.7      
Balance at Jan. 02, 2022 1,929.4 $ 0.0 279.8 0.4 1,649.2
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net (loss) income 518.4        
Balance (in shares) at Oct. 02, 2022   66.0      
Balance at Oct. 02, 2022 4,795.3 $ 0.0 2,772.2 (144.5) 2,167.6
Balance (in shares) at Apr. 03, 2022   41.8      
Balance at Apr. 03, 2022 2,414.9 $ 0.0 285.6 0.2 2,129.1
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock under equity compensation plans (in shares)   0.1      
Issuance of common stock under equity compensation plans 0.8   0.8    
Stock-based compensation expense 14.7   14.7    
Issuance of shares in connection with the Combinations (in shares)   25.1      
Issuance of shares in connection with the Combinations 2,495.4   2,495.4    
Issuance of equity replacement awards in connection with the Combinations 36.1   36.1    
Tax withholdings related to vesting of stock-based awards (0.7)   (0.7)    
Other comprehensive income (loss), net of tax (60.9)     (60.9)  
Net (loss) income 19.3       19.3
Balance (in shares) at Jul. 03, 2022   67.0      
Balance at Jul. 03, 2022 4,919.6 $ 0.0 2,831.9 (60.7) 2,148.4
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock under equity compensation plans 2.6   2.6    
Stock-based compensation expense 12.6   12.6    
Tax withholdings related to vesting of stock-based awards (0.6)   (0.6)    
Repurchases of common stock (in shares)   (1.0)      
Repurchases of common stock (74.3)   (74.3)    
Other comprehensive income (loss), net of tax (83.8)     (83.8)  
Net (loss) income 19.2       19.2
Balance (in shares) at Oct. 02, 2022   66.0      
Balance at Oct. 02, 2022 4,795.3 $ 0.0 2,772.2 (144.5) 2,167.6
Balance (in shares) at Jan. 01, 2023   66.4      
Balance at Jan. 01, 2023 4,934.6 $ 0.0 2,804.3 (67.6) 2,197.9
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock under equity compensation plans (in shares)   0.3      
Issuance of common stock under equity compensation plans 3.9 $ 0.1 3.8    
Stock-based compensation expense 10.4   10.4    
Tax withholdings related to vesting of stock-based awards (in shares)   (0.1)      
Tax withholdings related to vesting of stock-based awards (9.5)   (9.5)    
Other comprehensive income (loss), net of tax 8.3     8.3  
Net (loss) income 48.8       48.8
Balance (in shares) at Apr. 02, 2023   66.6      
Balance at Apr. 02, 2023 4,996.5 $ 0.1 2,809.0 (59.3) 2,246.7
Balance (in shares) at Jan. 01, 2023   66.4      
Balance at Jan. 01, 2023 4,934.6 $ 0.0 2,804.3 (67.6) 2,197.9
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net (loss) income (17.1)        
Balance (in shares) at Oct. 01, 2023   66.8      
Balance at Oct. 01, 2023 4,966.7 $ 0.1 2,839.0 (53.2) 2,180.8
Balance (in shares) at Apr. 02, 2023   66.6      
Balance at Apr. 02, 2023 4,996.5 $ 0.1 2,809.0 (59.3) 2,246.7
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock under equity compensation plans (in shares)   0.2      
Issuance of common stock under equity compensation plans 5.5   5.5    
Stock-based compensation expense 13.7   13.7    
Tax withholdings related to vesting of stock-based awards (3.0)   (3.0)    
Other comprehensive income (loss), net of tax 43.0     43.0  
Net (loss) income (53.2)       (53.2)
Balance (in shares) at Jul. 02, 2023   66.8      
Balance at Jul. 02, 2023 5,002.5 $ 0.1 2,825.2 (16.3) 2,193.5
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock under equity compensation plans 0.8   0.8    
Stock-based compensation expense 13.5   13.5    
Tax withholdings related to vesting of stock-based awards (0.5)   (0.5)    
Other comprehensive income (loss), net of tax (36.9)     (36.9)  
Net (loss) income (12.7)       (12.7)
Balance (in shares) at Oct. 01, 2023   66.8      
Balance at Oct. 01, 2023 $ 4,966.7 $ 0.1 $ 2,839.0 $ (53.2) $ 2,180.8
XML 16 R7.htm IDEA: XBRL DOCUMENT v3.23.3
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
 9 Months Ended
Oct. 01, 2023
Oct. 02, 2022
OPERATING ACTIVITIES    
Net (loss) income $ (17.1) $ 518.4
Adjustments to reconcile net (loss) income to net cash provided by operating activities:    
Depreciation and amortization 341.8 167.0
Stock-based compensation expense 39.3 36.6
Net change in operating lease right-of-use assets and liabilities 0.1 9.9
Payment of accreted interest on contingent and deferred consideration (9.7) (10.4)
Loss on extinguishment of debt 0.0 24.0
Unwind inventory fair value adjustment 0.0 46.6
Other non-cash, net (4.9) (3.7)
Changes in assets and liabilities:    
Accounts receivable 124.1 181.6
Inventories (146.0) (97.9)
Prepaid expenses and other current and non-current assets (35.1) (41.3)
Accounts payable (6.3) 9.2
Accrued payroll and related expenses (31.0) (3.6)
Income taxes payable (51.3) (9.2)
Other current and non-current liabilities (4.1) (111.3)
Net cash provided by operating activities 199.8 715.9
INVESTING ACTIVITIES    
Acquisitions of property, plant, equipment, investments and intangibles (160.7) (79.2)
Acquisition of businesses, net of cash and restricted cash acquired 0.0 (1,511.4)
Proceeds from government assistance allocated to fixed assets 10.5 15.8
Purchases of marketable securities (50.6) (49.4)
Proceeds from sale of marketable securities 68.3 39.3
Net cash used for investing activities (132.5) (1,584.9)
FINANCING ACTIVITIES    
Proceeds from issuance of common stock 8.1 5.2
Short-term borrowings, net 2.9 0.0
Proceeds from long-term borrowings, net of debt issuance costs 0.0 2,734.5
Payments on long-term borrowings and extinguishment costs (175.7) (2,336.1)
Payments of tax withholdings related to vesting of stock-based awards (13.0) (8.0)
Repurchases of common stock 0.0 (74.3)
Principal payments of acquisition contingent consideration 0.0 (4.2)
Principal payments of deferred consideration (30.3) (33.4)
Net cash (used for) provided by financing activities (208.0) 283.7
Effect of exchange rates on cash (3.3) (4.3)
Net decrease in cash, cash equivalents and restricted cash (144.0) (589.6)
Cash, cash equivalents and restricted cash at beginning of period 293.9 802.8
Cash, cash equivalents and restricted cash at end of period 149.9 213.2
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION    
Purchase of property, equipment and intangibles by incurring current liabilities 11.4 17.4
Capital expenditures to be reimbursed under a government contract 3.0 0.0
Transfer of instrument inventories to fixed assets 105.8 48.6
Reduction of other current liabilities upon issuance of restricted share units $ 1.9 $ 4.6
XML 17 R8.htm IDEA: XBRL DOCUMENT v3.23.3
Basis of Presentation and Summary of Significant Accounting Policies
 9 Months Ended
Oct. 01, 2023
Accounting Policies [Abstract]  
Basis of Presentation and Summary of Significant Accounting Policies Basis of Presentation and Summary of Significant Accounting Policies
Basis of Presentation
The accompanying unaudited Consolidated Financial Statements of QuidelOrtho Corporation and its subsidiaries (the “Company” or “QuidelOrtho”) have been prepared in accordance with generally accepted accounting principles in the U.S. (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation (consisting of normal recurring accruals) have been included.
The information at October 1, 2023, and for the three and nine months ended October 1, 2023 and October 2, 2022, is unaudited. For further information, refer to the Company’s Consolidated Financial Statements and notes thereto for the fiscal year ended January 1, 2023 included in QuidelOrtho’s 2022 Annual Report on Form 10-K. Operating results for any quarter are historically seasonal in nature and are not necessarily indicative of the results expected for the full year.
The Company follows the concept of a fiscal year that ends on the Sunday nearest to the end of the month of December, and fiscal quarters that end on the Sunday nearest to the end of the months of March, June and September. For 2023 and 2022, the Company’s fiscal year will end or has ended on December 31, 2023 and January 1, 2023, respectively. For 2023 and 2022, the Company’s third quarter ended on October 1, 2023 and October 2, 2022, respectively. The three and nine months ended October 1, 2023 and October 2, 2022 each included 13 and 39 weeks, respectively.
Use of Estimates
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses and the related disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
Significant Accounting Policies
During the nine months ended October 1, 2023, there have been no changes to the Company’s significant accounting policies as described in the Company’s 2022 Annual Report on Form 10-K, except for the following policy, which was the result of a change in accounting estimates:
Revenue Recognition
The Company generates a portion of its revenue from sales of the QuickVue At-Home OTC COVID-19 tests to retail customers. The Company estimates the transaction price for revenue from sales to retail customers based on historical experience and current trends to evaluate when uncertainties related to right of return provisions are resolved. In prior periods, due to a lack of history on which to base an estimate of products to be returned from retailers, the Company established a reserve based on an estimate of total inventory remaining at our retailers that was subject to return.
During the three months ended October 1, 2023, the Company concluded that it had developed sufficient historical experience regarding the pattern in customer returns to be able to estimate the amount of consideration to which we expect to be entitled, excluding consideration for the products expected to be returned. Amounts received or receivable that are expected to be returned are recognized as a refund liability, which is included in Other current liabilities. The refund liability is estimated utilizing historical sale and return rates over the period during which customers have a right of return, taking into account available information on competitive products and contract changes. The refund liability is remeasured at each reporting period to reflect changes in assumptions about expected returns. Revenue from sales to retail customers amounted to approximately 3% of Total revenues for the nine months ended October 1, 2023. This change in estimate did not have a material impact on the Company’s Consolidated Financial Statements.
Recent Accounting Pronouncements
There have been no accounting pronouncements issued or adopted during the nine months ended October 1, 2023 that are expected to have a material impact on the Company’s Consolidated Financial Statements.
XML 18 R9.htm IDEA: XBRL DOCUMENT v3.23.3
Business Combination
 9 Months Ended
Oct. 01, 2023
Business Combination and Asset Acquisition [Abstract]  
Business Combination Business Combination
On May 27, 2022, pursuant to a Business Combination Agreement entered into as of December 22, 2021 (the “BCA”), by and among Quidel Corporation (“Quidel”), Ortho Clinical Diagnostics Holdings plc (“Ortho”), QuidelOrtho (formerly Coronado Topco, Inc.), Orca Holdco, Inc., Laguna Merger Sub, Inc. and Orca Holdco 2, Inc., Quidel and Ortho consummated a business combination (the “Combinations”) and each of Quidel and Ortho became a wholly owned subsidiary of QuidelOrtho. As a result of the Combinations, QuidelOrtho became the successor issuer to Quidel. The Combinations enhance the Company’s revenue profile and expand the Company’s geographic footprint and product diversity.
The Combinations were completed for a total consideration of approximately $4.3 billion, which included the fair value of equity issued based on the May 26, 2022 closing price of $99.60 per share of Quidel common stock. Former Ortho shareholders received $7.14 in cash and 0.1055 shares of QuidelOrtho common stock for each Ortho ordinary share. The Company funded the cash portion of the purchase price with cash on its balance sheet and a portion of the Term Loan proceeds from the Financing (each as defined in Note 8).
The Combinations have been accounted for as a business combination, which requires that assets acquired and liabilities assumed be recognized at their fair value as of the date of the consummation of the Combinations, with Quidel considered the accounting and the legal acquirer. The assessment of the fair value of assets acquired and liabilities assumed was finalized in the second quarter of 2023. Measurement period adjustments in fiscal year 2023 decreased goodwill by $23.9 million, reflecting (i) a decrease of $22.3 million to deferred tax liability, (ii) a decrease of $2.9 million to income tax payable and (iii) a decrease of $1.3 million in deferred tax asset. The related impact to net earnings that would have been recognized in previous periods if the adjustments were recognized as of the date of the consummation of the Combinations is immaterial to the Company’s Consolidated Financial Statements.
The following unaudited supplemental pro forma financial information shows the combined results of operations of the Company as if the Combinations had occurred on January 4, 2021, the beginning of the periods presented:
Three Months EndedNine Months Ended
(In millions)October 2, 2022October 3, 2021October 2, 2022October 3, 2021
Pro forma total revenues$783.8 $1,032.3 $3,184.7 $2,583.5 
Pro forma net income50.2 225.2 549.5 340.2 
This unaudited supplemental pro forma financial information is presented for informational purposes only and is not indicative of the results of operations that would have been achieved had the Combinations been completed at the beginning of fiscal year 2021. In addition, the unaudited supplemental pro forma financial information is not a projection of the Company’s future results of operations, nor does it reflect the expected realization of any synergies or cost savings associated with the Combinations. The unaudited supplemental pro forma financial information includes adjustments for:
•incremental intangible assets amortization expense based on the preliminary fair values of the identifiable intangible assets acquired;
•incremental cost of sales related to the fair value step-up of inventory;
•decreases in interest expense associated with the issuance of debt to finance the Combinations and to repay Ortho’s then-outstanding indebtedness, including the net impact of the removal of the amortization of the discount on Ortho’s indebtedness and the change in amortization of deferred financing fees;
•the removal of loss on extinguishment of debt from Ortho’s results in fiscal year 2021 and the reclassification of loss on extinguishment of debt in fiscal years 2021 and 2022;
•the reclassification of expense related to the accelerated vesting of certain stock awards of Ortho’s former chief executive officer; and
•tax impacts related to the above adjustments.
XML 19 R10.htm IDEA: XBRL DOCUMENT v3.23.3
Computation of Earnings Per Share
 9 Months Ended
Oct. 01, 2023
Earnings Per Share [Abstract]  
Computation of Earnings Per Share Computation of Earnings Per ShareBasic earnings per share (“EPS”) is computed by dividing Net (loss) income by the weighted-average number of shares of common stock outstanding. Diluted EPS is computed based on the sum of the weighted-average number of shares of common stock and potentially dilutive shares of common stock outstanding during the period. Potentially dilutive shares of common stock consist of shares issuable from stock options and unvested restricted stock units (“RSUs”). Potentially dilutive shares of common stock from outstanding stock options and unvested RSUs are determined using the average share price for each period under the treasury stock method.
The following table presents the calculation of the weighted-average shares used in computing basic and diluted EPS:
Three Months EndedNine Months Ended
(In millions)October 1, 2023October 2, 2022October 1, 2023October 2, 2022
Basic weighted-average shares of common stock outstanding66.9 66.9 66.8 53.6 
Dilutive potential shares issuable from stock options and RSUs(1)
— 0.6 — 0.6 
Diluted weighted-average shares of common stock outstanding66.9 67.5 66.8 54.2 
(1) In the three and nine months ended October 1, 2023, all potential shares of common stock issuable for stock options and RSUs were excluded from the dilutive calculations above because the effect of including them would have been anti-dilutive. The dilutive effect of potential shares of common stock issuable for stock options and RSUs on the weighted-average number of shares of common stock outstanding would have been as follows:
Three Months EndedNine Months Ended
(In millions)October 1, 2023October 1, 2023
Basic weighted-average shares of common stock outstanding66.9 66.8 
Dilutive potential shares issuable from stock options and RSUs0.4 0.5 
Diluted weighted-average shares of common stock outstanding67.3 67.3 
Stock options and RSUs where the combined exercise price and unrecognized stock-based compensation was greater than the average market price for the Company’s common stock were not included in the computations of diluted weighted-average shares because the effect would have been anti-dilutive. These stock options and RSUs represented 1.7 million and 1.6 million shares of common stock for the three and nine months ended October 1, 2023, respectively, and 1.0 million shares of common stock for each of the three and nine months ended October 2, 2022.
XML 20 R11.htm IDEA: XBRL DOCUMENT v3.23.3
Revenue
 9 Months Ended
Oct. 01, 2023
Revenue from Contract with Customer [Abstract]  
Revenue Revenue
Contract Balances
Timing of revenue recognition may differ from timing of invoicing to customers. The Company records an asset when revenue is recognized prior to invoicing a customer (a “contract asset”). Contract assets are included within Prepaid expenses and other current assets in the Company’s Consolidated Balance Sheets and are transferred to accounts receivable when the right to payment becomes unconditional. The balance of contract assets recorded in the Company’s Consolidated Balance Sheets as of October 1, 2023 and January 1, 2023 was $53.5 million and $49.6 million, respectively.
The contract asset balance consisted of the following components, all of which related to agreements acquired by the Company in connection with the Combinations:
•a customer supply agreement under which the difference between the timing of invoicing and revenue recognition resulted in a contract asset of $3.8 million and $6.8 million as of October 1, 2023 and January 1, 2023, respectively;
•contractual arrangements with certain customers under which the Company invoices the customers based on reportable results generated by its reagents; however, control of the goods transfers to the customers upon shipment or delivery of the products, as determined under the terms of the contract. Using the expected value method, the Company estimates the number of reagents that will generate a reportable result. The Company records the revenue upon shipment and an associated contract asset, and relieves the contract asset upon completion of the invoicing. The balance of the contract asset related to these arrangements was $42.4 million and $38.5 million as of October 1, 2023 and January 1, 2023, respectively; and
•one of the Company’s contract manufacturing agreements that recognizes revenue as the products are manufactured resulted in a contract asset of $7.3 million and $4.3 million as of October 1, 2023 and January 1, 2023, respectively.
The Company reviews contract assets for expected credit losses resulting from the collectability of customer accounts. Expected losses are established based on historical losses, customer mix and credit policies, current economic conditions in customers’ country or industry, and expectations associated with reasonable and supportable forecasts. No credit losses related to contract assets were recognized during the three and nine months ended October 1, 2023.
The Company recognizes a contract liability when a customer pays an invoice prior to the Company transferring control of the goods or services (“contract liabilities”). The Company’s contract liabilities consist of deferred revenue primarily related to customer service contracts. The Company classifies deferred revenue as current or non-current based on the timing of the transfer of control or performance of the service. The balance of the Company’s current deferred revenue was $34.6 million as
of October 1, 2023 and $76.4 million as of January 1, 2023. The Company has one arrangement with a customer where the revenue is expected to be recognized beyond one year. The balance of the deferred revenue included in long-term liabilities was $13.5 million and $9.4 million as of October 1, 2023 and January 1, 2023, respectively, and was included in Other liabilities in the Consolidated Balance Sheets. The amount of deferred revenue as of January 1, 2023 that was recorded in Total revenues during the three and nine months ended October 1, 2023 was $2.4 million and $70.9 million, respectively.
Joint Business with Grifols
In connection with the Combinations, the Company acquired the ongoing collaboration arrangement (the “Joint Business”) between Ortho and Grifols Diagnostic Solutions, Inc. (“Grifols”), under which Ortho and Grifols agreed to pursue a collaboration relating to Ortho’s Hepatitis and HIV diagnostics business. The governance of the Joint Business is shared through a supervisory board made up of equal representation by Ortho and Grifols, which is responsible for all significant decisions relating to the Joint Business that are not exclusively assigned to either Ortho or Grifols, as defined in the Joint Business agreement. The Company’s portion of the pre-tax net profit shared under the Joint Business was $8.9 million and $38.6 million during the three and nine months ended October 1, 2023, respectively, and $7.9 million and $13.5 million during the three and nine months ended October 2, 2022, respectively. These amounts included the Company’s portion of the pre-tax net profit of $7.3 million and $14.0 million during the three and nine months ended October 1, 2023, respectively, and $5.2 million and $8.8 million during the three and nine months ended October 2, 2022, respectively, on sales transactions with third parties where the Company is the principal. The Company recognized revenues, cost of sales, excluding amortization of intangibles, and operating expenses, on a gross basis on these sales transactions in their respective lines in the Consolidated Statements of (Loss) Income. The Company’s portion of the pre-tax net profit also included revenue from collaboration and royalty agreements of $1.6 million and $24.6 million during the three and nine months ended October 1, 2023, respectively, and $2.7 million and $4.7 million during the three and nine months ended October 2, 2022, respectively, which is presented on a net basis within Total revenues.
Disaggregation of Revenue
The following table summarizes Total revenues by business unit:
Three Months EndedNine Months Ended
(In millions)October 1, 2023October 2, 2022October 1, 2023October 2, 2022
Labs$341.4 $334.8 $1,073.5 $505.5 
Transfusion Medicine163.9 163.1 483.1 231.3 
Point of Care233.1 270.5 675.4 1,580.6 
Molecular Diagnostics5.6 15.4 23.2 82.1 
Total revenues$744.0 $783.8 $2,255.2 $2,399.5 
Concentration of Revenue and Credit Risk
For the nine months ended October 1, 2023, no customers individually accounted for more than 10% of Total revenues. For the nine months ended October 2, 2022, one customer and one distributor represented 27% and 10%, respectively, of Total revenues.
As of October 1, 2023 and January 1, 2023, customers with a balance due in excess of 10% of Accounts receivable, net totaled $99.4 million and $161.9 million, respectively. Revenue related to our respiratory products accounted for 25% and 24% of Total revenues for the three and nine months ended October 1, 2023, respectively, and 30% and 63% for the three and nine months ended October 2, 2022, respectively.
XML 21 R12.htm IDEA: XBRL DOCUMENT v3.23.3
Segment and Geographic Information
 9 Months Ended
Oct. 01, 2023
Industry And Geographic Information [Abstract]  
Segment and Geographic Information Segment and Geographic Information
Total revenues by reportable segment are as follows:
Three Months EndedNine Months Ended
(In millions)October 1, 2023October 2, 2022October 1, 2023October 2, 2022
North America$465.2 $517.6 $1,426.8 $1,917.3 
EMEA74.5 73.7 236.4 131.0 
China81.1 80.8 233.0 163.1 
Other123.2 111.7 359.0 188.1 
Total revenues$744.0 $783.8 $2,255.2 $2,399.5 
In the fourth quarter of 2022, the Company revised the internal allocation of certain global costs primarily between the North America segment and Corporate to better align costs that impact the Company as a whole. Prior periods have been revised to align with the current period presentation. The following table sets forth Adjusted EBITDA by segment and the reconciliations to (Loss) income before income taxes for the three and nine months ended October 1, 2023 and October 2, 2022:
Three Months EndedNine Months Ended
(In millions)October 1, 2023October 2, 2022October 1, 2023October 2, 2022
North America$253.4 $293.5 $708.1 $1,246.1 
EMEA10.2 17.2 22.7 33.4 
China37.3 45.0 96.0 84.2 
Other31.2 29.8 89.3 64.1 
Total segment Adjusted EBITDA332.1 385.5 916.1 1,427.8 
Corporate (1)
(162.9)(158.7)(388.3)(341.9)
Interest expense, net(37.7)(29.7)(110.9)(41.0)
Depreciation and amortization(113.1)(104.2)(341.8)(167.0)
Acquisition and integration costs(26.5)(26.4)(80.4)(109.6)
Amortization of deferred cloud computing
   implementation costs
(2.8)(1.6)(5.9)(3.9)
Impairment of long-lived assets(2.2)— (3.2)— 
Loss on investments(1.0)— (1.2)(0.8)
EU medical device regulation transition costs (2)
(0.4)(0.6)(1.9)(1.0)
Unwind inventory fair value adjustment— (35.4)— (46.6)
Employee compensation charges— (1.0)— (1.5)
Loss on extinguishment of debt— — — (24.0)
Derivative mark-to-market gain— 3.4 — 4.4 
Tax indemnification income0.1 0.3 0.2 0.3 
Other adjustments(1.1)(0.3)(2.6)(0.4)
(Loss) income before income taxes$(15.5)$31.3 $(19.9)$694.8 
(1) Primarily consists of costs related to executive and staff functions, including certain finance, human resources, manufacturing and information technology (“IT”) functions, which benefit the Company as a whole. These costs are primarily related to the general management of these functions on a corporate level and the design and development of programs, policies and procedures that are then implemented in the individual segments, with each segment bearing its own cost of implementation. The Company’s corporate function also includes debt and stock-based compensation associated with all employee stock-based awards.
(2) Represents incremental consulting costs and research and development (“R&D”) manufacturing site costs to align compliance of the Company’s existing, on-market products that were previously registered under the European In Vitro Diagnostics Directive regulatory framework with the requirements under the EU’s In Vitro Diagnostic Regulation, which generally apply from May 2022 onwards.
The chief operating decision maker does not review capital expenditures, total depreciation and amortization or assets by segment, and therefore this information has been excluded as it does not comprise part of management’s key performance metrics.
XML 22 R13.htm IDEA: XBRL DOCUMENT v3.23.3
Income Taxes
 9 Months Ended
Oct. 01, 2023
Income Tax Disclosure [Abstract]  
Income Taxes Income Taxes
The Company calculates its interim income tax provision in accordance with ASC 270, Interim Reporting, and ASC 740, Accounting for Income Taxes. At the end of each interim period, the Company estimates its annual effective tax rate and applies that rate to its ordinary quarterly earnings to calculate the tax related to ordinary income. The tax effects for other items that are excluded from ordinary income are discretely calculated and recognized in the period in which they occur.
For the three months ended October 1, 2023, the Company recognized an income tax benefit of $2.8 million in relation to loss before income taxes of $15.5 million, resulting in an effective benefit tax rate of 18.1%. For the three months ended October 2, 2022, the Company recognized a provision for income taxes of $12.1 million in relation to income before income taxes of $31.3 million, resulting in an effective tax rate of 38.7%. For the three months ended October 1, 2023, the effective tax rate differed from the U.S. federal statutory rate primarily due to operating losses in certain subsidiaries not being benefited due to the establishment of valuation allowances and Global Intangible Low-Tax Income, partially offset by non-U.S. earnings being taxed at rates that are different than the U.S. statutory rate, R&D credits, foreign tax credits and foreign exchange losses. For the three months ended October 2, 2022, the effective tax rate was impacted primarily by income taxes owed in certain U.S. states.
For the nine months ended October 1, 2023, the Company recognized an income tax benefit of $2.8 million in relation to loss before income taxes of $19.9 million, resulting in an effective benefit tax rate of 14.1%. For the nine months ended October 2, 2022, the Company recognized a provision for income taxes of $176.4 million in relation to income before income taxes of $694.8 million, resulting in an effective tax rate of 25.4%. For the nine months ended October 1, 2023, the effective tax rate differed from the U.S. federal statutory rate primarily due to net operating losses in certain subsidiaries not being benefited due to the establishment of valuation allowances and Global Intangible Low-Tax Income, partially offset by non-U.S. earnings being taxed at rates that are different than the U.S. statutory rate, R&D credits, foreign tax credits and foreign exchange losses. For the nine months ended October 2, 2022, the effective tax rate was primarily impacted by incomes taxes owed in certain U.S. states.
The balance of unrecognized tax benefits at October 1, 2023, not including interest and penalties, was $38.7 million, of which $27.5 million could affect the effective income tax rate in future periods, if recognized. The Company also recognizes interest and penalties related to unrecognized tax benefits in tax expense. At October 1, 2023, the Company had approximately $8.5 million of interest and penalties accrued related to unrecognized tax benefits. The Company estimates that within the next 12 months, its uncertain tax positions, excluding interest, will decrease by $14.2 million.
The Company is subject to periodic audits by domestic and foreign tax authorities. Due to the carryforward of unutilized credits, the Company’s federal tax years from 2012 and onwards are subject to examination by the U.S. authorities. The Company’s state and foreign tax years for 2001 and onwards are subject to examination by applicable tax authorities. The Company believes that it has appropriate support for the income tax positions taken on its tax returns and that its accruals for tax liabilities are adequate for all open years based on an assessment of many factors, including past experience and interpretations of tax laws applied to the facts of each matter.
Indemnification Assets
On January 16, 2014, Ortho entered into a stock and asset purchase agreement of (i) certain assets and liabilities and (ii) all of the equity interests and substantially all of the assets and liabilities of certain entities, which, together with their subsidiaries, comprised the Ortho business from Johnson & Johnson. The agreement generally provided that Johnson & Johnson retained all income tax liabilities accrued as of the date of the acquisition, including reserves for unrecognized tax benefits. The indemnification receivable from Johnson & Johnson totaled $16.4 million and $16.8 million as of October 1, 2023 and January 1, 2023, respectively, and is included as a component of Prepaid expenses and other current assets and Other assets on the Consolidated Balance Sheets. The Company recorded $0.3 million and $1.0 million of interest and penalties during the three and nine months ended October 1, 2023, respectively, and $0.3 million and $0.4 million during the three and nine months ended October 2, 2022, respectively.
XML 23 R14.htm IDEA: XBRL DOCUMENT v3.23.3
Balance Sheet Account Details
 9 Months Ended
Oct. 01, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Balance Sheet Account Details Balance Sheet Account Details
Cash, Cash Equivalents and Restricted Cash
(In millions)October 1, 2023January 1, 2023
Cash and cash equivalents$149.3 $292.9 
Restricted cash included in Other assets0.6 1.0 
Cash, cash equivalents and restricted cash$149.9 $293.9 
Marketable Securities
The following table is a summary of marketable securities:
October 1, 2023January 1, 2023
(In millions)Amortized CostGross Unrealized LossesFair ValueAmortized CostGross Unrealized LossesFair Value
Corporate bonds$32.8 $(0.2)$32.6 $40.5 $(0.5)$40.0 
Corporate asset-backed securities7.8 — 7.8 6.7 — 6.7 
U.S. government securities— — — 2.0 — 2.0 
Agency bonds1.5 — 1.5 1.0 — 1.0 
Sovereign government bonds2.0 — 2.0 1.9 — 1.9 
Foreign and other— — — 0.5 — 0.5 
Total marketable securities, current44.1 (0.2)43.9 52.6 (0.5)52.1 
Corporate bonds, non-current8.8 (0.1)8.7 13.3 (0.1)13.2 
Corporate asset-backed securities, non-current3.2 — 3.2 7.9 (0.1)7.8 
Agency bonds, non-current— — — — — — 
Total marketable securities$56.1 $(0.3)$55.8 $73.8 $(0.7)$73.1 
Accounts Receivable, Net
Accounts receivables primarily consisted of trade accounts receivables with maturities of one year or less and are presented net of reserves:
(In millions)October 1, 2023January 1, 2023
Accounts receivable$419.1 $543.0 
Allowance for contract rebates and discounts(75.2)(77.1)
Allowance for doubtful accounts(12.7)(12.0)
Total accounts receivable, net$331.2 $453.9 
Inventories
Inventories are stated at the lower of cost (first-in, first-out) or net realizable value. Inventories consisted of the following:
(In millions)October 1, 2023January 1, 2023
Raw materials$197.9 $185.2 
Work-in-process (materials, labor and overhead)104.7 82.7 
Finished goods (materials, labor and overhead)295.5 295.1 
Total inventories (1)
$598.1 $563.0 
Inventories$551.7 $524.1 
Other assets (2)
46.4 38.9 
Total inventories$598.1 $563.0 
(1) Includes adjustment of approximately $39 million in the nine months ended October 1, 2023 due to changes in estimates to decrease inventory obsolescence reserves from the prior period.
(2) Other assets includes inventory expected to remain on hand beyond one year.
Prepaid Expenses and Other Current Assets
Prepaid expenses and other current assets consisted of the following:
(In millions)October 1, 2023January 1, 2023
Income taxes and other tax receivables$93.1 $38.6 
Prepaid expenses92.2 96.7 
Contract assets53.5 49.6 
Other receivables42.4 44.3 
Derivatives10.9 22.0 
Other3.1 0.9 
Total prepaid expenses and other current assets$295.2 $252.1 
Goodwill
Changes in goodwill were as follows:
(In millions)North AmericaEMEAChinaOtherTotal
Balance at January 1, 2023$1,547.7 $358.6 $118.1 $452.4 $2,476.8 
Purchase accounting adjustments(13.4)(4.1)(1.3)(5.1)(23.9)
Foreign currency translation(0.1)(4.1)(6.4)0.6 (10.0)
Balance at October 1, 2023$1,534.2 $350.4 $110.4 $447.9 $2,442.9 
Other Current Liabilities
Other current liabilities consisted of the following:
(In millions)October 1, 2023January 1, 2023
Accrued commissions, rebates and returns$51.5 $57.5 
Accrued other taxes payable39.7 9.3 
Deferred revenue34.6 76.4 
Accrued interest32.2 1.4 
Operating lease liabilities26.3 24.4 
Derivatives6.7 19.7 
Deferred consideration— 39.3 
Other114.4 97.4 
Total other current liabilities$305.4 $325.4 
XML 24 R15.htm IDEA: XBRL DOCUMENT v3.23.3
Borrowings
 9 Months Ended
Oct. 01, 2023
Debt Disclosure [Abstract]  
Borrowings Borrowings
The components of borrowings were as follows:
(In millions)October 1, 2023January 1, 2023
Term Loan$2,472.2 $2,646.9 
Financing lease obligation 0.5 0.8 
Other short-term borrowings2.9 — 
Other long-term borrowings0.7 1.2 
Unamortized deferred financing costs(8.7)(10.6)
Total borrowings2,467.6 2,638.3 
Less: current portion(193.0)(207.5)
Long-term borrowings$2,274.6 $2,430.8 
The credit agreement, dated May 27, 2022, by and among the Company, as borrower, Bank of America, N.A., as administrative agent and swing line lender, and the other lenders and L/C issuers party thereto (the “Credit Agreement”) consists of a $2,750.0 million senior secured term loan facility (the “Term Loan”) and an $800.0 million revolving credit facility (the “Revolving Credit Facility” and with the Term Loan, the “Financing”). As of October 1, 2023 and January 1, 2023, there were no amounts outstanding under the Revolving Credit Facility. As of October 1, 2023, letters of credit issued under the Revolving Credit Facility totaled $12.9 million, which reduced the available amount under the Revolving Credit Facility to $787.1 million. During the nine months ended October 1, 2023, the Company made $174.7 million in payments on the Term Loan, including a voluntary prepayment of $20.0 million.
The Credit Agreement contains affirmative and negative covenants that are customary for credit agreements of this nature. The negative covenants include, among other things, limitations on asset sales, mergers, indebtedness, liens, investments and transactions with affiliates. The Credit Agreement contains two financial covenants: (i) a maximum Consolidated Leverage Ratio (as defined in the Credit Agreement) as of the last day of each fiscal quarter of (a) 4.50 to 1.00 for the first four fiscal quarters ending after the closing date of the Credit Agreement (the “Initial Measurement Period”), (b) 4.00 to 1.00 for the first four fiscal quarters ending after the Initial Measurement Period and (c) 3.50 to 1.00 for each fiscal quarter thereafter; and (ii) a minimum Consolidated Interest Coverage Ratio (as defined in the Credit Agreement) of 3.00 to 1.00 as of the end of any fiscal quarter for the most recently completed four fiscal quarters. The Company was in compliance with the financial covenants as of October 1, 2023.
The following table provides the detailed amounts within Interest expense, net for the three and nine months ended October 1, 2023 and October 2, 2022:
Three Months EndedNine Months Ended
(In millions)October 1, 2023October 2, 2022October 1, 2023October 2, 2022
Term Loan$45.7 $27.9 $130.8 $36.3 
Revolving Credit Facility0.9 0.6 1.9 1.0 
Amortization of deferred financing costs0.9 0.9 2.5 1.2 
Derivative instruments and other(8.5)0.6 (20.2)3.5 
Interest income(1.3)(0.3)(4.1)(1.0)
Interest expense, net$37.7 $29.7 $110.9 $41.0 
XML 25 R16.htm IDEA: XBRL DOCUMENT v3.23.3
Stock-Based Compensation
 9 Months Ended
Oct. 01, 2023
Equity [Abstract]  
Stock-Based Compensation Stock-based Compensation
Stock-based compensation expense was as follows:
Three Months EndedNine Months Ended
(In millions)October 1, 2023October 2, 2022October 1, 2023October 2, 2022
Cost of sales$1.2 $0.8 $3.3 $2.0 
Research and development1.6 1.3 4.2 3.8 
Selling, marketing and administrative
10.3 7.2 27.5 20.5 
Acquisition and integration costs4.0 6.9 13.1 24.2 
Total stock-based compensation expense$17.1 $16.2 $48.1 $50.5 
The table above includes compensation expense related to liability-classified awards of $3.0 million and $8.8 million for the three and nine months ended October 1, 2023, respectively, and $3.0 million and $13.9 million for the three and nine months ended October 2, 2022, respectively, which has been or is expected to be settled in cash. These awards primarily represent the $7.14 per share cash-settled portion of the replacement awards issued in connection with the Combinations.
The Company granted 253 thousand stock options during the nine months ended October 1, 2023. As of October 1, 2023, total unrecognized compensation expense related to stock options was approximately $20.0 million and the related weighted-average period over which it is expected to be recognized is approximately 2.0 years. The maximum contractual term of the Company’s stock options is ten years.
The estimated fair value of each stock option was determined on the date of grant using the Black-Scholes option valuation model with the following weighted-average assumptions for the option grants:
Nine Months Ended
October 1, 2023October 2, 2022
Risk-free interest rate3.52 %1.99 %
Expected option life (in years)5.534.89
Volatility rate57 %58 %
Dividend rate0 %0 %
Weighted-average grant date fair value$48.17$50.86
In January 2023, the Compensation Committee of the Company’s Board of Directors approved a modification to the vesting terms of certain stock options that were previously granted by Ortho to certain Ortho employees, such that the stock options will vest on December 31, 2023. The modification resulted in an additional $2.9 million and $8.0 million of stock-based compensation expense recognized during the three and nine months ended October 1, 2023, respectively. The total unrecognized expense relating to unvested shares for these stock options as of October 1, 2023 was $3.1 million and will be recognized through December 31, 2023.
The Company granted 609 thousand RSUs during the nine months ended October 1, 2023. The fair value of RSUs is determined based on the closing market price of the Company’s common stock on the grant date. The weighted-average fair value of RSUs granted during the nine months ended October 1, 2023 and October 2, 2022 was $87.14 and $97.52, respectively. The total amount of unrecognized compensation expense related to non-vested RSUs as of October 1, 2023 was approximately $78.4 million, which is expected to be recognized over a weighted-average period of approximately 2.2 years.
XML 26 R17.htm IDEA: XBRL DOCUMENT v3.23.3
Commitments and Contingencies
 9 Months Ended
Oct. 01, 2023
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies Commitments and Contingencies
From time to time, the Company is involved in litigation and other legal proceedings, including matters related to product liability claims, commercial disputes and intellectual property claims, as well as regulatory, employment, and other claims related to its business. The Company accrues for legal claims when, and to the extent that, amounts associated with the claims become probable and are reasonably estimable. If the reasonable estimate of a known or probable loss is a range, and no amount within the range is a better estimate than any other, the minimum amount of the range is accrued. When determining the estimated loss or range of loss, significant judgment is required to estimate the amount and timing of a loss to be recorded. Estimates of probable losses resulting from these matters are inherently difficult to predict. The actual costs of resolving legal claims may be substantially higher or lower than the amounts accrued for those claims. For those matters as to which the Company is not able to estimate a possible loss or range of loss, the Company is not able to determine whether the loss will have a material adverse effect on its business, financial condition, results of operations or liquidity.
Management believes that all such current legal actions, in the aggregate, are not expected to have a material adverse effect on the Company. However, the resolution of, or increase in any accruals for, one or more matters may have a material adverse effect on the Company’s results of operations and cash flows.
XML 27 R18.htm IDEA: XBRL DOCUMENT v3.23.3
Fair Value Measurements
 9 Months Ended
Oct. 01, 2023
Fair Value Disclosures [Abstract]  
Fair Value Measurements Fair Value Measurements
The following table presents the Company’s hierarchy for its assets and liabilities measured at fair value on a recurring basis as of the following periods:
 October 1, 2023January 1, 2023
(In millions)Level 1Level 2Level 3TotalLevel 1Level 2Level 3Total
Assets:
Cash equivalents$2.0 $— $— $2.0 $0.6 $2.1 $— $2.7 
Marketable securities— 55.8 — 55.8 2.0 71.1 — 73.1 
Derivative assets— 49.9 — 49.9 — 22.0 — 22.0 
Total assets measured at fair value$2.0 $105.7 $— $107.7 $2.6 $95.2 $— $97.8 
Liabilities:
Derivative liabilities$— $6.7 $— $6.7 $— $21.8 $— $21.8 
Contingent consideration— — 0.1 0.1 — — 0.1 0.1 
Deferred consideration— — — — — 39.3 — 39.3 
Total liabilities measured at fair value$— $6.7 $0.1 $6.8 $— $61.1 $0.1 $61.2 
There were no transfers of assets or liabilities into or out of Level 3 of the fair value hierarchy during the three and nine months ended October 1, 2023 and fiscal year 2022.
Cash equivalents consist of funds held in money market accounts that are valued using quoted prices in active markets for identical instruments and highly liquid corporate debt securities with maturities within three months from purchase. Marketable securities consist of investment-grade corporate and government debt securities, corporate asset-backed securities and commercial paper. Derivative financial instruments are based on observable inputs that are corroborated by market data. Observable inputs include broker quotes, daily market foreign currency rates and forward pricing curves.
In connection with the acquisition of the B-type Natriuretic Peptide assay business run on Beckman Coulter analyzers from Alere Inc., the Company paid its last annual installment of $40.0 million during the nine months ended October 1, 2023.
Financial Instruments Not Measured at Fair Value
The estimated fair value of the Company’s borrowings under the Term Loan was $2,444.4 million at October 1, 2023, compared to the carrying amount, excluding debt issuance costs, of $2,472.2 million. The estimated fair value of the Company’s borrowings under the Term Loan was $2,630.3 million at January 1, 2023, compared to the carrying amount,
excluding debt issuance costs, of $2,646.9 million. The estimate of fair value is generally based on the quoted market prices for similar issuances of long-term debt with the same maturities, which is classified as a Level 2 input.
XML 28 R19.htm IDEA: XBRL DOCUMENT v3.23.3
Derivative Instruments and Hedging Activities
 9 Months Ended
Oct. 01, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Derivative Instruments and Hedging Activities Derivative Instruments and Hedging Activities
The Company selectively uses derivative and non-derivative instruments to manage market risk associated with changes in interest rates and foreign currency exchange rates. The use of derivatives is intended for hedging purposes only, and the Company does not enter into derivative transactions for speculative purposes.
Credit risk represents the Company’s gross exposure to potential accounting loss on derivative instruments that are outstanding or unsettled if all counterparties failed to perform according to the terms of the contract. The Company generally enters into master netting arrangements that reduce credit risk by permitting net settlement of transactions with the same counterparty. The Company does not have any derivative instruments with credit-risk related contingent features that would require it to post collateral.
Interest Rate Hedging Instruments
The Company’s interest rate risk relates primarily to interest rate exposures on variable rate debt, including the Revolving Credit Facility and Term Loan. See Note 8 for additional information on the currently outstanding components of the Revolving Credit Facility and Term Loan. The Company entered into interest rate swap agreements to hedge the related risk of the variability to the Company’s cash flows due to the rates specified for these credit facilities.
The Company designates its interest rate swaps as cash flow hedges. The Company records gains and losses due to changes in fair value of the derivatives within Other comprehensive (loss) income (“OCI”) and reclassifies these amounts to Interest expense, net in the same period or periods for which the underlying hedged transaction affects earnings. In the event the Company determines the hedged transaction is no longer probable to occur or concludes the hedge relationship is no longer effective, the hedge is prospectively de-designated. Pre-tax unrealized gains of $29.0 million as of October 1, 2023 are expected to be reclassified from OCI to earnings in the next 12 months.
The following table summarizes the Company’s interest rate derivative agreements as of October 1, 2023, all of which were interest rate swaps:
Notional Amount
(In millions) (1)
DescriptionHedge DesignationEffective DateExpiration Date
$500.0 
Pay 1.58% fixed, receive floating rate
(1-month USD-SOFR)
Designated cash flow hedgeMay 29, 2022December 31, 2023
$397.2 
Pay 3.765% fixed, receive floating rate
(1-month USD-SOFR)
Designated cash flow hedgeDecember 30, 2022May 27, 2027
$144.4 
Pay 3.7725% fixed, receive floating rate
(1-month USD-SOFR)
Designated cash flow hedgeDecember 30, 2022May 27, 2027
$216.7 
Pay 3.7675% fixed, receive floating rate
(1-month USD-SOFR)
Designated cash flow hedgeDecember 30, 2022May 27, 2027
$288.9 
Pay 3.7575% fixed, receive floating rate
(1-month USD-SOFR)
Designated cash flow hedgeDecember 30, 2022May 27, 2027
$252.8 
Pay 3.7725% fixed, receive floating rate
(1-month USD-SOFR)
Designated cash flow hedgeDecember 30, 2022May 27, 2027
(1) The notional value of interest rate swap contracts with an effective date of December 30, 2022 is expected to increase to $1.8 billion on December 29, 2023.
Currency Hedging Instruments
The Company has currency risk exposures relating primarily to foreign currency denominated monetary assets and liabilities and forecasted foreign currency denominated intercompany and third-party transactions. The Company uses foreign currency forward contracts and may use option contracts and cross currency swaps to manage its currency risk exposures. The Company’s foreign currency forward contracts are denominated primarily in Australian Dollar, Brazilian Real, British Pound, Canadian Dollar, Chilean Peso, Chinese Yuan/Renminbi, Colombian Peso, Euro, Indian Rupee, Japanese Yen, Mexican Peso, Philippine Peso, South Korean Won, Swiss Franc and the Thai Baht.
The Company designates certain foreign currency forward contracts as cash flow hedges. The Company records gains and losses due to changes in fair value of the derivatives within OCI and reclassifies these amounts to Total revenues and Cost of sales, excluding amortization of intangibles in the same period or periods for which the underlying hedged transaction affects
earnings. In the event the Company determines the hedged transaction is no longer probable to occur or concludes the hedge relationship is no longer effective, the hedge is prospectively de-designated. Pre-tax unrealized loss of $2.0 million as of October 1, 2023 is expected to be reclassified from OCI to earnings in the next 12 months.
The Company also enters into foreign currency forward contracts that are not part of designated hedging relationships and which are intended to mitigate exchange rate risk of monetary assets and liabilities and related forecasted transactions. The Company records these non-designated derivatives at mark-to-market with gains and losses recognized in earnings within Other expense (income), net.
The following table provides details of the currency hedging instruments outstanding as of October 1, 2023:
DescriptionNotional Amount
(In millions)		Hedge Designation
Foreign currency forward contracts$127.0 Cash Flow Hedge
Foreign currency forward contracts$616.9 Non-designated
The following table summarizes pre-tax gains and losses from designated derivative and non-derivative instruments within Accumulated other comprehensive (loss) income (“AOCI”) for the three and nine months ended October 1, 2023 and October 2, 2022:
Designated Hedging Instruments
(In millions)Amount of Loss (Gain) Recognized in OCI on HedgesLocation of Amounts Reclassified From AOCI Into IncomeAmount of Loss (Gain) Reclassified From AOCI Into Income
Three Months Ended October 1, 2023
Foreign currency forward contracts (sales)$(1.0)Total revenues$1.8 
Foreign currency forward contracts (purchases)$(0.1)Cost of sales, excluding amortization of intangibles$0.4 
Interest rate derivatives$(28.0)Interest expense, net$(8.5)
Nine Months Ended October 1, 2023
Foreign currency forward contracts (sales)$0.7 Total revenues$2.7 
Foreign currency forward contracts (purchases)$(2.2)Cost of sales, excluding amortization of intangibles$2.1 
Interest rate derivatives$(54.1)Interest expense, net$(21.1)
Three Months Ended October 2, 2022
Foreign currency forward contracts (sales)$(2.6)Total revenues$(0.7)
Foreign currency forward contracts (purchases)$(0.6)Cost of sales, excluding amortization of intangibles$(0.1)
Interest rate derivatives$(7.9)Interest expense, net$0.4 
Nine Months Ended October 2, 2022
Foreign currency forward contracts (sales)$(5.0)Total revenues$(0.9)
Foreign currency forward contracts (purchases)$(0.8)Cost of sales, excluding amortization of intangibles$(0.1)
Interest rate derivatives$(11.0)Interest expense, net$1.7 
Fair value (gains) and losses on foreign currency forward contracts, as determined using Level 2 inputs, that do not qualify for hedge accounting treatment are recorded in Other expense (income), net. Fair value losses were $0.2 million for the three months ended October 1, 2023 and fair value gains were $0.3 million for the nine months ended October 1, 2023. Fair value losses on foreign currency forward contracts, as determined using Level 2 inputs, that do not qualify for hedge accounting treatment are recorded in Other expense (income), net and were $2.7 million and $3.0 million for the three and nine months ended October 2, 2022, respectively.
Fair value gains on interest rate derivatives, as determined using Level 2 inputs, that do not qualify for hedge accounting treatment are recorded in Other expense (income), net and were $3.4 million and $4.4 million for the three and nine months ended October 2, 2022, respectively.
The following table summarizes the fair value of designated and non-designated hedging instruments recognized within the Consolidated Balance Sheets as of October 1, 2023 and January 1, 2023:
(In millions)October 1, 2023January 1, 2023
Designated cash flow hedges
Interest rate derivatives:
Prepaid expenses and other current assets$4.9 $15.9 
Other assets$39.0 $— 
Other liabilities$— $2.1 
Foreign currency forward contracts:
Prepaid expenses and other current assets$2.1 $4.6 
Other current liabilities$3.4 $14.3 
Non-designated hedging instruments
Foreign currency forward contracts:
Prepaid expenses and other current assets$3.9 $1.5 
Other current liabilities$3.3 $5.4 
XML 29 R20.htm IDEA: XBRL DOCUMENT v3.23.3
Related Party Transactions
 9 Months Ended
Oct. 01, 2023
Related Party Transactions [Abstract]  
Related Party Transactions Related Party Transactions
Quotient Limited
As a result of the consummation of the Combinations, the Company acquired Ortho’s Letter Agreement (the “Letter Agreement”), entered into in September 2020 with Quotient Limited (“Quotient”), in which Ortho partnered with Quotient to commercialize, when approved, Quotient’s next generation product in immunohematology, a transfusion diagnostic patient immunohematology microarray intended for use with Quotient’s MosaiQ® instruments. Under the Letter Agreement, the Company was required to make certain milestone payments to Quotient as specified milestones and benchmarks were achieved. Quotient subsequently revised its business strategy to pause development and commercialization of its MosaiQ testing solutions in immunohematology and infectious disease immunoassay screening. On January 10, 2023, Quotient filed a voluntary petition for relief under Chapter 11 of Title 11 of the United States Code in the United States Bankruptcy Court for the Southern District of Texas (the “Bankruptcy Proceeding”). Following the completion of the Bankruptcy Proceeding, the Company’s equity interests in Quotient were canceled for no consideration. Quotient is no longer considered a related party of the Company.
XML 30 R21.htm IDEA: XBRL DOCUMENT v3.23.3
Accumulated Other Comprehensive Loss
 9 Months Ended
Oct. 01, 2023
Equity [Abstract]  
Accumulated Other Comprehensive Loss Accumulated Other Comprehensive Loss
The following table summarizes the changes in Accumulated other comprehensive loss by component:
Three Months Ended October 1, 2023
(In millions)Pension and Other Post-
Employment Benefits		Cash Flow HedgesAvailable-for-Sale InvestmentsUnrealized Foreign Currency Translation AdjustmentsAccumulated Other Comprehensive (Loss) Income
Balance at July 2, 2023$0.7 $14.6 $(0.4)$(31.2)$(16.3)
Current period deferrals (1)
— 24.5 0.2 (55.3)(30.6)
Amounts reclassified to net income— (6.3)— — (6.3)
Net change— 18.2 0.2 (55.3)(36.9)
Balance at October 1, 2023$0.7 $32.8 $(0.2)$(86.5)$(53.2)
Nine Months Ended October 1, 2023
Pension and Other Post-
Employment Benefits		Cash Flow HedgesAvailable-for-Sale InvestmentsUnrealized Foreign Currency Translation AdjustmentsAccumulated Other Comprehensive (Loss) Income
Balance at January 1, 2023$0.7 $1.5 $(0.5)$(69.3)$(67.6)
Current period deferrals (1)
— 47.6 0.3 (17.2)30.7 
Amounts reclassified to net income— (16.3)— — (16.3)
Net change— 31.3 0.3 (17.2)14.4 
Balance at October 1, 2023$0.7 $32.8 $(0.2)$(86.5)$(53.2)
Three Months Ended October 2, 2022
(In millions)Cash Flow HedgesAvailable-for-Sale InvestmentsUnrealized Foreign Currency Translation AdjustmentsAccumulated Other Comprehensive Income (Loss)
Balance at July 3, 2022$5.5 $(0.7)$(65.5)$(60.7)
Current period deferrals (2)
9.3 — (92.9)(83.6)
Amounts reclassified to net income(0.2)— — (0.2)
Net change9.1 — (92.9)(83.8)
Balance at October 2, 2022$14.6 $(0.7)$(158.4)$(144.5)
Nine Months Ended October 2, 2022
Cash Flow HedgesAvailable-for-Sale InvestmentsUnrealized Foreign Currency Translation AdjustmentsAccumulated Other Comprehensive Income (Loss)
Balance at January 2, 2022$— $(0.1)$0.5 $0.4 
Current period deferrals (2)
13.9 (0.6)(158.9)(145.6)
Amounts reclassified to net income0.7 — — 0.7 
Net change14.6 (0.6)(158.9)(144.9)
Balance at October 2, 2022$14.6 $(0.7)$(158.4)$(144.5)
(1) Includes tax impact of $4.6 million and $8.0 million related to cash flow hedges for the three and nine months ended October 1, 2023, respectively.
(2) Includes tax impact of $1.7 million and $2.8 million related to cash flow hedges for the three and nine months ended October 2, 2022, respectively.
XML 31 R22.htm IDEA: XBRL DOCUMENT v3.23.3
Pay vs Performance Disclosure - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Oct. 01, 2023
Jul. 02, 2023
Apr. 02, 2023
Oct. 02, 2022
Jul. 03, 2022
Apr. 03, 2022
Oct. 01, 2023
Oct. 02, 2022
Pay vs Performance Disclosure                
Net (loss) income $ (12.7) $ (53.2) $ 48.8 $ 19.2 $ 19.3 $ 479.9 $ (17.1) $ 518.4
XML 32 R23.htm IDEA: XBRL DOCUMENT v3.23.3
Insider Trading Arrangements
 3 Months Ended
Oct. 01, 2023
Trading Arrangements, by Individual  
Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
XML 33 R24.htm IDEA: XBRL DOCUMENT v3.23.3
Basis of Presentation and Summary of Significant Accounting Policies (Policies)
 9 Months Ended
Oct. 01, 2023
Accounting Policies [Abstract]  
Basis of Presentation
Basis of Presentation
The accompanying unaudited Consolidated Financial Statements of QuidelOrtho Corporation and its subsidiaries (the “Company” or “QuidelOrtho”) have been prepared in accordance with generally accepted accounting principles in the U.S. (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation (consisting of normal recurring accruals) have been included.
The information at October 1, 2023, and for the three and nine months ended October 1, 2023 and October 2, 2022, is unaudited. For further information, refer to the Company’s Consolidated Financial Statements and notes thereto for the fiscal year ended January 1, 2023 included in QuidelOrtho’s 2022 Annual Report on Form 10-K. Operating results for any quarter are historically seasonal in nature and are not necessarily indicative of the results expected for the full year.
The Company follows the concept of a fiscal year that ends on the Sunday nearest to the end of the month of December, and fiscal quarters that end on the Sunday nearest to the end of the months of March, June and September. For 2023 and 2022, the Company’s fiscal year will end or has ended on December 31, 2023 and January 1, 2023, respectively. For 2023 and 2022, the Company’s third quarter ended on October 1, 2023 and October 2, 2022, respectively. The three and nine months ended October 1, 2023 and October 2, 2022 each included 13 and 39 weeks, respectively.
Use of Estimates
Use of Estimates
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses and the related disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
Revenue Recognition
Revenue Recognition
The Company generates a portion of its revenue from sales of the QuickVue At-Home OTC COVID-19 tests to retail customers. The Company estimates the transaction price for revenue from sales to retail customers based on historical experience and current trends to evaluate when uncertainties related to right of return provisions are resolved. In prior periods, due to a lack of history on which to base an estimate of products to be returned from retailers, the Company established a reserve based on an estimate of total inventory remaining at our retailers that was subject to return.
During the three months ended October 1, 2023, the Company concluded that it had developed sufficient historical experience regarding the pattern in customer returns to be able to estimate the amount of consideration to which we expect to be entitled, excluding consideration for the products expected to be returned. Amounts received or receivable that are expected to be returned are recognized as a refund liability, which is included in Other current liabilities. The refund liability is estimated utilizing historical sale and return rates over the period during which customers have a right of return, taking into account available information on competitive products and contract changes. The refund liability is remeasured at each reporting period to reflect changes in assumptions about expected returns. Revenue from sales to retail customers amounted to approximately 3% of Total revenues for the nine months ended October 1, 2023. This change in estimate did not have a material impact on the Company’s Consolidated Financial Statements.
Recent Accounting Pronouncements
Recent Accounting Pronouncements
There have been no accounting pronouncements issued or adopted during the nine months ended October 1, 2023 that are expected to have a material impact on the Company’s Consolidated Financial Statements.
XML 34 R25.htm IDEA: XBRL DOCUMENT v3.23.3
Business Combination (Tables)
 9 Months Ended
Oct. 01, 2023
Business Combination and Asset Acquisition [Abstract]  
Pro Forma Financial Information
The following unaudited supplemental pro forma financial information shows the combined results of operations of the Company as if the Combinations had occurred on January 4, 2021, the beginning of the periods presented:
Three Months EndedNine Months Ended
(In millions)October 2, 2022October 3, 2021October 2, 2022October 3, 2021
Pro forma total revenues$783.8 $1,032.3 $3,184.7 $2,583.5 
Pro forma net income50.2 225.2 549.5 340.2 
XML 35 R26.htm IDEA: XBRL DOCUMENT v3.23.3
Computation of Earnings Per Share (Tables)
 9 Months Ended
Oct. 01, 2023
Earnings Per Share [Abstract]  
Schedule of Earnings Per Share, Basic and Diluted
The following table presents the calculation of the weighted-average shares used in computing basic and diluted EPS:
Three Months EndedNine Months Ended
(In millions)October 1, 2023October 2, 2022October 1, 2023October 2, 2022
Basic weighted-average shares of common stock outstanding66.9 66.9 66.8 53.6 
Dilutive potential shares issuable from stock options and RSUs(1)
— 0.6 — 0.6 
Diluted weighted-average shares of common stock outstanding66.9 67.5 66.8 54.2 
(1) In the three and nine months ended October 1, 2023, all potential shares of common stock issuable for stock options and RSUs were excluded from the dilutive calculations above because the effect of including them would have been anti-dilutive. The dilutive effect of potential shares of common stock issuable for stock options and RSUs on the weighted-average number of shares of common stock outstanding would have been as follows:
Three Months EndedNine Months Ended
(In millions)October 1, 2023October 1, 2023
Basic weighted-average shares of common stock outstanding66.9 66.8 
Dilutive potential shares issuable from stock options and RSUs0.4 0.5 
Diluted weighted-average shares of common stock outstanding67.3 67.3 
XML 36 R27.htm IDEA: XBRL DOCUMENT v3.23.3
Revenue (Tables)
 9 Months Ended
Oct. 01, 2023
Revenue from Contract with Customer [Abstract]  
Disaggregation of Revenue
The following table summarizes Total revenues by business unit:
Three Months EndedNine Months Ended
(In millions)October 1, 2023October 2, 2022October 1, 2023October 2, 2022
Labs$341.4 $334.8 $1,073.5 $505.5 
Transfusion Medicine163.9 163.1 483.1 231.3 
Point of Care233.1 270.5 675.4 1,580.6 
Molecular Diagnostics5.6 15.4 23.2 82.1 
Total revenues$744.0 $783.8 $2,255.2 $2,399.5 
XML 37 R28.htm IDEA: XBRL DOCUMENT v3.23.3
Segment and Geographic Information (Tables)
 9 Months Ended
Oct. 01, 2023
Industry And Geographic Information [Abstract]  
Revenue from External Customers by Geographic Areas
Total revenues by reportable segment are as follows:
Three Months EndedNine Months Ended
(In millions)October 1, 2023October 2, 2022October 1, 2023October 2, 2022
North America$465.2 $517.6 $1,426.8 $1,917.3 
EMEA74.5 73.7 236.4 131.0 
China81.1 80.8 233.0 163.1 
Other123.2 111.7 359.0 188.1 
Total revenues$744.0 $783.8 $2,255.2 $2,399.5 
Schedule of Segment Reporting Information, by Segment The following table sets forth Adjusted EBITDA by segment and the reconciliations to (Loss) income before income taxes for the three and nine months ended October 1, 2023 and October 2, 2022:
Three Months EndedNine Months Ended
(In millions)October 1, 2023October 2, 2022October 1, 2023October 2, 2022
North America$253.4 $293.5 $708.1 $1,246.1 
EMEA10.2 17.2 22.7 33.4 
China37.3 45.0 96.0 84.2 
Other31.2 29.8 89.3 64.1 
Total segment Adjusted EBITDA332.1 385.5 916.1 1,427.8 
Corporate (1)
(162.9)(158.7)(388.3)(341.9)
Interest expense, net(37.7)(29.7)(110.9)(41.0)
Depreciation and amortization(113.1)(104.2)(341.8)(167.0)
Acquisition and integration costs(26.5)(26.4)(80.4)(109.6)
Amortization of deferred cloud computing
   implementation costs
(2.8)(1.6)(5.9)(3.9)
Impairment of long-lived assets(2.2)— (3.2)— 
Loss on investments(1.0)— (1.2)(0.8)
EU medical device regulation transition costs (2)
(0.4)(0.6)(1.9)(1.0)
Unwind inventory fair value adjustment— (35.4)— (46.6)
Employee compensation charges— (1.0)— (1.5)
Loss on extinguishment of debt— — — (24.0)
Derivative mark-to-market gain— 3.4 — 4.4 
Tax indemnification income0.1 0.3 0.2 0.3 
Other adjustments(1.1)(0.3)(2.6)(0.4)
(Loss) income before income taxes$(15.5)$31.3 $(19.9)$694.8 
(1) Primarily consists of costs related to executive and staff functions, including certain finance, human resources, manufacturing and information technology (“IT”) functions, which benefit the Company as a whole. These costs are primarily related to the general management of these functions on a corporate level and the design and development of programs, policies and procedures that are then implemented in the individual segments, with each segment bearing its own cost of implementation. The Company’s corporate function also includes debt and stock-based compensation associated with all employee stock-based awards.
(2) Represents incremental consulting costs and research and development (“R&D”) manufacturing site costs to align compliance of the Company’s existing, on-market products that were previously registered under the European In Vitro Diagnostics Directive regulatory framework with the requirements under the EU’s In Vitro Diagnostic Regulation, which generally apply from May 2022 onwards.
XML 38 R29.htm IDEA: XBRL DOCUMENT v3.23.3
Balance Sheet Account Details (Tables)
 9 Months Ended
Oct. 01, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Cash, Cash Equivalents and Restricted Cash
Cash, Cash Equivalents and Restricted Cash
(In millions)October 1, 2023January 1, 2023
Cash and cash equivalents$149.3 $292.9 
Restricted cash included in Other assets0.6 1.0 
Cash, cash equivalents and restricted cash$149.9 $293.9 
Marketable Securities
The following table is a summary of marketable securities:
October 1, 2023January 1, 2023
(In millions)Amortized CostGross Unrealized LossesFair ValueAmortized CostGross Unrealized LossesFair Value
Corporate bonds$32.8 $(0.2)$32.6 $40.5 $(0.5)$40.0 
Corporate asset-backed securities7.8 — 7.8 6.7 — 6.7 
U.S. government securities— — — 2.0 — 2.0 
Agency bonds1.5 — 1.5 1.0 — 1.0 
Sovereign government bonds2.0 — 2.0 1.9 — 1.9 
Foreign and other— — — 0.5 — 0.5 
Total marketable securities, current44.1 (0.2)43.9 52.6 (0.5)52.1 
Corporate bonds, non-current8.8 (0.1)8.7 13.3 (0.1)13.2 
Corporate asset-backed securities, non-current3.2 — 3.2 7.9 (0.1)7.8 
Agency bonds, non-current— — — — — — 
Total marketable securities$56.1 $(0.3)$55.8 $73.8 $(0.7)$73.1 
Accounts Receivable, Net
Accounts receivables primarily consisted of trade accounts receivables with maturities of one year or less and are presented net of reserves:
(In millions)October 1, 2023January 1, 2023
Accounts receivable$419.1 $543.0 
Allowance for contract rebates and discounts(75.2)(77.1)
Allowance for doubtful accounts(12.7)(12.0)
Total accounts receivable, net$331.2 $453.9 
Inventories
Inventories are stated at the lower of cost (first-in, first-out) or net realizable value. Inventories consisted of the following:
(In millions)October 1, 2023January 1, 2023
Raw materials$197.9 $185.2 
Work-in-process (materials, labor and overhead)104.7 82.7 
Finished goods (materials, labor and overhead)295.5 295.1 
Total inventories (1)
$598.1 $563.0 
Inventories$551.7 $524.1 
Other assets (2)
46.4 38.9 
Total inventories$598.1 $563.0 
(1) Includes adjustment of approximately $39 million in the nine months ended October 1, 2023 due to changes in estimates to decrease inventory obsolescence reserves from the prior period.
(2) Other assets includes inventory expected to remain on hand beyond one year.
Prepaid Expenses and Other Current Assets
Prepaid expenses and other current assets consisted of the following:
(In millions)October 1, 2023January 1, 2023
Income taxes and other tax receivables$93.1 $38.6 
Prepaid expenses92.2 96.7 
Contract assets53.5 49.6 
Other receivables42.4 44.3 
Derivatives10.9 22.0 
Other3.1 0.9 
Total prepaid expenses and other current assets$295.2 $252.1 
Goodwill
Changes in goodwill were as follows:
(In millions)North AmericaEMEAChinaOtherTotal
Balance at January 1, 2023$1,547.7 $358.6 $118.1 $452.4 $2,476.8 
Purchase accounting adjustments(13.4)(4.1)(1.3)(5.1)(23.9)
Foreign currency translation(0.1)(4.1)(6.4)0.6 (10.0)
Balance at October 1, 2023$1,534.2 $350.4 $110.4 $447.9 $2,442.9 
Other Current Liabilities
Other current liabilities consisted of the following:
(In millions)October 1, 2023January 1, 2023
Accrued commissions, rebates and returns$51.5 $57.5 
Accrued other taxes payable39.7 9.3 
Deferred revenue34.6 76.4 
Accrued interest32.2 1.4 
Operating lease liabilities26.3 24.4 
Derivatives6.7 19.7 
Deferred consideration— 39.3 
Other114.4 97.4 
Total other current liabilities$305.4 $325.4 
XML 39 R30.htm IDEA: XBRL DOCUMENT v3.23.3
Borrowings (Tables)
 9 Months Ended
Oct. 01, 2023
Debt Disclosure [Abstract]  
Schedule of Debt
The components of borrowings were as follows:
(In millions)October 1, 2023January 1, 2023
Term Loan$2,472.2 $2,646.9 
Financing lease obligation 0.5 0.8 
Other short-term borrowings2.9 — 
Other long-term borrowings0.7 1.2 
Unamortized deferred financing costs(8.7)(10.6)
Total borrowings2,467.6 2,638.3 
Less: current portion(193.0)(207.5)
Long-term borrowings$2,274.6 $2,430.8 
Schedule of Interest Expense
The following table provides the detailed amounts within Interest expense, net for the three and nine months ended October 1, 2023 and October 2, 2022:
Three Months EndedNine Months Ended
(In millions)October 1, 2023October 2, 2022October 1, 2023October 2, 2022
Term Loan$45.7 $27.9 $130.8 $36.3 
Revolving Credit Facility0.9 0.6 1.9 1.0 
Amortization of deferred financing costs0.9 0.9 2.5 1.2 
Derivative instruments and other(8.5)0.6 (20.2)3.5 
Interest income(1.3)(0.3)(4.1)(1.0)
Interest expense, net$37.7 $29.7 $110.9 $41.0 
XML 40 R31.htm IDEA: XBRL DOCUMENT v3.23.3
Stock-Based Compensation (Tables)
 9 Months Ended
Oct. 01, 2023
Equity [Abstract]  
Compensation Expense Related to Stock-Based Compensation Plans
Stock-based compensation expense was as follows:
Three Months EndedNine Months Ended
(In millions)October 1, 2023October 2, 2022October 1, 2023October 2, 2022
Cost of sales$1.2 $0.8 $3.3 $2.0 
Research and development1.6 1.3 4.2 3.8 
Selling, marketing and administrative
10.3 7.2 27.5 20.5 
Acquisition and integration costs4.0 6.9 13.1 24.2 
Total stock-based compensation expense$17.1 $16.2 $48.1 $50.5 
Estimated Fair Value of Each Stock Option Award
The estimated fair value of each stock option was determined on the date of grant using the Black-Scholes option valuation model with the following weighted-average assumptions for the option grants:
Nine Months Ended
October 1, 2023October 2, 2022
Risk-free interest rate3.52 %1.99 %
Expected option life (in years)5.534.89
Volatility rate57 %58 %
Dividend rate0 %0 %
Weighted-average grant date fair value$48.17$50.86
XML 41 R32.htm IDEA: XBRL DOCUMENT v3.23.3
Fair Value Measurements (Tables)
 9 Months Ended
Oct. 01, 2023
Fair Value Disclosures [Abstract]  
Assets and Liabilities Measured at Fair Value on Recurring Basis
The following table presents the Company’s hierarchy for its assets and liabilities measured at fair value on a recurring basis as of the following periods:
 October 1, 2023January 1, 2023
(In millions)Level 1Level 2Level 3TotalLevel 1Level 2Level 3Total
Assets:
Cash equivalents$2.0 $— $— $2.0 $0.6 $2.1 $— $2.7 
Marketable securities— 55.8 — 55.8 2.0 71.1 — 73.1 
Derivative assets— 49.9 — 49.9 — 22.0 — 22.0 
Total assets measured at fair value$2.0 $105.7 $— $107.7 $2.6 $95.2 $— $97.8 
Liabilities:
Derivative liabilities$— $6.7 $— $6.7 $— $21.8 $— $21.8 
Contingent consideration— — 0.1 0.1 — — 0.1 0.1 
Deferred consideration— — — — — 39.3 — 39.3 
Total liabilities measured at fair value$— $6.7 $0.1 $6.8 $— $61.1 $0.1 $61.2 
XML 42 R33.htm IDEA: XBRL DOCUMENT v3.23.3
Derivative Instruments and Hedging Activities (Tables)
 9 Months Ended
Oct. 01, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Schedule of Interest Rate Derivatives
The following table summarizes the Company’s interest rate derivative agreements as of October 1, 2023, all of which were interest rate swaps:
Notional Amount
(In millions) (1)
DescriptionHedge DesignationEffective DateExpiration Date
$500.0 
Pay 1.58% fixed, receive floating rate
(1-month USD-SOFR)
Designated cash flow hedgeMay 29, 2022December 31, 2023
$397.2 
Pay 3.765% fixed, receive floating rate
(1-month USD-SOFR)
Designated cash flow hedgeDecember 30, 2022May 27, 2027
$144.4 
Pay 3.7725% fixed, receive floating rate
(1-month USD-SOFR)
Designated cash flow hedgeDecember 30, 2022May 27, 2027
$216.7 
Pay 3.7675% fixed, receive floating rate
(1-month USD-SOFR)
Designated cash flow hedgeDecember 30, 2022May 27, 2027
$288.9 
Pay 3.7575% fixed, receive floating rate
(1-month USD-SOFR)
Designated cash flow hedgeDecember 30, 2022May 27, 2027
$252.8 
Pay 3.7725% fixed, receive floating rate
(1-month USD-SOFR)
Designated cash flow hedgeDecember 30, 2022May 27, 2027
(1) The notional value of interest rate swap contracts with an effective date of December 30, 2022 is expected to increase to $1.8 billion on December 29, 2023.
Schedule of Currency Hedging Instruments
The following table provides details of the currency hedging instruments outstanding as of October 1, 2023:
DescriptionNotional Amount
(In millions)		Hedge Designation
Foreign currency forward contracts$127.0 Cash Flow Hedge
Foreign currency forward contracts$616.9 Non-designated
Schedule of Derivative Instruments, Effect on Other Comprehensive (Loss) Income
The following table summarizes pre-tax gains and losses from designated derivative and non-derivative instruments within Accumulated other comprehensive (loss) income (“AOCI”) for the three and nine months ended October 1, 2023 and October 2, 2022:
Designated Hedging Instruments
(In millions)Amount of Loss (Gain) Recognized in OCI on HedgesLocation of Amounts Reclassified From AOCI Into IncomeAmount of Loss (Gain) Reclassified From AOCI Into Income
Three Months Ended October 1, 2023
Foreign currency forward contracts (sales)$(1.0)Total revenues$1.8 
Foreign currency forward contracts (purchases)$(0.1)Cost of sales, excluding amortization of intangibles$0.4 
Interest rate derivatives$(28.0)Interest expense, net$(8.5)
Nine Months Ended October 1, 2023
Foreign currency forward contracts (sales)$0.7 Total revenues$2.7 
Foreign currency forward contracts (purchases)$(2.2)Cost of sales, excluding amortization of intangibles$2.1 
Interest rate derivatives$(54.1)Interest expense, net$(21.1)
Three Months Ended October 2, 2022
Foreign currency forward contracts (sales)$(2.6)Total revenues$(0.7)
Foreign currency forward contracts (purchases)$(0.6)Cost of sales, excluding amortization of intangibles$(0.1)
Interest rate derivatives$(7.9)Interest expense, net$0.4 
Nine Months Ended October 2, 2022
Foreign currency forward contracts (sales)$(5.0)Total revenues$(0.9)
Foreign currency forward contracts (purchases)$(0.8)Cost of sales, excluding amortization of intangibles$(0.1)
Interest rate derivatives$(11.0)Interest expense, net$1.7 
Schedule of Derivative Assets at Fair Value
The following table summarizes the fair value of designated and non-designated hedging instruments recognized within the Consolidated Balance Sheets as of October 1, 2023 and January 1, 2023:
(In millions)October 1, 2023January 1, 2023
Designated cash flow hedges
Interest rate derivatives:
Prepaid expenses and other current assets$4.9 $15.9 
Other assets$39.0 $— 
Other liabilities$— $2.1 
Foreign currency forward contracts:
Prepaid expenses and other current assets$2.1 $4.6 
Other current liabilities$3.4 $14.3 
Non-designated hedging instruments
Foreign currency forward contracts:
Prepaid expenses and other current assets$3.9 $1.5 
Other current liabilities$3.3 $5.4 
XML 43 R34.htm IDEA: XBRL DOCUMENT v3.23.3
Accumulated Other Comprehensive Loss (Tables)
 9 Months Ended
Oct. 01, 2023
Equity [Abstract]  
Schedule of Accumulated Other Comprehensive Income (Loss)
The following table summarizes the changes in Accumulated other comprehensive loss by component:
Three Months Ended October 1, 2023
(In millions)Pension and Other Post-
Employment Benefits		Cash Flow HedgesAvailable-for-Sale InvestmentsUnrealized Foreign Currency Translation AdjustmentsAccumulated Other Comprehensive (Loss) Income
Balance at July 2, 2023$0.7 $14.6 $(0.4)$(31.2)$(16.3)
Current period deferrals (1)
— 24.5 0.2 (55.3)(30.6)
Amounts reclassified to net income— (6.3)— — (6.3)
Net change— 18.2 0.2 (55.3)(36.9)
Balance at October 1, 2023$0.7 $32.8 $(0.2)$(86.5)$(53.2)
Nine Months Ended October 1, 2023
Pension and Other Post-
Employment Benefits		Cash Flow HedgesAvailable-for-Sale InvestmentsUnrealized Foreign Currency Translation AdjustmentsAccumulated Other Comprehensive (Loss) Income
Balance at January 1, 2023$0.7 $1.5 $(0.5)$(69.3)$(67.6)
Current period deferrals (1)
— 47.6 0.3 (17.2)30.7 
Amounts reclassified to net income— (16.3)— — (16.3)
Net change— 31.3 0.3 (17.2)14.4 
Balance at October 1, 2023$0.7 $32.8 $(0.2)$(86.5)$(53.2)
Three Months Ended October 2, 2022
(In millions)Cash Flow HedgesAvailable-for-Sale InvestmentsUnrealized Foreign Currency Translation AdjustmentsAccumulated Other Comprehensive Income (Loss)
Balance at July 3, 2022$5.5 $(0.7)$(65.5)$(60.7)
Current period deferrals (2)
9.3 — (92.9)(83.6)
Amounts reclassified to net income(0.2)— — (0.2)
Net change9.1 — (92.9)(83.8)
Balance at October 2, 2022$14.6 $(0.7)$(158.4)$(144.5)
Nine Months Ended October 2, 2022
Cash Flow HedgesAvailable-for-Sale InvestmentsUnrealized Foreign Currency Translation AdjustmentsAccumulated Other Comprehensive Income (Loss)
Balance at January 2, 2022$— $(0.1)$0.5 $0.4 
Current period deferrals (2)
13.9 (0.6)(158.9)(145.6)
Amounts reclassified to net income0.7 — — 0.7 
Net change14.6 (0.6)(158.9)(144.9)
Balance at October 2, 2022$14.6 $(0.7)$(158.4)$(144.5)
(1) Includes tax impact of $4.6 million and $8.0 million related to cash flow hedges for the three and nine months ended October 1, 2023, respectively.
(2) Includes tax impact of $1.7 million and $2.8 million related to cash flow hedges for the three and nine months ended October 2, 2022, respectively.
XML 44 R35.htm IDEA: XBRL DOCUMENT v3.23.3
Basis of Presentation and Summary of Significant Accounting Policies - Narrative (Details)
 9 Months Ended
Oct. 01, 2023
Revenue Benchmark | Customer Concentration Risk | Retail Customers  
Reclassification [Line Items]  
Percentage of risk concentration 3.00%
XML 45 R36.htm IDEA: XBRL DOCUMENT v3.23.3
Business Combination - Narrative (Details) - USD ($)
$ / shares in Units, $ in Millions
 9 Months Ended
May 26, 2022
Oct. 01, 2023
Business Acquisition [Line Items]    
Measurement period adjustments of goodwill   $ (23.9)
Goodwill adjustment, decrease to deferred tax liabilities   22.3
Goodwill adjustment, decrease to income taxes payable   2.9
Goodwill adjustment, decrease to deferred tax assets   $ 1.3
Ortho    
Business Acquisition [Line Items]    
Business Combination, Consideration Transferred $ 4,300.0  
Closing price of Quidel Common Stock (in usd per share) $ 99.60  
Cash paid to former Ortho stockholders per Ortho Share (in usd per share) $ 7.14  
Ortho Exchange Ratio (in shares) 0.1055  
XML 46 R37.htm IDEA: XBRL DOCUMENT v3.23.3
Business Combination - Pro Forma Information (Details) - Ortho - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Oct. 02, 2022
Oct. 03, 2021
Oct. 02, 2022
Oct. 03, 2021
Business Acquisition, Pro Forma Information, Nonrecurring Adjustment [Line Items]        
Pro forma total revenues $ 783.8 $ 1,032.3 $ 3,184.7 $ 2,583.5
Pro forma net income $ 50.2 $ 225.2 $ 549.5 $ 340.2
XML 47 R38.htm IDEA: XBRL DOCUMENT v3.23.3
Computation of Earnings Per Share - Calculation of Basic and Diluted Earnings Per Share (Details) - shares
shares in Millions
 3 Months Ended 9 Months Ended
Oct. 01, 2023
Oct. 02, 2022
Oct. 01, 2023
Oct. 02, 2022
Earnings Per Share [Abstract]        
Basic weighted-average shares of common stock outstanding 66.9 66.9 66.8 53.6
Dilutive potential shares issuable from stock options and RSUs 0.0 0.6 0.0 0.6
Diluted weighted-average shares of common stock outstanding 66.9 67.5 66.8 54.2
Potentially dilutive shares excluded from calculation due to anti-dilutive effect 0.4   0.5  
PotentialWeightedAverageNumberOfDilutedSharesOutstandingDiluted weighted-average shares of common stock outstanding 67.3   67.3  
XML 48 R39.htm IDEA: XBRL DOCUMENT v3.23.3
Computation of Earnings Per Share - Narrative (Details) - shares
shares in Millions
 3 Months Ended 9 Months Ended
Oct. 01, 2023
Oct. 02, 2022
Oct. 01, 2023
Oct. 02, 2022
Statement [Line Items]        
Potentially dilutive shares excluded from calculation due to anti-dilutive effect 0.4   0.5  
Share-Based Payment Arrangement        
Statement [Line Items]        
Potentially dilutive shares excluded from calculation due to anti-dilutive effect 1.7 1.0 1.6 1.0
XML 49 R40.htm IDEA: XBRL DOCUMENT v3.23.3
Revenue - Narrative (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Oct. 01, 2023
Oct. 02, 2022
Oct. 01, 2023
Oct. 02, 2022
Jan. 01, 2023
Disaggregation of Revenue [Line Items]          
Deferred revenue, current $ 34.6   $ 34.6   $ 76.4
Deferred revenue, noncurrent 13.5   13.5   9.4
Deferred revenue, revenue recognized 2.4   70.9    
Accounts receivable, net $ 331.2   $ 331.2   453.9
Revenue Benchmark | Product Concentration Risk | Respiratory          
Disaggregation of Revenue [Line Items]          
Percentage of risk concentration 25.00% 30.00% 24.00% 63.00%  
Collaborative Arrangement, Transaction with Party to Collaborative Arrangement          
Disaggregation of Revenue [Line Items]          
Gross Profit $ 8.9 $ 7.9 $ 38.6 $ 13.5  
Revenue 1.6 2.7 24.6 4.7  
Collaborative Arrangement, Transaction with Party to Collaborative Arrangement and Third Party          
Disaggregation of Revenue [Line Items]          
Gross Profit 7.3 $ 5.2 14.0 $ 8.8  
Prepaid expenses and other current assets          
Disaggregation of Revenue [Line Items]          
Contract assets 53.5   53.5   49.6
Customer 1          
Disaggregation of Revenue [Line Items]          
Contract assets 3.8   3.8   6.8
Expected Value Contract Customers | Prepaid expenses and other current assets          
Disaggregation of Revenue [Line Items]          
Contract assets 42.4   42.4   38.5
Customer 2          
Disaggregation of Revenue [Line Items]          
Contract assets 7.3   7.3   4.3
Customer A | Total revenues | Customer Concentration Risk          
Disaggregation of Revenue [Line Items]          
Percentage of risk concentration       27.00%  
Customer B | Total revenues | Customer Concentration Risk          
Disaggregation of Revenue [Line Items]          
Percentage of risk concentration       10.00%  
Customers With Balances Due In Excess of 10% Of Accounts Receivable | Accounts Receivable | Customer Concentration Risk          
Disaggregation of Revenue [Line Items]          
Accounts receivable, net $ 99.4   $ 99.4   $ 161.9
XML 50 R41.htm IDEA: XBRL DOCUMENT v3.23.3
Revenue - Disaggregation of Revenue (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Oct. 01, 2023
Oct. 02, 2022
Oct. 01, 2023
Oct. 02, 2022
Disaggregation of Revenue [Line Items]        
Total revenues $ 744.0 $ 783.8 $ 2,255.2 $ 2,399.5
Labs        
Disaggregation of Revenue [Line Items]        
Total revenues 341.4 334.8 1,073.5 505.5
Transfusion Medicine        
Disaggregation of Revenue [Line Items]        
Total revenues 163.9 163.1 483.1 231.3
Point of Care        
Disaggregation of Revenue [Line Items]        
Total revenues 233.1 270.5 675.4 1,580.6
Molecular Diagnostics        
Disaggregation of Revenue [Line Items]        
Total revenues $ 5.6 $ 15.4 $ 23.2 $ 82.1
XML 51 R42.htm IDEA: XBRL DOCUMENT v3.23.3
Segment and Geographic Information - Total Revenues by Reportable Segment (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Oct. 01, 2023
Oct. 02, 2022
Oct. 01, 2023
Oct. 02, 2022
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]        
Total revenues $ 744.0 $ 783.8 $ 2,255.2 $ 2,399.5
North America        
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]        
Total revenues 465.2 517.6 1,426.8 1,917.3
EMEA        
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]        
Total revenues 74.5 73.7 236.4 131.0
China        
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]        
Total revenues 81.1 80.8 233.0 163.1
Other        
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]        
Total revenues $ 123.2 $ 111.7 $ 359.0 $ 188.1
XML 52 R43.htm IDEA: XBRL DOCUMENT v3.23.3
Segment and Geographic Information - Reconciliation to Income (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Oct. 01, 2023
Oct. 02, 2022
Oct. 01, 2023
Oct. 02, 2022
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]        
Segment Adjusted EBITDA $ 332.1 $ 385.5 $ 916.1 $ 1,427.8
Corporate (162.9) (158.7) (388.3) (341.9)
Interest expense, net (37.7) (29.7) (110.9) (41.0)
Depreciation and amortization (113.1) (104.2) (341.8) (167.0)
Acquisition and integration costs (26.5) (26.4) (80.4) (109.6)
Amortization of deferred cloud computing implementation costs (2.8) (1.6) (5.9) (3.9)
Impairment of long-lived assets (2.2) 0.0 (3.2) 0.0
Loss on investments (1.0) 0.0 (1.2) (0.8)
EU medical device regulation transition costs (0.4) (0.6) (1.9) (1.0)
Unwind inventory fair value adjustment 0.0 (35.4) 0.0 (46.6)
Employee compensation charges 0.0 (1.0) 0.0 (1.5)
Loss on extinguishment of debt 0.0 0.0 0.0 (24.0)
Derivative mark-to-market gain 0.0 3.4 0.0 4.4
Tax indemnification income 0.1 0.3 0.2 0.3
Other adjustments (1.1) (0.3) (2.6) (0.4)
(Loss) income before income taxes (15.5) 31.3 (19.9) 694.8
North America        
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]        
Segment Adjusted EBITDA 253.4 293.5 708.1 1,246.1
EMEA        
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]        
Segment Adjusted EBITDA 10.2 17.2 22.7 33.4
China        
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]        
Segment Adjusted EBITDA 37.3 45.0 96.0 84.2
Other        
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]        
Segment Adjusted EBITDA $ 31.2 $ 29.8 $ 89.3 $ 64.1
XML 53 R44.htm IDEA: XBRL DOCUMENT v3.23.3
Income Taxes (Detail) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Oct. 01, 2023
Oct. 02, 2022
Oct. 01, 2023
Oct. 02, 2022
Jan. 01, 2023
Income Tax Disclosure [Abstract]          
(Benefit from) provision for income taxes $ (2.8) $ 12.1 $ (2.8) $ 176.4  
(Loss) income before income taxes $ (15.5) $ 31.3 $ (19.9) $ 694.8  
Effective income tax rate 18.10% 38.70% 14.10% 25.40%  
Unrecognized tax benefits $ 38.7   $ 38.7    
Unrecognized tax benefits the could impact effective tax rate 27.5   27.5    
Unrecognized tax benefits, income tax interest and penalties accrued 8.5   8.5    
Decrease in unrecognized tax benefits is reasonably possible 14.2   14.2    
Indemnification receivable 16.4   16.4   $ 16.8
Penalties and interest expense $ 0.3 $ 0.3 $ 1.0 $ 0.4  
XML 54 R45.htm IDEA: XBRL DOCUMENT v3.23.3
Balance Sheet Account Details Cash, Cash Equivalents and Restricted Cash (Details) - USD ($)
$ in Millions
Oct. 01, 2023
Jan. 01, 2023
Oct. 02, 2022
Jan. 02, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]        
Cash and cash equivalents $ 149.3 $ 292.9    
Restricted Cash, Noncurrent 0.6 1.0    
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $ 149.9 $ 293.9 $ 213.2 $ 802.8
XML 55 R46.htm IDEA: XBRL DOCUMENT v3.23.3
Balance Sheet Account Details Marketable Securities (Details) - USD ($)
$ in Millions
Oct. 01, 2023
Jan. 01, 2023
Marketable Securities [Line Items]    
Debt Securities, Available-for-sale, Amortized Cost $ 56.1 $ 73.8
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax (0.3) (0.7)
Marketable securities 43.9 52.1
Marketable securities 11.9 21.0
Total marketable securities 55.8 73.1
Short-term Investments    
Marketable Securities [Line Items]    
Debt Securities, Available-for-sale, Amortized Cost 44.1 52.6
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax (0.2) (0.5)
Marketable securities 43.9 52.1
Short-term Investments | Corporate bonds    
Marketable Securities [Line Items]    
Debt Securities, Available-for-sale, Amortized Cost 32.8 40.5
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax (0.2) (0.5)
Marketable securities 32.6 40.0
Short-term Investments | Corporate asset-backed securities    
Marketable Securities [Line Items]    
Debt Securities, Available-for-sale, Amortized Cost 7.8 6.7
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax 0.0 0.0
Marketable securities 7.8 6.7
Short-term Investments | U.S. government securities    
Marketable Securities [Line Items]    
Debt Securities, Available-for-sale, Amortized Cost 0.0 2.0
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax 0.0 0.0
Marketable securities 0.0 2.0
Short-term Investments | Agency bonds    
Marketable Securities [Line Items]    
Debt Securities, Available-for-sale, Amortized Cost 1.5 1.0
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax 0.0 0.0
Marketable securities 1.5 1.0
Short-term Investments | Sovereign government bonds    
Marketable Securities [Line Items]    
Debt Securities, Available-for-sale, Amortized Cost 2.0 1.9
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax 0.0 0.0
Marketable securities 2.0 1.9
Short-term Investments | Foreign and other    
Marketable Securities [Line Items]    
Debt Securities, Available-for-sale, Amortized Cost 0.0 0.5
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax 0.0 0.0
Marketable securities 0.0 0.5
Long-Term Investments | Corporate bonds    
Marketable Securities [Line Items]    
Debt Securities, Available-for-sale, Amortized Cost 8.8 13.3
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax (0.1) (0.1)
Marketable securities 8.7 13.2
Long-Term Investments | Corporate asset-backed securities    
Marketable Securities [Line Items]    
Debt Securities, Available-for-sale, Amortized Cost 3.2 7.9
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax 0.0 (0.1)
Marketable securities 3.2 7.8
Long-Term Investments | Agency bonds    
Marketable Securities [Line Items]    
Debt Securities, Available-for-sale, Amortized Cost 0.0 0.0
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax 0.0 0.0
Marketable securities $ 0.0 $ 0.0
XML 56 R47.htm IDEA: XBRL DOCUMENT v3.23.3
Balance Sheet Account Details Accounts Receivable (Details) - USD ($)
$ in Millions
Oct. 01, 2023
Jan. 01, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Accounts receivable $ 419.1 $ 543.0
Allowance for contract rebates and discounts (75.2) (77.1)
Allowance for doubtful accounts (12.7) (12.0)
Total accounts receivable, net $ 331.2 $ 453.9
XML 57 R48.htm IDEA: XBRL DOCUMENT v3.23.3
Balance Sheet Account Details Inventories (Details) - USD ($)
$ in Millions
Oct. 01, 2023
Jan. 01, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Raw materials $ 197.9 $ 185.2
Work-in-process (materials, labor and overhead) 104.7 82.7
Finished goods (materials, labor and overhead) 295.5 295.1
Inventories, including noncurrent portion, net 598.1 563.0
Inventories 551.7 524.1
Inventory, Noncurrent 46.4 $ 38.9
Inventory Adjustments $ 39.0  
XML 58 R49.htm IDEA: XBRL DOCUMENT v3.23.3
Balance Sheet Account Details Prepaid expenses and other current assets (Details) - USD ($)
$ in Millions
Oct. 01, 2023
Jan. 01, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Income taxes and other tax receivables $ 93.1 $ 38.6
Prepaid expenses 92.2 96.7
Contract assets 53.5 49.6
Other receivables 42.4 44.3
Derivatives 10.9 22.0
Other 3.1 0.9
Total prepaid expenses and other current assets $ 295.2 $ 252.1
XML 59 R50.htm IDEA: XBRL DOCUMENT v3.23.3
Balance Sheet Account Details - Goodwill Rollforward (Details)
$ in Millions
 9 Months Ended
Oct. 01, 2023
USD ($)
Goodwill [Roll Forward]  
Goodwill, Beginning Balance $ 2,476.8
Purchase accounting adjustments (23.9)
Foreign currency translation (10.0)
Goodwill, Ending Balance 2,442.9
North America  
Goodwill [Roll Forward]  
Goodwill, Beginning Balance 1,547.7
Purchase accounting adjustments (13.4)
Foreign currency translation (0.1)
Goodwill, Ending Balance 1,534.2
EMEA  
Goodwill [Roll Forward]  
Goodwill, Beginning Balance 358.6
Purchase accounting adjustments (4.1)
Foreign currency translation (4.1)
Goodwill, Ending Balance 350.4
China  
Goodwill [Roll Forward]  
Goodwill, Beginning Balance 118.1
Purchase accounting adjustments (1.3)
Foreign currency translation (6.4)
Goodwill, Ending Balance 110.4
Other  
Goodwill [Roll Forward]  
Goodwill, Beginning Balance 452.4
Purchase accounting adjustments (5.1)
Foreign currency translation 0.6
Goodwill, Ending Balance $ 447.9
XML 60 R51.htm IDEA: XBRL DOCUMENT v3.23.3
Balance Sheet Account Details Other Current Liabilities (Details) - USD ($)
$ in Millions
Oct. 01, 2023
Jan. 01, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Accrued commissions, rebates and returns $ 51.5 $ 57.5
Accrued other taxes payable 39.7 9.3
Deferred revenue 34.6 76.4
Accrued interest $ 32.2 $ 1.4
Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration] Total other current liabilities Total other current liabilities
Operating lease liabilities $ 26.3 $ 24.4
Derivatives 6.7 19.7
Deferred consideration 0.0 39.3
Other 114.4 97.4
Total other current liabilities $ 305.4 $ 325.4
XML 61 R52.htm IDEA: XBRL DOCUMENT v3.23.3
Borrowings - Schedule of Borrowings (Details) - USD ($)
$ in Millions
Oct. 01, 2023
Jan. 01, 2023
May 27, 2022
Debt Instrument [Line Items]      
Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration] Other liabilities Other liabilities  
Financing lease obligation $ 0.5 $ 0.8  
Other short-term borrowings 2.9 0.0  
Other long-term borrowings 0.7 1.2  
Unamortized deferred financing costs (8.7) (10.6)  
Total borrowings 2,467.6 2,638.3  
Less: current portion (193.0) (207.5)  
Long-term borrowings 2,274.6 2,430.8  
Line of Credit | Term Loan | Credit Agreement      
Debt Instrument [Line Items]      
Term Loan $ 2,472.2 $ 2,646.9 $ 2,750.0
XML 62 R53.htm IDEA: XBRL DOCUMENT v3.23.3
Borrowings - Narrative (Details)
$ in Millions
 9 Months Ended
Oct. 01, 2023
USD ($)
covenant
Jan. 01, 2023
USD ($)
Aug. 04, 2022
USD ($)
May 27, 2022
USD ($)
Debt Instrument [Line Items]        
Number of financial covenants | covenant 2      
Credit Agreement | Line of Credit        
Debt Instrument [Line Items]        
Leverage ratio maximum 3.50      
Leverage ratio, minimum 3.00      
Credit Agreement | Line of Credit | Ending after the closing date of the credit agreement        
Debt Instrument [Line Items]        
Leverage ratio maximum 4.50      
Credit Agreement | Line of Credit | Ending after initial measurement period        
Debt Instrument [Line Items]        
Leverage ratio maximum 4.00      
Term Loan | Credit Agreement | Line of Credit        
Debt Instrument [Line Items]        
Term Loan $ 2,472.2 $ 2,646.9   $ 2,750.0
Payments of term loan 174.7      
Term Loan | Credit Agreement | Line of Credit | Voluntary Prepayment        
Debt Instrument [Line Items]        
Payments of term loan 20.0      
Revolving Credit Facility | Credit Agreement | Line of Credit        
Debt Instrument [Line Items]        
Line of credit, maximum borrowing capacity     $ 800.0  
Remaining borrowing capacity 787.1      
Letter of Credit | Credit Agreement | Line of Credit        
Debt Instrument [Line Items]        
Proceeds from lines of credit $ 12.9      
XML 63 R54.htm IDEA: XBRL DOCUMENT v3.23.3
Borrowings - Interest Expense (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Oct. 01, 2023
Oct. 02, 2022
Oct. 01, 2023
Oct. 02, 2022
Debt Instrument [Line Items]        
Amortization of deferred financing costs $ 0.9 $ 0.9 $ 2.5 $ 1.2
Derivative instruments and other (8.5) 0.6 (20.2) 3.5
Interest income (1.3) (0.3) (4.1) (1.0)
Interest expense, net 37.7 29.7 110.9 41.0
Line of Credit | Term Loan | Credit Agreement        
Debt Instrument [Line Items]        
Interest expense, debt 45.7 27.9 130.8 36.3
Line of Credit | Revolving Credit Facility | Credit Agreement        
Debt Instrument [Line Items]        
Interest expense, debt $ 0.9 $ 0.6 $ 1.9 $ 1.0
XML 64 R55.htm IDEA: XBRL DOCUMENT v3.23.3
Stock-Based Compensation - Compensation Expense Related to Stock-Based Compensation Plans (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Oct. 01, 2023
Oct. 02, 2022
Oct. 01, 2023
Oct. 02, 2022
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]        
Total stock-based compensation expense $ 17.1 $ 16.2 $ 48.1 $ 50.5
Cost of sales        
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]        
Total stock-based compensation expense 1.2 0.8 3.3 2.0
Research and development        
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]        
Total stock-based compensation expense 1.6 1.3 4.2 3.8
Selling, marketing and administrative        
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]        
Total stock-based compensation expense 10.3 7.2 27.5 20.5
Acquisition and integration costs        
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]        
Total stock-based compensation expense $ 4.0 $ 6.9 $ 13.1 $ 24.2
XML 65 R56.htm IDEA: XBRL DOCUMENT v3.23.3
Stock-Based Compensation - Narrative (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Millions
 3 Months Ended 9 Months Ended
May 26, 2022
Oct. 01, 2023
Oct. 02, 2022
Oct. 01, 2023
Oct. 02, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Share-based liabilities paid   $ 3.0 $ 3.0 $ 8.8 $ 13.9
Stock options granted (in shares)       253  
Increase to share based compensation from modification of vesting awards   2.9   $ 8.0  
Unrecognized share based compensation expense relating to unvested shares   3.1   $ 3.1  
RSUs granted (in shares)       609  
Maximum          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Stock options, term (in years)       10 years  
Ortho          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Cash paid to former Ortho stockholders per Ortho Share (in usd per share) $ 7.14        
Stock Options          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Unrecognized compensation expense   20.0   $ 20.0  
Expected weighted-average period of recognition for unrecognized compensation expense       2 years  
RSUs          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Unrecognized compensation expense   $ 78.4   $ 78.4  
Expected weighted-average period of recognition for unrecognized compensation expense       2 years 2 months 12 days  
Weighted-Average Grant Date Fair Value, Granted (in USD per share)       $ 87.14 $ 97.52
XML 66 R57.htm IDEA: XBRL DOCUMENT v3.23.3
Stock-Based Compensation - Estimated Fair Value of Each Stock Option Award (Details) - $ / shares
 9 Months Ended
Oct. 01, 2023
Oct. 02, 2022
Equity [Abstract]    
Risk-free interest rate 3.52% 1.99%
Expected option life (in years) 5 years 6 months 10 days 4 years 10 months 20 days
Volatility rate 57.00% 58.00%
Dividend rate 0.00% 0.00%
Weighted-average grant date fair value of stock options granted (in USD per share) $ 48.17 $ 50.86
XML 67 R58.htm IDEA: XBRL DOCUMENT v3.23.3
Fair Value Measurements - Assets and Liabilities Measured at Fair Value on Recurring Basis (Details) - USD ($)
$ in Millions
Oct. 01, 2023
Jan. 01, 2023
Assets:    
Cash equivalents $ 2.0 $ 2.7
Marketable securities 55.8 73.1
Derivative assets 49.9 22.0
Total assets measured at fair value 107.7 97.8
Liabilities:    
Derivative liabilities 6.7 21.8
Contingent consideration 0.1 0.1
Deferred consideration 0.0 39.3
Total liabilities measured at fair value 6.8 61.2
Level 1    
Assets:    
Cash equivalents 2.0 0.6
Marketable securities 0.0 2.0
Derivative assets 0.0 0.0
Total assets measured at fair value 2.0 2.6
Liabilities:    
Derivative liabilities 0.0 0.0
Contingent consideration 0.0 0.0
Deferred consideration 0.0 0.0
Total liabilities measured at fair value 0.0 0.0
Level 2    
Assets:    
Cash equivalents 0.0 2.1
Marketable securities 55.8 71.1
Derivative assets 49.9 22.0
Total assets measured at fair value 105.7 95.2
Liabilities:    
Derivative liabilities 6.7 21.8
Contingent consideration 0.0 0.0
Deferred consideration 0.0 39.3
Total liabilities measured at fair value 6.7 61.1
Level 3    
Assets:    
Cash equivalents 0.0 0.0
Marketable securities 0.0 0.0
Derivative assets 0.0 0.0
Total assets measured at fair value 0.0 0.0
Liabilities:    
Derivative liabilities 0.0 0.0
Contingent consideration 0.1 0.1
Deferred consideration 0.0 0.0
Total liabilities measured at fair value $ 0.1 $ 0.1
XML 68 R59.htm IDEA: XBRL DOCUMENT v3.23.3
Fair Value Measurements - Narrative (Details) - USD ($)
$ in Millions
Oct. 01, 2023
Apr. 30, 2023
Jan. 01, 2023
May 27, 2022
BNP Business        
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]        
Installment payment   $ 40.0    
Term Loan | Credit Agreement | Line of Credit        
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]        
Long-Term Debt, Fair Value $ 2,444.4   $ 2,630.3  
Term Loan $ 2,472.2   $ 2,646.9 $ 2,750.0
XML 69 R60.htm IDEA: XBRL DOCUMENT v3.23.3
Derivative Instruments and Hedging Activities - Narrative (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Oct. 01, 2023
Oct. 02, 2022
Oct. 01, 2023
Oct. 02, 2022
Derivative [Line Items]        
Pre tax gain (loss) from reclassification $ 29.0   $ 29.0  
Foreign currency cash flow hedge, gain (loss) to be reclassified during next 12 months (2.0)   (2.0)  
Foreign Exchange Forward | Other Nonoperating Income (Expense)        
Derivative [Line Items]        
Fair value gain (loss) on derivative instruments not designated as hedging instruments $ (0.2) $ (2.7) $ 0.3 $ (3.0)
Interest Rate Swap | Other Nonoperating Income (Expense)        
Derivative [Line Items]        
Fair value gain (loss) on derivative instruments not designated as hedging instruments   $ 3.4   $ 4.4
XML 70 R61.htm IDEA: XBRL DOCUMENT v3.23.3
Derivative Instruments and Hedging Activities - Schedule of Interest Rate Derivatives (Details) - Designated cash flow hedges - USD ($)
$ in Millions
Dec. 29, 2023
Oct. 01, 2023
Interest Rate Swap    
Derivative [Line Items]    
Derivative, Notional Amount   $ 500.0
Derivative, Fixed Interest Rate   1.58%
Interest Rate Swap | Forecast    
Derivative [Line Items]    
Derivative, Notional Amount $ 1,800.0  
Interest Rate Swap One    
Derivative [Line Items]    
Derivative, Notional Amount   $ 397.2
Derivative, Fixed Interest Rate   3.765%
Interest Rate Swap Two    
Derivative [Line Items]    
Derivative, Notional Amount   $ 144.4
Derivative, Fixed Interest Rate   3.7725%
Interest Rate Swap Three    
Derivative [Line Items]    
Derivative, Notional Amount   $ 216.7
Derivative, Fixed Interest Rate   3.7675%
Interest Rate Swap Four    
Derivative [Line Items]    
Derivative, Notional Amount   $ 288.9
Derivative, Fixed Interest Rate   3.7575%
Interest Rate Swap Five    
Derivative [Line Items]    
Derivative, Notional Amount   $ 252.8
Derivative, Fixed Interest Rate   3.7725%
XML 71 R62.htm IDEA: XBRL DOCUMENT v3.23.3
Derivative Instruments and Hedging Activities - Schedule of Currency Hedging Instruments (Details) - Foreign Exchange Contract
$ in Millions
Oct. 01, 2023
USD ($)
Designated cash flow hedges  
Derivative [Line Items]  
Derivative, Notional Amount $ 127.0
Non-designated hedging instruments  
Derivative [Line Items]  
Derivative, Notional Amount $ 616.9
XML 72 R63.htm IDEA: XBRL DOCUMENT v3.23.3
Derivative Instruments and Hedging Activities - Schedule of Gain (Loss) (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Oct. 01, 2023
Oct. 02, 2022
Oct. 01, 2023
Oct. 02, 2022
Interest Rate Swap | Interest expense, net        
Derivative Instruments and Hedging Activities Disclosures [Line Items]        
Amount of Loss (Gain) Recognized in OCI on Hedges $ (28.0) $ (7.9) $ (54.1) $ (11.0)
Amount of Loss (Gain) Reclassified From AOCI Into Income (8.5) 0.4 (21.1) 1.7
Foreign Exchange Forward | Total revenues        
Derivative Instruments and Hedging Activities Disclosures [Line Items]        
Amount of Loss (Gain) Recognized in OCI on Hedges (1.0) (2.6) 0.7 (5.0)
Amount of Loss (Gain) Reclassified From AOCI Into Income 1.8 (0.7) 2.7 (0.9)
Foreign Exchange Forward | Cost of sales        
Derivative Instruments and Hedging Activities Disclosures [Line Items]        
Amount of Loss (Gain) Recognized in OCI on Hedges (0.1) (0.6) (2.2) (0.8)
Amount of Loss (Gain) Reclassified From AOCI Into Income $ 0.4 $ (0.1) $ 2.1 $ (0.1)
XML 73 R64.htm IDEA: XBRL DOCUMENT v3.23.3
Derivative Instruments and Hedging Activities - Schedule of Fair Value (Details) - USD ($)
$ in Millions
Oct. 01, 2023
Jan. 01, 2023
Derivative [Line Items]    
Derivative Asset, Current $ 10.9 $ 22.0
Derivative Liability, Current $ 6.7 $ 19.7
Interest Rate Swap | Designated cash flow hedges    
Derivative [Line Items]    
Derivative Asset, Current, Statement of Financial Position [Extensible Enumeration] Prepaid expenses and other current assets Prepaid expenses and other current assets
Derivative Asset, Current $ 4.9 $ 15.9
Derivative Asset, Noncurrent, Statement of Financial Position [Extensible Enumeration] Other assets Other assets
Derivative Asset, Noncurrent $ 39.0 $ 0.0
Derivative Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration] Other liabilities Other liabilities
Derivative Liability, Noncurrent $ 0.0 $ 2.1
Foreign Exchange Contract | Designated cash flow hedges    
Derivative [Line Items]    
Derivative Asset, Current, Statement of Financial Position [Extensible Enumeration] Prepaid expenses and other current assets Prepaid expenses and other current assets
Derivative Asset, Current $ 2.1 $ 4.6
Derivative Liability, Current, Statement of Financial Position [Extensible Enumeration] Other current liabilities Other current liabilities
Derivative Liability, Current $ 3.4 $ 14.3
Foreign Exchange Contract | Non-designated hedging instruments    
Derivative [Line Items]    
Derivative Asset, Current, Statement of Financial Position [Extensible Enumeration] Prepaid expenses and other current assets Prepaid expenses and other current assets
Derivative Asset, Current $ 3.9 $ 1.5
Derivative Liability, Current, Statement of Financial Position [Extensible Enumeration] Other current liabilities Other current liabilities
Derivative Liability, Current $ 3.3 $ 5.4
XML 74 R65.htm IDEA: XBRL DOCUMENT v3.23.3
Accumulated Other Comprehensive Loss (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Oct. 01, 2023
Oct. 02, 2022
Oct. 01, 2023
Oct. 02, 2022
Accumulated Other Comprehensive Income (Loss) [Line Items]        
Beginning balance $ (16.3) $ (60.7) $ (67.6) $ 0.4
Current period deferrals (30.6) (83.6) 30.7 (145.6)
Amounts reclassified to net income (6.3) (0.2) (16.3) 0.7
Net change (36.9) (83.8) 14.4 (144.9)
Ending balance (53.2) (144.5) (53.2) (144.5)
Tax impact related to cash flow hedges 4.6 1.7 8.0 2.8
Pension and Other Post- Employment Benefits        
Accumulated Other Comprehensive Income (Loss) [Line Items]        
Beginning balance 0.7   0.7  
Current period deferrals 0.0   0.0  
Amounts reclassified to net income 0.0   0.0  
Net change 0.0   0.0  
Ending balance 0.7   0.7  
Cash Flow Hedges        
Accumulated Other Comprehensive Income (Loss) [Line Items]        
Beginning balance 14.6 5.5 1.5 0.0
Current period deferrals 24.5 9.3 47.6 13.9
Amounts reclassified to net income (6.3) (0.2) (16.3) 0.7
Net change 18.2 9.1 31.3 14.6
Ending balance 32.8 14.6 32.8 14.6
Available-for-Sale Investments        
Accumulated Other Comprehensive Income (Loss) [Line Items]        
Beginning balance (0.4) (0.7) (0.5) (0.1)
Current period deferrals 0.2 0.0 0.3 (0.6)
Amounts reclassified to net income 0.0 0.0 0.0 0.0
Net change 0.2 0.0 0.3 (0.6)
Ending balance (0.2) (0.7) (0.2) (0.7)
Unrealized Foreign Currency Translation Adjustments        
Accumulated Other Comprehensive Income (Loss) [Line Items]        
Beginning balance (31.2) (65.5) (69.3) 0.5
Current period deferrals (55.3) (92.9) (17.2) (158.9)
Amounts reclassified to net income 0.0 0.0 0.0 0.0
Net change (55.3) (92.9) (17.2) (158.9)
Ending balance $ (86.5) $ (158.4) $ (86.5) $ (158.4)
XML 75 qdel-20231001_htm.xml IDEA: XBRL DOCUMENT 0001906324 2023-01-02 2023-10-01 0001906324 2023-10-25 0001906324 2023-10-01 0001906324 2023-01-01 0001906324 2023-07-03 2023-10-01 0001906324 2022-07-04 2022-10-02 0001906324 2022-01-03 2022-10-02 0001906324 us-gaap:CommonStockMember 2023-01-01 0001906324 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2023-01-01 0001906324 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 0001906324 us-gaap:RetainedEarningsMember 2023-01-01 0001906324 us-gaap:CommonStockMember 2023-01-02 2023-04-02 0001906324 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2023-01-02 2023-04-02 0001906324 2023-01-02 2023-04-02 0001906324 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-02 2023-04-02 0001906324 us-gaap:RetainedEarningsMember 2023-01-02 2023-04-02 0001906324 us-gaap:CommonStockMember 2023-04-02 0001906324 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2023-04-02 0001906324 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-04-02 0001906324 us-gaap:RetainedEarningsMember 2023-04-02 0001906324 2023-04-02 0001906324 us-gaap:CommonStockMember 2023-04-03 2023-07-02 0001906324 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2023-04-03 2023-07-02 0001906324 2023-04-03 2023-07-02 0001906324 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-04-03 2023-07-02 0001906324 us-gaap:RetainedEarningsMember 2023-04-03 2023-07-02 0001906324 us-gaap:CommonStockMember 2023-07-02 0001906324 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2023-07-02 0001906324 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-07-02 0001906324 us-gaap:RetainedEarningsMember 2023-07-02 0001906324 2023-07-02 0001906324 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2023-07-03 2023-10-01 0001906324 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-07-03 2023-10-01 0001906324 us-gaap:RetainedEarningsMember 2023-07-03 2023-10-01 0001906324 us-gaap:CommonStockMember 2023-10-01 0001906324 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2023-10-01 0001906324 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-10-01 0001906324 us-gaap:RetainedEarningsMember 2023-10-01 0001906324 us-gaap:CommonStockMember 2022-01-02 0001906324 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2022-01-02 0001906324 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-02 0001906324 us-gaap:RetainedEarningsMember 2022-01-02 0001906324 2022-01-02 0001906324 us-gaap:CommonStockMember 2022-01-03 2022-04-03 0001906324 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2022-01-03 2022-04-03 0001906324 2022-01-03 2022-04-03 0001906324 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-03 2022-04-03 0001906324 us-gaap:RetainedEarningsMember 2022-01-03 2022-04-03 0001906324 us-gaap:CommonStockMember 2022-04-03 0001906324 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2022-04-03 0001906324 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-04-03 0001906324 us-gaap:RetainedEarningsMember 2022-04-03 0001906324 2022-04-03 0001906324 us-gaap:CommonStockMember 2022-04-04 2022-07-03 0001906324 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2022-04-04 2022-07-03 0001906324 2022-04-04 2022-07-03 0001906324 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-04-04 2022-07-03 0001906324 us-gaap:RetainedEarningsMember 2022-04-04 2022-07-03 0001906324 us-gaap:CommonStockMember 2022-07-03 0001906324 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2022-07-03 0001906324 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-07-03 0001906324 us-gaap:RetainedEarningsMember 2022-07-03 0001906324 2022-07-03 0001906324 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2022-07-04 2022-10-02 0001906324 us-gaap:CommonStockMember 2022-07-04 2022-10-02 0001906324 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-07-04 2022-10-02 0001906324 us-gaap:RetainedEarningsMember 2022-07-04 2022-10-02 0001906324 us-gaap:CommonStockMember 2022-10-02 0001906324 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2022-10-02 0001906324 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-10-02 0001906324 us-gaap:RetainedEarningsMember 2022-10-02 0001906324 2022-10-02 0001906324 qdel:RetailCustomersMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-01-02 2023-10-01 0001906324 qdel:OrthoMember 2022-05-26 2022-05-26 0001906324 qdel:OrthoMember 2022-05-26 0001906324 qdel:OrthoMember 2022-07-04 2022-10-02 0001906324 qdel:OrthoMember 2021-07-05 2021-10-03 0001906324 qdel:OrthoMember 2022-01-03 2022-10-02 0001906324 qdel:OrthoMember 2021-01-04 2021-10-03 0001906324 us-gaap:StockCompensationPlanMember 2023-07-03 2023-10-01 0001906324 us-gaap:StockCompensationPlanMember 2023-01-02 2023-10-01 0001906324 us-gaap:StockCompensationPlanMember 2022-07-04 2022-10-02 0001906324 us-gaap:StockCompensationPlanMember 2022-01-03 2022-10-02 0001906324 us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember 2023-10-01 0001906324 us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember 2023-01-01 0001906324 qdel:Customer1Member 2023-10-01 0001906324 qdel:Customer1Member 2023-01-01 0001906324 qdel:ExpectedValueContractCustomersMember us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember 2023-10-01 0001906324 qdel:ExpectedValueContractCustomersMember us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember 2023-01-01 0001906324 qdel:Customer2Member 2023-10-01 0001906324 qdel:Customer2Member 2023-01-01 0001906324 us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember 2023-07-03 2023-10-01 0001906324 us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember 2023-01-02 2023-10-01 0001906324 us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember 2022-07-04 2022-10-02 0001906324 us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember 2022-01-03 2022-10-02 0001906324 us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementAndThirdPartyMember 2023-07-03 2023-10-01 0001906324 us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementAndThirdPartyMember 2023-01-02 2023-10-01 0001906324 us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementAndThirdPartyMember 2022-07-04 2022-10-02 0001906324 us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementAndThirdPartyMember 2022-01-03 2022-10-02 0001906324 qdel:LabsMember 2023-07-03 2023-10-01 0001906324 qdel:LabsMember 2022-07-04 2022-10-02 0001906324 qdel:LabsMember 2023-01-02 2023-10-01 0001906324 qdel:LabsMember 2022-01-03 2022-10-02 0001906324 qdel:TransfusionMedicineMember 2023-07-03 2023-10-01 0001906324 qdel:TransfusionMedicineMember 2022-07-04 2022-10-02 0001906324 qdel:TransfusionMedicineMember 2023-01-02 2023-10-01 0001906324 qdel:TransfusionMedicineMember 2022-01-03 2022-10-02 0001906324 qdel:PointOfCareMember 2023-07-03 2023-10-01 0001906324 qdel:PointOfCareMember 2022-07-04 2022-10-02 0001906324 qdel:PointOfCareMember 2023-01-02 2023-10-01 0001906324 qdel:PointOfCareMember 2022-01-03 2022-10-02 0001906324 qdel:MolecularDiagnosticsMember 2023-07-03 2023-10-01 0001906324 qdel:MolecularDiagnosticsMember 2022-07-04 2022-10-02 0001906324 qdel:MolecularDiagnosticsMember 2023-01-02 2023-10-01 0001906324 qdel:MolecularDiagnosticsMember 2022-01-03 2022-10-02 0001906324 qdel:CustomerAMember us-gaap:SalesMember us-gaap:CustomerConcentrationRiskMember 2022-01-03 2022-10-02 0001906324 qdel:CustomerBMember us-gaap:SalesMember us-gaap:CustomerConcentrationRiskMember 2022-01-03 2022-10-02 0001906324 qdel:CustomersWithBalancesDueInExcessOf10OfAccountsReceivableMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-10-01 0001906324 qdel:CustomersWithBalancesDueInExcessOf10OfAccountsReceivableMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 0001906324 qdel:RespiratoryMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2023-07-03 2023-10-01 0001906324 qdel:RespiratoryMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2023-01-02 2023-10-01 0001906324 qdel:RespiratoryMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2022-07-04 2022-10-02 0001906324 qdel:RespiratoryMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2022-01-03 2022-10-02 0001906324 qdel:NorthAmericaSegmentMember 2023-07-03 2023-10-01 0001906324 qdel:NorthAmericaSegmentMember 2022-07-04 2022-10-02 0001906324 qdel:NorthAmericaSegmentMember 2023-01-02 2023-10-01 0001906324 qdel:NorthAmericaSegmentMember 2022-01-03 2022-10-02 0001906324 qdel:EMEASegmentMember 2023-07-03 2023-10-01 0001906324 qdel:EMEASegmentMember 2022-07-04 2022-10-02 0001906324 qdel:EMEASegmentMember 2023-01-02 2023-10-01 0001906324 qdel:EMEASegmentMember 2022-01-03 2022-10-02 0001906324 qdel:ChinaMember 2023-07-03 2023-10-01 0001906324 qdel:ChinaMember 2022-07-04 2022-10-02 0001906324 qdel:ChinaMember 2023-01-02 2023-10-01 0001906324 qdel:ChinaMember 2022-01-03 2022-10-02 0001906324 qdel:OtherMember 2023-07-03 2023-10-01 0001906324 qdel:OtherMember 2022-07-04 2022-10-02 0001906324 qdel:OtherMember 2023-01-02 2023-10-01 0001906324 qdel:OtherMember 2022-01-03 2022-10-02 0001906324 us-gaap:ShortTermInvestmentsMember us-gaap:CorporateDebtSecuritiesMember 2023-10-01 0001906324 us-gaap:ShortTermInvestmentsMember us-gaap:CorporateDebtSecuritiesMember 2023-01-01 0001906324 us-gaap:ShortTermInvestmentsMember us-gaap:AssetBackedSecuritiesMember 2023-10-01 0001906324 us-gaap:ShortTermInvestmentsMember us-gaap:AssetBackedSecuritiesMember 2023-01-01 0001906324 us-gaap:ShortTermInvestmentsMember us-gaap:USGovernmentDebtSecuritiesMember 2023-10-01 0001906324 us-gaap:ShortTermInvestmentsMember us-gaap:USGovernmentDebtSecuritiesMember 2023-01-01 0001906324 us-gaap:ShortTermInvestmentsMember qdel:AgencyBondsMember 2023-10-01 0001906324 us-gaap:ShortTermInvestmentsMember qdel:AgencyBondsMember 2023-01-01 0001906324 us-gaap:ShortTermInvestmentsMember us-gaap:ForeignGovernmentDebtSecuritiesMember 2023-10-01 0001906324 us-gaap:ShortTermInvestmentsMember us-gaap:ForeignGovernmentDebtSecuritiesMember 2023-01-01 0001906324 us-gaap:ShortTermInvestmentsMember us-gaap:OtherDebtSecuritiesMember 2023-10-01 0001906324 us-gaap:ShortTermInvestmentsMember us-gaap:OtherDebtSecuritiesMember 2023-01-01 0001906324 us-gaap:ShortTermInvestmentsMember 2023-10-01 0001906324 us-gaap:ShortTermInvestmentsMember 2023-01-01 0001906324 qdel:LongTermInvestmentsMember us-gaap:CorporateDebtSecuritiesMember 2023-10-01 0001906324 qdel:LongTermInvestmentsMember us-gaap:CorporateDebtSecuritiesMember 2023-01-01 0001906324 qdel:LongTermInvestmentsMember us-gaap:AssetBackedSecuritiesMember 2023-10-01 0001906324 qdel:LongTermInvestmentsMember us-gaap:AssetBackedSecuritiesMember 2023-01-01 0001906324 qdel:LongTermInvestmentsMember qdel:AgencyBondsMember 2023-10-01 0001906324 qdel:LongTermInvestmentsMember qdel:AgencyBondsMember 2023-01-01 0001906324 qdel:NorthAmericaSegmentMember 2023-01-01 0001906324 qdel:EMEASegmentMember 2023-01-01 0001906324 qdel:ChinaMember 2023-01-01 0001906324 qdel:OtherMember 2023-01-01 0001906324 qdel:NorthAmericaSegmentMember 2023-10-01 0001906324 qdel:EMEASegmentMember 2023-10-01 0001906324 qdel:ChinaMember 2023-10-01 0001906324 qdel:OtherMember 2023-10-01 0001906324 us-gaap:SecuredDebtMember qdel:BankOfAmericaCreditFacilityMember us-gaap:LineOfCreditMember 2023-10-01 0001906324 us-gaap:SecuredDebtMember qdel:BankOfAmericaCreditFacilityMember us-gaap:LineOfCreditMember 2023-01-01 0001906324 us-gaap:SecuredDebtMember qdel:BankOfAmericaCreditFacilityMember us-gaap:LineOfCreditMember 2022-05-27 0001906324 us-gaap:RevolvingCreditFacilityMember qdel:BankOfAmericaCreditFacilityMember us-gaap:LineOfCreditMember 2022-08-04 0001906324 us-gaap:LetterOfCreditMember qdel:BankOfAmericaCreditFacilityMember us-gaap:LineOfCreditMember 2023-01-02 2023-10-01 0001906324 us-gaap:RevolvingCreditFacilityMember qdel:BankOfAmericaCreditFacilityMember us-gaap:LineOfCreditMember 2023-10-01 0001906324 us-gaap:SecuredDebtMember qdel:BankOfAmericaCreditFacilityMember us-gaap:LineOfCreditMember 2023-01-02 2023-10-01 0001906324 us-gaap:SecuredDebtMember qdel:BankOfAmericaCreditFacilityMember us-gaap:LineOfCreditMember qdel:VoluntaryPrepaymentMember 2023-01-02 2023-10-01 0001906324 qdel:BankOfAmericaCreditFacilityMember us-gaap:LineOfCreditMember qdel:EndingAfterTheClosingDateOfTheCreditAgreementMember 2023-10-01 0001906324 qdel:BankOfAmericaCreditFacilityMember us-gaap:LineOfCreditMember qdel:EndingAfterInitialMeasurementPeriodMember 2023-10-01 0001906324 qdel:BankOfAmericaCreditFacilityMember us-gaap:LineOfCreditMember 2023-10-01 0001906324 us-gaap:SecuredDebtMember qdel:BankOfAmericaCreditFacilityMember us-gaap:LineOfCreditMember 2023-07-03 2023-10-01 0001906324 us-gaap:SecuredDebtMember qdel:BankOfAmericaCreditFacilityMember us-gaap:LineOfCreditMember 2022-07-04 2022-10-02 0001906324 us-gaap:SecuredDebtMember qdel:BankOfAmericaCreditFacilityMember us-gaap:LineOfCreditMember 2022-01-03 2022-10-02 0001906324 us-gaap:RevolvingCreditFacilityMember qdel:BankOfAmericaCreditFacilityMember us-gaap:LineOfCreditMember 2023-07-03 2023-10-01 0001906324 us-gaap:RevolvingCreditFacilityMember qdel:BankOfAmericaCreditFacilityMember us-gaap:LineOfCreditMember 2022-07-04 2022-10-02 0001906324 us-gaap:RevolvingCreditFacilityMember qdel:BankOfAmericaCreditFacilityMember us-gaap:LineOfCreditMember 2023-01-02 2023-10-01 0001906324 us-gaap:RevolvingCreditFacilityMember qdel:BankOfAmericaCreditFacilityMember us-gaap:LineOfCreditMember 2022-01-03 2022-10-02 0001906324 us-gaap:CostOfSalesMember 2023-07-03 2023-10-01 0001906324 us-gaap:CostOfSalesMember 2022-07-04 2022-10-02 0001906324 us-gaap:CostOfSalesMember 2023-01-02 2023-10-01 0001906324 us-gaap:CostOfSalesMember 2022-01-03 2022-10-02 0001906324 us-gaap:ResearchAndDevelopmentExpenseMember 2023-07-03 2023-10-01 0001906324 us-gaap:ResearchAndDevelopmentExpenseMember 2022-07-04 2022-10-02 0001906324 us-gaap:ResearchAndDevelopmentExpenseMember 2023-01-02 2023-10-01 0001906324 us-gaap:ResearchAndDevelopmentExpenseMember 2022-01-03 2022-10-02 0001906324 us-gaap:SellingAndMarketingExpenseMember 2023-07-03 2023-10-01 0001906324 us-gaap:SellingAndMarketingExpenseMember 2022-07-04 2022-10-02 0001906324 us-gaap:SellingAndMarketingExpenseMember 2023-01-02 2023-10-01 0001906324 us-gaap:SellingAndMarketingExpenseMember 2022-01-03 2022-10-02 0001906324 us-gaap:AcquisitionRelatedCostsMember 2023-07-03 2023-10-01 0001906324 us-gaap:AcquisitionRelatedCostsMember 2022-07-04 2022-10-02 0001906324 us-gaap:AcquisitionRelatedCostsMember 2023-01-02 2023-10-01 0001906324 us-gaap:AcquisitionRelatedCostsMember 2022-01-03 2022-10-02 0001906324 us-gaap:EmployeeStockOptionMember 2023-10-01 0001906324 us-gaap:EmployeeStockOptionMember 2023-01-02 2023-10-01 0001906324 srt:MaximumMember 2023-01-02 2023-10-01 0001906324 us-gaap:RestrictedStockUnitsRSUMember 2023-01-02 2023-10-01 0001906324 us-gaap:RestrictedStockUnitsRSUMember 2022-01-03 2022-10-02 0001906324 us-gaap:RestrictedStockUnitsRSUMember 2023-10-01 0001906324 us-gaap:FairValueInputsLevel1Member 2023-10-01 0001906324 us-gaap:FairValueInputsLevel2Member 2023-10-01 0001906324 us-gaap:FairValueInputsLevel3Member 2023-10-01 0001906324 us-gaap:FairValueInputsLevel1Member 2023-01-01 0001906324 us-gaap:FairValueInputsLevel2Member 2023-01-01 0001906324 us-gaap:FairValueInputsLevel3Member 2023-01-01 0001906324 qdel:BNPBusinessMember 2023-04-30 0001906324 us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-10-01 0001906324 qdel:InterestRateSwapOneMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-10-01 0001906324 qdel:InterestRateSwapTwoMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-10-01 0001906324 qdel:InterestRateSwapThreeMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-10-01 0001906324 qdel:InterestRateSwapFourMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-10-01 0001906324 qdel:InterestRateSwapFiveMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-10-01 0001906324 srt:ScenarioForecastMember us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-12-29 0001906324 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-10-01 0001906324 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2023-10-01 0001906324 us-gaap:ForeignExchangeForwardMember us-gaap:SalesMember 2023-07-03 2023-10-01 0001906324 us-gaap:ForeignExchangeForwardMember us-gaap:CostOfSalesMember 2023-07-03 2023-10-01 0001906324 us-gaap:InterestRateSwapMember us-gaap:InterestExpenseMember 2023-07-03 2023-10-01 0001906324 us-gaap:ForeignExchangeForwardMember us-gaap:SalesMember 2023-01-02 2023-10-01 0001906324 us-gaap:ForeignExchangeForwardMember us-gaap:CostOfSalesMember 2023-01-02 2023-10-01 0001906324 us-gaap:InterestRateSwapMember us-gaap:InterestExpenseMember 2023-01-02 2023-10-01 0001906324 us-gaap:ForeignExchangeForwardMember us-gaap:SalesMember 2022-07-04 2022-10-02 0001906324 us-gaap:ForeignExchangeForwardMember us-gaap:CostOfSalesMember 2022-07-04 2022-10-02 0001906324 us-gaap:InterestRateSwapMember us-gaap:InterestExpenseMember 2022-07-04 2022-10-02 0001906324 us-gaap:ForeignExchangeForwardMember us-gaap:SalesMember 2022-01-03 2022-10-02 0001906324 us-gaap:ForeignExchangeForwardMember us-gaap:CostOfSalesMember 2022-01-03 2022-10-02 0001906324 us-gaap:InterestRateSwapMember us-gaap:InterestExpenseMember 2022-01-03 2022-10-02 0001906324 us-gaap:ForeignExchangeForwardMember us-gaap:OtherNonoperatingIncomeExpenseMember 2023-07-03 2023-10-01 0001906324 us-gaap:ForeignExchangeForwardMember us-gaap:OtherNonoperatingIncomeExpenseMember 2023-01-02 2023-10-01 0001906324 us-gaap:ForeignExchangeForwardMember us-gaap:OtherNonoperatingIncomeExpenseMember 2022-07-04 2022-10-02 0001906324 us-gaap:ForeignExchangeForwardMember us-gaap:OtherNonoperatingIncomeExpenseMember 2022-01-03 2022-10-02 0001906324 us-gaap:InterestRateSwapMember us-gaap:OtherNonoperatingIncomeExpenseMember 2022-07-04 2022-10-02 0001906324 us-gaap:InterestRateSwapMember us-gaap:OtherNonoperatingIncomeExpenseMember 2022-01-03 2022-10-02 0001906324 us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-01-01 0001906324 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-01-01 0001906324 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2023-01-01 0001906324 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember 2023-07-02 0001906324 us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember 2023-07-02 0001906324 us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember 2023-07-02 0001906324 us-gaap:AccumulatedTranslationAdjustmentMember 2023-07-02 0001906324 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember 2023-07-03 2023-10-01 0001906324 us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember 2023-07-03 2023-10-01 0001906324 us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember 2023-07-03 2023-10-01 0001906324 us-gaap:AccumulatedTranslationAdjustmentMember 2023-07-03 2023-10-01 0001906324 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember 2023-10-01 0001906324 us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember 2023-10-01 0001906324 us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember 2023-10-01 0001906324 us-gaap:AccumulatedTranslationAdjustmentMember 2023-10-01 0001906324 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember 2023-01-01 0001906324 us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember 2023-01-01 0001906324 us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember 2023-01-01 0001906324 us-gaap:AccumulatedTranslationAdjustmentMember 2023-01-01 0001906324 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember 2023-01-02 2023-10-01 0001906324 us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember 2023-01-02 2023-10-01 0001906324 us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember 2023-01-02 2023-10-01 0001906324 us-gaap:AccumulatedTranslationAdjustmentMember 2023-01-02 2023-10-01 0001906324 us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember 2022-07-03 0001906324 us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember 2022-07-03 0001906324 us-gaap:AccumulatedTranslationAdjustmentMember 2022-07-03 0001906324 us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember 2022-07-04 2022-10-02 0001906324 us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember 2022-07-04 2022-10-02 0001906324 us-gaap:AccumulatedTranslationAdjustmentMember 2022-07-04 2022-10-02 0001906324 us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember 2022-10-02 0001906324 us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember 2022-10-02 0001906324 us-gaap:AccumulatedTranslationAdjustmentMember 2022-10-02 0001906324 us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember 2022-01-02 0001906324 us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember 2022-01-02 0001906324 us-gaap:AccumulatedTranslationAdjustmentMember 2022-01-02 0001906324 us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember 2022-01-03 2022-10-02 0001906324 us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember 2022-01-03 2022-10-02 0001906324 us-gaap:AccumulatedTranslationAdjustmentMember 2022-01-03 2022-10-02 shares iso4217:USD iso4217:USD shares pure qdel:covenant 0001906324 --12-31 2023 Q3 false http://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent http://fasb.org/us-gaap/2023#PrepaidExpenseAndOtherAssetsCurrent http://fasb.org/us-gaap/2023#PrepaidExpenseAndOtherAssetsCurrent http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent http://fasb.org/us-gaap/2023#PrepaidExpenseAndOtherAssetsCurrent http://fasb.org/us-gaap/2023#PrepaidExpenseAndOtherAssetsCurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent http://fasb.org/us-gaap/2023#PrepaidExpenseAndOtherAssetsCurrent http://fasb.org/us-gaap/2023#PrepaidExpenseAndOtherAssetsCurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent 10-Q true 2023-10-01 false 001-41409 QUIDELORTHO CORP DE 87-4496285 9975 Summers Ridge Road San Diego CA 92121 858 552-1100 Common Stock, $0.001 Par Value QDEL NASDAQ Yes Yes Large Accelerated Filer false false false 66818718 149300000 292900000 43900000 52100000 331200000 453900000 551700000 524100000 295200000 252100000 1371300000 1575100000 1369400000 1339000000 11900000 21000000.0 172200000 181000000.0 2442900000 2476800000 2976500000 3123800000 15700000 16400000 179200000 122700000 8539100000 8855800000 253000000.0 283300000 106800000 139200000 1800000 51600000 193000000.0 207500000 305400000 325400000 860000000.0 1007000000 175900000 186400000 2274600000 2430800000 196500000 213200000 65400000 83800000 3572400000 3921200000 0.001 0.001 5000000.0 5000000.0 0 0 0 0 0 0 0.001 0.001 126200000 126200000 66800000 66800000 66400000 66400000 100000 0 2839000000 2804300000 -53200000 -67600000 2180800000 2197900000 4966700000 4934600000 8539100000 8855800000 744000000.0 783800000 2255200000 2399500000 375900000 376300000 1142100000 912500000 194100000 204200000 575600000 407400000 62400000 65600000 187500000 126200000 51400000 50500000 153600000 78600000 26500000 26400000 80400000 109600000 7400000 4000000.0 17000000.0 8000000.0 26300000 56800000 99000000.0 757200000 -37700000 -29700000 -110900000 -41000000.0 0 0 0 -24000000.0 -4100000 4200000 -8000000.0 2600000 -15500000 31300000 -19900000 694800000 -2800000 12100000 -2800000 176400000 -12700000 19200000 -17100000 518400000 -0.19 0.29 -0.26 9.67 -0.19 0.28 -0.26 9.56 66900000 66900000 66800000 53600000 66900000 67500000 66800000 54200000 -12700000 19200000 -17100000 518400000 -55300000 -92900000 -17200000 -158900000 200000 0 300000 -600000 24500000 9300000 47600000 13900000 6300000 200000 16300000 -700000 18200000 9100000 31300000 14600000 -49600000 -64600000 -2700000 373500000 66400000 0 2804300000 -67600000 2197900000 4934600000 300000 100000 3800000 3900000 10400000 10400000 100000 9500000 9500000 8300000 8300000 48800000 48800000 66600000 100000 2809000000 -59300000 2246700000 4996500000 200000 5500000 5500000 13700000 13700000 3000000.0 3000000.0 43000000.0 43000000.0 -53200000 -53200000 66800000 100000 2825200000 -16300000 2193500000 5002500000 800000 800000 13500000 13500000 500000 500000 -36900000 -36900000 -12700000 -12700000 66800000 100000 2839000000 -53200000 2180800000 4966700000 41700000 0 279800000 400000 1649200000 1929400000 200000 6400000 6400000 6200000 6200000 100000 6800000 6800000 -200000 -200000 479900000 479900000 41800000 0 285600000 200000 2129100000 2414900000 100000 800000 800000 14700000 14700000 25100000 2495400000 2495400000 36100000 36100000 700000 700000 -60900000 -60900000 19300000 19300000 67000000.0 0 2831900000 -60700000 2148400000 4919600000 2600000 2600000 12600000 12600000 600000 600000 1000000.0 74300000 74300000 -83800000 -83800000 19200000 19200000 66000000.0 0 2772200000 -144500000 2167600000 4795300000 -17100000 518400000 341800000 167000000.0 39300000 36600000 100000 9900000 9700000 10400000 0 -24000000.0 0 46600000 -4900000 -3700000 -124100000 -181600000 146000000.0 97900000 35100000 41300000 -6300000 9200000 -31000000.0 -3600000 -51300000 -9200000 -4100000 -111300000 199800000 715900000 160700000 79200000 0 1511400000 10500000 15800000 50600000 49400000 68300000 39300000 -132500000 -1584900000 8100000 5200000 2900000 0 0 2734500000 175700000 2336100000 13000000.0 8000000.0 0 74300000 0 4200000 30300000 33400000 -208000000.0 283700000 -3300000 -4300000 -144000000.0 -589600000 293900000 802800000 149900000 213200000 11400000 17400000 3000000.0 0 105800000 48600000 1900000 4600000 Basis of Presentation and Summary of Significant Accounting Policies<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited Consolidated Financial Statements of QuidelOrtho Corporation and its subsidiaries (the “Company” or “QuidelOrtho”) have been prepared in accordance with generally accepted accounting principles in the U.S. (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation (consisting of normal recurring accruals) have been included.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information at October 1, 2023, and for the three and nine months ended October 1, 2023 and October 2, 2022, is unaudited. For further information, refer to the Company’s Consolidated Financial Statements and notes thereto for the fiscal year ended January 1, 2023 included in QuidelOrtho’s 2022 Annual Report on Form 10-K. Operating results for any quarter are historically seasonal in nature and are not necessarily indicative of the results expected for the full year.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company follows the concept of a fiscal year that ends on the Sunday nearest to the end of the month of December, and fiscal quarters that end on the Sunday nearest to the end of the months of March, June and September. For 2023 and 2022, the Company’s fiscal year will end or has ended on December 31, 2023 and January 1, 2023, respectively. For 2023 and 2022, the Company’s third quarter ended on October 1, 2023 and October 2, 2022, respectively. The three and nine months ended October 1, 2023 and October 2, 2022 each included 13 and 39 weeks, respectively.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses and the related disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Significant Accounting Policies </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended October 1, 2023, there have been no changes to the Company’s significant accounting policies as described in the Company’s 2022 Annual Report on Form 1</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0-K, except for the following policy, which was the result of a change in accounting estimates: </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue Recognition</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company generates a portion of its revenue from sales of the QuickVue At-Home OTC COVID-19 tests to retail customers. The Company estimates the transaction price for revenue from sales to retail customers based on historical experience and current trends to evaluate when uncertainties related to right of return provisions are resolved. In prior periods, due to a lack of history on which to base an estimate of products to be returned from retailers, the Company established a reserve based on an estimate of total inventory remaining at our retailers that was subject to return. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended October 1, 2023, the Company concluded that it had developed sufficient historical experience regarding the pattern in customer returns to be able to estimate the amount of consideration to which we expect to be entitled, excluding consideration for the products expected to be returned. Amounts received or receivable that are expected to be returned are recognized as a refund liability, which is included in Other current liabilities. The refund liability is estimated utilizing historical sale and return rates over the period during which customers have a right of return, taking into account available information on competitive products and contract changes. The refund liability is remeasured at each reporting period to reflect changes in assumptions about expected returns. Revenue from sales to retail customers amounted to approximately 3% of Total revenues for the nine months ended October 1, 2023. This change in estimate did not have a material impact on the Company’s Consolidated Financial Statements.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no accounting pronouncements issued or adopted during the nine months ended October 1, 2023 that are expected to have a material impact on the Company’s Consolidated Financial Statements.</span></div> <div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited Consolidated Financial Statements of QuidelOrtho Corporation and its subsidiaries (the “Company” or “QuidelOrtho”) have been prepared in accordance with generally accepted accounting principles in the U.S. (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation (consisting of normal recurring accruals) have been included.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information at October 1, 2023, and for the three and nine months ended October 1, 2023 and October 2, 2022, is unaudited. For further information, refer to the Company’s Consolidated Financial Statements and notes thereto for the fiscal year ended January 1, 2023 included in QuidelOrtho’s 2022 Annual Report on Form 10-K. Operating results for any quarter are historically seasonal in nature and are not necessarily indicative of the results expected for the full year.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company follows the concept of a fiscal year that ends on the Sunday nearest to the end of the month of December, and fiscal quarters that end on the Sunday nearest to the end of the months of March, June and September. For 2023 and 2022, the Company’s fiscal year will end or has ended on December 31, 2023 and January 1, 2023, respectively. For 2023 and 2022, the Company’s third quarter ended on October 1, 2023 and October 2, 2022, respectively. The three and nine months ended October 1, 2023 and October 2, 2022 each included 13 and 39 weeks, respectively.</span></div> <div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses and the related disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</span></div> <div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue Recognition</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company generates a portion of its revenue from sales of the QuickVue At-Home OTC COVID-19 tests to retail customers. The Company estimates the transaction price for revenue from sales to retail customers based on historical experience and current trends to evaluate when uncertainties related to right of return provisions are resolved. In prior periods, due to a lack of history on which to base an estimate of products to be returned from retailers, the Company established a reserve based on an estimate of total inventory remaining at our retailers that was subject to return. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended October 1, 2023, the Company concluded that it had developed sufficient historical experience regarding the pattern in customer returns to be able to estimate the amount of consideration to which we expect to be entitled, excluding consideration for the products expected to be returned. Amounts received or receivable that are expected to be returned are recognized as a refund liability, which is included in Other current liabilities. The refund liability is estimated utilizing historical sale and return rates over the period during which customers have a right of return, taking into account available information on competitive products and contract changes. The refund liability is remeasured at each reporting period to reflect changes in assumptions about expected returns. Revenue from sales to retail customers amounted to approximately 3% of Total revenues for the nine months ended October 1, 2023. This change in estimate did not have a material impact on the Company’s Consolidated Financial Statements.</span></div> 0.03 <div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no accounting pronouncements issued or adopted during the nine months ended October 1, 2023 that are expected to have a material impact on the Company’s Consolidated Financial Statements.</span></div> Business Combination<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 27, 2022, pursuant to a Business Combination Agreement entered into as of December 22, 2021 (the “BCA”), by and among Quidel Corporation (“Quidel”), Ortho Clinical Diagnostics Holdings plc (“Ortho”), QuidelOrtho (formerly Coronado Topco, Inc.), Orca Holdco, Inc., Laguna Merger Sub, Inc. and Orca Holdco 2, Inc., Quidel and Ortho consummated a business combination (the “Combinations”) and each of Quidel and Ortho became a wholly owned subsidiary of QuidelOrtho. As a result of the Combinations, QuidelOrtho became the successor issuer to Quidel. The Combinations enhance the Company’s revenue profile and expand the Company’s geographic footprint and product diversity.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Combinations were completed for a total consideration of approximately $4.3 billion, which included the fair value of equity issued based on the May 26, 2022 closing price of $99.60 per share of Quidel common stock. Former Ortho shareholders received $7.14 in cash and 0.1055 shares of QuidelOrtho common stock for each Ortho ordinary share. The Company funded the cash portion of the purchase price with cash on its balance sheet and a portion of the Term Loan proceeds from the Financing (each as defined in Note 8). </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Combinations have been accounted for as a business combination, which requires that assets acquired and liabilities assumed be recognized at their fair value as of the date of the consummation of the Combinations, with Quidel considered the accounting and the legal acquirer. The assessment of the fair value of assets acquired and liabilities assumed was finalized in the second quarter of 2023. Measurement period adjustments in fiscal year 2023 decreased goodwill by $23.9 million, reflecting (i) a decrease of $22.3 million to deferred tax liability, (ii) a decrease of $2.9 million to income tax payable and (iii) a decrease of $1.3 million in deferred tax asset. The related impact to net earnings that would have been recognized in previous periods if the adjustments were recognized as of the date of the consummation of the Combinations is immaterial to the Company’s Consolidated Financial Statements.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following unaudited supplemental pro forma financial information shows the combined results of operations of the Company as if the Combinations had occurred on January 4, 2021, the beginning of the periods presented:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 2, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 3, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 2, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 3, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pro forma total revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">783.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,032.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,184.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,583.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pro forma net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">225.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">549.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">340.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This unaudited supplemental pro forma financial information is presented for informational purposes only and is not indicative of the results of operations that would have been achieved had the Combinations been completed at the beginning of fiscal year 2021. In addition, the unaudited supplemental pro forma financial information is not a projection of the Company’s future results of operations, nor does it reflect the expected realization of any synergies or cost savings associated with the Combinations. The unaudited supplemental pro forma financial information includes adjustments for:</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">incremental intangible assets amortization expense based on the preliminary fair values of the identifiable intangible assets acquired; </span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">incremental cost of sales related to the fair value step-up of inventory; </span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">decreases in interest expense associated with the issuance of debt to finance the Combinations and to repay Ortho’s then-outstanding indebtedness, including the net impact of the removal of the amortization of the discount on Ortho’s indebtedness and the change in amortization of deferred financing fees;</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the removal of loss on extinguishment of debt from Ortho’s results in fiscal year 2021 and the reclassification of loss on extinguishment of debt in fiscal years 2021 and 2022;</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the reclassification of expense related to the accelerated vesting of certain stock awards of Ortho’s former chief executive officer; and</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">tax impacts related to the above adjustments.</span></div> 4300000000 99.60 7.14 0.1055 -23900000 22300000 2900000 1300000 <div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following unaudited supplemental pro forma financial information shows the combined results of operations of the Company as if the Combinations had occurred on January 4, 2021, the beginning of the periods presented:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 2, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 3, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 2, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 3, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pro forma total revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">783.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,032.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,184.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,583.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pro forma net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">225.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">549.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">340.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 783800000 1032300000 3184700000 2583500000 50200000 225200000 549500000 340200000 Computation of Earnings Per ShareBasic earnings per share (“EPS”) is computed by dividing Net (loss) income by the weighted-average number of shares of common stock outstanding. Diluted EPS is computed based on the sum of the weighted-average number of shares of common stock and potentially dilutive shares of common stock outstanding during the period. Potentially dilutive shares of common stock consist of shares issuable from stock options and unvested restricted stock units (“RSUs”). Potentially dilutive shares of common stock from outstanding stock options and unvested RSUs are determined using the average share price for each period under the treasury stock method.<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the calculation of the weighted-average shares used in computing basic and diluted EPS:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.057%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.678%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 1, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 2, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 1, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 2, 2022</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic weighted-average shares of common stock outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive potential shares issuable from stock options and RSUs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted weighted-average shares of common stock outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.9 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67.5 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.8 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54.2 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) In the three and nine months ended October 1, 2023, all potential shares of common stock issuable for stock options and RSUs were excluded from the dilutive calculations above because the effect of including them would have been anti-dilutive. The dilutive effect of potential shares of common stock issuable for stock options and RSUs on the weighted-average number of shares of common stock outstanding would have been as follows:</span></div><div style="padding-left:6.75pt;padding-right:6.75pt;text-align:center;text-indent:-13.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:84.649%"><tr><td style="width:1.0%"></td><td style="width:61.248%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.490%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.490%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.038%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 1, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 1, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic weighted-average shares of common stock outstanding</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">66.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">66.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dilutive potential shares issuable from stock options and RSUs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted weighted-average shares of common stock outstanding</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">67.3 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">67.3 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock options and RSUs where the combined exercise price and unrecognized stock-based compensation was greater than the average market price for the Company’s common stock were not included in the computations of diluted weighted-average shares because the effect would have been anti-dilutive. These stock options and RSUs represented 1.7 million and 1.6 million shares of common stock for the three and nine months ended October 1, 2023, respectively, and 1.0 million shares of common stock for each of the three and nine months ended October 2, 2022.</span></div> <div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the calculation of the weighted-average shares used in computing basic and diluted EPS:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.057%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.678%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 1, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 2, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 1, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 2, 2022</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic weighted-average shares of common stock outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive potential shares issuable from stock options and RSUs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted weighted-average shares of common stock outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.9 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67.5 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.8 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54.2 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) In the three and nine months ended October 1, 2023, all potential shares of common stock issuable for stock options and RSUs were excluded from the dilutive calculations above because the effect of including them would have been anti-dilutive. The dilutive effect of potential shares of common stock issuable for stock options and RSUs on the weighted-average number of shares of common stock outstanding would have been as follows:</span></div><div style="padding-left:6.75pt;padding-right:6.75pt;text-align:center;text-indent:-13.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:84.649%"><tr><td style="width:1.0%"></td><td style="width:61.248%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.490%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.490%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.038%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 1, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 1, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic weighted-average shares of common stock outstanding</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">66.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">66.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dilutive potential shares issuable from stock options and RSUs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted weighted-average shares of common stock outstanding</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">67.3 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">67.3 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 66900000 66900000 66800000 53600000 0 600000 0 600000 66900000 67500000 66800000 54200000 66900000 66800000 400000 500000 67300000 67300000 1700000 1600000 1000000 1000000 Revenue<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contract Balances</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Timing of revenue recognition may differ from timing of invoicing to customers. The Company records an asset when revenue is recognized prior to invoicing a customer (a “contract asset”). Contract assets are included within Prepaid expenses and other current assets in the Company’s Consolidated Balance Sheets and are transferred to accounts receivable when the right to payment becomes unconditional. The balance of contract assets recorded in the Company’s Consolidated Balance Sheets as of October 1, 2023 and January 1, 2023 was $53.5 million and $49.6 million, respectively. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The contract asset balance consisted of the following components, all of which related to agreements acquired by the Company in connection with the Combinations:</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a customer supply agreement under which the difference between the timing of invoicing and revenue recognition resulted in a contract asset of $3.8 million and $6.8 million as of October 1, 2023 and January 1, 2023, respectively;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">contractual arrangements with certain customers under which the Company invoices the customers based on reportable results generated by its reagents; however, control of the goods transfers to the customers upon shipment or delivery of the products, as determined under the terms of the contract. Using the expected value method, the Company estimates the number of reagents that will generate a reportable result. The Company records the revenue upon shipment and an associated contract asset, and relieves the contract asset upon completion of the invoicing. The balance of the contract asset related to these arrangements was $42.4 million and $38.5 million as of October 1, 2023 and January 1, 2023, respectively; and</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">one of the Company’s contract manufacturing agreements that recognizes revenue as the products are manufactured resulted in a contract asset of $7.3 million and $4.3 million as of October 1, 2023 and January 1, 2023, respectively.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reviews contract assets for expected credit losses resulting from the collectability of customer accounts. Expected losses are established based on historical losses, customer mix and credit policies, current economic conditions in customers’ country or industry, and expectations associated with reasonable and supportable forecasts. No credit losses related to contract assets were recognized during the three and nine months ended October 1, 2023.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes a contract liability when a customer pays an invoice prior to the Company transferring control of the goods or services (“contract liabilities”). The Company’s contract liabilities consist of deferred revenue primarily related to customer service contracts. The Company classifies deferred revenue as current or non-current based on the timing of the transfer of control or performance of the service. The balance of the Company’s current deferred revenue was $34.6 million as </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of October 1, 2023 and $76.4 million as of January 1, 2023. The Company has one arrangement with a customer where the revenue is expected to be recognized beyond one year. The balance of the deferred revenue included in long-term liabilities was $13.5 million and $9.4 million as of October 1, 2023 and January 1, 2023, respectively, and was included in Other liabilities in the Consolidated Balance Sheets. The amount of deferred revenue as of January 1, 2023 that was recorded in Total revenues during the three and nine months ended October 1, 2023 was $2.4 million and $70.9 million, respectively. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Joint Business with Grifols</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Combinations, the Company acquired the ongoing collaboration arrangement (the “Joint Business”) between Ortho and Grifols Diagnostic Solutions, Inc. (“Grifols”), under which Ortho and Grifols agreed to pursue a collaboration relating to Ortho’s Hepatitis and HIV diagnostics business. The governance of the Joint Business is shared through a supervisory board made up of equal representation by Ortho and Grifols, which is responsible for all significant decisions relating to the Joint Business that are not exclusively assigned to either Ortho or Grifols, as defined in the Joint Business agreement. The Company’s portion of the pre-tax net profit shared under the Joint Business was $8.9 million and $38.6 million during the three and nine months ended October 1, 2023, respectively, and $7.9 million and $13.5 million during the three and nine months ended October 2, 2022, respectively. These amounts included the Company’s portion of the pre-tax net profit of $7.3 million and $14.0 million during the three and nine months ended October 1, 2023, respectively, and $5.2 million and $8.8 million during the three and nine months ended October 2, 2022, respectively, on sales transactions with third parties where the Company is the principal. The Company recognized revenues, cost of sales, excluding amortization of intangibles, and operating expenses, on a gross basis on these sales transactions in their respective lines in the Consolidated Statements of (Loss) Income. The Company’s portion of the pre-tax net profit also included revenue from collaboration and royalty agreements of $1.6 million and $24.6 million during the three and nine months ended October 1, 2023, respectively, and $2.7 million and $4.7 million during the three and nine months ended October 2, 2022, respectively, which is presented on a net basis within Total revenues. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Disaggregation of Revenue</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes Total revenues by business unit:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 1, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 2, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 1, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 2, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Labs</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">341.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">334.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,073.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">505.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfusion Medicine</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">483.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">231.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Point of Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">233.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">270.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">675.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,580.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Molecular Diagnostics</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">744.0 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">783.8 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,255.2 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,399.5 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Concentration of Revenue and Credit Risk</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the nine months ended October 1, 2023, no customers individually accounted for more than 10% of Total revenues. For the nine months ended October 2, 2022, one customer and one distributor represented 27% and 10%, respectively, of Total revenues. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of October 1, 2023 and January 1, 2023, customers with a balance due in excess of 10% of Accounts receivable, net totaled $99.4 million and $161.9 million, respectively. Revenue related to our respiratory products accounted for 25% and 24% of Total revenues for the three and nine months ended October 1, 2023, respectively, and 30% and 63% for the three and nine months ended October 2, 2022, respectively.</span></div> 53500000 49600000 3800000 6800000 42400000 38500000 7300000 4300000 34600000 76400000 13500000 9400000 2400000 70900000 8900000 38600000 7900000 13500000 7300000 14000000 5200000 8800000 1600000 24600000 2700000 4700000 <div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes Total revenues by business unit:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 1, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 2, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 1, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 2, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Labs</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">341.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">334.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,073.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">505.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfusion Medicine</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">483.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">231.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Point of Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">233.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">270.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">675.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,580.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Molecular Diagnostics</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">744.0 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">783.8 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,255.2 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,399.5 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 341400000 334800000 1073500000 505500000 163900000 163100000 483100000 231300000 233100000 270500000 675400000 1580600000 5600000 15400000 23200000 82100000 744000000.0 783800000 2255200000 2399500000 0.27 0.10 99400000 161900000 0.25 0.24 0.30 0.63 Segment and Geographic Information<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total revenues by reportable segment are as follows:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 1, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 2, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 1, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 2, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">465.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">517.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,426.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,917.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EMEA</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">236.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">China</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">233.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">359.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">744.0 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">783.8 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,255.2 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,399.5 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the fourth quarter of 2022, the Company revised the internal allocation of certain global costs primarily between the North America segment and Corporate to better align costs that impact the Company as a whole. Prior periods have been revised to align with the current period presentation. The following table sets forth Adjusted EBITDA by segment and the reconciliations to (Loss) income before income taxes for the three and nine months ended October 1, 2023 and October 2, 2022:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 1, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 2, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 1, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 2, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">293.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">708.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,246.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EMEA</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">China</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment Adjusted EBITDA</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">332.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">385.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">916.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,427.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(162.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(158.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(388.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(341.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(110.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(113.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(104.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(341.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(167.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition and integration costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(80.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(109.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of deferred cloud computing </span><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">   implementation costs</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment of long-lived assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EU medical device regulation transition costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unwind inventory fair value adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee compensation charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on extinguishment of debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative mark-to-market gain</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax indemnification income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Loss) income before income taxes</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15.5)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.3 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19.9)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">694.8 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) Primarily consists of costs related to executive and staff functions, including certain finance, human resources, manufacturing and information technology (“IT”) functions, which benefit the Company as a whole. These costs are primarily related to the general management of these functions on a corporate level and the design and development of programs, policies and procedures that are then implemented in the individual segments, with each segment bearing its own cost of implementation. The Company’s corporate function also includes debt and stock-based compensation associated with all employee stock-based awards.</span></div><div style="margin-top:6pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2) Represents incremental consulting costs and research and development (“R&amp;D”) manufacturing site costs to align compliance of the Company’s existing, on-market products that were previously registered under the European In Vitro Diagnostics Directive regulatory framework with the requirements under the EU’s In Vitro Diagnostic Regulation, which generally apply from May 2022 onwards. </span></div>The chief operating decision maker does not review capital expenditures, total depreciation and amortization or assets by segment, and therefore this information has been excluded as it does not comprise part of management’s key performance metrics. <div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total revenues by reportable segment are as follows:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 1, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 2, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 1, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 2, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">465.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">517.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,426.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,917.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EMEA</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">236.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">China</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">233.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">359.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">744.0 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">783.8 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,255.2 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,399.5 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 465200000 517600000 1426800000 1917300000 74500000 73700000 236400000 131000000.0 81100000 80800000 233000000.0 163100000 123200000 111700000 359000000.0 188100000 744000000.0 783800000 2255200000 2399500000 The following table sets forth Adjusted EBITDA by segment and the reconciliations to (Loss) income before income taxes for the three and nine months ended October 1, 2023 and October 2, 2022:<div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 1, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 2, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 1, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 2, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">293.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">708.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,246.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EMEA</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">China</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment Adjusted EBITDA</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">332.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">385.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">916.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,427.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(162.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(158.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(388.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(341.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(110.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(113.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(104.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(341.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(167.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition and integration costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(80.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(109.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of deferred cloud computing </span><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">   implementation costs</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment of long-lived assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EU medical device regulation transition costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unwind inventory fair value adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee compensation charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on extinguishment of debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative mark-to-market gain</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax indemnification income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Loss) income before income taxes</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15.5)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.3 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19.9)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">694.8 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) Primarily consists of costs related to executive and staff functions, including certain finance, human resources, manufacturing and information technology (“IT”) functions, which benefit the Company as a whole. These costs are primarily related to the general management of these functions on a corporate level and the design and development of programs, policies and procedures that are then implemented in the individual segments, with each segment bearing its own cost of implementation. The Company’s corporate function also includes debt and stock-based compensation associated with all employee stock-based awards.</span></div>(2) Represents incremental consulting costs and research and development (“R&amp;D”) manufacturing site costs to align compliance of the Company’s existing, on-market products that were previously registered under the European In Vitro Diagnostics Directive regulatory framework with the requirements under the EU’s In Vitro Diagnostic Regulation, which generally apply from May 2022 onwards. 253400000 293500000 708100000 1246100000 10200000 17200000 22700000 33400000 37300000 45000000.0 96000000.0 84200000 31200000 29800000 89300000 64100000 332100000 385500000 916100000 1427800000 -162900000 -158700000 -388300000 -341900000 -37700000 -29700000 -110900000 -41000000.0 113100000 104200000 341800000 167000000.0 26500000 26400000 80400000 109600000 2800000 1600000 5900000 3900000 2200000 0 3200000 0 -1000000.0 0 -1200000 -800000 400000 600000 1900000 1000000.0 0 35400000 0 46600000 0 1000000.0 0 1500000 0 0 0 -24000000.0 0 3400000 0 4400000 100000 300000 200000 300000 1100000 300000 2600000 400000 -15500000 31300000 -19900000 694800000 Income Taxes<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company calculates its interim income tax provision in accordance with ASC 270,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Interim Reporting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and ASC 740, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounting for Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. At the end of each interim period, the Company estimates its annual effective tax rate and applies that rate to its ordinary quarterly earnings to calculate the tax related to ordinary income. The tax effects for other items that are excluded from ordinary income are discretely calculated and recognized in the period in which they occur.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended October 1, 2023, the Company recognized an income tax benefit of $2.8 million in relation to loss before income taxes of $15.5 million, resulting in an effective benefit tax rate of 18.1%. For the three months ended October 2, 2022, the Company recognized a provision for income taxes of $12.1 million in relation to income before income taxes of $31.3 million, resulting in an effective tax rate of 38.7%. For the three months ended October 1, 2023, the effective tax rate differed from the U.S. federal statutory rate primarily due to operating losses in certain subsidiaries not being benefited due to the establishment of valuation allowances and Global Intangible Low-Tax Income, partially offset by non-U.S. earnings being taxed at rates that are different than the U.S. statutory rate, R&amp;D credits, foreign tax credits and foreign exchange losses. For the three months ended October 2, 2022, the effective tax rate was impacted primarily by income taxes owed in certain U.S. states. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the nine months ended October 1, 2023, the Company recognized an income tax benefit of $2.8 million in relation to loss before income taxes of $19.9 million, resulting in an effective benefit tax rate of 14.1%. For the nine months ended October 2, 2022, the Company recognized a provision for income taxes of $176.4 million in relation to income before income taxes of $694.8 million, resulting in an effective tax rate of 25.4%. For the nine months ended October 1, 2023, the effective tax rate differed from the U.S. federal statutory rate primarily due to net operating losses in certain subsidiaries not being benefited due to the establishment of valuation allowances and Global Intangible Low-Tax Income, partially offset by non-U.S. earnings being taxed at rates that are different than the U.S. statutory rate, R&amp;D credits, foreign tax credits and foreign exchange losses. For the nine months ended October 2, 2022, the effective tax rate was primarily impacted by incomes taxes owed in certain U.S. states. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The balance of unrecognized tax benefits at October 1, 2023, not including interest and penalties, was $38.7 million, of which $27.5 million could affect the effective income tax rate in future periods, if recognized. The Company also recognizes interest and penalties related to unrecognized tax benefits in tax expense. At October 1, 2023, the Company had approximately $8.5 million of interest and penalties accrued related to unrecognized tax benefits. The Company estimates that within the next 12 months, its uncertain tax positions, excluding interest, will decrease by $14.2 million.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to periodic audits by domestic and foreign tax authorities. Due to the carryforward of unutilized credits, the Company’s federal tax years from 2012 and onwards are subject to examination by the U.S. authorities. The Company’s state and foreign tax years for 2001 and onwards are subject to examination by applicable tax authorities. The Company believes that it has appropriate support for the income tax positions taken on its tax returns and that its accruals for tax liabilities are adequate for all open years based on an assessment of many factors, including past experience and interpretations of tax laws applied to the facts of each matter. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Indemnification Assets</span></div>On January 16, 2014, Ortho entered into a stock and asset purchase agreement of (i) certain assets and liabilities and (ii) all of the equity interests and substantially all of the assets and liabilities of certain entities, which, together with their subsidiaries, comprised the Ortho business from Johnson &amp; Johnson. The agreement generally provided that Johnson &amp; Johnson retained all income tax liabilities accrued as of the date of the acquisition, including reserves for unrecognized tax benefits. The indemnification receivable from Johnson &amp; Johnson totaled $16.4 million and $16.8 million as of October 1, 2023 and January 1, 2023, respectively, and is included as a component of Prepaid expenses and other current assets and Other assets on the Consolidated Balance Sheets. The Company recorded $0.3 million and $1.0 million of interest and penalties during the three and nine months ended October 1, 2023, respectively, and $0.3 million and $0.4 million during the three and nine months ended October 2, 2022, respectively. -2800000 -15500000 0.181 12100000 31300000 0.387 -2800000 -19900000 0.141 176400000 694800000 0.254 38700000 27500000 8500000 14200000 16400000 16800000 300000 1000000 300000 400000 Balance Sheet Account Details<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash, Cash Equivalents and Restricted Cash</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.075%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.522%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 1, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 1, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash included in Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149.9 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">293.9 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Marketable Securities</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of marketable securities:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:37.204%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.701%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 1, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 1, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agency bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sovereign government bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total marketable securities, current</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds, non-current</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate asset-backed securities, non-current</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agency bonds, non-current</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total marketable securities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.1 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55.8 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.8 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.1 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounts Receivable, Net</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivables primarily consisted of trade accounts receivables with maturities of one year or less and are presented net of reserves:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.075%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.522%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 1, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 1, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">419.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">543.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for contract rebates and discounts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(75.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(77.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for doubtful accounts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total accounts receivable, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">331.2 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">453.9 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Inventories</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories are stated at the lower of cost (first-in, first-out) or net realizable value. Inventories consisted of the following:</span></div><div style="margin-bottom:3pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.075%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.522%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 1, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 1, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-process (materials, labor and overhead)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods (materials, labor and overhead)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventories </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">598.1 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">563.0 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">551.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">524.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventories</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">598.1 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">563.0 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) Includes adjustment of approximately $39 million in the nine months ended October 1, 2023 due to changes in estimates to decrease inventory obsolescence reserves from the prior period.</span></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2) Other assets includes inventory expected to remain on hand beyond one year.</span></div><div style="margin-bottom:3pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Prepaid Expenses and Other Current Assets</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaid expenses and other current assets consisted of the following:</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.075%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.522%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 1, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 1, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes and other tax receivables</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total prepaid expenses and other current assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295.2 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252.1 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:12pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Goodwill</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in goodwill were as follows:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.081%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.603%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">North America</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">EMEA</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">China</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at January 1, 2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,547.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">358.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">452.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,476.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase accounting adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at October 1, 2023</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,534.2 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">350.4 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110.4 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">447.9 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,442.9 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Current Liabilities</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other current liabilities consisted of the following:</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.075%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.522%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 1, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 1, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued commissions, rebates and returns</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued other taxes payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-788"><span style="-sec-ix-hidden:f-789">Operating lease liabilities</span></span></span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other current liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">305.4 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325.4 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> <div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash, Cash Equivalents and Restricted Cash</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.075%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.522%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 1, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 1, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash included in Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149.9 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">293.9 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 149300000 292900000 600000 1000000.0 149900000 293900000 <div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of marketable securities:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:37.204%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.701%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 1, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 1, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agency bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sovereign government bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total marketable securities, current</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds, non-current</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate asset-backed securities, non-current</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agency bonds, non-current</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total marketable securities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.1 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55.8 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.8 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.1 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 32800000 200000 32600000 40500000 500000 40000000.0 7800000 0 7800000 6700000 0 6700000 0 0 0 2000000.0 0 2000000.0 1500000 0 1500000 1000000.0 0 1000000.0 2000000.0 0 2000000.0 1900000 0 1900000 0 0 0 500000 0 500000 44100000 200000 43900000 52600000 500000 52100000 8800000 100000 8700000 13300000 100000 13200000 3200000 0 3200000 7900000 100000 7800000 0 0 0 0 0 0 56100000 300000 55800000 73800000 700000 73100000 <div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivables primarily consisted of trade accounts receivables with maturities of one year or less and are presented net of reserves:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.075%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.522%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 1, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 1, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">419.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">543.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for contract rebates and discounts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(75.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(77.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for doubtful accounts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total accounts receivable, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">331.2 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">453.9 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 419100000 543000000.0 75200000 77100000 12700000 12000000.0 331200000 453900000 <div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories are stated at the lower of cost (first-in, first-out) or net realizable value. Inventories consisted of the following:</span></div><div style="margin-bottom:3pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.075%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.522%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 1, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 1, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-process (materials, labor and overhead)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods (materials, labor and overhead)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventories </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">598.1 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">563.0 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">551.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">524.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventories</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">598.1 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">563.0 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) Includes adjustment of approximately $39 million in the nine months ended October 1, 2023 due to changes in estimates to decrease inventory obsolescence reserves from the prior period.</span></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2) Other assets includes inventory expected to remain on hand beyond one year.</span></div> 197900000 185200000 104700000 82700000 295500000 295100000 598100000 563000000.0 551700000 524100000 46400000 38900000 598100000 563000000.0 39000000 <div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaid expenses and other current assets consisted of the following:</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.075%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.522%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 1, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 1, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes and other tax receivables</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total prepaid expenses and other current assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295.2 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252.1 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 93100000 38600000 92200000 96700000 53500000 49600000 42400000 44300000 10900000 22000000.0 3100000 900000 295200000 252100000 <div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in goodwill were as follows:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.081%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.603%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">North America</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">EMEA</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">China</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at January 1, 2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,547.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">358.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">452.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,476.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase accounting adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at October 1, 2023</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,534.2 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">350.4 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110.4 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">447.9 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,442.9 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 1547700000 358600000 118100000 452400000 2476800000 -13400000 -4100000 -1300000 -5100000 -23900000 -100000 -4100000 -6400000 600000 -10000000.0 1534200000 350400000 110400000 447900000 2442900000 <div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other current liabilities consisted of the following:</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.075%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.522%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 1, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 1, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued commissions, rebates and returns</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued other taxes payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-788"><span style="-sec-ix-hidden:f-789">Operating lease liabilities</span></span></span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other current liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">305.4 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325.4 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 51500000 57500000 39700000 9300000 34600000 76400000 32200000 1400000 26300000 24400000 6700000 19700000 0 39300000 114400000 97400000 305400000 325400000 Borrowings<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of borrowings were as follows:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.075%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.522%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 1, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 1, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,472.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,646.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-804"><span style="-sec-ix-hidden:f-805">Financing lease obligation</span></span> </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other short-term borrowings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term borrowings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized deferred financing costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total borrowings</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,467.6 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,638.3 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(193.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(207.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term borrowings</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,274.6 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,430.8 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The credit agreement, dated May 27, 2022, by and among the Company, as borrower, Bank of America, N.A., as administrative agent and swing line lender, and the other lenders and L/C issuers party thereto (the “Credit Agreement”) consists of a $2,750.0 million senior secured term loan facility (the “Term Loan”) and an $800.0 million revolving credit facility (the “Revolving Credit Facility” and with the Term Loan, the “Financing”). As of October 1, 2023 and January 1, 2023, there were no amounts outstanding under the Revolving Credit Facility. As of October 1, 2023, letters of credit issued under the Revolving Credit Facility totaled $12.9 million, which reduced the available amount under the Revolving Credit Facility to $787.1 million. During the nine months ended October 1, 2023, the Company made $174.7 million in payments on the Term Loan, including a voluntary prepayment of $20.0 million.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Credit Agreement contains affirmative and negative covenants that are customary for credit agreements of this nature. The negative covenants include, among other things, limitations on asset sales, mergers, indebtedness, liens, investments and transactions with affiliates. The Credit Agreement contains two financial covenants: (i) a maximum Consolidated Leverage Ratio (as defined in the Credit Agreement) as of the last day of each fiscal quarter of (a) 4.50 to 1.00 for the first four fiscal quarters ending after the closing date of the Credit Agreement (the “Initial Measurement Period”), (b) 4.00 to 1.00 for the first four fiscal quarters ending after the Initial Measurement Period and (c) 3.50 to 1.00 for each fiscal quarter thereafter; and (ii) a minimum Consolidated Interest Coverage Ratio (as defined in the Credit Agreement) of 3.00 to 1.00 as of the end of any fiscal quarter for the most recently completed four fiscal quarters. The Company was in compliance with the financial covenants as of October 1, 2023.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides the detailed amounts within Interest expense, net for the three and nine months ended October 1, 2023 and October 2, 2022:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 1, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 2, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 1, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 2, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revolving Credit Facility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of deferred financing costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative instruments and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.7 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.7 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110.9 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.0 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> <div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of borrowings were as follows:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.075%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.522%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 1, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 1, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,472.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,646.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-804"><span style="-sec-ix-hidden:f-805">Financing lease obligation</span></span> </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other short-term borrowings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term borrowings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized deferred financing costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total borrowings</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,467.6 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,638.3 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(193.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(207.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term borrowings</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,274.6 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,430.8 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 2472200000 2646900000 500000 800000 2900000 0 700000 1200000 8700000 10600000 2467600000 2638300000 193000000.0 207500000 2274600000 2430800000 2750000000 800000000 12900000 787100000 174700000 20000000 2 4.50 4.00 3.50 3.00 <div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides the detailed amounts within Interest expense, net for the three and nine months ended October 1, 2023 and October 2, 2022:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 1, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 2, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 1, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 2, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revolving Credit Facility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of deferred financing costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative instruments and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.7 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.7 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110.9 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.0 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 45700000 27900000 130800000 36300000 900000 600000 1900000 1000000.0 900000 900000 2500000 1200000 -8500000 600000 -20200000 3500000 1300000 300000 4100000 1000000.0 -37700000 -29700000 -110900000 -41000000.0 Stock-based Compensation<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation expense was as follows:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 1, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 2, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 1, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 2, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, marketing and administrative</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition and integration costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.1 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.2 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.1 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.5 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table above includes compensation expense related to liability-classified awards of $3.0 million and $8.8 million for the three and nine months ended October 1, 2023, respectively, and $3.0 million and $13.9 million for the three and nine months ended October 2, 2022, respectively, which has been or is expected to be settled in cash. These awards primarily represent the $7.14 per share cash-settled portion of the replacement awards issued in connection with the Combinations.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company granted 253 thousand stock options during the nine months ended October 1, 2023. As of October 1, 2023, total unrecognized compensation expense related to stock options was approximately $20.0 million and the related weighted-average period over which it is expected to be recognized is approximately 2.0 years. The maximum contractual term of the Company’s stock options is ten years.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of each stock option was determined on the date of grant using the Black-Scholes option valuation model with the following weighted-average assumptions for the option grants:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.075%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.522%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 1, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 2, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.52 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.99 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected option life (in years)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.53</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.89</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Volatility rate</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend rate</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average grant date fair value</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$48.17</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$50.86</span></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2023, the Compensation Committee of the Company’s Board of Directors approved a modification to the vesting terms of certain stock options that were previously granted by Ortho to certain Ortho employees, such that the stock options will vest on December 31, 2023. The modification resulted in an additional $2.9 million and $8.0 million of stock-based compensation expense recognized during the three and nine months ended October 1, 2023, respectively. The total unrecognized expense relating to unvested shares for these stock options as of October 1, 2023 was $3.1 million and will be recognized through December 31, 2023.</span></div>The Company granted 609 thousand RSUs during the nine months ended October 1, 2023. The fair value of RSUs is determined based on the closing market price of the Company’s common stock on the grant date. The weighted-average fair value of RSUs granted during the nine months ended October 1, 2023 and October 2, 2022 was $87.14 and $97.52, respectively. The total amount of unrecognized compensation expense related to non-vested RSUs as of October 1, 2023 was approximately $78.4 million, which is expected to be recognized over a weighted-average period of approximately 2.2 years. <div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation expense was as follows:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 1, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 2, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 1, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 2, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, marketing and administrative</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition and integration costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.1 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.2 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.1 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.5 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 1200000 800000 3300000 2000000.0 1600000 1300000 4200000 3800000 10300000 7200000 27500000 20500000 4000000.0 6900000 13100000 24200000 17100000 16200000 48100000 50500000 3000000 8800000 3000000 13900000 7.14 253000 20000000 P2Y P10Y <div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of each stock option was determined on the date of grant using the Black-Scholes option valuation model with the following weighted-average assumptions for the option grants:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.075%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.522%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 1, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 2, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.52 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.99 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected option life (in years)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.53</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.89</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Volatility rate</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend rate</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average grant date fair value</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$48.17</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$50.86</span></td></tr></table></div> 0.0352 0.0199 P5Y6M10D P4Y10M20D 0.57 0.58 0 0 48.17 50.86 2900000 8000000 3100000 609000 87.14 97.52 78400000 P2Y2M12D Commitments and Contingencies<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company is involved in litigation and other legal proceedings, including matters related to product liability claims, commercial disputes and intellectual property claims, as well as regulatory, employment, and other claims related to its business. The Company accrues for legal claims when, and to the extent that, amounts associated with the claims become probable and are reasonably estimable. If the reasonable estimate of a known or probable loss is a range, and no amount within the range is a better estimate than any other, the minimum amount of the range is accrued. When determining the estimated loss or range of loss, significant judgment is required to estimate the amount and timing of a loss to be recorded. Estimates of probable losses resulting from these matters are inherently difficult to predict. The actual costs of resolving legal claims may be substantially higher or lower than the amounts accrued for those claims. For those matters as to which the Company is not able to estimate a possible loss or range of loss, the Company is not able to determine whether the loss will have a material adverse effect on its business, financial condition, results of operations or liquidity. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management believes that all such current legal actions, in the aggregate, are not expected to have a material adverse effect on the Company. However, the resolution of, or increase in any accruals for, one or more matters may have a material adverse effect on the Company’s results of operations and cash flows.</span></div> Fair Value Measurements<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the Company’s hierarchy for its assets and liabilities measured at fair value on a recurring basis as of the following periods:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.508%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.537%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 1, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 1, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets measured at fair value</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities measured at fair value</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.8 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.1 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.2 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no transfers of assets or liabilities into or out of Level 3 of the fair value hierarchy during the three and nine months ended October 1, 2023 and fiscal year 2022.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash equivalents consist of funds held in money market accounts that are valued using quoted prices in active markets for identical instruments and highly liquid corporate debt securities with maturities within three months from purchase. Marketable securities consist of investment-grade corporate and government debt securities, corporate asset-backed securities and commercial paper. Derivative financial instruments are based on observable inputs that are corroborated by market data. Observable inputs include broker quotes, daily market foreign currency rates and forward pricing curves</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the acquisition of the B-type Natriuretic Peptide assay business run on Beckman Coulter analyzers from Alere Inc., the Company paid its last annual installment of $40.0 million during the nine months ended October 1, 2023.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financial Instruments Not Measured at Fair Value</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of the Company’s borrowings under the Term Loan was $2,444.4 million at October 1, 2023, compared to the carrying amount, excluding debt issuance costs, of $2,472.2 million. The estimated fair value of the Company’s borrowings under the Term Loan was $2,630.3 million at January 1, 2023, compared to the carrying amount, </span></div>excluding debt issuance costs, of $2,646.9 million. The estimate of fair value is generally based on the quoted market prices for similar issuances of long-term debt with the same maturities, which is classified as a Level 2 input. <div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the Company’s hierarchy for its assets and liabilities measured at fair value on a recurring basis as of the following periods:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.508%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.537%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 1, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 1, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets measured at fair value</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities measured at fair value</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.8 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.1 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.2 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 2000000.0 0 0 2000000.0 600000 2100000 0 2700000 0 55800000 0 55800000 2000000.0 71100000 0 73100000 0 49900000 0 49900000 0 22000000.0 0 22000000.0 2000000.0 105700000 0 107700000 2600000 95200000 0 97800000 0 6700000 0 6700000 0 21800000 0 21800000 0 0 100000 100000 0 0 100000 100000 0 0 0 0 0 39300000 0 39300000 0 6700000 100000 6800000 0 61100000 100000 61200000 40000000 2444400000 2472200000 2630300000 2646900000 Derivative Instruments and Hedging Activities<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company selectively uses derivative and non-derivative instruments to manage market risk associated with changes in interest rates and foreign currency exchange rates. The use of derivatives is intended for hedging purposes only, and the Company does not enter into derivative transactions for speculative purposes. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Credit risk represents the Company’s gross exposure to potential accounting loss on derivative instruments that are outstanding or unsettled if all counterparties failed to perform according to the terms of the contract. The Company generally enters into master netting arrangements that reduce credit risk by permitting net settlement of transactions with the same counterparty. The Company does not have any derivative instruments with credit-risk related contingent features that would require it to post collateral.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Interest Rate Hedging Instruments</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s interest rate risk relates primarily to interest rate exposures on variable rate debt, including the Revolving Credit Facility and Term Loan. See Note 8 for additional information on the currently outstanding components of the Revolving Credit Facility and Term Loan. The Company entered into interest rate swap agreements to hedge the related risk of the variability to the Company’s cash flows due to the rates specified for these credit facilities. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company designates its interest rate swaps as cash flow hedges. The Company records gains and losses due to changes in fair value of the derivatives within Other comprehensive (loss) income (“OCI”) and reclassifies these amounts to Interest expense, net in the same period or periods for which the underlying hedged transaction affects earnings. In the event the Company determines the hedged transaction is no longer probable to occur or concludes the hedge relationship is no longer effective, the hedge is prospectively de-designated. Pre-tax unrealized gains of $29.0 million as of October 1, 2023 are expected to be reclassified from OCI to earnings in the next 12 months.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company’s interest rate derivative agreements as of October 1, 2023, all of which were interest rate swaps:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.297%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.303%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">Notional Amount</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">(In millions) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:112%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">Description</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">Hedge Designation</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">Effective Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">Expiration Date</span></td></tr><tr><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">500.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Pay 1.58% fixed, receive floating rate</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(1-month USD-SOFR)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Designated cash flow hedge</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">May 29, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">December 31, 2023</span></td></tr><tr><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">397.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Pay 3.765% fixed, receive floating rate</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(1-month USD-SOFR)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Designated cash flow hedge</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">December 30, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">May 27, 2027</span></td></tr><tr><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">144.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Pay 3.7725% fixed, receive floating rate</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(1-month USD-SOFR)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Designated cash flow hedge</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">December 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">May 27, 2027</span></td></tr><tr><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">216.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Pay 3.7675% fixed, receive floating rate</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(1-month USD-SOFR)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Designated cash flow hedge</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">December 30, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">May 27, 2027</span></td></tr><tr><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">288.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Pay 3.7575% fixed, receive floating rate</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(1-month USD-SOFR)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Designated cash flow hedge</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">December 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">May 27, 2027</span></td></tr><tr><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">252.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Pay 3.7725% fixed, receive floating rate</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(1-month USD-SOFR)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Designated cash flow hedge</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">December 30, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">May 27, 2027</span></td></tr></table></div><div style="margin-top:6pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The notional value of interest rate swap contracts with an effective date of December 30, 2022 is expected to increase to $1.8 billion on December 29, 2023.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Currency Hedging Instruments</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has currency risk exposures relating primarily to foreign currency denominated monetary assets and liabilities and forecasted foreign currency denominated intercompany and third-party transactions. The Company uses foreign currency forward contracts and may use option contracts and cross currency swaps to manage its currency risk exposures. The Company’s foreign currency forward contracts are denominated primarily in Australian Dollar, Brazilian Real, British Pound, Canadian Dollar, Chilean Peso, Chinese Yuan/Renminbi, Colombian Peso, Euro, Indian Rupee, Japanese Yen, Mexican Peso, Philippine Peso, South Korean Won, Swiss Franc and the Thai Baht.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company designates certain foreign currency forward contracts as cash flow hedges. The Company records gains and losses due to changes in fair value of the derivatives within OCI and reclassifies these amounts to Total revenues and Cost of sales, excluding amortization of intangibles in the same period or periods for which the underlying hedged transaction affects </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">earnings. In the event the Company determines the hedged transaction is no longer probable to occur or concludes the hedge relationship is no longer effective, the hedge is prospectively de-designated. Pre-tax unrealized loss of $2.0 million as of October 1, 2023 is expected to be reclassified from OCI to earnings in the next 12 months.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also enters into foreign currency forward contracts that are not part of designated hedging relationships and which are intended to mitigate exchange rate risk of monetary assets and liabilities and related forecasted transactions. The Company records these non-designated derivatives at mark-to-market with gains and losses recognized in earnings within Other expense (income), net. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides details of the currency hedging instruments outstanding as of October 1, 2023:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.215%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.707%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.610%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">Description</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">Notional Amount<br/>(In millions)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">Hedge Designation</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">127.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Cash Flow Hedge</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">616.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Non-designated</span></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes pre-tax gains and losses from designated derivative and non-derivative instruments within Accumulated other comprehensive (loss) income (“AOCI”) for the three and nine months ended October 1, 2023 and October 2, 2022:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:26.092%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.730%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.876%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.734%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Designated Hedging Instruments</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Loss (Gain) Recognized in OCI on Hedges</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of Amounts Reclassified From AOCI Into Income</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Loss (Gain) Reclassified From AOCI Into Income</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended October 1, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts (sales)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts (purchases)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales, excluding amortization of intangibles</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate derivatives</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended October 1, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts (sales)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts (purchases)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales, excluding amortization of intangibles</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate derivatives</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended October 2, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts (sales)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts (purchases)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales, excluding amortization of intangibles</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate derivatives</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended October 2, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts (sales)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts (purchases)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales, excluding amortization of intangibles</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate derivatives</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value (gains) and losses on foreign currency forward contracts, as determined using Level 2 inputs, that do not qualify for hedge accounting treatment are recorded in Other expense (income), net. Fair value losses were $0.2 million for the three months ended October 1, 2023 and fair value gains were $0.3 million for the nine months ended October 1, 2023. Fair value losses on foreign currency forward contracts, as determined using Level 2 inputs, that do not qualify for hedge accounting treatment are recorded in Other expense (income), net and were $2.7 million and $3.0 million for the three and nine months ended October 2, 2022, respectively. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value gains on interest rate derivatives, as determined using Level 2 inputs, that do not qualify for hedge accounting treatment are recorded in Other expense (income), net and were $3.4 million and $4.4 million for the three and nine months ended October 2, 2022, respectively.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the fair value of designated and non-designated hedging instruments recognized within the Consolidated Balance Sheets as of October 1, 2023 and January 1, 2023:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.075%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.522%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 1, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 1, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Designated cash flow hedges</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate derivatives:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-1030"><span style="-sec-ix-hidden:f-1031">Prepaid expenses and other current assets</span></span></span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-1034"><span style="-sec-ix-hidden:f-1035">Other assets</span></span></span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-1038"><span style="-sec-ix-hidden:f-1039">Other liabilities</span></span></span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-1042"><span style="-sec-ix-hidden:f-1043">Prepaid expenses and other current assets</span></span></span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-1046"><span style="-sec-ix-hidden:f-1047">Other current liabilities</span></span></span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-designated hedging instruments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-1050"><span style="-sec-ix-hidden:f-1051">Prepaid expenses and other current assets</span></span></span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-1054"><span style="-sec-ix-hidden:f-1055">Other current liabilities</span></span></span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 29000000 <div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company’s interest rate derivative agreements as of October 1, 2023, all of which were interest rate swaps:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.297%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.303%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">Notional Amount</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">(In millions) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:112%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">Description</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">Hedge Designation</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">Effective Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">Expiration Date</span></td></tr><tr><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">500.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Pay 1.58% fixed, receive floating rate</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(1-month USD-SOFR)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Designated cash flow hedge</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">May 29, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">December 31, 2023</span></td></tr><tr><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">397.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Pay 3.765% fixed, receive floating rate</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(1-month USD-SOFR)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Designated cash flow hedge</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">December 30, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">May 27, 2027</span></td></tr><tr><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">144.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Pay 3.7725% fixed, receive floating rate</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(1-month USD-SOFR)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Designated cash flow hedge</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">December 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">May 27, 2027</span></td></tr><tr><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">216.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Pay 3.7675% fixed, receive floating rate</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(1-month USD-SOFR)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Designated cash flow hedge</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">December 30, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">May 27, 2027</span></td></tr><tr><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">288.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Pay 3.7575% fixed, receive floating rate</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(1-month USD-SOFR)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Designated cash flow hedge</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">December 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">May 27, 2027</span></td></tr><tr><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">252.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Pay 3.7725% fixed, receive floating rate</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(1-month USD-SOFR)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Designated cash flow hedge</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">December 30, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">May 27, 2027</span></td></tr></table></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The notional value of interest rate swap contracts with an effective date of December 30, 2022 is expected to increase to $1.8 billion on December 29, 2023.</span> 500000000.0 0.0158 397200000 0.03765 144400000 0.037725 216700000 0.037675 288900000 0.037575 252800000 0.037725 1800000000 -2000000 <div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides details of the currency hedging instruments outstanding as of October 1, 2023:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.215%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.707%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.610%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">Description</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">Notional Amount<br/>(In millions)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">Hedge Designation</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">127.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Cash Flow Hedge</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">616.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Non-designated</span></td></tr></table></div> 127000000.0 616900000 <div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes pre-tax gains and losses from designated derivative and non-derivative instruments within Accumulated other comprehensive (loss) income (“AOCI”) for the three and nine months ended October 1, 2023 and October 2, 2022:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:26.092%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.730%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.876%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.734%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Designated Hedging Instruments</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Loss (Gain) Recognized in OCI on Hedges</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of Amounts Reclassified From AOCI Into Income</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Loss (Gain) Reclassified From AOCI Into Income</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended October 1, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts (sales)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts (purchases)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales, excluding amortization of intangibles</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate derivatives</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended October 1, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts (sales)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts (purchases)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales, excluding amortization of intangibles</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate derivatives</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended October 2, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts (sales)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts (purchases)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales, excluding amortization of intangibles</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate derivatives</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended October 2, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts (sales)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts (purchases)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales, excluding amortization of intangibles</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate derivatives</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> -1000000.0 1800000 -100000 400000 -28000000.0 -8500000 700000 2700000 -2200000 2100000 -54100000 -21100000 -2600000 -700000 -600000 -100000 -7900000 400000 -5000000.0 -900000 -800000 -100000 -11000000.0 1700000 -200000 300000 -2700000 -3000000 3400000 4400000 <div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the fair value of designated and non-designated hedging instruments recognized within the Consolidated Balance Sheets as of October 1, 2023 and January 1, 2023:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.075%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.522%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 1, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 1, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Designated cash flow hedges</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate derivatives:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-1030"><span style="-sec-ix-hidden:f-1031">Prepaid expenses and other current assets</span></span></span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-1034"><span style="-sec-ix-hidden:f-1035">Other assets</span></span></span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-1038"><span style="-sec-ix-hidden:f-1039">Other liabilities</span></span></span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-1042"><span style="-sec-ix-hidden:f-1043">Prepaid expenses and other current assets</span></span></span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-1046"><span style="-sec-ix-hidden:f-1047">Other current liabilities</span></span></span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-designated hedging instruments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-1050"><span style="-sec-ix-hidden:f-1051">Prepaid expenses and other current assets</span></span></span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-1054"><span style="-sec-ix-hidden:f-1055">Other current liabilities</span></span></span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 4900000 15900000 39000000.0 0 0 2100000 2100000 4600000 3400000 14300000 3900000 1500000 3300000 5400000 Related Party Transactions<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Quotient Limited</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the consummation of the Combinations, the Company acquired Ortho’s Letter Agreement (the “Letter Agreement”), entered into in September 2020 with Quotient Limited (“Quotient”), in which Ortho partnered with Quotient to commercialize, when approved, Quotient’s next generation product in immunohematology, a transfusion diagnostic patient immunohematology microarray intended for use with Quotient’s MosaiQ</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">®</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> instruments. Under the Letter Agreement, the Company was required to make certain milestone payments to Quotient as specified milestones and benchmarks were achieved. Quotient subsequently revised its business strategy to pause development and commercialization of its MosaiQ testing solutions in immunohematology and infectious disease immunoassay screening. On January 10, 2023, Quotient filed a voluntary petition for relief under Chapter 11 of Title 11 of the United States Code in the United States Bankruptcy Court for the Southern District of Texas (the “Bankruptcy Proceeding”). Following the completion of the Bankruptcy Proceeding, the Company’s equity interests in Quotient were canceled for no consideration. Quotient is no longer considered a related party of the Company.</span></div> Accumulated Other Comprehensive Loss <div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the changes in Accumulated other comprehensive loss by component:</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.525%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.381%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended October 1, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pension and Other Post-<br/>Employment Benefits</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash Flow Hedges</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Available-for-Sale Investments</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Foreign Currency Translation Adjustments</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive (Loss) Income</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at July 2, 2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current period deferrals </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.2 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55.3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36.9)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at October 1, 2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(86.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended October 1, 2023</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pension and Other Post-<br/>Employment Benefits</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash Flow Hedges</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Available-for-Sale Investments</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Foreign Currency Translation Adjustments</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive (Loss) Income</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at January 1, 2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(69.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(67.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current period deferrals </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.3 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17.2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.4 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at October 1, 2023</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.8 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(86.5)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53.2)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.806%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.379%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="21" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended October 2, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash Flow Hedges</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Available-for-Sale Investments</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Foreign Currency Translation Adjustments</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Income (Loss)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at July 3, 2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(60.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current period deferrals</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(92.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(83.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to net income</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.1 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(92.9)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(83.8)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at October 2, 2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.6 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(158.4)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(144.5)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.806%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.379%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="21" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended October 2, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash Flow Hedges</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Available-for-Sale Investments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Foreign Currency Translation Adjustments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Income (Loss)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at January 2, 2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current period deferrals</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(158.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(145.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to net income</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.6 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(158.9)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(144.9)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at October 2, 2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.6 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(158.4)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(144.5)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Includes tax impact of $4.6 million and $8.0 million related to cash flow hedges for the three and nine months ended October 1, 2023, respectively.</span></div>(2) Includes tax impact of $1.7 million and $2.8 million related to cash flow hedges for the three and nine months ended October 2, 2022, respectively. <div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the changes in Accumulated other comprehensive loss by component:</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.525%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.381%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended October 1, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pension and Other Post-<br/>Employment Benefits</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash Flow Hedges</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Available-for-Sale Investments</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Foreign Currency Translation Adjustments</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive (Loss) Income</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at July 2, 2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current period deferrals </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.2 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55.3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36.9)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at October 1, 2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(86.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended October 1, 2023</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pension and Other Post-<br/>Employment Benefits</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash Flow Hedges</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Available-for-Sale Investments</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Foreign Currency Translation Adjustments</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive (Loss) Income</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at January 1, 2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(69.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(67.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current period deferrals </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.3 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17.2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.4 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at October 1, 2023</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.8 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(86.5)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53.2)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.806%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.379%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="21" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended October 2, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash Flow Hedges</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Available-for-Sale Investments</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Foreign Currency Translation Adjustments</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Income (Loss)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at July 3, 2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(60.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current period deferrals</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(92.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(83.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to net income</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.1 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(92.9)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(83.8)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at October 2, 2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.6 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(158.4)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(144.5)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.806%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.379%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="21" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended October 2, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash Flow Hedges</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Available-for-Sale Investments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Foreign Currency Translation Adjustments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Income (Loss)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at January 2, 2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current period deferrals</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(158.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(145.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to net income</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.6 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(158.9)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(144.9)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at October 2, 2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.6 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(158.4)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(144.5)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Includes tax impact of $4.6 million and $8.0 million related to cash flow hedges for the three and nine months ended October 1, 2023, respectively.</span></div>(2) Includes tax impact of $1.7 million and $2.8 million related to cash flow hedges for the three and nine months ended October 2, 2022, respectively. 700000 14600000 -400000 -31200000 -16300000 0 24500000 200000 -55300000 -30600000 0 6300000 0 0 6300000 0 18200000 200000 -55300000 -36900000 700000 32800000 -200000 -86500000 -53200000 700000 1500000 -500000 -69300000 -67600000 0 47600000 300000 -17200000 30700000 0 16300000 0 0 16300000 0 31300000 300000 -17200000 14400000 700000 32800000 -200000 -86500000 -53200000 5500000 -700000 -65500000 -60700000 9300000 0 -92900000 -83600000 200000 0 0 200000 9100000 0 -92900000 -83800000 14600000 -700000 -158400000 -144500000 0 -100000 500000 400000 13900000 -600000 -158900000 -145600000 -700000 0 0 -700000 14600000 -600000 -158900000 -144900000 14600000 -700000 -158400000 -144500000 4600000 8000000 1700000 2800000 false false false false EXCEL 76 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0 ( )&085<'04UB@0 +$ 0 9&]C4')O<',O87!P+GAM M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGDK7A.YNJQ<&4GPZ4A!0W_J=0U[R;UEA_6\#MI7E!+ P04 M " "1D&%7%)UW?>X K @ $0 &1O8U!R;W!S+V-O&ULS9+/ M2L0P$(=?17)O)TEE#Z';B^))07!!\1:2V=U@\X=DI-VWMZV[740?P&-F?OGF M&YC6)&5BQN<<$V9R6&Y&WX>B3-JR(U%2 ,4M23XDP-?TW3,Q\@:?.A M#PB2\PUX)&TU:9B!55J)K&NM42:CIIC/>&M6?/K,_0*S!K!'CX$*B%H Z^:) MZ33V+5P!,XPP^_)=0+L2E^J?V*4#[)P$6W:9_-K\>6">Y;"HA*BYV4BI^J\3F?7;]X7<5]M&ZO?O' MQA?!KH5?=]%] 5!+ P04 " "1D&%7F5R<(Q & "<)P $P 'AL+W1H M96UE+W1H96UE,2YX;6SM6EMSVC@4?N^OT'AG]FT+QC:!MK03621A'^_1S80RY8-[9)-NIL\!"SI^\Y%1^?H.'GS[BYBZ(:(E/)X M8-DOV]:[MR_>X%#BVR]*+ M41B1%G\@M MNN01.+5)#3(3/PB=AIAJ4!P"I DQEJ&&^+3&K!'@$WVWO@C(WXV(]ZMOFCU7 MH5A)VH3X$$8:XIQSYG/1;/L'I4;1]E6\W*.76!4!EQC?-*HU+,76>)7 \:V< M/!T3$LV4"P9!AI@S M&L%&KQMUAVC2/'K^!?F<-0HACA*FNVB<5@$_9Y>PTG!Z(++9OVX?H;5,VPLCO='U!=*Y \FIS_I,C0' MHYI9";V$5FJ?JH,@H%\;D>/N5Z> HWEL:\4*Z">P'_T=HWPJOX@L Y M?RY]SZ7ON?0]H=*W-R-]9\'3BUO>1FY;Q/NN,=K7-"XH8U=RSTS0LS0[=R2^JVE+ZU)CA* M]+',<$X>RPP[9SR2';9WH!TU^_9==N0CI3!3ET.X&D*^ VVZG=PZ.)Z8D;D* MTU*0;\/YZ<5X&N(YV02Y?9A7;>?8T='[Y\%1L*/O/)8=QXCRHB'NH8:8S\-# MAWE[7YAGE<90-!1M;*PD+$:W8+C7\2P4X&1@+: '@Z]1 O)256 Q6\8#*Y"B M?$R,1>APYY=<7^/1DN/;IF6U;J\I=QEM(E(YPFF8$V>KRMYEL<%5'<]56_*P MOFH]M!5.S_Y9KF4Q9Z;RWRT,"2Q;B%D2XDU=[=7GFYRN>B)V^I=W MP6#R_7#)1P_E.^=?]%U#KG[VW>/Z;I,[2$R<><41 71% B.5' 86%S+D4.Z2 MD 83 >LX=SFWJXPD6L_UC6'ODRWSEPVSK> U[F M$RQ#I'[!?8J*@!&K8KZZKT_Y)9P[M'OQ@2";_-;;I/;=X Q\U*M:I60K$3]+ M!WP?D@9CC%OT-%^/%&*MIK&MQMHQ#'F 6/,,H68XWX=%FAHSU8NL.8T*;T'5 M0.4_V]0-:/8--!R1!5XQF;8VH^1."CS<_N\-L,+$CN'MB[\!4$L#!!0 ( M )&085=@:>90Z04 .T> 8 >&PO=V]R:W-H965T&UL MM9EK<^(V%(;_BH9V.KLS$"P9"*0),\1)NDRS"9?L=M)./PA;@">V164Y)/^^ M1S;822H+U[-\27P[+WIT='DEG6^Y>(K7C$GT$@91?-%82[DY:[=C=\U"&I_P M#8O@S9*+D$JX%:MVO!&,>FE0&+2)9?7:(?6CQO \?381PW.>R,"/V$2@. E# M*EXO6<"W%PWV ^HJ/9<''#G]F DT@8ZB%XC45+#YO M2Q!6K]ON3N0R$R$E(@/TE4=R':/KR&/>^_@V%"@O%=F7ZI(8!>]=>8(LW$3$ M(K:F/$Z%<-+5A;\KCIU7DIWJV25Z5]Q-H.E*-(H\8)2^?$7C*.M#JBW^-5K$ M4D"+_%M7=YEV1Z^MNNE9O*$NNVA /XR9>&:-X2\_X9[UJP[\!XF]JX9.7@T= MDWI1#0^O&Z8C-8=CJS75(1FC:B)UH C=C*U^-HY#&.QIJ&ZE99_IM?'5]>S][^'*/G/O91,=I5*C) MB:UBMK6JD(XCEPMHG>GTT41S"7T2<8$35+#@:G730'H\U$C&:^!V9MQJFGA3"QI@/[T-^7CE%EQ0##!6M)CF"5P1KCP1MAL:&ZY"_F:K'ED\@X'1+I=TL+8LK1\QW!&N+!&V.QK M'GP)KH@O$2:?%I_1G+F)@$QJ(T@EWW,-KGNE.N9OH"#78 W"#8WTJ34+EH,>P_:0PO80LVO9 M)W+-()$F/+-,.=XQ[ \I[ \Q.Y?]2/MN;I^G6]WH/I%@9B,UAVJ)?Y"QV=5# MIM9-U=3YRO.PU^OC_BD&U_BL8RPL$*FT/>3 B"K ZXTCC[V@WYD^C8=VB2P\ ML'HVZ6@9CN%W2.%WB-FN[*?+&S]6GO:1@3D&NU,&G9VJ6(.;(FJ%T8 M(/O 5LY^0_,MZ0T\U(ZP!\3*=FS-8749"PMDFPW+1\;=)G5*B3Y-<7-*FE.[ M>?/X6'01_I6KVC%' EA!JG9S"\">RL]7L1O)- M>CRYX%+R,+U<,^HQH3Z ]TO.Y?Y&_4!^PCW\%U!+ P04 " "1D&%77*R9 M0.8& "5'0 & 'AL+W=O#+0IMJ58EZ!9M\^,3,=")-$E*2?9K]_I)99D4G2*QA\2 MR3X>GSOQ[GE(G3T(>:_6G&OTF&>%.I^LM=ZBU%E:\&N)5)GG3#Y]XIEX.)_@ MR?,7W]*[M:Z^F"W.-NR.WW#]?7,MX6ZV\[),#@8$>5HT_]ECFXC> .R/#"#M /+2 ;0=0.M &V1U6)^99HLS*1Z0 MK*S!6W51YZ8>#=&D1?48;[2$7U,8IQ<7HE B2Y=,\R7ZQ#)6)!S=5.X4.D;? M;SZC]V\_H+?@($8]0R_ + M]_ OK!@;/H-P=S&37Q4I?WQ053:\2*)4JJ"_ZC3+<\UN,XX43TJ9ZI1; M,39NPM[L/NU-WD TC0(RQ7:$P0YAX$3X,4E$"8F#YI5PR") /4(%US:0@3$_ MI7A*]E":5GY QQ(YW\&<.V%>%EMXO$*.I&]N9B; TW /F<6*^&,)#'?(0B>R M:\DW+%TB_@@YK:I] Y2K1]=I;($\ MCZ?^'N3&+!B8T9%UBKV.>;S7*?G6SP F-FJ^M>JC)"-)Q3UVQ$Z,M:PY%JOC M4G''HV^]#!"&Q%B>K=D@D=$8QH[-L)- %K\+L7P ;K8"(V9%^#XQDV>S"^?3 M: 1<1S_8S3^7A6;%75H]Y"9]HVNQ=30L<8 0[$,U[2@F=!1JQT#834&?^8I# MC2^19H\-6"M,DUMP8#10F]6\5U=#B!T%83<'7=7=TK$.34K!86RN0XL9(;T@ MAO ZZL%N[FDZI0.>R2M10.->[VOQ6>RB +(<=Y\1K!T9X?!%(C!+V6V:U;W' MJ@2QD]1^5@J^EK=AT!V383>5[33,ACU5C=<:<&3VT6"?Q+#)8B2B/:X; NQ8 M#+MI# #*$DH0\$F1936-29[5NY-GW6 %;6$RK]^^6M@VPNO7QW _T5$9<5/9 M99&(G->-PY%98N$Q Z+%" 3:? 1A1V3$363/RWTC9+U]%BMT*R2X28L[:T:) MA:OB_65 3-XC7MAKV4.TO0V:F]*N!JJP5Z)6I"9W42\P1(S-C 1C/9ET#$?< M##>4AX>P4B.KT=S;1VH:8<\;ZF&P@'>D1-^D- M9,-S3I^L4$U:P[$I<"QF!-/1)M4Q'G'OOYJB.O34S2W4'(K$ZWWVV=HR)!J5 M8Z3C*O*2;=NM-H3A $BT95G) M$?1;I-9,\E,43+WF$E9)J=="IO_QY2DJ1,%1JE0E>81$HM0*MDO+JD;:@+X2RGS*;BN$XH,8FU68V!VT9QP=W@;13&=2M M,KYQS> KV%PP68Q)#&J1#CCR#.ENM8O#L1-=VDD,^I)]M1IMME;0IHKP8ZBF M_9,*JQWUQW87VYY@SBJ S@]Y4 KF]OJC=SNS>Q MB_\!4$L#!!0 ( )&085>7/:;M\ ( &D* 8 >&PO=V]R:W-H965T M&ULK59=;]HP%/TK5C9-K=01)T"@'41JF:IMTC14M.UAVH-) M+L2J8V>V@6Z_?K834FC#5U4>P!_WG'N.:-F2E1,!+L)TUU-O3Z'DIA1A9,WXG5)Z@,=2U?(IARWVA5QD;8 M0\E":9%78*,@I[S\)0_506P @LX.0%@!PF,![0K0=D9+9<[61Z))/)!BA:2- M-FQVX,[&H8T;RNUCG&AI=JG!Z7@DN!*,ID1#BFX((SP!-+%T"IV-B02N,] T M(>P*BU-E?UNLEIR M=YJY[=6[4@5)8.B9NZ5 +L&+W[T)(ORAR?@KD6T=0[L^AO8^]GAL;@U(:1Z^ M*;7D_@(51*(E80M !-YU+F:SODME_D&6,6Q@' W^Y M:?A0U):33NVDA,2/K/;%@?Y6JC^)*_NR&KB]WGB?S#<5L&NK6! M[HL,4*46A\5WGXEZ*GM?Q);@J!85LH37A*^?R0ZNB@ZGT16ZI[M>K> M7M4CD>?F?K]*N?>.*O=#45LV^K6-_@DV3J[U_K-C#<(H;*KV8R*W'%S6#BY/ M=W!Q*>K/Z'R*_HC/#1&-IKP-_H VX1])7). MN4(,9@:*6SW#(=>\AR2EX?L[1,77^26,86>\ZR0=Y.M4KN; MZ53&6Y93:?$=*^"7-138EM^].'%]\3#=;5;Z8SF]W=,,>F?JT^R#@:=IF2=*< M%3+E!1)L?3>YQS=+4@54B#]2]B0[WU%)9<7YE_+A;7(WLL8S%JDQ!X>/ M%BS+RDS0CZ]-TDG;9AG8_7[,_G-%'LBLJ&0+GGU.$[6]F\PF*&%KNL_41_[T M"VL(>66^F&>R^A<]U=@ P/%>*IXWP="#/"WJ3_K<"-$)@#SF -($D'Z .Q#@ M- '.:UMPFP#WM2UX34!%?5ISKX2+J*+S6\&?D"C1D*W\4JE?18->:5%.E$8=](X7:BO1LDA88HB/QN/#D?@I M2-'J08YZ/)#1A.]C92$;7R%B$\?0G\5KPDD53DQT_E_KR__<^ID83CLYG"J? M,Y"OF0'MM$!_WJ^D$K"X_S(-=9W,-2968ZZE:#3.R?PK+ GB GE6TY/ M$!V%L4LLW!-$AX68#.GAMWKXHWH\PE8*]*^@]HLO3%5*% FB">P):;DFR_W6 M)("O=SIT^WU>Z"ABN_VACG24!V+Z/?XZRK4#RS7S#UK^P2C_C["4J(BW%>L$ MYG_&=V5),E$.M [XQ.JO 0/(L[RP^]=CKT?@6= 9UYJ] 47\CI)G[&I M3&N#"=, 5& ;48L20[TPJA#J,]OO$UP803VI(ATTLRW7[OSU*X$>@>VPH]N9 M"M@^639[5(?W:LL$@K-"R1T* 7N&8X,TU[\FU=FH:).@ 7G=)=LC;X#@H$?7 M@)D-<.W84SS.M6695F;$R!&;AL_ID]11GJ]M>@VJRZ%?"):&3($7#*UQ3$Y< MR2C7MS"?P3*HXX!>H8(9"UR3YWR_LH(^81U%PCXJ,J PMOL[Y+*!G4T1/$#X M9"_QJ%>:_\HEG#0*X%N.,*SM;>4RH< E;&5F[FC=L/NT7X1$+T.6!@@9V,+P MR;SA-RS/5"9QD?*X%T+*'$2P796WZ,8Z=<9RWWTU&7;POWCB@EG6Z1O6 ?2 MD;YQ,^' I@0#"ISL&A[W:U&:[ 6?:'J"[GV;7O_?E_=.O?>/^";!3:\C_#-LKY=/Z6O M+_O?4;%)"XDRMH:F;"N C4[4]^?U@^*[ZH)XQ97B>?5URVC"1 F W]>M-)9BZ\8YO4]DQBZ/1FFKM, MTFL_=/I! =G0 ^1*LIWVU]]*$ Z#3-+6_A"#O/NL]M&SDC;S V5?>$:(0,]E M4?&%D0FQO;8LGF2DQ-RD6U+!+VO*2BS@E6TLOF4$I\JI+"S7MB=6B?/*6,[5 MV#U;SNE.%'E%[AGBN[+$[.];4M##PG",EX&'?),).6 MYUN\(8]$?-[>,WBS M6I0T+TG%R*^A^YH)3*.XBHEJ<8_ M&OZNJPU-XW@F\5A G]?#[S1,7#,K]#]W:U^B^'EWN@==\BQ.R, "8$[8GQO+[ M[YR)_8..^'."1><$B\\$=K1$?KM$_ACZ\B,<)A>%*LI<+8EN'6J(B8*01\=^ M>>6XYG1N[;L$#ZVQH72;MNDQ&);C*<+4A7!X$R:[<%5B>_0AVA8K+ M9WD=2/^$HTQN).]11=1N(O"S;KGJ2-.NO(+ ]'I*U5B%KAG:G4]/D9'&!73; M4W>LLPIF9J@7[K0E:/I6@G857.>*_!\X;3=PC>.U@ E(>,UH"19[4A/%7V-J M.IBJW4]G5=L$79L>+3J4'MOQT.;*-B=Z2F8M);-7MZT!%Z"4E+!\7PL(1@3; M*2YT^<\&LW)],^@1,#0*3<\>T\G0PY]VDJT9&1HYWBF1A"TCX2@C#R0I,.?Y M.D_JHH&EEPIH.;I0)%VB6C"GR9*;8;&#VY#46_66XR$<+O!D4',:HX'@(HV1 M,X"*AU9VYS Z8L^QOUUD[5'^?J$"%RA1I::M-%5@">896D-[A#*20DV^5F5- MT*.EG@WJ3&,5]L_$2&/D.0-N= ']4]7F=*[YSO@6].].S0;MZ)CWPWX=K'1F M$ZC"L/OITZ#Q&=Q%8HV5-_4Z]5WS8'4ZGY*PC6HY.=P1=I6HK[GM:-O6WJAF MKC=^ZURO',UX)-M@U6E]@Z][Z#O,-E)6!5E#*! P;+.L;DOK%T&WJN]ZH@*Z M./6802M/F#2 W]>4BI<7&:#]Y\#R*U!+ P04 " "1D&%7^AOS42<- "* MA@ & 'AL+W=OR55,4;ZXDSTEV'B9V M0IY+\?#K'EY2MT_Y\6.QSK+2^;S;[HN[T;HL#]]-)L5RG>W28IP?LKWZRX?\ MN$M+]?7X,"D.QRQ=G3+MMA/?=>/)+MWL1_>WI]_];A[69?6+R?WM(7W(WF7E;X=?CNK;Y(*RVNRR?;') M]\XQ^W W^M[[3D[=*L,IQ;\VV5/1^.Q4C_(^SS]67WY@XXN-JN,S<]_HLO3PZN'>9\6V3S?_GNS*M=WH^G(664? MTL=M^39_^B&K'RBJ\);YMCC][SS5:=V1LWPLRGQ79U8EV&WVYY_IY[HB&AF\ MX)D,?IW![YLAJ#,$K0Q^\DR&L,X0MC*$\3,9HCI#U"[2])D,<9TA/M7]N;). M-;U(R_3^]I@_.<N/D=O*I22/2HD"" M21"8P5]PX2_HQ5\?SLY(<:.:O9D_&X=F1<_/R6:-9&Z+"AO(3V;CJ9E*V*G< MMBU)%"D.9V/_DLRHE/!2*>$I7_!,I?RX7ZH)MU"M>I&=/U6=CA[;_O,VWVX= M-6$]I]8M[)SKQ7([,:EM/34N>@.E'1' .I=L!:'=H.(FO(?5:ID[G[*B5+^KNE71("ZMYL7.L9$U.W1LG%J4W+ACKS4X(BT*))@$ M@1D$SRX$SUZ&8(K4FR],_%0E= MSON;&L-P8Y5;-&N3P9H:3 8234#19&>%F&QHR<*[2K/X_G!4_F_PO/_+PPZ= MI3Q2M6@-5@NH30%%DR@TDT:M7'B]I8MNZ@*KLOW0"^W.U2U>4%#3:!RW9ADB M&3$L$5B>/VLL5LRZT0*&QWK(5\MR/.S@)A[V$>:@-@443:+03!JU$N'Q4L00 M=K",],3C\ORXX1 M#JH2U&A14[F)VP,A5"6 HDD4FDFB%@H\7BEH3$W=Q-E^N5K(1^.@W0-GW5.3 M#>4GB6]);D2Z&R\,QU%[>B+PO#AI+.?,;5'MFON\:WZMD\'##MX9M;UCPLF MVA10-(E",VG4GKO/>^Y#G S?]E=))Z-.QS5S"HIP,HADMI-!83%.AM_8^O=? M<07F8T,"D&@+*)J HDD4FMD(M!?N\U[X2^V6\F8'-P?*&V]O"4!-"BB:1*&9 M+&L]P>?U!.2FJ6^K JZU+<"79W#_[6%20$U*%)I)F%8.?%XYN&;OU"=<]; M MU\QYPX.9Z6-30&U*%)I)C18N_/X!"#H*;_8FW M[O$2*F#X=J"!']D#)E28@*))%)I)LA8F?%Z8N(YDDEA;O?!#Y3RUY0N^0(/[ M93^K FI5HM!,TK0PX?/"1).T>DH[9FH>6YZ#E^M0AFMYM,,2@KC=I>9\"0>S MV,>F@-J4*#230ZU+^*\8P> 3*H)KSXC0&(9>-@74ID2AF2'(6BL)7CB,(2"" M &+7GN'%VI10-$D"LTDL7'\HO_YBT[B;!$C MG*F6%+=[5H\3&%000^"UAQM!I*M&I:0]*E%Q#&%SB\VL'JT[!.$K2HP!-+H! MBK: H@DHFD2AF8U :QG!RQS(()L $=I@=R"HQ-''I(":E"@TDS"M< 2\PG&- M^!38BH-', ,-K.AE4T!M2A2:28W6)0)>EX"Z1X$M$BA7Q>(,*DSTLBF@-B4* MS>1,RQ(!+TN\S0Z/Q^5:D5%80V"'*L@C#Y[Q[)")F[8F"+4HH&@2A6;RJ*6) M@)6'D/#=IX&UI\478_#A M7:C\T.\1),JHR926'T* _!"2[G;[3 MO:3 94/D!BB:[ZL/D0LL/X57R0V

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

    &PO=V]R:W-H965TSA2] ( -\) 9 M " @7$' 0!X;"]W;W)K&UL4$L! A0#% M @ D9!A5Y'+E,"+!@ 9#, !D ("!G H! 'AL+W=O&UL4$L! A0#% @ D9!A5PF '%0; M P /0D !D ("!QA&PO=V]R:W-H965T&UL4$L! A0#% @ D9!A5S@MC $!! OQ !D M ("!5R,! 'AL+W=O&PO=V]R M:W-H965T&UL M4$L! A0#% @ D9!A5Y#W8.IS! _!D !D ("!Q#$! M 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ MD9!A5S&IIG&3!0 >2( !D ("!,$ ! 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ D9!A5[ +BP)6! M+AP !D ("!MTT! 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ D9!A5\HU&)*:! ,AD !D M ("!C%D! 'AL+W=O&PO=V]R:W-H M965T.RJ'%9 , 'D7 - M " :-E 0!X;"]S='EL97,N>&UL4$L! A0#% @ D9!A M5Y>*NQS $P( L ( !,FD! %]R96QS+RYR96QS4$L! M A0#% @ D9!A5ZC/Z9L*!0 0BL \ ( !&VH! 'AL M+W=OU<6!\%@( *HF : M " 5)O 0!X;"]?7!E&UL4$L%!@ !) $D ]A, +US 0 $! end XML 77 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 78 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 79 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.3 html 279 312 1 false 75 0 false 5 false false R1.htm 0000001 - Document - Cover Page Sheet http://www.quidel.com/role/CoverPage Cover Page Cover 1 false false R2.htm 0000002 - Statement - Consolidated Balance Sheets Sheet http://www.quidel.com/role/ConsolidatedBalanceSheets Consolidated Balance Sheets Statements 2 false false R3.htm 0000003 - Statement - Consolidated Balance Sheets (Parenthetical) Sheet http://www.quidel.com/role/ConsolidatedBalanceSheetsParenthetical Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 0000004 - Statement - Consolidated Statements of Income Sheet http://www.quidel.com/role/ConsolidatedStatementsofIncome Consolidated Statements of Income Statements 4 false false R5.htm 0000005 - Statement - Consolidated Statements of Comprehensive Income (Loss) Sheet http://www.quidel.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss Consolidated Statements of Comprehensive Income (Loss) Statements 5 false false R6.htm 0000006 - Statement - Consolidated Statements of Stockholders' Equity Statement Sheet http://www.quidel.com/role/ConsolidatedStatementsofStockholdersEquityStatement Consolidated Statements of Stockholders' Equity Statement Statements 6 false false R7.htm 0000007 - Statement - Consolidated Statements of Cash Flows Sheet http://www.quidel.com/role/ConsolidatedStatementsofCashFlows Consolidated Statements of Cash Flows Statements 7 false false R8.htm 0000008 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies Sheet http://www.quidel.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies Basis of Presentation and Summary of Significant Accounting Policies Notes 8 false false R9.htm 0000009 - Disclosure - Business Combination Sheet http://www.quidel.com/role/BusinessCombination Business Combination Notes 9 false false R10.htm 0000010 - Disclosure - Computation of Earnings Per Share Sheet http://www.quidel.com/role/ComputationofEarningsPerShare Computation of Earnings Per Share Notes 10 false false R11.htm 0000011 - Disclosure - Revenue Sheet http://www.quidel.com/role/Revenue Revenue Notes 11 false false R12.htm 0000012 - Disclosure - Segment and Geographic Information Sheet http://www.quidel.com/role/SegmentandGeographicInformation Segment and Geographic Information Notes 12 false false R13.htm 0000013 - Disclosure - Income Taxes Sheet http://www.quidel.com/role/IncomeTaxes Income Taxes Notes 13 false false R14.htm 0000014 - Disclosure - Balance Sheet Account Details Sheet http://www.quidel.com/role/BalanceSheetAccountDetails Balance Sheet Account Details Notes 14 false false R15.htm 0000015 - Disclosure - Borrowings Sheet http://www.quidel.com/role/Borrowings Borrowings Notes 15 false false R16.htm 0000016 - Disclosure - Stock-Based Compensation Sheet http://www.quidel.com/role/StockBasedCompensation Stock-Based Compensation Notes 16 false false R17.htm 0000017 - Disclosure - Commitments and Contingencies Sheet http://www.quidel.com/role/CommitmentsandContingencies Commitments and Contingencies Notes 17 false false R18.htm 0000018 - Disclosure - Fair Value Measurements Sheet http://www.quidel.com/role/FairValueMeasurements Fair Value Measurements Notes 18 false false R19.htm 0000019 - Disclosure - Derivative Instruments and Hedging Activities Sheet http://www.quidel.com/role/DerivativeInstrumentsandHedgingActivities Derivative Instruments and Hedging Activities Notes 19 false false R20.htm 0000020 - Disclosure - Related Party Transactions Sheet http://www.quidel.com/role/RelatedPartyTransactions Related Party Transactions Notes 20 false false R21.htm 0000021 - Disclosure - Accumulated Other Comprehensive Loss Sheet http://www.quidel.com/role/AccumulatedOtherComprehensiveLoss Accumulated Other Comprehensive Loss Notes 21 false false R22.htm 995410 - Disclosure - Pay vs Performance Disclosure Sheet http://xbrl.sec.gov/ecd/role/PvpDisclosure Pay vs Performance Disclosure Notes 22 false false R23.htm 995445 - Disclosure - Insider Trading Arrangements Sheet http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements Insider Trading Arrangements Notes 23 false false R24.htm 9954471 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies) Sheet http://www.quidel.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies Basis of Presentation and Summary of Significant Accounting Policies (Policies) Policies http://www.quidel.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies 24 false false R25.htm 9954472 - Disclosure - Business Combination (Tables) Sheet http://www.quidel.com/role/BusinessCombinationTables Business Combination (Tables) Tables http://www.quidel.com/role/BusinessCombination 25 false false R26.htm 9954473 - Disclosure - Computation of Earnings Per Share (Tables) Sheet http://www.quidel.com/role/ComputationofEarningsPerShareTables Computation of Earnings Per Share (Tables) Tables http://www.quidel.com/role/ComputationofEarningsPerShare 26 false false R27.htm 9954474 - Disclosure - Revenue (Tables) Sheet http://www.quidel.com/role/RevenueTables Revenue (Tables) Tables http://www.quidel.com/role/Revenue 27 false false R28.htm 9954475 - Disclosure - Segment and Geographic Information (Tables) Sheet http://www.quidel.com/role/SegmentandGeographicInformationTables Segment and Geographic Information (Tables) Tables http://www.quidel.com/role/SegmentandGeographicInformation 28 false false R29.htm 9954476 - Disclosure - Balance Sheet Account Details (Tables) Sheet http://www.quidel.com/role/BalanceSheetAccountDetailsTables Balance Sheet Account Details (Tables) Tables http://www.quidel.com/role/BalanceSheetAccountDetails 29 false false R30.htm 9954477 - Disclosure - Borrowings (Tables) Sheet http://www.quidel.com/role/BorrowingsTables Borrowings (Tables) Tables http://www.quidel.com/role/Borrowings 30 false false R31.htm 9954478 - Disclosure - Stock-Based Compensation (Tables) Sheet http://www.quidel.com/role/StockBasedCompensationTables Stock-Based Compensation (Tables) Tables http://www.quidel.com/role/StockBasedCompensation 31 false false R32.htm 9954479 - Disclosure - Fair Value Measurements (Tables) Sheet http://www.quidel.com/role/FairValueMeasurementsTables Fair Value Measurements (Tables) Tables http://www.quidel.com/role/FairValueMeasurements 32 false false R33.htm 9954480 - Disclosure - Derivative Instruments and Hedging Activities (Tables) Sheet http://www.quidel.com/role/DerivativeInstrumentsandHedgingActivitiesTables Derivative Instruments and Hedging Activities (Tables) Tables http://www.quidel.com/role/DerivativeInstrumentsandHedgingActivities 33 false false R34.htm 9954481 - Disclosure - Accumulated Other Comprehensive Loss (Tables) Sheet http://www.quidel.com/role/AccumulatedOtherComprehensiveLossTables Accumulated Other Comprehensive Loss (Tables) Tables http://www.quidel.com/role/AccumulatedOtherComprehensiveLoss 34 false false R35.htm 9954482 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Narrative (Details) Sheet http://www.quidel.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails Basis of Presentation and Summary of Significant Accounting Policies - Narrative (Details) Details http://www.quidel.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies 35 false false R36.htm 9954483 - Disclosure - Business Combination - Narrative (Details) Sheet http://www.quidel.com/role/BusinessCombinationNarrativeDetails Business Combination - Narrative (Details) Details 36 false false R37.htm 9954484 - Disclosure - Business Combination - Pro Forma Information (Details) Sheet http://www.quidel.com/role/BusinessCombinationProFormaInformationDetails Business Combination - Pro Forma Information (Details) Details 37 false false R38.htm 9954485 - Disclosure - Computation of Earnings Per Share - Calculation of Basic and Diluted Earnings Per Share (Details) Sheet http://www.quidel.com/role/ComputationofEarningsPerShareCalculationofBasicandDilutedEarningsPerShareDetails Computation of Earnings Per Share - Calculation of Basic and Diluted Earnings Per Share (Details) Details 38 false false R39.htm 9954486 - Disclosure - Computation of Earnings Per Share - Narrative (Details) Sheet http://www.quidel.com/role/ComputationofEarningsPerShareNarrativeDetails Computation of Earnings Per Share - Narrative (Details) Details 39 false false R40.htm 9954487 - Disclosure - Revenue - Narrative (Details) Sheet http://www.quidel.com/role/RevenueNarrativeDetails Revenue - Narrative (Details) Details 40 false false R41.htm 9954488 - Disclosure - Revenue - Disaggregation of Revenue (Details) Sheet http://www.quidel.com/role/RevenueDisaggregationofRevenueDetails Revenue - Disaggregation of Revenue (Details) Details 41 false false R42.htm 9954489 - Disclosure - Segment and Geographic Information - Total Revenues by Reportable Segment (Details) Sheet http://www.quidel.com/role/SegmentandGeographicInformationTotalRevenuesbyReportableSegmentDetails Segment and Geographic Information - Total Revenues by Reportable Segment (Details) Details 42 false false R43.htm 9954490 - Disclosure - Segment and Geographic Information - Reconciliation to Income (Details) Sheet http://www.quidel.com/role/SegmentandGeographicInformationReconciliationtoIncomeDetails Segment and Geographic Information - Reconciliation to Income (Details) Details 43 false false R44.htm 9954491 - Disclosure - Income Taxes (Detail) Sheet http://www.quidel.com/role/IncomeTaxesDetail Income Taxes (Detail) Details http://www.quidel.com/role/IncomeTaxes 44 false false R45.htm 9954492 - Disclosure - Balance Sheet Account Details Cash, Cash Equivalents and Restricted Cash (Details) Sheet http://www.quidel.com/role/BalanceSheetAccountDetailsCashCashEquivalentsandRestrictedCashDetails Balance Sheet Account Details Cash, Cash Equivalents and Restricted Cash (Details) Details 45 false false R46.htm 9954493 - Disclosure - Balance Sheet Account Details Marketable Securities (Details) Sheet http://www.quidel.com/role/BalanceSheetAccountDetailsMarketableSecuritiesDetails Balance Sheet Account Details Marketable Securities (Details) Details 46 false false R47.htm 9954494 - Disclosure - Balance Sheet Account Details Accounts Receivable (Details) Sheet http://www.quidel.com/role/BalanceSheetAccountDetailsAccountsReceivableDetails Balance Sheet Account Details Accounts Receivable (Details) Details 47 false false R48.htm 9954495 - Disclosure - Balance Sheet Account Details Inventories (Details) Sheet http://www.quidel.com/role/BalanceSheetAccountDetailsInventoriesDetails Balance Sheet Account Details Inventories (Details) Details 48 false false R49.htm 9954496 - Disclosure - Balance Sheet Account Details Prepaid expenses and other current assets (Details) Sheet http://www.quidel.com/role/BalanceSheetAccountDetailsPrepaidexpensesandothercurrentassetsDetails Balance Sheet Account Details Prepaid expenses and other current assets (Details) Details 49 false false R50.htm 9954497 - Disclosure - Balance Sheet Account Details - Goodwill Rollforward (Details) Sheet http://www.quidel.com/role/BalanceSheetAccountDetailsGoodwillRollforwardDetails Balance Sheet Account Details - Goodwill Rollforward (Details) Details 50 false false R51.htm 9954498 - Disclosure - Balance Sheet Account Details Other Current Liabilities (Details) Sheet http://www.quidel.com/role/BalanceSheetAccountDetailsOtherCurrentLiabilitiesDetails Balance Sheet Account Details Other Current Liabilities (Details) Details 51 false false R52.htm 9954499 - Disclosure - Borrowings - Schedule of Borrowings (Details) Sheet http://www.quidel.com/role/BorrowingsScheduleofBorrowingsDetails Borrowings - Schedule of Borrowings (Details) Details 52 false false R53.htm 9954500 - Disclosure - Borrowings - Narrative (Details) Sheet http://www.quidel.com/role/BorrowingsNarrativeDetails Borrowings - Narrative (Details) Details 53 false false R54.htm 9954501 - Disclosure - Borrowings - Interest Expense (Details) Sheet http://www.quidel.com/role/BorrowingsInterestExpenseDetails Borrowings - Interest Expense (Details) Details 54 false false R55.htm 9954502 - Disclosure - Stock-Based Compensation - Compensation Expense Related to Stock-Based Compensation Plans (Details) Sheet http://www.quidel.com/role/StockBasedCompensationCompensationExpenseRelatedtoStockBasedCompensationPlansDetails Stock-Based Compensation - Compensation Expense Related to Stock-Based Compensation Plans (Details) Details 55 false false R56.htm 9954503 - Disclosure - Stock-Based Compensation - Narrative (Details) Sheet http://www.quidel.com/role/StockBasedCompensationNarrativeDetails Stock-Based Compensation - Narrative (Details) Details 56 false false R57.htm 9954504 - Disclosure - Stock-Based Compensation - Estimated Fair Value of Each Stock Option Award (Details) Sheet http://www.quidel.com/role/StockBasedCompensationEstimatedFairValueofEachStockOptionAwardDetails Stock-Based Compensation - Estimated Fair Value of Each Stock Option Award (Details) Details 57 false false R58.htm 9954505 - Disclosure - Fair Value Measurements - Assets and Liabilities Measured at Fair Value on Recurring Basis (Details) Sheet http://www.quidel.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails Fair Value Measurements - Assets and Liabilities Measured at Fair Value on Recurring Basis (Details) Details 58 false false R59.htm 9954506 - Disclosure - Fair Value Measurements - Narrative (Details) Sheet http://www.quidel.com/role/FairValueMeasurementsNarrativeDetails Fair Value Measurements - Narrative (Details) Details 59 false false R60.htm 9954507 - Disclosure - Derivative Instruments and Hedging Activities - Narrative (Details) Sheet http://www.quidel.com/role/DerivativeInstrumentsandHedgingActivitiesNarrativeDetails Derivative Instruments and Hedging Activities - Narrative (Details) Details 60 false false R61.htm 9954508 - Disclosure - Derivative Instruments and Hedging Activities - Schedule of Interest Rate Derivatives (Details) Sheet http://www.quidel.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofInterestRateDerivativesDetails Derivative Instruments and Hedging Activities - Schedule of Interest Rate Derivatives (Details) Details 61 false false R62.htm 9954509 - Disclosure - Derivative Instruments and Hedging Activities - Schedule of Currency Hedging Instruments (Details) Sheet http://www.quidel.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofCurrencyHedgingInstrumentsDetails Derivative Instruments and Hedging Activities - Schedule of Currency Hedging Instruments (Details) Details 62 false false R63.htm 9954510 - Disclosure - Derivative Instruments and Hedging Activities - Schedule of Gain (Loss) (Details) Sheet http://www.quidel.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofGainLossDetails Derivative Instruments and Hedging Activities - Schedule of Gain (Loss) (Details) Details 63 false false R64.htm 9954511 - Disclosure - Derivative Instruments and Hedging Activities - Schedule of Fair Value (Details) Sheet http://www.quidel.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofFairValueDetails Derivative Instruments and Hedging Activities - Schedule of Fair Value (Details) Details 64 false false R65.htm 9954512 - Disclosure - Accumulated Other Comprehensive Loss (Details) Sheet http://www.quidel.com/role/AccumulatedOtherComprehensiveLossDetails Accumulated Other Comprehensive Loss (Details) Details http://www.quidel.com/role/AccumulatedOtherComprehensiveLossTables 65 false false All Reports Book All Reports qdel-20231001.htm qdel-20231001.xsd qdel-20231001_cal.xml qdel-20231001_def.xml qdel-20231001_lab.xml qdel-20231001_pre.xml http://fasb.org/us-gaap/2023 http://xbrl.sec.gov/dei/2023 http://xbrl.sec.gov/ecd/2023 true true JSON 82 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "qdel-20231001.htm": { "nsprefix": "qdel", "nsuri": "http://www.quidel.com/20231001", "dts": { "inline": { "local": [ "qdel-20231001.htm" ] }, "schema": { "local": [ "qdel-20231001.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd", "https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd" ] }, "calculationLink": { "local": [ "qdel-20231001_cal.xml" ] }, "definitionLink": { "local": [ "qdel-20231001_def.xml" ] }, "labelLink": { "local": [ "qdel-20231001_lab.xml" ] }, "presentationLink": { "local": [ "qdel-20231001_pre.xml" ] } }, "keyStandard": 280, "keyCustom": 32, "axisStandard": 21, "axisCustom": 3, "memberStandard": 45, "memberCustom": 29, "hidden": { "total": 23, "http://fasb.org/us-gaap/2023": 18, "http://xbrl.sec.gov/dei/2023": 5 }, "contextCount": 279, "entityCount": 1, "segmentCount": 75, "elementCount": 589, "unitCount": 5, "baseTaxonomies": { "http://fasb.org/us-gaap/2023": 1031, "http://xbrl.sec.gov/ecd/2023": 4, "http://xbrl.sec.gov/dei/2023": 29 }, "report": { "R1": { "role": "http://www.quidel.com/role/CoverPage", "longName": "0000001 - Document - Cover Page", "shortName": "Cover Page", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20231001.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20231001.htm", "first": true, "unique": true } }, "R2": { "role": "http://www.quidel.com/role/ConsolidatedBalanceSheets", "longName": "0000002 - Statement - Consolidated Balance Sheets", "shortName": "Consolidated Balance Sheets", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "2", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20231001.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "us-gaap:AssetsCurrent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20231001.htm", "unique": true } }, "R3": { "role": "http://www.quidel.com/role/ConsolidatedBalanceSheetsParenthetical", "longName": "0000003 - Statement - Consolidated Balance Sheets (Parenthetical)", "shortName": "Consolidated Balance Sheets (Parenthetical)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "3", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "unitRef": "usdPerShare", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "us-gaap:PreferredStockParOrStatedValuePerShare", "span", "div", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20231001.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "unitRef": "usdPerShare", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "us-gaap:PreferredStockParOrStatedValuePerShare", "span", "div", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20231001.htm", "first": true, "unique": true } }, "R4": { "role": "http://www.quidel.com/role/ConsolidatedStatementsofIncome", "longName": "0000004 - Statement - Consolidated Statements of Income", "shortName": "Consolidated Statements of Income", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "4", "firstAnchor": { "contextRef": "c-5", "name": "us-gaap:Revenues", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20231001.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-5", "name": "us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20231001.htm", "unique": true } }, "R5": { "role": "http://www.quidel.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss", "longName": "0000005 - Statement - Consolidated Statements of Comprehensive Income (Loss)", "shortName": "Consolidated Statements of Comprehensive Income (Loss)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "5", "firstAnchor": { "contextRef": "c-5", "name": "us-gaap:NetIncomeLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20231001.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-5", "name": "us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20231001.htm", "unique": true } }, "R6": { "role": "http://www.quidel.com/role/ConsolidatedStatementsofStockholdersEquityStatement", "longName": "0000006 - Statement - Consolidated Statements of Stockholders' Equity Statement", "shortName": "Consolidated Statements of Stockholders' Equity Statement", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "6", "firstAnchor": { "contextRef": "c-39", "name": "us-gaap:SharesOutstanding", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20231001.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-44", "name": "us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20231001.htm", "unique": true } }, "R7": { "role": "http://www.quidel.com/role/ConsolidatedStatementsofCashFlows", "longName": "0000007 - Statement - Consolidated Statements of Cash Flows", "shortName": "Consolidated Statements of Cash Flows", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "7", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:NetIncomeLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20231001.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ShareBasedCompensation", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20231001.htm", "unique": true } }, "R8": { "role": "http://www.quidel.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies", "longName": "0000008 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies", "shortName": "Basis of Presentation and Summary of Significant Accounting Policies", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "8", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20231001.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20231001.htm", "first": true, "unique": true } }, "R9": { "role": "http://www.quidel.com/role/BusinessCombination", "longName": "0000009 - Disclosure - Business Combination", "shortName": "Business Combination", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "9", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20231001.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20231001.htm", "first": true, "unique": true } }, "R10": { "role": "http://www.quidel.com/role/ComputationofEarningsPerShare", "longName": "0000010 - Disclosure - Computation of Earnings Per Share", "shortName": "Computation of Earnings Per Share", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "10", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:EarningsPerShareTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20231001.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:EarningsPerShareTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20231001.htm", "first": true, "unique": true } }, "R11": { "role": "http://www.quidel.com/role/Revenue", "longName": "0000011 - Disclosure - Revenue", "shortName": "Revenue", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "11", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20231001.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20231001.htm", "first": true, "unique": true } }, "R12": { "role": "http://www.quidel.com/role/SegmentandGeographicInformation", "longName": "0000012 - Disclosure - Segment and Geographic Information", "shortName": "Segment and Geographic Information", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "12", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20231001.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20231001.htm", "first": true, "unique": true } }, "R13": { "role": "http://www.quidel.com/role/IncomeTaxes", "longName": "0000013 - Disclosure - Income Taxes", "shortName": "Income Taxes", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "13", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20231001.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20231001.htm", "first": true, "unique": true } }, "R14": { "role": "http://www.quidel.com/role/BalanceSheetAccountDetails", "longName": "0000014 - Disclosure - Balance Sheet Account Details", "shortName": "Balance Sheet Account Details", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "14", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20231001.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20231001.htm", "first": true, "unique": true } }, "R15": { "role": "http://www.quidel.com/role/Borrowings", "longName": "0000015 - Disclosure - Borrowings", "shortName": "Borrowings", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "15", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:DebtDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20231001.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:DebtDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20231001.htm", "first": true, "unique": true } }, "R16": { "role": "http://www.quidel.com/role/StockBasedCompensation", "longName": "0000016 - Disclosure - Stock-Based Compensation", "shortName": "Stock-Based Compensation", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "16", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20231001.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20231001.htm", "first": true, "unique": true } }, "R17": { "role": "http://www.quidel.com/role/CommitmentsandContingencies", "longName": "0000017 - Disclosure - Commitments and Contingencies", "shortName": "Commitments and Contingencies", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "17", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20231001.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20231001.htm", "first": true, "unique": true } }, "R18": { "role": "http://www.quidel.com/role/FairValueMeasurements", "longName": "0000018 - Disclosure - Fair Value Measurements", "shortName": "Fair Value Measurements", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "18", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:FairValueDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20231001.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:FairValueDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20231001.htm", "first": true, "unique": true } }, "R19": { "role": "http://www.quidel.com/role/DerivativeInstrumentsandHedgingActivities", "longName": "0000019 - Disclosure - Derivative Instruments and Hedging Activities", "shortName": "Derivative Instruments and Hedging Activities", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "19", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20231001.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20231001.htm", "first": true, "unique": true } }, "R20": { "role": "http://www.quidel.com/role/RelatedPartyTransactions", "longName": "0000020 - Disclosure - Related Party Transactions", "shortName": "Related Party Transactions", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "20", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20231001.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20231001.htm", "first": true, "unique": true } }, "R21": { "role": "http://www.quidel.com/role/AccumulatedOtherComprehensiveLoss", "longName": "0000021 - Disclosure - Accumulated Other Comprehensive Loss", "shortName": "Accumulated Other Comprehensive Loss", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "21", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ComprehensiveIncomeNoteTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20231001.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ComprehensiveIncomeNoteTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20231001.htm", "first": true, "unique": true } }, "R22": { "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure", "longName": "995410 - Disclosure - Pay vs Performance Disclosure", "shortName": "Pay vs Performance Disclosure", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "22", "firstAnchor": { "contextRef": "c-5", "name": "us-gaap:NetIncomeLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20231001.htm", "first": true }, "uniqueAnchor": null }, "R23": { "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "longName": "995445 - Disclosure - Insider Trading Arrangements", "shortName": "Insider Trading Arrangements", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "23", "firstAnchor": { "contextRef": "c-5", "name": "ecd:Rule10b51ArrAdoptedFlag", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ecd:NonRule10b51ArrAdoptedFlag", "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20231001.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-5", "name": "ecd:Rule10b51ArrAdoptedFlag", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ecd:NonRule10b51ArrAdoptedFlag", "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20231001.htm", "first": true, "unique": true } }, "R24": { "role": "http://www.quidel.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies", "longName": "9954471 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies)", "shortName": "Basis of Presentation and Summary of Significant Accounting Policies (Policies)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "policies", "menuCat": "Policies", "order": "24", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20231001.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20231001.htm", "first": true, "unique": true } }, "R25": { "role": "http://www.quidel.com/role/BusinessCombinationTables", "longName": "9954472 - Disclosure - Business Combination (Tables)", "shortName": "Business Combination (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "25", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:BusinessAcquisitionProFormaInformationTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20231001.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:BusinessAcquisitionProFormaInformationTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20231001.htm", "first": true, "unique": true } }, "R26": { "role": "http://www.quidel.com/role/ComputationofEarningsPerShareTables", "longName": "9954473 - Disclosure - Computation of Earnings Per Share (Tables)", "shortName": "Computation of Earnings Per Share (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "26", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20231001.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20231001.htm", "first": true, "unique": true } }, "R27": { "role": "http://www.quidel.com/role/RevenueTables", "longName": "9954474 - Disclosure - Revenue (Tables)", "shortName": "Revenue (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "27", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20231001.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20231001.htm", "first": true, "unique": true } }, "R28": { "role": "http://www.quidel.com/role/SegmentandGeographicInformationTables", "longName": "9954475 - Disclosure - Segment and Geographic Information (Tables)", "shortName": "Segment and Geographic Information (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "28", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20231001.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20231001.htm", "first": true, "unique": true } }, "R29": { "role": "http://www.quidel.com/role/BalanceSheetAccountDetailsTables", "longName": "9954476 - Disclosure - Balance Sheet Account Details (Tables)", "shortName": "Balance Sheet Account Details (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "29", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20231001.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20231001.htm", "first": true, "unique": true } }, "R30": { "role": "http://www.quidel.com/role/BorrowingsTables", "longName": "9954477 - Disclosure - Borrowings (Tables)", "shortName": "Borrowings (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "30", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20231001.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20231001.htm", "first": true, "unique": true } }, "R31": { "role": "http://www.quidel.com/role/StockBasedCompensationTables", "longName": "9954478 - Disclosure - Stock-Based Compensation (Tables)", "shortName": "Stock-Based Compensation (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "31", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20231001.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20231001.htm", "first": true, "unique": true } }, "R32": { "role": "http://www.quidel.com/role/FairValueMeasurementsTables", "longName": "9954479 - Disclosure - Fair Value Measurements (Tables)", "shortName": "Fair Value Measurements (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "32", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20231001.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20231001.htm", "first": true, "unique": true } }, "R33": { "role": "http://www.quidel.com/role/DerivativeInstrumentsandHedgingActivitiesTables", "longName": "9954480 - Disclosure - Derivative Instruments and Hedging Activities (Tables)", "shortName": "Derivative Instruments and Hedging Activities (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "33", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfInterestRateDerivativesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20231001.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfInterestRateDerivativesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20231001.htm", "first": true, "unique": true } }, "R34": { "role": "http://www.quidel.com/role/AccumulatedOtherComprehensiveLossTables", "longName": "9954481 - Disclosure - Accumulated Other Comprehensive Loss (Tables)", "shortName": "Accumulated Other Comprehensive Loss (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "34", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20231001.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20231001.htm", "first": true, "unique": true } }, "R35": { "role": "http://www.quidel.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails", "longName": "9954482 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Narrative (Details)", "shortName": "Basis of Presentation and Summary of Significant Accounting Policies - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "35", "firstAnchor": { "contextRef": "c-73", "name": "us-gaap:ConcentrationRiskPercentage1", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "2", "ancestors": [ "span", "div", "us-gaap:RevenueFromContractWithCustomerPolicyTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20231001.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-73", "name": "us-gaap:ConcentrationRiskPercentage1", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "2", "ancestors": [ "span", "div", "us-gaap:RevenueFromContractWithCustomerPolicyTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20231001.htm", "first": true, "unique": true } }, "R36": { "role": "http://www.quidel.com/role/BusinessCombinationNarrativeDetails", "longName": "9954483 - Disclosure - Business Combination - Narrative (Details)", "shortName": "Business Combination - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "36", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:GoodwillPurchaseAccountingAdjustments", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20231001.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "qdel:GoodwillPurchaseAccountingAdjustmentDecreaseToDeferredTaxLiabilities", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20231001.htm", "unique": true } }, "R37": { "role": "http://www.quidel.com/role/BusinessCombinationProFormaInformationDetails", "longName": "9954484 - Disclosure - Business Combination - Pro Forma Information (Details)", "shortName": "Business Combination - Pro Forma Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "37", "firstAnchor": { "contextRef": "c-76", "name": "us-gaap:BusinessAcquisitionsProFormaRevenue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:BusinessAcquisitionProFormaInformationTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20231001.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-76", "name": "us-gaap:BusinessAcquisitionsProFormaRevenue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:BusinessAcquisitionProFormaInformationTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20231001.htm", "first": true, "unique": true } }, "R38": { "role": "http://www.quidel.com/role/ComputationofEarningsPerShareCalculationofBasicandDilutedEarningsPerShareDetails", "longName": "9954485 - Disclosure - Computation of Earnings Per Share - Calculation of Basic and Diluted Earnings Per Share (Details)", "shortName": "Computation of Earnings Per Share - Calculation of Basic and Diluted Earnings Per Share (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "38", "firstAnchor": { "contextRef": "c-5", "name": "us-gaap:WeightedAverageNumberOfSharesOutstandingBasic", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20231001.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-5", "name": "us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20231001.htm", "unique": true } }, "R39": { "role": "http://www.quidel.com/role/ComputationofEarningsPerShareNarrativeDetails", "longName": "9954486 - Disclosure - Computation of Earnings Per Share - Narrative (Details)", "shortName": "Computation of Earnings Per Share - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "39", "firstAnchor": { "contextRef": "c-5", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20231001.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-80", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20231001.htm", "unique": true } }, "R40": { "role": "http://www.quidel.com/role/RevenueNarrativeDetails", "longName": "9954487 - Disclosure - Revenue - Narrative (Details)", "shortName": "Revenue - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "40", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:DeferredRevenueCurrent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20231001.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-4", "name": "us-gaap:DeferredRevenueNoncurrent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20231001.htm", "unique": true } }, "R41": { "role": "http://www.quidel.com/role/RevenueDisaggregationofRevenueDetails", "longName": "9954488 - Disclosure - Revenue - Disaggregation of Revenue (Details)", "shortName": "Revenue - Disaggregation of Revenue (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "41", "firstAnchor": { "contextRef": "c-5", "name": "us-gaap:Revenues", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20231001.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-100", "name": "us-gaap:Revenues", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:DisaggregationOfRevenueTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20231001.htm", "unique": true } }, "R42": { "role": "http://www.quidel.com/role/SegmentandGeographicInformationTotalRevenuesbyReportableSegmentDetails", "longName": "9954489 - Disclosure - Segment and Geographic Information - Total Revenues by Reportable Segment (Details)", "shortName": "Segment and Geographic Information - Total Revenues by Reportable Segment (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "42", "firstAnchor": { "contextRef": "c-5", "name": "us-gaap:Revenues", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20231001.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-124", "name": "us-gaap:Revenues", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20231001.htm", "unique": true } }, "R43": { "role": "http://www.quidel.com/role/SegmentandGeographicInformationReconciliationtoIncomeDetails", "longName": "9954490 - Disclosure - Segment and Geographic Information - Reconciliation to Income (Details)", "shortName": "Segment and Geographic Information - Reconciliation to Income (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "43", "firstAnchor": { "contextRef": "c-5", "name": "qdel:SegmentAdjustedEBITDA", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20231001.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-5", "name": "qdel:SegmentAdjustedEBITDA", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20231001.htm", "first": true, "unique": true } }, "R44": { "role": "http://www.quidel.com/role/IncomeTaxesDetail", "longName": "9954491 - Disclosure - Income Taxes (Detail)", "shortName": "Income Taxes (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "44", "firstAnchor": { "contextRef": "c-5", "name": "us-gaap:IncomeTaxExpenseBenefit", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20231001.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-5", "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "3", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20231001.htm", "unique": true } }, "R45": { "role": "http://www.quidel.com/role/BalanceSheetAccountDetailsCashCashEquivalentsandRestrictedCashDetails", "longName": "9954492 - Disclosure - Balance Sheet Account Details Cash, Cash Equivalents and Restricted Cash (Details)", "shortName": "Balance Sheet Account Details Cash, Cash Equivalents and Restricted Cash (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "45", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20231001.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "us-gaap:RestrictedCashNoncurrent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20231001.htm", "unique": true } }, "R46": { "role": "http://www.quidel.com/role/BalanceSheetAccountDetailsMarketableSecuritiesDetails", "longName": "9954493 - Disclosure - Balance Sheet Account Details Marketable Securities (Details)", "shortName": "Balance Sheet Account Details Marketable Securities (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "46", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:MarketableSecuritiesTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20231001.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:MarketableSecuritiesTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20231001.htm", "first": true, "unique": true } }, "R47": { "role": "http://www.quidel.com/role/BalanceSheetAccountDetailsAccountsReceivableDetails", "longName": "9954494 - Disclosure - Balance Sheet Account Details Accounts Receivable (Details)", "shortName": "Balance Sheet Account Details Accounts Receivable (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "47", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:AccountsReceivableGrossCurrent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20231001.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "us-gaap:AccountsReceivableGrossCurrent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20231001.htm", "first": true, "unique": true } }, "R48": { "role": "http://www.quidel.com/role/BalanceSheetAccountDetailsInventoriesDetails", "longName": "9954495 - Disclosure - Balance Sheet Account Details Inventories (Details)", "shortName": "Balance Sheet Account Details Inventories (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "48", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:InventoryRawMaterialsNetOfReserves", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20231001.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "us-gaap:InventoryRawMaterialsNetOfReserves", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20231001.htm", "first": true, "unique": true } }, "R49": { "role": "http://www.quidel.com/role/BalanceSheetAccountDetailsPrepaidexpensesandothercurrentassetsDetails", "longName": "9954496 - Disclosure - Balance Sheet Account Details Prepaid expenses and other current assets (Details)", "shortName": "Balance Sheet Account Details Prepaid expenses and other current assets (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "49", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:IncomeTaxesReceivable", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20231001.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "us-gaap:IncomeTaxesReceivable", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20231001.htm", "first": true, "unique": true } }, "R50": { "role": "http://www.quidel.com/role/BalanceSheetAccountDetailsGoodwillRollforwardDetails", "longName": "9954497 - Disclosure - Balance Sheet Account Details - Goodwill Rollforward (Details)", "shortName": "Balance Sheet Account Details - Goodwill Rollforward (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "50", "firstAnchor": { "contextRef": "c-4", "name": "us-gaap:Goodwill", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20231001.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:GoodwillForeignCurrencyTranslationGainLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfGoodwillTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20231001.htm", "unique": true } }, "R51": { "role": "http://www.quidel.com/role/BalanceSheetAccountDetailsOtherCurrentLiabilitiesDetails", "longName": "9954498 - Disclosure - Balance Sheet Account Details Other Current Liabilities (Details)", "shortName": "Balance Sheet Account Details Other Current Liabilities (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "51", "firstAnchor": { "contextRef": "c-3", "name": "qdel:CustomerIncentivePayableCurrent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:OtherCurrentLiabilitiesTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20231001.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "qdel:CustomerIncentivePayableCurrent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:OtherCurrentLiabilitiesTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20231001.htm", "first": true, "unique": true } }, "R52": { "role": "http://www.quidel.com/role/BorrowingsScheduleofBorrowingsDetails", "longName": "9954499 - Disclosure - Borrowings - Schedule of Borrowings (Details)", "shortName": "Borrowings - Schedule of Borrowings (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "52", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:FinanceLeaseLiabilityNoncurrent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20231001.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "us-gaap:FinanceLeaseLiabilityNoncurrent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20231001.htm", "first": true, "unique": true } }, "R53": { "role": "http://www.quidel.com/role/BorrowingsNarrativeDetails", "longName": "9954500 - Disclosure - Borrowings - Narrative (Details)", "shortName": "Borrowings - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "53", "firstAnchor": { "contextRef": "c-3", "name": "qdel:NumberOfFinancialCovenants", "unitRef": "covenant", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20231001.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "qdel:NumberOfFinancialCovenants", "unitRef": "covenant", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20231001.htm", "first": true, "unique": true } }, "R54": { "role": "http://www.quidel.com/role/BorrowingsInterestExpenseDetails", "longName": "9954501 - Disclosure - Borrowings - Interest Expense (Details)", "shortName": "Borrowings - Interest Expense (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "54", "firstAnchor": { "contextRef": "c-5", "name": "us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:InterestIncomeAndInterestExpenseDisclosureTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20231001.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-5", "name": "us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:InterestIncomeAndInterestExpenseDisclosureTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20231001.htm", "first": true, "unique": true } }, "R55": { "role": "http://www.quidel.com/role/StockBasedCompensationCompensationExpenseRelatedtoStockBasedCompensationPlansDetails", "longName": "9954502 - Disclosure - Stock-Based Compensation - Compensation Expense Related to Stock-Based Compensation Plans (Details)", "shortName": "Stock-Based Compensation - Compensation Expense Related to Stock-Based Compensation Plans (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "55", "firstAnchor": { "contextRef": "c-5", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20231001.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-5", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20231001.htm", "first": true, "unique": true } }, "R56": { "role": "http://www.quidel.com/role/StockBasedCompensationNarrativeDetails", "longName": "9954503 - Disclosure - Stock-Based Compensation - Narrative (Details)", "shortName": "Stock-Based Compensation - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "56", "firstAnchor": { "contextRef": "c-5", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsShareBasedLiabilitiesPaid", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20231001.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-5", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsShareBasedLiabilitiesPaid", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20231001.htm", "first": true, "unique": true } }, "R57": { "role": "http://www.quidel.com/role/StockBasedCompensationEstimatedFairValueofEachStockOptionAwardDetails", "longName": "9954504 - Disclosure - Stock-Based Compensation - Estimated Fair Value of Each Stock Option Award (Details)", "shortName": "Stock-Based Compensation - Estimated Fair Value of Each Stock Option Award (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "57", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "4", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20231001.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "4", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20231001.htm", "first": true, "unique": true } }, "R58": { "role": "http://www.quidel.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails", "longName": "9954505 - Disclosure - Fair Value Measurements - Assets and Liabilities Measured at Fair Value on Recurring Basis (Details)", "shortName": "Fair Value Measurements - Assets and Liabilities Measured at Fair Value on Recurring Basis (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "58", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:MoneyMarketFundsAtCarryingValue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20231001.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "us-gaap:MoneyMarketFundsAtCarryingValue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20231001.htm", "first": true, "unique": true } }, "R59": { "role": "http://www.quidel.com/role/FairValueMeasurementsNarrativeDetails", "longName": "9954506 - Disclosure - Fair Value Measurements - Narrative (Details)", "shortName": "Fair Value Measurements - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "59", "firstAnchor": { "contextRef": "c-214", "name": "qdel:BusinessCombinationsContingentConsiderationInstallmentPaymentMade", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20231001.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-214", "name": "qdel:BusinessCombinationsContingentConsiderationInstallmentPaymentMade", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20231001.htm", "first": true, "unique": true } }, "R60": { "role": "http://www.quidel.com/role/DerivativeInstrumentsandHedgingActivitiesNarrativeDetails", "longName": "9954507 - Disclosure - Derivative Instruments and Hedging Activities - Narrative (Details)", "shortName": "Derivative Instruments and Hedging Activities - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "60", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20231001.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-236", "name": "us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20231001.htm", "unique": true } }, "R61": { "role": "http://www.quidel.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofInterestRateDerivativesDetails", "longName": "9954508 - Disclosure - Derivative Instruments and Hedging Activities - Schedule of Interest Rate Derivatives (Details)", "shortName": "Derivative Instruments and Hedging Activities - Schedule of Interest Rate Derivatives (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "61", "firstAnchor": { "contextRef": "c-215", "name": "us-gaap:DerivativeNotionalAmount", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfInterestRateDerivativesTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20231001.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-215", "name": "us-gaap:DerivativeNotionalAmount", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfInterestRateDerivativesTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20231001.htm", "first": true, "unique": true } }, "R62": { "role": "http://www.quidel.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofCurrencyHedgingInstrumentsDetails", "longName": "9954509 - Disclosure - Derivative Instruments and Hedging Activities - Schedule of Currency Hedging Instruments (Details)", "shortName": "Derivative Instruments and Hedging Activities - Schedule of Currency Hedging Instruments (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "62", "firstAnchor": { "contextRef": "c-222", "name": "us-gaap:DerivativeNotionalAmount", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDerivativeInstrumentsTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20231001.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-222", "name": "us-gaap:DerivativeNotionalAmount", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDerivativeInstrumentsTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20231001.htm", "first": true, "unique": true } }, "R63": { "role": "http://www.quidel.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofGainLossDetails", "longName": "9954510 - Disclosure - Derivative Instruments and Hedging Activities - Schedule of Gain (Loss) (Details)", "shortName": "Derivative Instruments and Hedging Activities - Schedule of Gain (Loss) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "63", "firstAnchor": { "contextRef": "c-226", "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20231001.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-226", "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20231001.htm", "first": true, "unique": true } }, "R64": { "role": "http://www.quidel.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofFairValueDetails", "longName": "9954511 - Disclosure - Derivative Instruments and Hedging Activities - Schedule of Fair Value (Details)", "shortName": "Derivative Instruments and Hedging Activities - Schedule of Fair Value (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "64", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:DerivativeAssetsCurrent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20231001.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-215", "name": "us-gaap:DerivativeAssetsCurrent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDerivativeAssetsAtFairValueTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20231001.htm", "unique": true } }, "R65": { "role": "http://www.quidel.com/role/AccumulatedOtherComprehensiveLossDetails", "longName": "9954512 - Disclosure - Accumulated Other Comprehensive Loss (Details)", "shortName": "Accumulated Other Comprehensive Loss (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "65", "firstAnchor": { "contextRef": "c-31", "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20231001.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-31", "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "qdel-20231001.htm", "first": true, "unique": true } } }, "tag": { "us-gaap_OtherAccruedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherAccruedLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.quidel.com/role/BalanceSheetAccountDetailsOtherCurrentLiabilitiesDetails": { "parentTag": "us-gaap_OtherLiabilitiesCurrent", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://www.quidel.com/role/BalanceSheetAccountDetailsOtherCurrentLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other", "label": "Other Accrued Liabilities, Current", "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r32" ] }, "qdel_BNPBusinessMember": { "xbrltype": "domainItemType", "nsuri": "http://www.quidel.com/20231001", "localname": "BNPBusinessMember", "presentation": [ "http://www.quidel.com/role/FairValueMeasurementsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "BNP Business", "label": "BNP Business [Member]", "documentation": "BNP Business [Member]" } } }, "auth_ref": [] }, "ecd_ExecutiveCategoryAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ExecutiveCategoryAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Executive Category:", "label": "Executive Category [Axis]" } } }, "auth_ref": [ "r834" ] }, "us-gaap_DerivativeFixedInterestRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeFixedInterestRate", "presentation": [ "http://www.quidel.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofInterestRateDerivativesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative, Fixed Interest Rate", "label": "Derivative, Fixed Interest Rate", "documentation": "Fixed interest rate related to the interest rate derivative." } } }, "auth_ref": [] }, "us-gaap_SellingGeneralAndAdministrativeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SellingGeneralAndAdministrativeExpense", "crdr": "debit", "calculation": { "http://www.quidel.com/role/ConsolidatedStatementsofIncome": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.quidel.com/role/ConsolidatedStatementsofIncome" ], "lang": { "en-us": { "role": { "terseLabel": "Selling, marketing and administrative", "label": "Selling, General and Administrative Expense", "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc." } } }, "auth_ref": [ "r138" ] }, "ecd_ErrCompRecoveryTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ErrCompRecoveryTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Erroneously Awarded Compensation Recovery", "label": "Erroneously Awarded Compensation Recovery [Table]" } } }, "auth_ref": [ "r789", "r800", "r810", "r835" ] }, "us-gaap_LongtermDebtTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongtermDebtTypeAxis", "presentation": [ "http://www.quidel.com/role/BorrowingsInterestExpenseDetails", "http://www.quidel.com/role/BorrowingsNarrativeDetails", "http://www.quidel.com/role/BorrowingsScheduleofBorrowingsDetails", "http://www.quidel.com/role/FairValueMeasurementsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long-term Debt, Type [Axis]", "label": "Long-Term Debt, Type [Axis]", "documentation": "Information by type of long-term debt." } } }, "auth_ref": [ "r34" ] }, "qdel_DebtPaymentTermsAxis": { "xbrltype": "stringItemType", "nsuri": "http://www.quidel.com/20231001", "localname": "DebtPaymentTermsAxis", "presentation": [ "http://www.quidel.com/role/BorrowingsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt Payment Terms [Axis]", "label": "Debt Payment Terms [Axis]", "documentation": "Debt Payment Terms" } } }, "auth_ref": [] }, "ecd_TabularListTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TabularListTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Tabular List, Table", "label": "Tabular List [Table Text Block]" } } }, "auth_ref": [ "r833" ] }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "crdr": "credit", "calculation": { "http://www.quidel.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.quidel.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Acquisitions of property, plant, equipment, investments and intangibles", "label": "Payments to Acquire Property, Plant, and Equipment", "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets." } } }, "auth_ref": [ "r141" ] }, "ecd_CompActuallyPaidVsOtherMeasureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsOtherMeasureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Actually Paid vs. Other Measure", "label": "Compensation Actually Paid vs. Other Measure [Text Block]" } } }, "auth_ref": [ "r832" ] }, "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain", "presentation": [ "http://www.quidel.com/role/BalanceSheetAccountDetailsMarketableSecuritiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value, Option, Eligible Item or Group", "label": "Financial Instruments [Domain]", "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms." } } }, "auth_ref": [ "r293", "r294", "r295", "r296", "r297", "r298", "r299", "r300", "r301", "r302", "r303", "r304", "r305", "r306", "r307", "r308", "r309", "r310", "r311", "r312", "r313", "r314", "r315", "r316", "r317", "r318", "r319", "r320", "r321", "r322", "r396", "r401", "r518", "r546", "r547", "r548", "r549", "r550", "r551", "r552", "r553", "r554", "r555", "r556", "r557", "r558", "r559", "r560", "r561", "r562", "r563", "r564", "r565", "r566", "r567", "r568", "r569", "r570", "r571", "r572", "r573", "r574", "r575", "r600", "r870", "r871", "r872", "r873", "r874", "r875", "r876", "r905", "r906", "r907", "r908" ] }, "us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfOtherCurrentAssetsTableTextBlock", "presentation": [ "http://www.quidel.com/role/BalanceSheetAccountDetailsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Prepaid Expenses and Other Current Assets", "label": "Schedule of Other Current Assets [Table Text Block]", "documentation": "Tabular disclosure of the carrying amounts of other current assets." } } }, "auth_ref": [] }, "us-gaap_OtherShortTermBorrowings": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherShortTermBorrowings", "crdr": "credit", "calculation": { "http://www.quidel.com/role/BorrowingsScheduleofBorrowingsDetails": { "parentTag": "us-gaap_LongTermDebtAndCapitalLeaseObligations", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.quidel.com/role/BorrowingsScheduleofBorrowingsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other short-term borrowings", "label": "Other Short-Term Borrowings", "documentation": "Amount of borrowings classified as other, maturing within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r28", "r656" ] }, "us-gaap_DebtInstrumentLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentLineItems", "presentation": [ "http://www.quidel.com/role/BorrowingsInterestExpenseDetails", "http://www.quidel.com/role/BorrowingsNarrativeDetails", "http://www.quidel.com/role/BorrowingsScheduleofBorrowingsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt Instrument [Line Items]", "label": "Debt Instrument [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r227", "r372", "r373", "r374", "r375", "r376", "r378", "r383", "r384", "r385", "r386", "r388", "r389", "r390", "r391", "r392", "r393", "r396", "r534", "r747", "r748", "r749", "r750", "r751", "r892" ] }, "us-gaap_DebtInstrumentAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentAxis", "presentation": [ "http://www.quidel.com/role/BorrowingsInterestExpenseDetails", "http://www.quidel.com/role/BorrowingsNarrativeDetails", "http://www.quidel.com/role/BorrowingsScheduleofBorrowingsDetails", "http://www.quidel.com/role/FairValueMeasurementsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt Instrument [Axis]", "label": "Debt Instrument [Axis]", "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities." } } }, "auth_ref": [ "r26", "r118", "r119", "r161", "r163", "r227", "r372", "r373", "r374", "r375", "r376", "r378", "r383", "r384", "r385", "r386", "r388", "r389", "r390", "r391", "r392", "r393", "r534", "r747", "r748", "r749", "r750", "r751", "r892" ] }, "us-gaap_MarketableSecuritiesNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MarketableSecuritiesNoncurrent", "crdr": "debit", "calculation": { "http://www.quidel.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.quidel.com/role/BalanceSheetAccountDetailsMarketableSecuritiesDetails", "http://www.quidel.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Marketable securities", "label": "Marketable Securities, Noncurrent", "documentation": "Amount of investment in marketable security, classified as noncurrent." } } }, "auth_ref": [ "r879" ] }, "us-gaap_DebtInstrumentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentTable", "presentation": [ "http://www.quidel.com/role/BorrowingsInterestExpenseDetails", "http://www.quidel.com/role/BorrowingsNarrativeDetails", "http://www.quidel.com/role/BorrowingsScheduleofBorrowingsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Long-term Debt Instruments [Table]", "label": "Schedule of Long-Term Debt Instruments [Table]", "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer." } } }, "auth_ref": [ "r34", "r71", "r72", "r108", "r109", "r111", "r116", "r151", "r152", "r227", "r372", "r373", "r374", "r375", "r376", "r378", "r383", "r384", "r385", "r386", "r388", "r389", "r390", "r391", "r392", "r393", "r396", "r534", "r747", "r748", "r749", "r750", "r751", "r892" ] }, "us-gaap_OtherCurrentLiabilitiesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherCurrentLiabilitiesTableTextBlock", "presentation": [ "http://www.quidel.com/role/BalanceSheetAccountDetailsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Other Current Liabilities", "label": "Other Current Liabilities [Table Text Block]", "documentation": "Tabular disclosure of other current liabilities." } } }, "auth_ref": [] }, "us-gaap_OtherNonoperatingIncomeExpenseMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherNonoperatingIncomeExpenseMember", "presentation": [ "http://www.quidel.com/role/DerivativeInstrumentsandHedgingActivitiesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other Nonoperating Income (Expense)", "label": "Other Nonoperating Income (Expense) [Member]", "documentation": "Primary financial statement caption encompassing other nonoperating income (expense)." } } }, "auth_ref": [] }, "us-gaap_SellingAndMarketingExpenseMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SellingAndMarketingExpenseMember", "presentation": [ "http://www.quidel.com/role/StockBasedCompensationCompensationExpenseRelatedtoStockBasedCompensationPlansDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Selling, marketing and administrative", "label": "Selling and Marketing Expense [Member]", "documentation": "Primary financial statement caption encompassing selling and marketing expense." } } }, "auth_ref": [ "r135" ] }, "us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation", "crdr": "debit", "presentation": [ "http://www.quidel.com/role/ConsolidatedStatementsofStockholdersEquityStatement" ], "lang": { "en-us": { "role": { "negatedLabel": "Tax withholdings related to vesting of stock-based awards", "label": "Share-Based Payment Arrangement, Decrease for Tax Withholding Obligation", "documentation": "Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement." } } }, "auth_ref": [] }, "us-gaap_DerivativeGainLossOnDerivativeNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeGainLossOnDerivativeNet", "crdr": "credit", "calculation": { "http://www.quidel.com/role/SegmentandGeographicInformationReconciliationtoIncomeDetails": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 13.0 } }, "presentation": [ "http://www.quidel.com/role/SegmentandGeographicInformationReconciliationtoIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative mark-to-market gain", "label": "Derivative, Gain (Loss) on Derivative, Net", "documentation": "Amount of increase (decrease) in the fair value of derivatives recognized in the income statement." } } }, "auth_ref": [ "r937" ] }, "us-gaap_CommonStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockParOrStatedValuePerShare", "presentation": [ "http://www.quidel.com/role/ConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, par value per share (in dollars per share)", "label": "Common Stock, Par or Stated Value Per Share", "documentation": "Face amount or stated value per share of common stock." } } }, "auth_ref": [ "r121" ] }, "us-gaap_OperatingLeaseLiabilityCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseLiabilityCurrent", "crdr": "credit", "calculation": { "http://www.quidel.com/role/BalanceSheetAccountDetailsOtherCurrentLiabilitiesDetails": { "parentTag": "us-gaap_OtherLiabilitiesCurrent", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.quidel.com/role/BalanceSheetAccountDetailsOtherCurrentLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating lease liabilities", "label": "Operating Lease, Liability, Current", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current." } } }, "auth_ref": [ "r536" ] }, "us-gaap_StockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityAbstract", "presentation": [ "http://www.quidel.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Stockholders\u2019 equity:", "label": "Equity, Attributable to Parent [Abstract]" } } }, "auth_ref": [] }, "qdel_PaymentOfAccretedInterestOnContingentConsiderationLiabilityAndDeferredConsiderationOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://www.quidel.com/20231001", "localname": "PaymentOfAccretedInterestOnContingentConsiderationLiabilityAndDeferredConsiderationOperatingActivities", "crdr": "credit", "calculation": { "http://www.quidel.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://www.quidel.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Payment of accreted interest on contingent and deferred consideration", "label": "Payment Of Accreted Interest On Contingent Consideration Liability And Deferred Consideration, Operating Activities", "documentation": "Payment Of Accreted Interest On Contingent Consideration Liability And Deferred Consideration, Operating Activities" } } }, "auth_ref": [] }, "us-gaap_BalanceSheetLocationDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BalanceSheetLocationDomain", "presentation": [ "http://www.quidel.com/role/BalanceSheetAccountDetailsMarketableSecuritiesDetails", "http://www.quidel.com/role/RevenueNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Balance Sheet Location [Domain]", "label": "Balance Sheet Location [Domain]", "documentation": "Location in the balance sheet (statement of financial position)." } } }, "auth_ref": [ "r90", "r94" ] }, "us-gaap_InventoryAdjustments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryAdjustments", "crdr": "credit", "presentation": [ "http://www.quidel.com/role/BalanceSheetAccountDetailsInventoriesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Inventory Adjustments", "label": "Inventory Adjustments", "documentation": "Amount of inventory reserves for last-in first-out (LIFO) and other inventory valuation methods." } } }, "auth_ref": [ "r62", "r883" ] }, "ecd_TradingArrByIndTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TradingArrByIndTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Arrangements, by Individual", "label": "Trading Arrangements, by Individual [Table]" } } }, "auth_ref": [ "r854" ] }, "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "lang": { "en-us": { "role": { "terseLabel": "Insider Trading Policies and Procedures Not Adopted", "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]" } } }, "auth_ref": [ "r788", "r858" ] }, "us-gaap_DerivativeAssetCurrentStatementOfFinancialPositionExtensibleEnumeration": { "xbrltype": "enumerationSetItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeAssetCurrentStatementOfFinancialPositionExtensibleEnumeration", "presentation": [ "http://www.quidel.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofFairValueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative Asset, Current, Statement of Financial Position [Extensible Enumeration]", "label": "Derivative Asset, Current, Statement of Financial Position [Extensible Enumeration]", "documentation": "Indicates line item in statement of financial position that includes derivative asset classified as current." } } }, "auth_ref": [ "r506" ] }, "us-gaap_DerivativeAssetNoncurrentStatementOfFinancialPositionExtensibleEnumeration": { "xbrltype": "enumerationSetItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeAssetNoncurrentStatementOfFinancialPositionExtensibleEnumeration", "presentation": [ "http://www.quidel.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofFairValueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative Asset, Noncurrent, Statement of Financial Position [Extensible Enumeration]", "label": "Derivative Asset, Noncurrent, Statement of Financial Position [Extensible Enumeration]", "documentation": "Indicates line item in statement of financial position that includes derivative asset classified as noncurrent." } } }, "auth_ref": [ "r506" ] }, "ecd_AllExecutiveCategoriesMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllExecutiveCategoriesMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "All Executive Categories", "label": "All Executive Categories [Member]" } } }, "auth_ref": [ "r834" ] }, "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract", "lang": { "en-us": { "role": { "terseLabel": "Statement of Comprehensive Income [Abstract]", "label": "Statement of Comprehensive Income [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DerivativeLiabilityCurrentStatementOfFinancialPositionExtensibleEnumeration": { "xbrltype": "enumerationSetItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeLiabilityCurrentStatementOfFinancialPositionExtensibleEnumeration", "presentation": [ "http://www.quidel.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofFairValueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative Liability, Current, Statement of Financial Position [Extensible Enumeration]", "label": "Derivative Liability, Current, Statement of Financial Position [Extensible Enumeration]", "documentation": "Indicates line item in statement of financial position that includes derivative liability classified as current." } } }, "auth_ref": [ "r506" ] }, "qdel_VoluntaryPrepaymentMember": { "xbrltype": "domainItemType", "nsuri": "http://www.quidel.com/20231001", "localname": "VoluntaryPrepaymentMember", "presentation": [ "http://www.quidel.com/role/BorrowingsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Voluntary Prepayment", "label": "Voluntary Prepayment [Member]", "documentation": "Voluntary Prepayment" } } }, "auth_ref": [] }, "us-gaap_DerivativeLiabilityNoncurrentStatementOfFinancialPositionExtensibleEnumeration": { "xbrltype": "enumerationSetItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeLiabilityNoncurrentStatementOfFinancialPositionExtensibleEnumeration", "presentation": [ "http://www.quidel.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofFairValueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]", "label": "Derivative Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]", "documentation": "Indicates line item in statement of financial position that includes derivative liability classified as noncurrent." } } }, "auth_ref": [ "r506" ] }, "ecd_InsiderTrdPoliciesProcAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTrdPoliciesProcAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "lang": { "en-us": { "role": { "terseLabel": "Insider Trading Policies and Procedures Adopted", "label": "Insider Trading Policies and Procedures Adopted [Flag]" } } }, "auth_ref": [ "r788", "r858" ] }, "us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtRelatedCommitmentFeesAndDebtIssuanceCosts", "crdr": "debit", "calculation": { "http://www.quidel.com/role/BorrowingsInterestExpenseDetails": { "parentTag": "us-gaap_InterestIncomeExpenseNet", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.quidel.com/role/BorrowingsInterestExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amortization of deferred financing costs", "label": "Debt Related Commitment Fees and Debt Issuance Costs", "documentation": "Represents the charge against earnings during the period for commitment fees and debt issuance expenses." } } }, "auth_ref": [ "r139" ] }, "ecd_Additional402vDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "Additional402vDisclosureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Additional 402(v) Disclosure", "label": "Additional 402(v) Disclosure [Text Block]" } } }, "auth_ref": [ "r821" ] }, "ecd_PeoMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "PEO", "label": "PEO [Member]" } } }, "auth_ref": [ "r834" ] }, "qdel_InterestRateSwapThreeMember": { "xbrltype": "domainItemType", "nsuri": "http://www.quidel.com/20231001", "localname": "InterestRateSwapThreeMember", "presentation": [ "http://www.quidel.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofInterestRateDerivativesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest Rate Swap Three", "label": "Interest Rate Swap Three [Member]", "documentation": "Interest Rate Swap Three" } } }, "auth_ref": [] }, "us-gaap_InventoryNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryNet", "crdr": "debit", "calculation": { "http://www.quidel.com/role/BalanceSheetAccountDetailsInventoriesDetails": { "parentTag": "qdel_InventoriesIncludingNoncurrentPortionNet", "weight": 1.0, "order": 1.0 }, "http://www.quidel.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.quidel.com/role/BalanceSheetAccountDetailsInventoriesDetails", "http://www.quidel.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Inventories", "label": "Inventory, Net", "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer." } } }, "auth_ref": [ "r194", "r733", "r768" ] }, "us-gaap_DerivativeNotionalAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeNotionalAmount", "presentation": [ "http://www.quidel.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofCurrencyHedgingInstrumentsDetails", "http://www.quidel.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofInterestRateDerivativesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative, Notional Amount", "label": "Derivative, Notional Amount", "documentation": "Nominal or face amount used to calculate payment on derivative." } } }, "auth_ref": [ "r935", "r936" ] }, "us-gaap_IncomeLossFromEquityMethodInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromEquityMethodInvestments", "crdr": "credit", "calculation": { "http://www.quidel.com/role/SegmentandGeographicInformationReconciliationtoIncomeDetails": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://www.quidel.com/role/SegmentandGeographicInformationReconciliationtoIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Loss on investments", "label": "Income (Loss) from Equity Method Investments", "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss)." } } }, "auth_ref": [ "r15", "r133", "r166", "r269", "r324", "r596" ] }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseLiabilityNoncurrent", "crdr": "credit", "calculation": { "http://www.quidel.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.quidel.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Operating lease liabilities", "label": "Operating Lease, Liability, Noncurrent", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent." } } }, "auth_ref": [ "r536" ] }, "qdel_BankOfAmericaCreditFacilityMember": { "xbrltype": "domainItemType", "nsuri": "http://www.quidel.com/20231001", "localname": "BankOfAmericaCreditFacilityMember", "presentation": [ "http://www.quidel.com/role/BorrowingsInterestExpenseDetails", "http://www.quidel.com/role/BorrowingsNarrativeDetails", "http://www.quidel.com/role/BorrowingsScheduleofBorrowingsDetails", "http://www.quidel.com/role/FairValueMeasurementsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Credit Agreement", "label": "Bank Of America Credit Facility [Member]", "documentation": "Bank Of America Credit Facility" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesFairValueDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesFairValueDisclosureAbstract", "presentation": [ "http://www.quidel.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Liabilities:", "label": "Liabilities, Fair Value Disclosure [Abstract]" } } }, "auth_ref": [] }, "ecd_RecoveryOfErrCompDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RecoveryOfErrCompDisclosureLineItems", "lang": { "en-us": { "role": { "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]" } } }, "auth_ref": [ "r789", "r800", "r810", "r835" ] }, "us-gaap_StatementOfStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfStockholdersEquityAbstract", "lang": { "en-us": { "role": { "terseLabel": "Statement of Stockholders' Equity [Abstract]", "label": "Statement of Stockholders' Equity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract", "presentation": [ "http://www.quidel.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Assets:", "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ResearchAndDevelopmentExpenseMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ResearchAndDevelopmentExpenseMember", "presentation": [ "http://www.quidel.com/role/StockBasedCompensationCompensationExpenseRelatedtoStockBasedCompensationPlansDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Research and development", "label": "Research and Development Expense [Member]", "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included." } } }, "auth_ref": [] }, "us-gaap_ForeignExchangeContractMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ForeignExchangeContractMember", "presentation": [ "http://www.quidel.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofCurrencyHedgingInstrumentsDetails", "http://www.quidel.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofFairValueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign Exchange Contract", "label": "Foreign Exchange Contract [Member]", "documentation": "Derivative instrument whose primary underlying risk is tied to foreign exchange rates." } } }, "auth_ref": [ "r740", "r760", "r767" ] }, "ecd_NonPeoNeoMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonPeoNeoMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-PEO NEO", "label": "Non-PEO NEO [Member]" } } }, "auth_ref": [ "r834" ] }, "us-gaap_StatementOfCashFlowsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfCashFlowsAbstract", "lang": { "en-us": { "role": { "terseLabel": "Statement of Cash Flows [Abstract]", "label": "Statement of Cash Flows [Abstract]" } } }, "auth_ref": [] }, "ecd_IndividualAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "IndividualAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Individual:", "label": "Individual [Axis]" } } }, "auth_ref": [ "r799", "r807", "r817", "r834", "r842", "r846", "r854" ] }, "ecd_AllIndividualsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllIndividualsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "All Individuals", "label": "All Individuals [Member]" } } }, "auth_ref": [ "r799", "r807", "r817", "r834", "r842", "r846", "r854" ] }, "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "presentation": [ "http://www.quidel.com/role/StockBasedCompensationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Estimated Fair Value of Each Stock Option Award", "label": "Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]", "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions." } } }, "auth_ref": [ "r155" ] }, "ecd_CoSelectedMeasureName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CoSelectedMeasureName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Company Selected Measure Name", "label": "Company Selected Measure Name" } } }, "auth_ref": [ "r826" ] }, "us-gaap_AccountsReceivableNetCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsReceivableNetCurrent", "crdr": "debit", "calculation": { "http://www.quidel.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 3.0 }, "http://www.quidel.com/role/BalanceSheetAccountDetailsAccountsReceivableDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.quidel.com/role/BalanceSheetAccountDetailsAccountsReceivableDetails", "http://www.quidel.com/role/ConsolidatedBalanceSheets", "http://www.quidel.com/role/RevenueNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts receivable, net", "totalLabel": "Total accounts receivable, net", "label": "Accounts Receivable, after Allowance for Credit Loss, Current", "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current." } } }, "auth_ref": [ "r291", "r292" ] }, "ecd_TotalShareholderRtnVsPeerGroupTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TotalShareholderRtnVsPeerGroupTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Total Shareholder Return Vs Peer Group", "label": "Total Shareholder Return Vs Peer Group [Text Block]" } } }, "auth_ref": [ "r832" ] }, "us-gaap_OperatingLeaseRightOfUseAsset": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseRightOfUseAsset", "crdr": "debit", "calculation": { "http://www.quidel.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.quidel.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Right-of-use assets", "label": "Operating Lease, Right-of-Use Asset", "documentation": "Amount of lessee's right to use underlying asset under operating lease." } } }, "auth_ref": [ "r535" ] }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IntangibleAssetsNetExcludingGoodwill", "crdr": "debit", "calculation": { "http://www.quidel.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.quidel.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Intangible assets, net", "label": "Intangible Assets, Net (Excluding Goodwill)", "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges." } } }, "auth_ref": [ "r64", "r66" ] }, "us-gaap_FinanceLeasePrincipalPayments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinanceLeasePrincipalPayments", "crdr": "credit", "calculation": { "http://www.quidel.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://www.quidel.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Payments on long-term borrowings and extinguishment costs", "label": "Finance Lease, Principal Payments", "documentation": "Amount of cash outflow for principal payment on finance lease." } } }, "auth_ref": [ "r538", "r539" ] }, "ecd_CoSelectedMeasureAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CoSelectedMeasureAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Company Selected Measure Amount", "label": "Company Selected Measure Amount" } } }, "auth_ref": [ "r826" ] }, "us-gaap_ProceedsFromContributionInAidOfConstruction": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromContributionInAidOfConstruction", "crdr": "debit", "calculation": { "http://www.quidel.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.quidel.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from government assistance allocated to fixed assets", "label": "Proceeds from Contribution in Aid of Construction", "documentation": "The cash inflow from developers, builders, governmental agencies and municipalities that provide the entity with cash to extend its construction services to their properties." } } }, "auth_ref": [ "r41" ] }, "us-gaap_ScheduleOfInterestRateDerivativesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfInterestRateDerivativesTableTextBlock", "presentation": [ "http://www.quidel.com/role/DerivativeInstrumentsandHedgingActivitiesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Interest Rate Derivatives", "label": "Schedule of Interest Rate Derivatives [Table Text Block]", "documentation": "Tabular disclosure of interest rate derivatives, including, but not limited to, the fair value of the derivatives, statement of financial position location, and statement of financial performance location of these instruments." } } }, "auth_ref": [ "r95" ] }, "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired", "crdr": "credit", "calculation": { "http://www.quidel.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.quidel.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Acquisition of businesses, net of cash and restricted cash acquired", "label": "Payments to Acquire Businesses, Net of Cash Acquired", "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase." } } }, "auth_ref": [ "r42" ] }, "us-gaap_ProceedsFromLinesOfCredit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromLinesOfCredit", "crdr": "debit", "presentation": [ "http://www.quidel.com/role/BorrowingsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from lines of credit", "label": "Proceeds from Lines of Credit", "documentation": "Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements." } } }, "auth_ref": [ "r43", "r892" ] }, "ecd_NonGaapMeasureDescriptionTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonGaapMeasureDescriptionTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-GAAP Measure Description", "label": "Non-GAAP Measure Description [Text Block]" } } }, "auth_ref": [ "r826" ] }, "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "crdr": "debit", "calculation": { "http://www.quidel.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.quidel.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Effect of exchange rates on cash", "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations", "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r526" ] }, "us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock", "presentation": [ "http://www.quidel.com/role/DerivativeInstrumentsandHedgingActivitiesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Derivative Instruments, Effect on Other Comprehensive (Loss) Income", "label": "Schedule of Derivative Instruments, Effect on Other Comprehensive Income (Loss) [Table Text Block]", "documentation": "Tabular disclosure of the effective portion of the gains and losses on derivative instruments designated (and non-derivative instruments) designated and qualifying in cash flow hedges and net investment hedges that was recognized in other comprehensive income (loss) during the current period." } } }, "auth_ref": [ "r96" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "crdr": "debit", "calculation": { "http://www.quidel.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.quidel.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net decrease in cash, cash equivalents and restricted cash", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r5", "r142" ] }, "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Actually Paid vs. Company Selected Measure", "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]" } } }, "auth_ref": [ "r831" ] }, "us-gaap_Goodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Goodwill", "crdr": "debit", "calculation": { "http://www.quidel.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.quidel.com/role/BalanceSheetAccountDetailsGoodwillRollforwardDetails", "http://www.quidel.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Goodwill", "periodStartLabel": "Goodwill, Beginning Balance", "periodEndLabel": "Goodwill, Ending Balance", "label": "Goodwill", "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized." } } }, "auth_ref": [ "r187", "r339", "r579", "r746", "r768", "r913", "r920" ] }, "ecd_MeasureAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MeasureAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Measure:", "label": "Measure [Axis]" } } }, "auth_ref": [ "r826" ] }, "us-gaap_BusinessAcquisitionProFormaInformationTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionProFormaInformationTextBlock", "presentation": [ "http://www.quidel.com/role/BusinessCombinationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Pro Forma Financial Information", "label": "Business Acquisition, Pro Forma Information [Table Text Block]", "documentation": "Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate." } } }, "auth_ref": [ "r864", "r865" ] }, "us-gaap_DisaggregationOfRevenueTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisaggregationOfRevenueTableTextBlock", "presentation": [ "http://www.quidel.com/role/RevenueTables" ], "lang": { "en-us": { "role": { "terseLabel": "Disaggregation of Revenue", "label": "Disaggregation of Revenue [Table Text Block]", "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor." } } }, "auth_ref": [ "r930" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "crdr": "debit", "calculation": { "http://www.quidel.com/role/BalanceSheetAccountDetailsCashCashEquivalentsandRestrictedCashDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.quidel.com/role/BalanceSheetAccountDetailsCashCashEquivalentsandRestrictedCashDetails", "http://www.quidel.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "periodStartLabel": "Cash, cash equivalents and restricted cash at beginning of period", "periodEndLabel": "Cash, cash equivalents and restricted cash at end of period", "totalLabel": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents", "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r45", "r142", "r223" ] }, "us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccrualForTaxesOtherThanIncomeTaxesCurrent", "crdr": "credit", "calculation": { "http://www.quidel.com/role/BalanceSheetAccountDetailsOtherCurrentLiabilitiesDetails": { "parentTag": "us-gaap_OtherLiabilitiesCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.quidel.com/role/BalanceSheetAccountDetailsOtherCurrentLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued other taxes payable", "label": "Accrual for Taxes Other than Income Taxes, Current", "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for real and property taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r32", "r77", "r736" ] }, "us-gaap_LongTermDebtFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtFairValue", "crdr": "credit", "presentation": [ "http://www.quidel.com/role/FairValueMeasurementsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long-Term Debt, Fair Value", "label": "Long-Term Debt, Fair Value", "documentation": "The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission." } } }, "auth_ref": [] }, "us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromSaleAndMaturityOfMarketableSecurities", "crdr": "debit", "calculation": { "http://www.quidel.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.quidel.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from sale of marketable securities", "label": "Proceeds from Sale and Maturity of Marketable Securities", "documentation": "The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities (held-to-maturity or available-for-sale) during the period." } } }, "auth_ref": [] }, "us-gaap_SupplementalBalanceSheetDisclosuresTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SupplementalBalanceSheetDisclosuresTextBlock", "presentation": [ "http://www.quidel.com/role/BalanceSheetAccountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Balance Sheet Account Details", "label": "Supplemental Balance Sheet Disclosures [Text Block]", "documentation": "The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity." } } }, "auth_ref": [ "r877" ] }, "us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueFromContractWithCustomerIncludingAssessedTax", "crdr": "credit", "presentation": [ "http://www.quidel.com/role/RevenueNarrativeDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Revenue", "label": "Revenue from Contract with Customer, Including Assessed Tax", "documentation": "Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise." } } }, "auth_ref": [ "r263", "r264", "r275", "r280", "r281", "r287", "r289", "r290", "r421", "r422", "r578" ] }, "us-gaap_IncreaseDecreaseInOtherOperatingLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOtherOperatingLiabilities", "crdr": "debit", "calculation": { "http://www.quidel.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 15.0 } }, "presentation": [ "http://www.quidel.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Other current and non-current liabilities", "label": "Increase (Decrease) in Other Operating Liabilities", "documentation": "Amount of increase (decrease) in operating liabilities classified as other." } } }, "auth_ref": [ "r14" ] }, "us-gaap_AwardTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AwardTypeAxis", "presentation": [ "http://www.quidel.com/role/StockBasedCompensationNarrativeDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Type [Axis]", "label": "Award Type [Axis]", "documentation": "Information by type of award under share-based payment arrangement." } } }, "auth_ref": [ "r440", "r441", "r442", "r443", "r444", "r445", "r446", "r447", "r448", "r449", "r450", "r451", "r452", "r453", "r454", "r455", "r456", "r457", "r458", "r459", "r460", "r461", "r462", "r463", "r464", "r465" ] }, "us-gaap_PaymentsForRepurchaseOfCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsForRepurchaseOfCommonStock", "crdr": "credit", "calculation": { "http://www.quidel.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 6.0 } }, "presentation": [ "http://www.quidel.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Repurchases of common stock", "label": "Payments for Repurchase of Common Stock", "documentation": "The cash outflow to reacquire common stock during the period." } } }, "auth_ref": [ "r44" ] }, "ecd_OtherPerfMeasureAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OtherPerfMeasureAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Other Performance Measure, Amount", "label": "Other Performance Measure, Amount" } } }, "auth_ref": [ "r826" ] }, "us-gaap_OtherReceivablesNetCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherReceivablesNetCurrent", "crdr": "debit", "calculation": { "http://www.quidel.com/role/BalanceSheetAccountDetailsPrepaidexpensesandothercurrentassetsDetails": { "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.quidel.com/role/BalanceSheetAccountDetailsPrepaidexpensesandothercurrentassetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other receivables", "label": "Other Receivables, Net, Current", "documentation": "Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer." } } }, "auth_ref": [] }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionsDisclosureTextBlock", "presentation": [ "http://www.quidel.com/role/RelatedPartyTransactions" ], "lang": { "en-us": { "role": { "terseLabel": "Related Party Transactions", "label": "Related Party Transactions Disclosure [Text Block]", "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates." } } }, "auth_ref": [ "r541", "r542", "r543", "r544", "r545", "r634", "r635", "r636", "r682", "r683", "r684", "r702", "r703" ] }, "ecd_MeasureName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MeasureName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Measure Name" } } }, "auth_ref": [ "r826" ] }, "us-gaap_BusinessAcquisitionsProFormaRevenue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionsProFormaRevenue", "crdr": "credit", "presentation": [ "http://www.quidel.com/role/BusinessCombinationProFormaInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Pro forma total revenues", "label": "Business Acquisition, Pro Forma Revenue", "documentation": "The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period." } } }, "auth_ref": [ "r495", "r496" ] }, "us-gaap_USGovernmentDebtSecuritiesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "USGovernmentDebtSecuritiesMember", "presentation": [ "http://www.quidel.com/role/BalanceSheetAccountDetailsMarketableSecuritiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "U.S. government securities", "label": "US Government Debt Securities [Member]", "documentation": "Debt securities issued by the United States government." } } }, "auth_ref": [ "r952" ] }, "us-gaap_ForeignGovernmentDebtSecuritiesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ForeignGovernmentDebtSecuritiesMember", "presentation": [ "http://www.quidel.com/role/BalanceSheetAccountDetailsMarketableSecuritiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Sovereign government bonds", "label": "Debt Security, Government, Non-US [Member]", "documentation": "Debt security issued by government not domiciled in United States of America (US)." } } }, "auth_ref": [ "r931", "r955" ] }, "us-gaap_DisaggregationOfRevenueLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisaggregationOfRevenueLineItems", "presentation": [ "http://www.quidel.com/role/RevenueDisaggregationofRevenueDetails", "http://www.quidel.com/role/RevenueNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disaggregation of Revenue [Line Items]", "label": "Disaggregation of Revenue [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r422", "r753", "r754", "r755", "r756", "r757", "r758", "r759" ] }, "us-gaap_AccountsReceivableMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsReceivableMember", "presentation": [ "http://www.quidel.com/role/RevenueNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts Receivable", "label": "Accounts Receivable [Member]", "documentation": "Due from customers or clients for goods or services that have been delivered or sold." } } }, "auth_ref": [ "r724" ] }, "ecd_AdjToCompAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToCompAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustment to Compensation:", "label": "Adjustment to Compensation [Axis]" } } }, "auth_ref": [ "r827" ] }, "us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionsProFormaNetIncomeLoss", "crdr": "credit", "presentation": [ "http://www.quidel.com/role/BusinessCombinationProFormaInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Pro forma net income", "label": "Business Acquisition, Pro Forma Net Income (Loss)", "documentation": "The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period." } } }, "auth_ref": [ "r495", "r496" ] }, "us-gaap_ForeignExchangeForwardMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ForeignExchangeForwardMember", "presentation": [ "http://www.quidel.com/role/DerivativeInstrumentsandHedgingActivitiesNarrativeDetails", "http://www.quidel.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofGainLossDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign Exchange Forward", "label": "Foreign Exchange Forward [Member]", "documentation": "Foreign exchange forward traded on an exchange (examples include but are not limited to the International Securities Exchange, Philadelphia Stock Exchange, or the Chicago Mercantile Exchange) for options or future contracts to buy or sell a certain currency, at a specified date, at a fixed exercise exchange rate." } } }, "auth_ref": [ "r665", "r669", "r674", "r689", "r695", "r712", "r713", "r714", "r773" ] }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract", "lang": { "en-us": { "role": { "terseLabel": "Derivative Instruments and Hedging Activities Disclosure [Abstract]", "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DisaggregationOfRevenueTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisaggregationOfRevenueTable", "presentation": [ "http://www.quidel.com/role/RevenueDisaggregationofRevenueDetails", "http://www.quidel.com/role/RevenueNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disaggregation of Revenue [Table]", "label": "Disaggregation of Revenue [Table]", "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor." } } }, "auth_ref": [ "r422", "r753", "r754", "r755", "r756", "r757", "r758", "r759" ] }, "us-gaap_ProceedsFromIssuanceOfCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromIssuanceOfCommonStock", "crdr": "debit", "calculation": { "http://www.quidel.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.quidel.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from issuance of common stock", "label": "Proceeds from Issuance of Common Stock", "documentation": "The cash inflow from the additional capital contribution to the entity." } } }, "auth_ref": [ "r10" ] }, "ecd_CompActuallyPaidVsNetIncomeTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsNetIncomeTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Actually Paid vs. Net Income", "label": "Compensation Actually Paid vs. Net Income [Text Block]" } } }, "auth_ref": [ "r830" ] }, "ecd_AdjToCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustment to Compensation, Amount", "label": "Adjustment to Compensation Amount" } } }, "auth_ref": [ "r827" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "presentation": [ "http://www.quidel.com/role/StockBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Stock options granted (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross", "documentation": "Gross number of share options (or share units) granted during the period." } } }, "auth_ref": [ "r447" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "crdr": "credit", "calculation": { "http://www.quidel.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.quidel.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated other comprehensive loss", "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax", "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source." } } }, "auth_ref": [ "r38", "r39", "r131", "r193", "r592", "r627", "r628" ] }, "ecd_AllAdjToCompMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllAdjToCompMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "All Adjustments to Compensation", "label": "All Adjustments to Compensation [Member]" } } }, "auth_ref": [ "r827" ] }, "us-gaap_IncomeStatementLocationAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementLocationAxis", "presentation": [ "http://www.quidel.com/role/DerivativeInstrumentsandHedgingActivitiesNarrativeDetails", "http://www.quidel.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofGainLossDetails", "http://www.quidel.com/role/StockBasedCompensationCompensationExpenseRelatedtoStockBasedCompensationPlansDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Income Statement Location [Axis]", "label": "Income Statement Location [Axis]", "documentation": "Information by location in the income statement." } } }, "auth_ref": [ "r351", "r353", "r684" ] }, "ecd_TrdArrAdoptionDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrAdoptionDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Adoption Date", "label": "Trading Arrangement Adoption Date" } } }, "auth_ref": [ "r855" ] }, "ecd_PeoName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "PEO Name", "label": "PEO Name" } } }, "auth_ref": [ "r827" ] }, "us-gaap_BusinessAcquisitionAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionAxis", "presentation": [ "http://www.quidel.com/role/BusinessCombinationNarrativeDetails", "http://www.quidel.com/role/BusinessCombinationProFormaInformationDetails", "http://www.quidel.com/role/FairValueMeasurementsNarrativeDetails", "http://www.quidel.com/role/StockBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Business Acquisition [Axis]", "label": "Business Acquisition [Axis]", "documentation": "Information by business combination or series of individually immaterial business combinations." } } }, "auth_ref": [ "r80", "r81", "r497", "r763", "r764" ] }, "ecd_NamedExecutiveOfficersFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NamedExecutiveOfficersFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Named Executive Officers, Footnote", "label": "Named Executive Officers, Footnote [Text Block]" } } }, "auth_ref": [ "r827" ] }, "us-gaap_ConcentrationRiskPercentage1": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskPercentage1", "presentation": [ "http://www.quidel.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails", "http://www.quidel.com/role/RevenueNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Percentage of risk concentration", "label": "Concentration Risk, Percentage", "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division." } } }, "auth_ref": [ "r50", "r53", "r106", "r107", "r290" ] }, "us-gaap_IncomeStatementLocationDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementLocationDomain", "presentation": [ "http://www.quidel.com/role/DerivativeInstrumentsandHedgingActivitiesNarrativeDetails", "http://www.quidel.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofGainLossDetails", "http://www.quidel.com/role/StockBasedCompensationCompensationExpenseRelatedtoStockBasedCompensationPlansDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Income Statement Location [Domain]", "label": "Income Statement Location [Domain]", "documentation": "Location in the income statement." } } }, "auth_ref": [ "r353", "r684" ] }, "ecd_AdjToNonPeoNeoCompFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToNonPeoNeoCompFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote", "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]" } } }, "auth_ref": [ "r827" ] }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionAcquireeDomain", "presentation": [ "http://www.quidel.com/role/BusinessCombinationNarrativeDetails", "http://www.quidel.com/role/BusinessCombinationProFormaInformationDetails", "http://www.quidel.com/role/FairValueMeasurementsNarrativeDetails", "http://www.quidel.com/role/StockBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Business Acquisition, Acquiree [Domain]", "label": "Business Acquisition, Acquiree [Domain]", "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree." } } }, "auth_ref": [ "r497", "r763", "r764" ] }, "us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsReceivableAllowanceForCreditLossTableTextBlock", "presentation": [ "http://www.quidel.com/role/BalanceSheetAccountDetailsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts Receivable, Net", "label": "Accounts Receivable, Allowance for Credit Loss [Table Text Block]", "documentation": "Tabular disclosure of allowance for credit loss on accounts receivable." } } }, "auth_ref": [ "r910" ] }, "ecd_AdjToPeoCompFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToPeoCompFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustment To PEO Compensation, Footnote", "label": "Adjustment To PEO Compensation, Footnote [Text Block]" } } }, "auth_ref": [ "r827" ] }, "ecd_NonRule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonRule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated", "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]" } } }, "auth_ref": [ "r853" ] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://www.quidel.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Address Line One", "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BasisOfAccountingPolicyPolicyTextBlock", "presentation": [ "http://www.quidel.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Basis of Presentation", "label": "Basis of Accounting, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)." } } }, "auth_ref": [] }, "ecd_EquityValuationAssumptionDifferenceFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "EquityValuationAssumptionDifferenceFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Valuation Assumption Difference, Footnote", "label": "Equity Valuation Assumption Difference, Footnote [Text Block]" } } }, "auth_ref": [ "r828" ] }, "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LineOfCreditFacilityMaximumBorrowingCapacity", "crdr": "credit", "presentation": [ "http://www.quidel.com/role/BorrowingsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Line of credit, maximum borrowing capacity", "label": "Line of Credit Facility, Maximum Borrowing Capacity", "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility." } } }, "auth_ref": [ "r30" ] }, "us-gaap_EmployeeBenefitsAndShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeBenefitsAndShareBasedCompensation", "crdr": "debit", "calculation": { "http://www.quidel.com/role/SegmentandGeographicInformationReconciliationtoIncomeDetails": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0, "order": 11.0 } }, "presentation": [ "http://www.quidel.com/role/SegmentandGeographicInformationReconciliationtoIncomeDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Employee compensation charges", "label": "Employee Benefits and Share-Based Compensation", "documentation": "Amount of expense for employee benefit and equity-based compensation." } } }, "auth_ref": [] }, "us-gaap_BusinessAcquisitionLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionLineItems", "presentation": [ "http://www.quidel.com/role/BusinessCombinationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Business Acquisition [Line Items]", "label": "Business Acquisition [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r497" ] }, "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return", "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]" } } }, "auth_ref": [ "r829" ] }, "qdel_TaxIndemnificationIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://www.quidel.com/20231001", "localname": "TaxIndemnificationIncomeExpense", "crdr": "credit", "calculation": { "http://www.quidel.com/role/SegmentandGeographicInformationReconciliationtoIncomeDetails": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 14.0 } }, "presentation": [ "http://www.quidel.com/role/SegmentandGeographicInformationReconciliationtoIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Tax indemnification income", "label": "Tax Indemnification Income (Expense)", "documentation": "Tax Indemnification Income (Expense)" } } }, "auth_ref": [] }, "ecd_AwardUndrlygSecuritiesAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardUndrlygSecuritiesAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Underlying Securities", "label": "Award Underlying Securities Amount" } } }, "auth_ref": [ "r848" ] }, "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueFromContractWithCustomerPolicyTextBlock", "presentation": [ "http://www.quidel.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Revenue Recognition", "label": "Revenue from Contract with Customer [Policy Text Block]", "documentation": "Disclosure of accounting policy for revenue from contract with customer." } } }, "auth_ref": [ "r178", "r413", "r414", "r415", "r416", "r417", "r418", "r419", "r420", "r728" ] }, "qdel_SegmentAdjustedEBITDA": { "xbrltype": "monetaryItemType", "nsuri": "http://www.quidel.com/20231001", "localname": "SegmentAdjustedEBITDA", "crdr": "credit", "calculation": { "http://www.quidel.com/role/SegmentandGeographicInformationReconciliationtoIncomeDetails": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.quidel.com/role/SegmentandGeographicInformationReconciliationtoIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Segment Adjusted EBITDA", "label": "Segment Adjusted EBITDA", "documentation": "Segment Adjusted EBITDA" } } }, "auth_ref": [] }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockParOrStatedValuePerShare", "presentation": [ "http://www.quidel.com/role/ConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred stock, par value per share (in dollars per share)", "label": "Preferred Stock, Par or Stated Value Per Share", "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer." } } }, "auth_ref": [ "r120", "r400" ] }, "us-gaap_InterestExpenseMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestExpenseMember", "presentation": [ "http://www.quidel.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofGainLossDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest expense, net", "label": "Interest Expense [Member]", "documentation": "Primary financial statement caption encompassing interest expense." } } }, "auth_ref": [ "r24" ] }, "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax", "crdr": "credit", "calculation": { "http://www.quidel.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.quidel.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "terseLabel": "Changes in cumulative translation adjustment, net of tax", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax", "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature." } } }, "auth_ref": [ "r7" ] }, "ecd_AwardExrcPrice": { "xbrltype": "perShareItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardExrcPrice", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Exercise Price", "label": "Award Exercise Price" } } }, "auth_ref": [ "r849" ] }, "us-gaap_OtherComprehensiveIncomeLossNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossNetOfTax", "crdr": "credit", "presentation": [ "http://www.quidel.com/role/ConsolidatedStatementsofStockholdersEquityStatement" ], "lang": { "en-us": { "role": { "terseLabel": "Other comprehensive income (loss), net of tax", "label": "Other Comprehensive Income (Loss), Net of Tax", "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss)." } } }, "auth_ref": [ "r20", "r25", "r209", "r212", "r217", "r527", "r528", "r533", "r580", "r599", "r885", "r886" ] }, "us-gaap_AmortizationOfIntangibleAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AmortizationOfIntangibleAssets", "crdr": "debit", "calculation": { "http://www.quidel.com/role/ConsolidatedStatementsofIncome": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://www.quidel.com/role/ConsolidatedStatementsofIncome" ], "lang": { "en-us": { "role": { "terseLabel": "Amortization of intangible assets", "label": "Amortization of Intangible Assets", "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method." } } }, "auth_ref": [ "r15", "r65", "r67" ] }, "us-gaap_InterestExpenseDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestExpenseDebt", "crdr": "debit", "calculation": { "http://www.quidel.com/role/BorrowingsInterestExpenseDetails": { "parentTag": "us-gaap_InterestIncomeExpenseNet", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.quidel.com/role/BorrowingsInterestExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest expense, debt", "label": "Interest Expense, Debt", "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt." } } }, "auth_ref": [ "r139", "r391", "r399", "r750", "r751" ] }, "us-gaap_EffectiveIncomeTaxRateContinuingOperations": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectiveIncomeTaxRateContinuingOperations", "presentation": [ "http://www.quidel.com/role/IncomeTaxesDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Effective income tax rate", "label": "Effective Income Tax Rate Reconciliation, Percent", "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations." } } }, "auth_ref": [ "r481" ] }, "us-gaap_SalesRevenueNetMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SalesRevenueNetMember", "presentation": [ "http://www.quidel.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails", "http://www.quidel.com/role/RevenueNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Revenue Benchmark", "label": "Revenue Benchmark [Member]", "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation." } } }, "auth_ref": [ "r290", "r862" ] }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetainedEarningsAccumulatedDeficit", "crdr": "credit", "calculation": { "http://www.quidel.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.quidel.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Retained earnings", "label": "Retained Earnings (Accumulated Deficit)", "documentation": "Amount of accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r123", "r153", "r593", "r626", "r628", "r632", "r660", "r768" ] }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1", "presentation": [ "http://www.quidel.com/role/StockBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Expected weighted-average period of recognition for unrecognized compensation expense", "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition", "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r469" ] }, "qdel_NumberOfFinancialCovenants": { "xbrltype": "integerItemType", "nsuri": "http://www.quidel.com/20231001", "localname": "NumberOfFinancialCovenants", "presentation": [ "http://www.quidel.com/role/BorrowingsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of financial covenants", "label": "Number Of Financial Covenants", "documentation": "Number Of Financial Covenants" } } }, "auth_ref": [] }, "ecd_AwardGrantDateFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardGrantDateFairValue", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value as of Grant Date", "label": "Award Grant Date Fair Value" } } }, "auth_ref": [ "r850" ] }, "qdel_CovenantPeriodAxis": { "xbrltype": "stringItemType", "nsuri": "http://www.quidel.com/20231001", "localname": "CovenantPeriodAxis", "presentation": [ "http://www.quidel.com/role/BorrowingsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Covenant Period [Axis]", "label": "Covenant Period [Axis]", "documentation": "Covenant Period" } } }, "auth_ref": [] }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable", "presentation": [ "http://www.quidel.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofGainLossDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative Instruments and Hedging Activities Disclosures [Table]", "label": "Derivative Instruments and Hedging Activities Disclosures [Table]", "documentation": "Disclosure of information about derivatives and hedging activities." } } }, "auth_ref": [] }, "ecd_UndrlygSecurityMktPriceChngPct": { "xbrltype": "pureItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "UndrlygSecurityMktPriceChngPct", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Underlying Security Market Price Change", "label": "Underlying Security Market Price Change, Percent" } } }, "auth_ref": [ "r851" ] }, "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2", "presentation": [ "http://www.quidel.com/role/StockBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Stock options, term (in years)", "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Remaining Contractual Term", "documentation": "Weighted average remaining contractual term of exercisable stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r154" ] }, "us-gaap_EmployeeRelatedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeRelatedLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.quidel.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.quidel.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued payroll and related expenses", "label": "Employee-related Liabilities, Current", "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r32" ] }, "ecd_AllTradingArrangementsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllTradingArrangementsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "All Trading Arrangements", "label": "All Trading Arrangements [Member]" } } }, "auth_ref": [ "r852" ] }, "us-gaap_OtherLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.quidel.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 5.0 }, "http://www.quidel.com/role/BalanceSheetAccountDetailsOtherCurrentLiabilitiesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.quidel.com/role/BalanceSheetAccountDetailsOtherCurrentLiabilitiesDetails", "http://www.quidel.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Other current liabilities", "totalLabel": "Total other current liabilities", "label": "Other Liabilities, Current", "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r32", "r768" ] }, "qdel_BusinessCombinationsContingentConsiderationInstallmentPaymentMade": { "xbrltype": "monetaryItemType", "nsuri": "http://www.quidel.com/20231001", "localname": "BusinessCombinationsContingentConsiderationInstallmentPaymentMade", "crdr": "credit", "presentation": [ "http://www.quidel.com/role/FairValueMeasurementsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Installment payment", "label": "Business Combinations, Contingent Consideration, Installment Payment Made", "documentation": "Business Combinations, Contingent Consideration, Installment Payment Made" } } }, "auth_ref": [] }, "qdel_CustomerIncentivePayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.quidel.com/20231001", "localname": "CustomerIncentivePayableCurrent", "crdr": "credit", "calculation": { "http://www.quidel.com/role/BalanceSheetAccountDetailsOtherCurrentLiabilitiesDetails": { "parentTag": "us-gaap_OtherLiabilitiesCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.quidel.com/role/BalanceSheetAccountDetailsOtherCurrentLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued commissions, rebates and returns", "label": "Customer Incentive, Payable, Current", "documentation": "Customer Incentive, Payable, Current" } } }, "auth_ref": [] }, "us-gaap_SalesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SalesMember", "presentation": [ "http://www.quidel.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofGainLossDetails", "http://www.quidel.com/role/RevenueNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Total revenues", "label": "Sales [Member]", "documentation": "Primary financial statement caption encompassing revenue from sale of goods and services rendered in the normal course of business." } } }, "auth_ref": [ "r24" ] }, "qdel_PaymentOnAcquisitionDeferredConsideration": { "xbrltype": "monetaryItemType", "nsuri": "http://www.quidel.com/20231001", "localname": "PaymentOnAcquisitionDeferredConsideration", "crdr": "credit", "calculation": { "http://www.quidel.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 8.0 } }, "presentation": [ "http://www.quidel.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Principal payments of deferred consideration", "label": "Payment On Acquisition Deferred Consideration", "documentation": "Payment On Acquisition Deferred Consideration" } } }, "auth_ref": [] }, "us-gaap_ReconciliationFromSegmentTotalsToConsolidatedAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ReconciliationFromSegmentTotalsToConsolidatedAbstract", "presentation": [ "http://www.quidel.com/role/SegmentandGeographicInformationTotalRevenuesbyReportableSegmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Segment Reconciliation [Abstract]", "label": "Segment Reconciliation [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems", "presentation": [ "http://www.quidel.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofGainLossDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative Instruments and Hedging Activities Disclosures [Line Items]", "label": "Derivative Instruments and Hedging Activities Disclosures [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_InterestIncomeExpenseNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestIncomeExpenseNet", "crdr": "credit", "calculation": { "http://www.quidel.com/role/ConsolidatedStatementsofIncome": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 2.0 }, "http://www.quidel.com/role/SegmentandGeographicInformationReconciliationtoIncomeDetails": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 3.0 }, "http://www.quidel.com/role/BorrowingsInterestExpenseDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.quidel.com/role/BorrowingsInterestExpenseDetails", "http://www.quidel.com/role/ConsolidatedStatementsofIncome", "http://www.quidel.com/role/SegmentandGeographicInformationReconciliationtoIncomeDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Interest expense, net", "terseLabel": "Interest expense, net", "negatedTotalLabel": "Interest expense, net", "label": "Interest Income (Expense), Net", "documentation": "The net amount of operating interest income (expense)." } } }, "auth_ref": [ "r169" ] }, "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax", "crdr": "debit", "presentation": [ "http://www.quidel.com/role/BalanceSheetAccountDetailsMarketableSecuritiesDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax", "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax", "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)." } } }, "auth_ref": [ "r298" ] }, "qdel_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuableCashPaidPerAcquireeShare": { "xbrltype": "perShareItemType", "nsuri": "http://www.quidel.com/20231001", "localname": "BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuableCashPaidPerAcquireeShare", "presentation": [ "http://www.quidel.com/role/BusinessCombinationNarrativeDetails", "http://www.quidel.com/role/StockBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash paid to former Ortho stockholders per Ortho Share (in usd per share)", "label": "Business Combination, Consideration Transferred, Equity Interests Issued and Issuable, Cash Paid Per Acquiree Share", "documentation": "Business Combination, Consideration Transferred, Equity Interests Issued and Issuable, Cash Paid Per Acquiree Share" } } }, "auth_ref": [] }, "us-gaap_OtherLiabilitiesNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherLiabilitiesNoncurrent", "crdr": "credit", "calculation": { "http://www.quidel.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.quidel.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Other liabilities", "label": "Other Liabilities, Noncurrent", "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r35" ] }, "us-gaap_NetIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLoss", "crdr": "credit", "calculation": { "http://www.quidel.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0, "order": 1.0 }, "http://www.quidel.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 1.0 }, "http://www.quidel.com/role/ConsolidatedStatementsofIncome": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.quidel.com/role/ConsolidatedStatementsofCashFlows", "http://www.quidel.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss", "http://www.quidel.com/role/ConsolidatedStatementsofIncome", "http://www.quidel.com/role/ConsolidatedStatementsofStockholdersEquityStatement", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "totalLabel": "Net (loss) income", "terseLabel": "Net (loss) income", "verboseLabel": "Net (loss) income", "label": "Net Income (Loss)", "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent." } } }, "auth_ref": [ "r134", "r144", "r168", "r183", "r208", "r211", "r215", "r225", "r231", "r233", "r234", "r235", "r236", "r239", "r240", "r249", "r262", "r276", "r282", "r285", "r325", "r362", "r363", "r364", "r365", "r366", "r367", "r368", "r369", "r370", "r521", "r525", "r598", "r679", "r697", "r698", "r743", "r781", "r927" ] }, "us-gaap_DeferredIncomeTaxLiabilitiesNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredIncomeTaxLiabilitiesNet", "crdr": "credit", "calculation": { "http://www.quidel.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.quidel.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred tax liability", "label": "Deferred Income Tax Liabilities, Net", "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting." } } }, "auth_ref": [ "r478", "r479", "r587" ] }, "qdel_IndemnificationReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://www.quidel.com/20231001", "localname": "IndemnificationReceivable", "crdr": "debit", "presentation": [ "http://www.quidel.com/role/IncomeTaxesDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Indemnification receivable", "label": "Indemnification Receivable", "documentation": "Indemnification Receivable" } } }, "auth_ref": [] }, "us-gaap_ComprehensiveIncomeNoteTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ComprehensiveIncomeNoteTextBlock", "presentation": [ "http://www.quidel.com/role/AccumulatedOtherComprehensiveLoss" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated Other Comprehensive Loss", "label": "Comprehensive Income (Loss) Note [Text Block]", "documentation": "The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income." } } }, "auth_ref": [ "r130", "r217", "r580", "r599" ] }, "qdel_BusinessUnitAxis": { "xbrltype": "stringItemType", "nsuri": "http://www.quidel.com/20231001", "localname": "BusinessUnitAxis", "presentation": [ "http://www.quidel.com/role/RevenueDisaggregationofRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Business Unit [Axis]", "label": "Business Unit [Axis]", "documentation": "Business Unit" } } }, "auth_ref": [] }, "us-gaap_NondesignatedMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NondesignatedMember", "presentation": [ "http://www.quidel.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofCurrencyHedgingInstrumentsDetails", "http://www.quidel.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofFairValueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Non-designated hedging instruments", "label": "Not Designated as Hedging Instrument [Member]", "documentation": "Derivative instrument not designated as hedging instrument under Generally Accepted Accounting Principles (GAAP)." } } }, "auth_ref": [ "r21" ] }, "us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ImpairmentOfLongLivedAssetsToBeDisposedOf", "crdr": "debit", "calculation": { "http://www.quidel.com/role/SegmentandGeographicInformationReconciliationtoIncomeDetails": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0, "order": 7.0 } }, "presentation": [ "http://www.quidel.com/role/SegmentandGeographicInformationReconciliationtoIncomeDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Impairment of long-lived assets", "label": "Impairment of Long-Lived Assets to be Disposed of", "documentation": "The aggregate amount of write-downs for impairments recognized during the period for long-lived assets held for abandonment, exchange or sale." } } }, "auth_ref": [ "r15", "r148" ] }, "us-gaap_CostOfSalesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CostOfSalesMember", "presentation": [ "http://www.quidel.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofGainLossDetails", "http://www.quidel.com/role/StockBasedCompensationCompensationExpenseRelatedtoStockBasedCompensationPlansDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cost of sales", "label": "Cost of Sales [Member]", "documentation": "Primary financial statement caption encompassing cost of sales." } } }, "auth_ref": [] }, "us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months", "crdr": "credit", "presentation": [ "http://www.quidel.com/role/DerivativeInstrumentsandHedgingActivitiesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign currency cash flow hedge, gain (loss) to be reclassified during next 12 months", "label": "Foreign Currency Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months", "documentation": "The estimated net amount of unrealized gains or losses on foreign currency cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months." } } }, "auth_ref": [ "r102" ] }, "us-gaap_MarketableSecuritiesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MarketableSecuritiesTextBlock", "presentation": [ "http://www.quidel.com/role/BalanceSheetAccountDetailsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Marketable Securities", "label": "Marketable Securities [Table Text Block]", "documentation": "Tabular disclosure of marketable securities. This may consist of investments in certain debt and equity securities, short-term investments and other assets." } } }, "auth_ref": [] }, "qdel_CovenantPeriodDomain": { "xbrltype": "domainItemType", "nsuri": "http://www.quidel.com/20231001", "localname": "CovenantPeriodDomain", "presentation": [ "http://www.quidel.com/role/BorrowingsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Covenant Period [Domain]", "label": "Covenant Period [Domain]", "documentation": "Covenant Period [Domain]" } } }, "auth_ref": [] }, "us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet", "crdr": "credit", "presentation": [ "http://www.quidel.com/role/DerivativeInstrumentsandHedgingActivitiesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Pre tax gain (loss) from reclassification", "label": "Interest Rate Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net", "documentation": "The estimated net amount of unrealized gains or losses on interest rate cash flow hedges as of the balance sheet date expected to be reclassified to earnings within the next twelve months." } } }, "auth_ref": [ "r102" ] }, "us-gaap_InterestAndDividendsPayableCurrentAndNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestAndDividendsPayableCurrentAndNoncurrent", "crdr": "credit", "calculation": { "http://www.quidel.com/role/BalanceSheetAccountDetailsOtherCurrentLiabilitiesDetails": { "parentTag": "us-gaap_OtherLiabilitiesCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.quidel.com/role/BalanceSheetAccountDetailsOtherCurrentLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued interest", "label": "Interest and Dividends Payable", "documentation": "Sum of the carrying values as of the balance sheet date of (a) interest payable on all forms of debt, including trade payables, that has been incurred, and (b) dividends declared but unpaid on equity securities issued by the entity and outstanding (also includes dividends collected on behalf of another owner of securities that are being held by the entity)." } } }, "auth_ref": [ "r113" ] }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskBenchmarkDomain", "presentation": [ "http://www.quidel.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails", "http://www.quidel.com/role/RevenueNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Concentration Risk Benchmark [Domain]", "label": "Concentration Risk Benchmark [Domain]", "documentation": "The denominator in a calculation of a disclosed concentration risk percentage." } } }, "auth_ref": [ "r50", "r53", "r106", "r107", "r290", "r724" ] }, "qdel_LabsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.quidel.com/20231001", "localname": "LabsMember", "presentation": [ "http://www.quidel.com/role/RevenueDisaggregationofRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Labs", "label": "Labs [Member]", "documentation": "Labs" } } }, "auth_ref": [] }, "us-gaap_CommitmentsAndContingencies": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingencies", "crdr": "credit", "calculation": { "http://www.quidel.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.quidel.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Commitments and contingencies (Note 10)", "label": "Commitments and Contingencies", "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur." } } }, "auth_ref": [ "r36", "r114", "r589", "r658" ] }, "qdel_DerivativeInstrumentsAndOther": { "xbrltype": "monetaryItemType", "nsuri": "http://www.quidel.com/20231001", "localname": "DerivativeInstrumentsAndOther", "crdr": "debit", "calculation": { "http://www.quidel.com/role/BorrowingsInterestExpenseDetails": { "parentTag": "us-gaap_InterestIncomeExpenseNet", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.quidel.com/role/BorrowingsInterestExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative instruments and other", "label": "Derivative instruments and other", "documentation": "Derivative instruments and other" } } }, "auth_ref": [] }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskByBenchmarkAxis", "presentation": [ "http://www.quidel.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails", "http://www.quidel.com/role/RevenueNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Concentration Risk Benchmark [Axis]", "label": "Concentration Risk Benchmark [Axis]", "documentation": "Information by benchmark of concentration risk." } } }, "auth_ref": [ "r50", "r53", "r106", "r107", "r290", "r629", "r724" ] }, "qdel_OtherAdjustments": { "xbrltype": "monetaryItemType", "nsuri": "http://www.quidel.com/20231001", "localname": "OtherAdjustments", "crdr": "debit", "calculation": { "http://www.quidel.com/role/SegmentandGeographicInformationReconciliationtoIncomeDetails": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0, "order": 15.0 } }, "presentation": [ "http://www.quidel.com/role/SegmentandGeographicInformationReconciliationtoIncomeDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Other adjustments", "label": "Other adjustments", "documentation": "Other adjustments" } } }, "auth_ref": [] }, "us-gaap_ComprehensiveIncomeNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ComprehensiveIncomeNetOfTax", "crdr": "credit", "calculation": { "http://www.quidel.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.quidel.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "totalLabel": "Comprehensive (loss) income", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent", "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r40", "r210", "r212", "r218", "r581", "r601" ] }, "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodValueShareBasedCompensation", "crdr": "credit", "presentation": [ "http://www.quidel.com/role/ConsolidatedStatementsofStockholdersEquityStatement" ], "lang": { "en-us": { "role": { "terseLabel": "Issuance of common stock under equity compensation plans", "label": "Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture", "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP)." } } }, "auth_ref": [ "r73", "r120", "r121", "r153" ] }, "qdel_AllowanceForContractRebatesAndDiscounts": { "xbrltype": "monetaryItemType", "nsuri": "http://www.quidel.com/20231001", "localname": "AllowanceForContractRebatesAndDiscounts", "crdr": "credit", "calculation": { "http://www.quidel.com/role/BalanceSheetAccountDetailsAccountsReceivableDetails": { "parentTag": "us-gaap_AccountsReceivableNetCurrent", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.quidel.com/role/BalanceSheetAccountDetailsAccountsReceivableDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Allowance for contract rebates and discounts", "label": "Allowance for contract rebates and discounts", "documentation": "Allowance for contract rebates and discounts" } } }, "auth_ref": [] }, "qdel_StockIssuedDuringPeriodValueEquityReplacementAwardsAcquisitions": { "xbrltype": "monetaryItemType", "nsuri": "http://www.quidel.com/20231001", "localname": "StockIssuedDuringPeriodValueEquityReplacementAwardsAcquisitions", "crdr": "credit", "presentation": [ "http://www.quidel.com/role/ConsolidatedStatementsofStockholdersEquityStatement" ], "lang": { "en-us": { "role": { "terseLabel": "Issuance of equity replacement awards in connection with the Combinations", "label": "Stock Issued During Period, Value, Equity Replacement Awards, Acquisitions", "documentation": "Stock Issued During Period, Value, Equity Replacement Awards, Acquisitions" } } }, "auth_ref": [] }, "us-gaap_SupplementalCashFlowInformationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SupplementalCashFlowInformationAbstract", "presentation": [ "http://www.quidel.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION", "label": "Supplemental Cash Flow Information [Abstract]" } } }, "auth_ref": [] }, "qdel_DebtInstrumentCovenantLeverageRatioMinimum": { "xbrltype": "pureItemType", "nsuri": "http://www.quidel.com/20231001", "localname": "DebtInstrumentCovenantLeverageRatioMinimum", "presentation": [ "http://www.quidel.com/role/BorrowingsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Leverage ratio, minimum", "label": "Debt instrument, Covenant, Leverage Ratio, Minimum", "documentation": "Debt instrument, Covenant, Leverage Ratio, Minimum" } } }, "auth_ref": [] }, "us-gaap_ConcentrationRiskByTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskByTypeAxis", "presentation": [ "http://www.quidel.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails", "http://www.quidel.com/role/RevenueNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Concentration Risk Type [Axis]", "label": "Concentration Risk Type [Axis]", "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender." } } }, "auth_ref": [ "r50", "r53", "r106", "r107", "r290", "r724", "r863" ] }, "qdel_DocumentAndEntityInformationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.quidel.com/20231001", "localname": "DocumentAndEntityInformationAbstract", "lang": { "en-us": { "role": { "terseLabel": "Document And Entity Information [Abstract]", "label": "Document And Entity Information [Abstract]", "documentation": "Document and Entity Information [Abstract]" } } }, "auth_ref": [] }, "ecd_TradingArrAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TradingArrAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Arrangement:", "label": "Trading Arrangement [Axis]" } } }, "auth_ref": [ "r852" ] }, "us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible", "crdr": "debit", "presentation": [ "http://www.quidel.com/role/IncomeTaxesDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Decrease in unrecognized tax benefits is reasonably possible", "label": "Decrease in Unrecognized Tax Benefits is Reasonably Possible", "documentation": "Amount of decrease reasonably possible in the next twelve months for the unrecognized tax benefit." } } }, "auth_ref": [ "r78" ] }, "us-gaap_AccountsPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsPayableCurrent", "crdr": "credit", "calculation": { "http://www.quidel.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.quidel.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts payable", "label": "Accounts Payable, Current", "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r29", "r768" ] }, "srt_StatementScenarioAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "StatementScenarioAxis", "presentation": [ "http://www.quidel.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofInterestRateDerivativesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Scenario [Axis]", "label": "Scenario [Axis]" } } }, "auth_ref": [ "r241", "r433", "r860", "r861", "r898" ] }, "us-gaap_DerivativeContractTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeContractTypeDomain", "presentation": [ "http://www.quidel.com/role/DerivativeInstrumentsandHedgingActivitiesNarrativeDetails", "http://www.quidel.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofCurrencyHedgingInstrumentsDetails", "http://www.quidel.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofFairValueDetails", "http://www.quidel.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofGainLossDetails", "http://www.quidel.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofInterestRateDerivativesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative Contract [Domain]", "label": "Derivative Contract [Domain]", "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset." } } }, "auth_ref": [ "r647", "r649", "r664", "r665", "r666", "r667", "r668", "r669", "r670", "r672", "r673", "r674", "r675", "r687", "r688", "r689", "r690", "r693", "r694", "r695", "r696", "r708", "r709", "r714", "r716", "r771", "r773" ] }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "presentation": [ "http://www.quidel.com/role/CommitmentsandContingencies" ], "lang": { "en-us": { "role": { "terseLabel": "Commitments and Contingencies", "label": "Commitments and Contingencies Disclosure [Text Block]", "documentation": "The entire disclosure for commitments and contingencies." } } }, "auth_ref": [ "r149", "r356", "r357", "r725", "r924" ] }, "us-gaap_InventoryFinishedGoodsNetOfReserves": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryFinishedGoodsNetOfReserves", "crdr": "debit", "calculation": { "http://www.quidel.com/role/BalanceSheetAccountDetailsInventoriesDetails_1": { "parentTag": "qdel_InventoriesIncludingNoncurrentPortionNet", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.quidel.com/role/BalanceSheetAccountDetailsInventoriesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Finished goods (materials, labor and overhead)", "label": "Inventory, Finished Goods, Net of Reserves", "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale." } } }, "auth_ref": [ "r147", "r737" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://www.quidel.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Title of 12(b) Security", "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r784" ] }, "qdel_EndingAfterInitialMeasurementPeriodMember": { "xbrltype": "domainItemType", "nsuri": "http://www.quidel.com/20231001", "localname": "EndingAfterInitialMeasurementPeriodMember", "presentation": [ "http://www.quidel.com/role/BorrowingsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Ending after initial measurement period", "label": "Ending After Initial Measurement Period [Member]", "documentation": "Ending After Initial Measurement Period" } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodValueAcquisitions": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodValueAcquisitions", "crdr": "credit", "presentation": [ "http://www.quidel.com/role/ConsolidatedStatementsofStockholdersEquityStatement" ], "lang": { "en-us": { "role": { "terseLabel": "Issuance of shares in connection with the Combinations", "label": "Stock Issued During Period, Value, Acquisitions", "documentation": "Value of stock issued pursuant to acquisitions during the period." } } }, "auth_ref": [ "r20", "r37", "r153" ] }, "us-gaap_InventoryWorkInProcessNetOfReserves": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryWorkInProcessNetOfReserves", "crdr": "debit", "calculation": { "http://www.quidel.com/role/BalanceSheetAccountDetailsInventoriesDetails_1": { "parentTag": "qdel_InventoriesIncludingNoncurrentPortionNet", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.quidel.com/role/BalanceSheetAccountDetailsInventoriesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Work-in-process (materials, labor and overhead)", "label": "Inventory, Work in Process, Net of Reserves", "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing." } } }, "auth_ref": [ "r147", "r738" ] }, "qdel_OrthoMember": { "xbrltype": "domainItemType", "nsuri": "http://www.quidel.com/20231001", "localname": "OrthoMember", "presentation": [ "http://www.quidel.com/role/BusinessCombinationNarrativeDetails", "http://www.quidel.com/role/BusinessCombinationProFormaInformationDetails", "http://www.quidel.com/role/StockBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Ortho", "label": "Ortho [Member]", "documentation": "Ortho" } } }, "auth_ref": [] }, "us-gaap_ProductConcentrationRiskMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProductConcentrationRiskMember", "presentation": [ "http://www.quidel.com/role/RevenueNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Product Concentration Risk", "label": "Product Concentration Risk [Member]", "documentation": "Reflects the percentage that revenues during the period from a specified product are to a specified benchmark, such as total net revenues, segment revenues or product line revenues. May also reflect the percentage contribution the product made to operating results. Risk is materially adverse effects of a loss of sales of a significant product or line of products, which could occur upon loss of rights to sell, distribute or license others; loss of patent or copyright protection; or technological obsolescence." } } }, "auth_ref": [ "r52" ] }, "qdel_IndustryAndGeographicInformationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.quidel.com/20231001", "localname": "IndustryAndGeographicInformationAbstract", "lang": { "en-us": { "role": { "terseLabel": "Industry And Geographic Information [Abstract]", "label": "Industry And Geographic Information [Abstract]", "documentation": "Industry and Geographic Information [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AntidilutiveSecuritiesNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AntidilutiveSecuritiesNameDomain", "presentation": [ "http://www.quidel.com/role/ComputationofEarningsPerShareNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Antidilutive Securities, Name [Domain]", "label": "Antidilutive Securities, Name [Domain]", "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented." } } }, "auth_ref": [ "r49" ] }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "presentation": [ "http://www.quidel.com/role/StockBasedCompensation" ], "lang": { "en-us": { "role": { "terseLabel": "Stock-Based Compensation", "label": "Share-Based Payment Arrangement [Text Block]", "documentation": "The entire disclosure for share-based payment arrangement." } } }, "auth_ref": [ "r434", "r439", "r467", "r468", "r470", "r766" ] }, "qdel_AmortizationOfDeferredCloudComputingImplementationCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://www.quidel.com/20231001", "localname": "AmortizationOfDeferredCloudComputingImplementationCosts", "crdr": "debit", "calculation": { "http://www.quidel.com/role/SegmentandGeographicInformationReconciliationtoIncomeDetails": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0, "order": 6.0 } }, "presentation": [ "http://www.quidel.com/role/SegmentandGeographicInformationReconciliationtoIncomeDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Amortization of deferred cloud computing implementation costs", "label": "Amortization of deferred cloud computing implementation costs", "documentation": "Amortization of deferred cloud computing implementation costs" } } }, "auth_ref": [] }, "us-gaap_DesignatedAsHedgingInstrumentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DesignatedAsHedgingInstrumentMember", "presentation": [ "http://www.quidel.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofCurrencyHedgingInstrumentsDetails", "http://www.quidel.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofFairValueDetails", "http://www.quidel.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofInterestRateDerivativesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Designated cash flow hedges", "label": "Designated as Hedging Instrument [Member]", "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP)." } } }, "auth_ref": [ "r21" ] }, "us-gaap_InventoryRawMaterialsNetOfReserves": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryRawMaterialsNetOfReserves", "crdr": "debit", "calculation": { "http://www.quidel.com/role/BalanceSheetAccountDetailsInventoriesDetails_1": { "parentTag": "qdel_InventoriesIncludingNoncurrentPortionNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.quidel.com/role/BalanceSheetAccountDetailsInventoriesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Raw materials", "label": "Inventory, Raw Materials, Net of Reserves", "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process." } } }, "auth_ref": [ "r147", "r739" ] }, "qdel_UnwindInventoryFairValueAdjustment": { "xbrltype": "monetaryItemType", "nsuri": "http://www.quidel.com/20231001", "localname": "UnwindInventoryFairValueAdjustment", "crdr": "debit", "calculation": { "http://www.quidel.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 7.0 }, "http://www.quidel.com/role/SegmentandGeographicInformationReconciliationtoIncomeDetails": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0, "order": 10.0 } }, "presentation": [ "http://www.quidel.com/role/ConsolidatedStatementsofCashFlows", "http://www.quidel.com/role/SegmentandGeographicInformationReconciliationtoIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unwind inventory fair value adjustment", "negatedTerseLabel": "Unwind inventory fair value adjustment", "label": "Unwind Inventory Fair Value Adjustment", "documentation": "Unwind Inventory Fair Value Adjustment" } } }, "auth_ref": [] }, "us-gaap_EmployeeStockOptionMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeStockOptionMember", "presentation": [ "http://www.quidel.com/role/StockBasedCompensationNarrativeDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Stock Options", "label": "Employee Stock Option [Member]", "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time." } } }, "auth_ref": [] }, "us-gaap_StatementTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementTable", "presentation": [ "http://www.quidel.com/role/ConsolidatedStatementsofStockholdersEquityStatement" ], "lang": { "en-us": { "role": { "terseLabel": "Statement [Table]", "label": "Statement [Table]", "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed." } } }, "auth_ref": [ "r228", "r229", "r230", "r257", "r578", "r630", "r639", "r650", "r651", "r652", "r653", "r654", "r655", "r659", "r662", "r663", "r664", "r665", "r666", "r667", "r668", "r669", "r670", "r672", "r673", "r674", "r675", "r676", "r678", "r680", "r681", "r685", "r686", "r687", "r688", "r689", "r690", "r691", "r692", "r693", "r694", "r695", "r696", "r699", "r774" ] }, "qdel_DebtInstrumentCovenantLeverageRatioMaximum": { "xbrltype": "pureItemType", "nsuri": "http://www.quidel.com/20231001", "localname": "DebtInstrumentCovenantLeverageRatioMaximum", "presentation": [ "http://www.quidel.com/role/BorrowingsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Leverage ratio maximum", "label": "Debt Instrument, Covenant, Leverage Ratio, Maximum", "documentation": "Debt Instrument, Covenant, Leverage Ratio, Maximum" } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation", "presentation": [ "http://www.quidel.com/role/ConsolidatedStatementsofStockholdersEquityStatement" ], "lang": { "en-us": { "role": { "terseLabel": "Issuance of common stock under equity compensation plans (in shares)", "label": "Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture", "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP)." } } }, "auth_ref": [ "r20", "r120", "r121", "r153" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://www.quidel.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Symbol", "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "presentation": [ "http://www.quidel.com/role/StockBasedCompensationEstimatedFairValueofEachStockOptionAwardDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted-average grant date fair value of stock options granted (in USD per share)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value", "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology." } } }, "auth_ref": [ "r457" ] }, "qdel_Customer2Member": { "xbrltype": "domainItemType", "nsuri": "http://www.quidel.com/20231001", "localname": "Customer2Member", "presentation": [ "http://www.quidel.com/role/RevenueNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Customer 2", "label": "Customer 2 [Member]", "documentation": "Customer 2" } } }, "auth_ref": [] }, "srt_NameOfMajorCustomerDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "NameOfMajorCustomerDomain", "presentation": [ "http://www.quidel.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails", "http://www.quidel.com/role/RevenueNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Customer [Domain]", "label": "Customer [Domain]" } } }, "auth_ref": [ "r290", "r755", "r930", "r953", "r954" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://www.quidel.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Security Exchange Name", "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r786" ] }, "us-gaap_ScheduleOfDerivativeInstrumentsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfDerivativeInstrumentsTextBlock", "presentation": [ "http://www.quidel.com/role/DerivativeInstrumentsandHedgingActivitiesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Currency Hedging Instruments", "label": "Schedule of Derivative Instruments [Table Text Block]", "documentation": "Tabular disclosure of pertinent information about a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item." } } }, "auth_ref": [ "r21", "r86", "r87", "r88", "r89", "r92", "r95", "r99", "r100" ] }, "qdel_RetailCustomersMember": { "xbrltype": "domainItemType", "nsuri": "http://www.quidel.com/20231001", "localname": "RetailCustomersMember", "presentation": [ "http://www.quidel.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Retail Customers", "label": "Retail Customers [Member]", "documentation": "Retail Customers" } } }, "auth_ref": [] }, "us-gaap_EquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityAbstract", "lang": { "en-us": { "role": { "terseLabel": "Equity [Abstract]", "label": "Equity [Abstract]" } } }, "auth_ref": [] }, "qdel_ConsiderationReceivedForCapitalExpendituresPaidButNotYetIncurred": { "xbrltype": "monetaryItemType", "nsuri": "http://www.quidel.com/20231001", "localname": "ConsiderationReceivedForCapitalExpendituresPaidButNotYetIncurred", "crdr": "debit", "presentation": [ "http://www.quidel.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Capital expenditures to be reimbursed under a government contract", "label": "Consideration Received for Capital Expenditures Paid but Not yet Incurred", "documentation": "Consideration Received for Capital Expenditures Paid but Not yet Incurred" } } }, "auth_ref": [] }, "qdel_PointOfCareMember": { "xbrltype": "domainItemType", "nsuri": "http://www.quidel.com/20231001", "localname": "PointOfCareMember", "presentation": [ "http://www.quidel.com/role/RevenueDisaggregationofRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Point of Care", "label": "Point of Care [Member]", "documentation": "Point of Care" } } }, "auth_ref": [] }, "qdel_AllowanceForDoubtfulAccounts": { "xbrltype": "monetaryItemType", "nsuri": "http://www.quidel.com/20231001", "localname": "AllowanceForDoubtfulAccounts", "crdr": "credit", "calculation": { "http://www.quidel.com/role/BalanceSheetAccountDetailsAccountsReceivableDetails": { "parentTag": "us-gaap_AccountsReceivableNetCurrent", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.quidel.com/role/BalanceSheetAccountDetailsAccountsReceivableDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Allowance for doubtful accounts", "label": "Allowance for doubtful accounts", "documentation": "Allowance for doubtful accounts" } } }, "auth_ref": [] }, "qdel_TransfusionMedicineMember": { "xbrltype": "domainItemType", "nsuri": "http://www.quidel.com/20231001", "localname": "TransfusionMedicineMember", "presentation": [ "http://www.quidel.com/role/RevenueDisaggregationofRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Transfusion Medicine", "label": "Transfusion Medicine [Member]", "documentation": "Transfusion Medicine" } } }, "auth_ref": [] }, "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense", "crdr": "debit", "presentation": [ "http://www.quidel.com/role/IncomeTaxesDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Penalties and interest expense", "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense", "documentation": "Amount of expense for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return." } } }, "auth_ref": [ "r483" ] }, "us-gaap_GainsLossesOnExtinguishmentOfDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GainsLossesOnExtinguishmentOfDebt", "crdr": "credit", "calculation": { "http://www.quidel.com/role/ConsolidatedStatementsofIncome": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 3.0 }, "http://www.quidel.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 6.0 }, "http://www.quidel.com/role/SegmentandGeographicInformationReconciliationtoIncomeDetails": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 12.0 } }, "presentation": [ "http://www.quidel.com/role/ConsolidatedStatementsofCashFlows", "http://www.quidel.com/role/ConsolidatedStatementsofIncome", "http://www.quidel.com/role/SegmentandGeographicInformationReconciliationtoIncomeDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Loss on extinguishment of debt", "terseLabel": "Loss on extinguishment of debt", "label": "Gain (Loss) on Extinguishment of Debt", "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity." } } }, "auth_ref": [ "r15", "r69", "r70" ] }, "us-gaap_CommonStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesIssued", "presentation": [ "http://www.quidel.com/role/ConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, shares issued (in shares)", "label": "Common Stock, Shares, Issued", "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury." } } }, "auth_ref": [ "r121" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "presentation": [ "http://www.quidel.com/role/StockBasedCompensationEstimatedFairValueofEachStockOptionAwardDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Dividend rate", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate", "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term." } } }, "auth_ref": [ "r463" ] }, "us-gaap_StockIssuedDuringPeriodSharesAcquisitions": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesAcquisitions", "presentation": [ "http://www.quidel.com/role/ConsolidatedStatementsofStockholdersEquityStatement" ], "lang": { "en-us": { "role": { "terseLabel": "Issuance of shares in connection with the Combinations (in shares)", "label": "Stock Issued During Period, Shares, Acquisitions", "documentation": "Number of shares of stock issued during the period pursuant to acquisitions." } } }, "auth_ref": [ "r120", "r121", "r153" ] }, "us-gaap_IncomeTaxDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxDisclosureTextBlock", "presentation": [ "http://www.quidel.com/role/IncomeTaxes" ], "lang": { "en-us": { "role": { "terseLabel": "Income Taxes", "label": "Income Tax Disclosure [Text Block]", "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information." } } }, "auth_ref": [ "r226", "r476", "r482", "r486", "r487", "r490", "r492", "r493", "r494", "r633" ] }, "qdel_DebtPaymentTermsDomain": { "xbrltype": "domainItemType", "nsuri": "http://www.quidel.com/20231001", "localname": "DebtPaymentTermsDomain", "presentation": [ "http://www.quidel.com/role/BorrowingsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt Payment Terms [Domain]", "label": "Debt Payment Terms [Domain]", "documentation": "Debt Payment Terms [Domain]" } } }, "auth_ref": [] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://www.quidel.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Common Stock, Shares Outstanding", "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "us-gaap_ResearchAndDevelopmentExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ResearchAndDevelopmentExpense", "crdr": "debit", "calculation": { "http://www.quidel.com/role/ConsolidatedStatementsofIncome": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://www.quidel.com/role/ConsolidatedStatementsofIncome" ], "lang": { "en-us": { "role": { "terseLabel": "Research and development", "label": "Research and Development Expense", "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use." } } }, "auth_ref": [ "r117", "r475", "r951" ] }, "us-gaap_CommonStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockValue", "crdr": "credit", "calculation": { "http://www.quidel.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.quidel.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, $0.001 par value per share; 126.2 shares authorized; 66.8 and 66.4 shares issued and outstanding at October\u00a01, 2023 and January\u00a01, 2023, respectively", "label": "Common Stock, Value, Issued", "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r121", "r591", "r768" ] }, "ecd_MtrlTermsOfTrdArrTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MtrlTermsOfTrdArrTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Material Terms of Trading Arrangement", "label": "Material Terms of Trading Arrangement [Text Block]" } } }, "auth_ref": [ "r853" ] }, "qdel_BusinessUnitDomain": { "xbrltype": "domainItemType", "nsuri": "http://www.quidel.com/20231001", "localname": "BusinessUnitDomain", "presentation": [ "http://www.quidel.com/role/RevenueDisaggregationofRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Business Unit [Domain]", "label": "Business Unit [Domain]", "documentation": "Business Unit [Domain]" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "presentation": [ "http://www.quidel.com/role/StockBasedCompensationNarrativeDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Type [Domain]", "label": "Award Type [Domain]", "documentation": "Award under share-based payment arrangement." } } }, "auth_ref": [ "r440", "r441", "r442", "r443", "r444", "r445", "r446", "r447", "r448", "r449", "r450", "r451", "r452", "r453", "r454", "r455", "r456", "r457", "r458", "r459", "r460", "r461", "r462", "r463", "r464", "r465" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "presentation": [ "http://www.quidel.com/role/StockBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r435", "r437", "r440", "r441", "r442", "r443", "r444", "r445", "r446", "r447", "r448", "r449", "r450", "r451", "r452", "r453", "r454", "r455", "r456", "r457", "r458", "r459", "r460", "r461", "r462", "r463", "r464", "r465" ] }, "us-gaap_CommonStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesAuthorized", "presentation": [ "http://www.quidel.com/role/ConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, shares authorized (in shares)", "label": "Common Stock, Shares Authorized", "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r121", "r659" ] }, "us-gaap_CommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesOutstanding", "presentation": [ "http://www.quidel.com/role/ConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, shares outstanding (in shares)", "label": "Common Stock, Shares, Outstanding", "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation." } } }, "auth_ref": [ "r20", "r121", "r659", "r677", "r959", "r960" ] }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "presentation": [ "http://www.quidel.com/role/StockBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]", "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]", "documentation": "Disclosure of information about share-based payment arrangement." } } }, "auth_ref": [ "r435", "r437", "r440", "r441", "r442", "r443", "r444", "r445", "r446", "r447", "r448", "r449", "r450", "r451", "r452", "r453", "r454", "r455", "r456", "r457", "r458", "r459", "r460", "r461", "r462", "r463", "r464", "r465" ] }, "qdel_CustomerBMember": { "xbrltype": "domainItemType", "nsuri": "http://www.quidel.com/20231001", "localname": "CustomerBMember", "presentation": [ "http://www.quidel.com/role/RevenueNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Customer B", "label": "Customer B [Member]", "documentation": "Customer B" } } }, "auth_ref": [] }, "us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1", "crdr": "debit", "presentation": [ "http://www.quidel.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Purchase of property, equipment and intangibles by incurring current liabilities", "label": "Noncash or Part Noncash Acquisition, Fixed Assets Acquired", "documentation": "The amount of fixed assets that an Entity acquires in a noncash (or part noncash) acquisition. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period." } } }, "auth_ref": [ "r46", "r47", "r48" ] }, "qdel_ShareBasedCompensationExpenseIncreaseFromModificationOfVesting": { "xbrltype": "monetaryItemType", "nsuri": "http://www.quidel.com/20231001", "localname": "ShareBasedCompensationExpenseIncreaseFromModificationOfVesting", "crdr": "debit", "presentation": [ "http://www.quidel.com/role/StockBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Increase to share based compensation from modification of vesting awards", "label": "Share-Based Compensation Expense, Increase From Modification Of Vesting", "documentation": "Share-Based Compensation Expense, Increase From Modification Of Vesting" } } }, "auth_ref": [] }, "us-gaap_FairValueByBalanceSheetGroupingTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueByBalanceSheetGroupingTable", "presentation": [ "http://www.quidel.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails", "http://www.quidel.com/role/FairValueMeasurementsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value, by Balance Sheet Grouping [Table]", "label": "Fair Value, by Balance Sheet Grouping [Table]", "documentation": "Disclosure of information about the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities." } } }, "auth_ref": [ "r103", "r104", "r105" ] }, "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAccrued": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAccrued", "crdr": "credit", "presentation": [ "http://www.quidel.com/role/IncomeTaxesDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Unrecognized tax benefits, income tax interest and penalties accrued", "label": "Unrecognized Tax Benefits, Income Tax Penalties Accrued", "documentation": "Amount of statutory penalties accrued for a tax position claimed or expected to be claimed by the entity, in its tax return." } } }, "auth_ref": [ "r933" ] }, "us-gaap_FinanceLeaseLiabilityNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinanceLeaseLiabilityNoncurrent", "crdr": "credit", "calculation": { "http://www.quidel.com/role/BorrowingsScheduleofBorrowingsDetails": { "parentTag": "us-gaap_LongTermDebtAndCapitalLeaseObligations", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.quidel.com/role/BorrowingsScheduleofBorrowingsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Financing lease obligation", "label": "Finance Lease, Liability, Noncurrent", "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent." } } }, "auth_ref": [ "r536" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "presentation": [ "http://www.quidel.com/role/StockBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "RSUs granted (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period", "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)." } } }, "auth_ref": [ "r454" ] }, "qdel_GoodwillPurchaseAccountingAdjustmentDecreaseToDeferredTaxLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://www.quidel.com/20231001", "localname": "GoodwillPurchaseAccountingAdjustmentDecreaseToDeferredTaxLiabilities", "crdr": "credit", "presentation": [ "http://www.quidel.com/role/BusinessCombinationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Goodwill adjustment, decrease to deferred tax liabilities", "label": "Goodwill, Purchase Accounting Adjustment, Decrease To Deferred Tax Liabilities", "documentation": "Goodwill, Purchase Accounting Adjustment, Decrease To Deferred Tax Liabilities" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "presentation": [ "http://www.quidel.com/role/StockBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted-Average Grant Date Fair Value, Granted (in USD per share)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value", "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)." } } }, "auth_ref": [ "r454" ] }, "qdel_RespiratoryMember": { "xbrltype": "domainItemType", "nsuri": "http://www.quidel.com/20231001", "localname": "RespiratoryMember", "presentation": [ "http://www.quidel.com/role/RevenueNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Respiratory", "label": "Respiratory [Member]", "documentation": "Respiratory" } } }, "auth_ref": [] }, "us-gaap_PaymentsToAcquireMarketableSecurities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquireMarketableSecurities", "crdr": "credit", "calculation": { "http://www.quidel.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://www.quidel.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Purchases of marketable securities", "label": "Payments to Acquire Marketable Securities", "documentation": "Amount of cash outflow for purchase of marketable security." } } }, "auth_ref": [ "r901" ] }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized", "crdr": "debit", "presentation": [ "http://www.quidel.com/role/StockBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unrecognized share based compensation expense relating to unvested shares", "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount", "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement." } } }, "auth_ref": [ "r469" ] }, "qdel_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuableEntitySharesIssuedPerAcquireeShare": { "xbrltype": "sharesItemType", "nsuri": "http://www.quidel.com/20231001", "localname": "BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuableEntitySharesIssuedPerAcquireeShare", "presentation": [ "http://www.quidel.com/role/BusinessCombinationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Ortho Exchange Ratio (in shares)", "label": "Business Combination, Consideration Transferred, Equity Interests Issued and Issuable, Entity Shares Issued Per Acquiree Share", "documentation": "Business Combination, Consideration Transferred, Equity Interests Issued and Issuable, Entity Shares Issued Per Acquiree Share" } } }, "auth_ref": [] }, "us-gaap_SecuredDebtMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SecuredDebtMember", "presentation": [ "http://www.quidel.com/role/BorrowingsInterestExpenseDetails", "http://www.quidel.com/role/BorrowingsNarrativeDetails", "http://www.quidel.com/role/BorrowingsScheduleofBorrowingsDetails", "http://www.quidel.com/role/FairValueMeasurementsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Term Loan", "label": "Secured Debt [Member]", "documentation": "Collateralized debt obligation backed by, for example, but not limited to, pledge, mortgage or other lien on the entity's assets." } } }, "auth_ref": [] }, "us-gaap_HedgingDesignationAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "HedgingDesignationAxis", "presentation": [ "http://www.quidel.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofCurrencyHedgingInstrumentsDetails", "http://www.quidel.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofFairValueDetails", "http://www.quidel.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofInterestRateDerivativesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Hedging Designation [Axis]", "label": "Hedging Designation [Axis]", "documentation": "Information by designation of purpose of derivative instrument." } } }, "auth_ref": [ "r21", "r509" ] }, "qdel_AgencyBondsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.quidel.com/20231001", "localname": "AgencyBondsMember", "presentation": [ "http://www.quidel.com/role/BalanceSheetAccountDetailsMarketableSecuritiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Agency bonds", "label": "Agency bonds [Member]", "documentation": "Agency bonds" } } }, "auth_ref": [] }, "us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems", "presentation": [ "http://www.quidel.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails", "http://www.quidel.com/role/FairValueMeasurementsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]", "label": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentNet", "crdr": "debit", "calculation": { "http://www.quidel.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.quidel.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Property, plant and equipment, net", "label": "Property, Plant and Equipment, Net", "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures." } } }, "auth_ref": [ "r16", "r584", "r595", "r768" ] }, "us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockIncludingAdditionalPaidInCapitalMember", "presentation": [ "http://www.quidel.com/role/ConsolidatedStatementsofStockholdersEquityStatement" ], "lang": { "en-us": { "role": { "terseLabel": "Additional paid-in capital", "label": "Common Stock Including Additional Paid in Capital [Member]", "documentation": "Common stock held by shareholders with par value plus amounts in excess of par value or issuance value (in cases of no-par value stock)." } } }, "auth_ref": [] }, "ecd_TrdArrDuration": { "xbrltype": "durationItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrDuration", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Arrangement Duration", "label": "Trading Arrangement Duration" } } }, "auth_ref": [ "r856" ] }, "us-gaap_ScheduleOfDebtInstrumentsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfDebtInstrumentsTextBlock", "presentation": [ "http://www.quidel.com/role/BorrowingsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Debt", "label": "Schedule of Long-Term Debt Instruments [Table Text Block]", "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer." } } }, "auth_ref": [ "r34", "r71", "r72", "r108", "r109", "r111", "r116", "r151", "r152", "r748", "r750", "r894" ] }, "qdel_InterestRateSwapTwoMember": { "xbrltype": "domainItemType", "nsuri": "http://www.quidel.com/20231001", "localname": "InterestRateSwapTwoMember", "presentation": [ "http://www.quidel.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofInterestRateDerivativesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest Rate Swap Two", "label": "Interest Rate Swap Two [Member]", "documentation": "Interest Rate Swap Two" } } }, "auth_ref": [] }, "us-gaap_ConcentrationRiskTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskTypeDomain", "presentation": [ "http://www.quidel.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails", "http://www.quidel.com/role/RevenueNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Concentration Risk Type [Domain]", "label": "Concentration Risk Type [Domain]", "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration." } } }, "auth_ref": [ "r50", "r53", "r106", "r107", "r290", "r724" ] }, "qdel_PotentialDilutiveEffectOnWeightedAverageNumberOfSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://www.quidel.com/20231001", "localname": "PotentialDilutiveEffectOnWeightedAverageNumberOfSharesOutstanding", "presentation": [ "http://www.quidel.com/role/ComputationofEarningsPerShareCalculationofBasicandDilutedEarningsPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "PotentialWeightedAverageNumberOfDilutedSharesOutstandingDiluted weighted-average shares of common stock outstanding", "label": "Potential Dilutive Effect On Weighted Average Number Of Shares Outstanding", "documentation": "PotentialWeightedAverageNumberOfDilutedSharesOutstanding" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable", "presentation": [ "http://www.quidel.com/role/BusinessCombinationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]", "label": "Schedule of Business Acquisitions, by Acquisition [Table]", "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities." } } }, "auth_ref": [ "r80", "r81", "r497" ] }, "us-gaap_PrepaidExpenseCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PrepaidExpenseCurrent", "crdr": "debit", "calculation": { "http://www.quidel.com/role/BalanceSheetAccountDetailsPrepaidexpensesandothercurrentassetsDetails": { "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.quidel.com/role/BalanceSheetAccountDetailsPrepaidexpensesandothercurrentassetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Prepaid expenses", "label": "Prepaid Expense, Current", "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r195", "r337", "r338", "r735" ] }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsAtCarryingValue", "crdr": "debit", "calculation": { "http://www.quidel.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 1.0 }, "http://www.quidel.com/role/BalanceSheetAccountDetailsCashCashEquivalentsandRestrictedCashDetails": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.quidel.com/role/BalanceSheetAccountDetailsCashCashEquivalentsandRestrictedCashDetails", "http://www.quidel.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Cash and cash equivalents", "label": "Cash and Cash Equivalents, at Carrying Value", "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation." } } }, "auth_ref": [ "r45", "r186", "r732" ] }, "us-gaap_ShortTermInvestmentsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortTermInvestmentsMember", "presentation": [ "http://www.quidel.com/role/BalanceSheetAccountDetailsMarketableSecuritiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Short-term Investments", "label": "Short-Term Investments [Member]", "documentation": "Investments which are not otherwise included in another category or item that the entity has the intent to sell or dispose of within one year from the date of the balance sheet." } } }, "auth_ref": [ "r719", "r720", "r721", "r731" ] }, "us-gaap_FinancialInstrumentAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinancialInstrumentAxis", "presentation": [ "http://www.quidel.com/role/BalanceSheetAccountDetailsMarketableSecuritiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Eligible Item or Group for Fair Value Option", "label": "Financial Instrument [Axis]", "documentation": "Information by type of financial instrument." } } }, "auth_ref": [ "r293", "r294", "r295", "r296", "r297", "r298", "r299", "r300", "r301", "r302", "r303", "r304", "r305", "r306", "r307", "r308", "r309", "r310", "r311", "r312", "r313", "r314", "r315", "r316", "r317", "r318", "r319", "r320", "r321", "r322", "r328", "r329", "r330", "r331", "r332", "r334", "r335", "r336", "r396", "r401", "r518", "r546", "r547", "r548", "r549", "r550", "r551", "r552", "r553", "r554", "r555", "r556", "r557", "r558", "r559", "r560", "r561", "r562", "r563", "r564", "r565", "r566", "r567", "r568", "r569", "r570", "r571", "r572", "r573", "r574", "r575", "r600", "r745", "r870", "r871", "r872", "r873", "r874", "r875", "r876", "r905", "r906", "r907", "r908" ] }, "us-gaap_MarketableSecuritiesLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MarketableSecuritiesLineItems", "presentation": [ "http://www.quidel.com/role/BalanceSheetAccountDetailsMarketableSecuritiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Marketable Securities [Line Items]", "label": "Marketable Securities [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember", "presentation": [ "http://www.quidel.com/role/AccumulatedOtherComprehensiveLossDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash Flow Hedges", "label": "Accumulated Gain (Loss), Cash Flow Hedge, Including Noncontrolling Interest [Member]", "documentation": "Accumulated other comprehensive income (loss) from gain (loss) of derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, including portion attributable to noncontrolling interest." } } }, "auth_ref": [ "r206", "r213", "r503", "r886", "r887" ] }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingenciesDisclosureAbstract", "lang": { "en-us": { "role": { "terseLabel": "Commitments and Contingencies Disclosure [Abstract]", "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems", "presentation": [ "http://www.quidel.com/role/AccumulatedOtherComprehensiveLossDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]", "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r213", "r214", "r527", "r529", "r530", "r531", "r532", "r533" ] }, "us-gaap_UnbilledContractsReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UnbilledContractsReceivable", "crdr": "debit", "calculation": { "http://www.quidel.com/role/BalanceSheetAccountDetailsPrepaidexpensesandothercurrentassetsDetails": { "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.quidel.com/role/BalanceSheetAccountDetailsPrepaidexpensesandothercurrentassetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Contract assets", "label": "Unbilled Contracts Receivable", "documentation": "Unbilled amounts due for services rendered or to be rendered, actions taken or to be taken, or a promise to refrain from taking certain actions in accordance with the terms of a legally binding agreement between the entity and, at a minimum, one other party. An example would be amounts associated with contracts or programs where the recognized revenue for performance thereunder exceeds the amounts billed under the terms thereof as of the date of the balance sheet." } } }, "auth_ref": [ "r577" ] }, "us-gaap_OtherOperatingActivitiesCashFlowStatement": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherOperatingActivitiesCashFlowStatement", "crdr": "debit", "calculation": { "http://www.quidel.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://www.quidel.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Other non-cash, net", "label": "Other Operating Activities, Cash Flow Statement", "documentation": "Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example, cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities)." } } }, "auth_ref": [] }, "us-gaap_ContractWithCustomerAssetNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ContractWithCustomerAssetNet", "crdr": "debit", "presentation": [ "http://www.quidel.com/role/RevenueNarrativeDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Contract assets", "label": "Contract with Customer, Asset, after Allowance for Credit Loss", "documentation": "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time." } } }, "auth_ref": [ "r403", "r404", "r423" ] }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "presentation": [ "http://www.quidel.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Recent Accounting Pronouncements", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact." } } }, "auth_ref": [] }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax", "crdr": "debit", "presentation": [ "http://www.quidel.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofGainLossDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amount of Loss (Gain) Reclassified From AOCI Into Income", "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax", "documentation": "Amount, before tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness." } } }, "auth_ref": [ "r176", "r204", "r207" ] }, "us-gaap_GoodwillForeignCurrencyTranslationGainLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillForeignCurrencyTranslationGainLoss", "crdr": "credit", "presentation": [ "http://www.quidel.com/role/BalanceSheetAccountDetailsGoodwillRollforwardDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign currency translation", "label": "Goodwill, Foreign Currency Translation Gain (Loss)", "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized." } } }, "auth_ref": [ "r346" ] }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax", "crdr": "debit", "calculation": { "http://www.quidel.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.quidel.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Reclassification of net realized (gains) losses on derivative instruments included in net (loss) income", "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax", "documentation": "Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness." } } }, "auth_ref": [ "r204", "r207" ] }, "us-gaap_PaymentsOfDebtExtinguishmentCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsOfDebtExtinguishmentCosts", "crdr": "credit", "presentation": [ "http://www.quidel.com/role/BorrowingsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt prepayment cost", "label": "Payment for Debt Extinguishment or Debt Prepayment Cost", "documentation": "Amount of cash outflow for cost from early extinguishment and prepayment of debt. Includes, but is not limited to, third-party cost, premium paid, and other fee paid to lender directly for debt extinguishment or debt prepayment. Excludes accrued interest." } } }, "auth_ref": [ "r12" ] }, "us-gaap_MarketableSecuritiesTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MarketableSecuritiesTable", "presentation": [ "http://www.quidel.com/role/BalanceSheetAccountDetailsMarketableSecuritiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Marketable Securities [Table]", "label": "Marketable Securities [Table]", "documentation": "Disclosure of information about investment in marketable security." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "presentation": [ "http://www.quidel.com/role/AccumulatedOtherComprehensiveLossTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Accumulated Other Comprehensive Income (Loss)", "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]", "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss)." } } }, "auth_ref": [ "r39", "r941", "r942" ] }, "ecd_TrdArrTerminationDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrTerminationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Termination Date", "label": "Trading Arrangement Termination Date" } } }, "auth_ref": [ "r855" ] }, "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements", "calculation": { "http://www.quidel.com/role/ComputationofEarningsPerShareCalculationofBasicandDilutedEarningsPerShareDetails": { "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.quidel.com/role/ComputationofEarningsPerShareCalculationofBasicandDilutedEarningsPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Dilutive potential shares issuable from stock options and RSUs", "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements", "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method." } } }, "auth_ref": [ "r246", "r247", "r248", "r252", "r438" ] }, "us-gaap_BusinessAcquisitionSharePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionSharePrice", "presentation": [ "http://www.quidel.com/role/BusinessCombinationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Closing price of Quidel Common Stock (in usd per share)", "label": "Business Acquisition, Share Price", "documentation": "Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://www.quidel.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Current Reporting Status", "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "us-gaap_MoneyMarketFundsAtCarryingValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MoneyMarketFundsAtCarryingValue", "crdr": "debit", "presentation": [ "http://www.quidel.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash equivalents", "label": "Money Market Funds, at Carrying Value", "documentation": "Investment in short-term money-market instruments (such as commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and so forth) which are highly liquid (that is, readily convertible to known amounts of cash) and so near their maturity that they present an insignificant risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify as cash equivalents by definition. Original maturity means an original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three-years ago does not become a cash equivalent when its remaining maturity is three months." } } }, "auth_ref": [] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://www.quidel.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Shell Company", "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r785" ] }, "us-gaap_DeferredRevenueRevenueRecognized1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredRevenueRevenueRecognized1", "crdr": "credit", "presentation": [ "http://www.quidel.com/role/RevenueNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred revenue, revenue recognized", "label": "Deferred Revenue, Revenue Recognized", "documentation": "Amount of revenue recognized that was previously reported as deferred or unearned revenue." } } }, "auth_ref": [] }, "us-gaap_StatementOfFinancialPositionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfFinancialPositionAbstract", "lang": { "en-us": { "role": { "terseLabel": "Statement of Financial Position [Abstract]", "label": "Statement of Financial Position [Abstract]" } } }, "auth_ref": [] }, "us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharesPaidForTaxWithholdingForShareBasedCompensation", "presentation": [ "http://www.quidel.com/role/ConsolidatedStatementsofStockholdersEquityStatement" ], "lang": { "en-us": { "role": { "negatedLabel": "Tax withholdings related to vesting of stock-based awards (in shares)", "label": "Share-Based Payment Arrangement, Shares Withheld for Tax Withholding Obligation", "documentation": "Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://www.quidel.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Filer Category", "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r785" ] }, "us-gaap_LongTermDebtCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtCurrent", "crdr": "credit", "calculation": { "http://www.quidel.com/role/BorrowingsScheduleofBorrowingsDetails_1": { "parentTag": "us-gaap_LongTermDebtAndCapitalLeaseObligations", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.quidel.com/role/BorrowingsScheduleofBorrowingsDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Less: current portion", "label": "Long-Term Debt, Current Maturities", "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as current. Excludes lease obligation." } } }, "auth_ref": [ "r190" ] }, "ecd_NonRule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonRule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted", "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]" } } }, "auth_ref": [ "r853" ] }, "us-gaap_IncomeTaxDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxDisclosureAbstract", "lang": { "en-us": { "role": { "terseLabel": "Income Tax Disclosure [Abstract]", "label": "Income Tax Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "crdr": "credit", "calculation": { "http://www.quidel.com/role/ConsolidatedStatementsofIncome": { "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0, "order": 1.0 }, "http://www.quidel.com/role/SegmentandGeographicInformationReconciliationtoIncomeDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.quidel.com/role/ConsolidatedStatementsofIncome", "http://www.quidel.com/role/IncomeTaxesDetail", "http://www.quidel.com/role/SegmentandGeographicInformationReconciliationtoIncomeDetails" ], "lang": { "en-us": { "role": { "totalLabel": "(Loss) income before income taxes", "terseLabel": "(Loss) income before income taxes", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest." } } }, "auth_ref": [ "r0", "r132", "r167", "r262", "r276", "r282", "r285", "r583", "r597", "r743" ] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://www.quidel.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Emerging Growth Company", "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r785" ] }, "us-gaap_StockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquity", "crdr": "credit", "calculation": { "http://www.quidel.com/role/ConsolidatedBalanceSheets": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.quidel.com/role/ConsolidatedBalanceSheets", "http://www.quidel.com/role/ConsolidatedStatementsofStockholdersEquityStatement" ], "lang": { "en-us": { "role": { "totalLabel": "Total stockholders\u2019 equity", "periodStartLabel": "Balance", "periodEndLabel": "Balance", "label": "Equity, Attributable to Parent", "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest." } } }, "auth_ref": [ "r121", "r124", "r125", "r146", "r661", "r677", "r700", "r701", "r768", "r783", "r893", "r909", "r940", "r959" ] }, "us-gaap_DebtAndCapitalLeaseObligations": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtAndCapitalLeaseObligations", "crdr": "credit", "calculation": { "http://www.quidel.com/role/BorrowingsScheduleofBorrowingsDetails_1": { "parentTag": "us-gaap_LongTermDebtAndCapitalLeaseObligations", "weight": 1.0, "order": 2.0 }, "http://www.quidel.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.quidel.com/role/BorrowingsScheduleofBorrowingsDetails", "http://www.quidel.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Long-term borrowings", "label": "Debt and Lease Obligation", "documentation": "Amount of short-term and long-term debt and lease obligation." } } }, "auth_ref": [ "r165" ] }, "us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueFromExternalCustomersByGeographicAreasTableTextBlock", "presentation": [ "http://www.quidel.com/role/SegmentandGeographicInformationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Revenue from External Customers by Geographic Areas", "label": "Revenue from External Customers by Geographic Areas [Table Text Block]", "documentation": "Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue." } } }, "auth_ref": [ "r23" ] }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PrepaidExpenseAndOtherAssetsCurrent", "crdr": "debit", "calculation": { "http://www.quidel.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 5.0 }, "http://www.quidel.com/role/BalanceSheetAccountDetailsPrepaidexpensesandothercurrentassetsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.quidel.com/role/BalanceSheetAccountDetailsPrepaidexpensesandothercurrentassetsDetails", "http://www.quidel.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Prepaid expenses and other current assets", "totalLabel": "Total prepaid expenses and other current assets", "label": "Prepaid Expense and Other Assets, Current", "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r884" ] }, "us-gaap_ProceedsFromDebtNetOfIssuanceCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromDebtNetOfIssuanceCosts", "crdr": "debit", "calculation": { "http://www.quidel.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.quidel.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from long-term borrowings, net of debt issuance costs", "label": "Proceeds from Debt, Net of Issuance Costs", "documentation": "The cash inflow from additional borrowings, net of cash paid to third parties in connection with debt origination." } } }, "auth_ref": [ "r220" ] }, "us-gaap_LongTermDebtAndCapitalLeaseObligations": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtAndCapitalLeaseObligations", "crdr": "credit", "calculation": { "http://www.quidel.com/role/BorrowingsScheduleofBorrowingsDetails": { "parentTag": null, "weight": null, "order": null, "root": true }, "http://www.quidel.com/role/BorrowingsScheduleofBorrowingsDetails_1": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.quidel.com/role/BorrowingsScheduleofBorrowingsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total borrowings", "label": "Long-Term Debt and Lease Obligation", "documentation": "Amount of long-term debt and lease obligation, classified as noncurrent." } } }, "auth_ref": [ "r26", "r588" ] }, "us-gaap_DebtDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtDisclosureAbstract", "lang": { "en-us": { "role": { "terseLabel": "Debt Disclosure [Abstract]", "label": "Debt Disclosure [Abstract]" } } }, "auth_ref": [] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://www.quidel.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Small Business", "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r785" ] }, "us-gaap_StockAppreciationRightsSARSMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockAppreciationRightsSARSMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Stock Appreciation Rights (SARs)", "label": "Stock Appreciation Rights (SARs) [Member]", "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period." } } }, "auth_ref": [] }, "us-gaap_DebtCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtCurrent", "crdr": "credit", "calculation": { "http://www.quidel.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.quidel.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Current portion of borrowings", "label": "Debt, Current", "documentation": "Amount of debt and lease obligation, classified as current." } } }, "auth_ref": [ "r191" ] }, "us-gaap_FairValueDisclosuresAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueDisclosuresAbstract", "lang": { "en-us": { "role": { "terseLabel": "Fair Value Disclosures [Abstract]", "label": "Fair Value Disclosures [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://www.quidel.com/role/ConsolidatedStatementsofIncome": { "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.quidel.com/role/ConsolidatedStatementsofIncome", "http://www.quidel.com/role/IncomeTaxesDetail" ], "lang": { "en-us": { "role": { "terseLabel": "(Benefit from) provision for income taxes", "label": "Income Tax Expense (Benefit)", "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations." } } }, "auth_ref": [ "r170", "r177", "r239", "r240", "r270", "r480", "r491", "r604" ] }, "us-gaap_DeferredFinanceCostsNoncurrentNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredFinanceCostsNoncurrentNet", "crdr": "debit", "calculation": { "http://www.quidel.com/role/BorrowingsScheduleofBorrowingsDetails": { "parentTag": "us-gaap_LongTermDebtAndCapitalLeaseObligations", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://www.quidel.com/role/BorrowingsScheduleofBorrowingsDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Unamortized deferred financing costs", "label": "Debt Issuance Costs, Noncurrent, Net", "documentation": "Amount, after accumulated amortization, of debt issuance costs classified as noncurrent. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs." } } }, "auth_ref": [ "r110" ] }, "us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "presentation": [ "http://www.quidel.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Basis of Presentation and Summary of Significant Accounting Policies", "label": "Basis of Presentation and Significant Accounting Policies [Text Block]", "documentation": "The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity." } } }, "auth_ref": [ "r145" ] }, "us-gaap_TypeOfArrangementAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TypeOfArrangementAxis", "presentation": [ "http://www.quidel.com/role/RevenueNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]", "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations." } } }, "auth_ref": [ "r500" ] }, "us-gaap_RestrictedStockUnitsRSUMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestrictedStockUnitsRSUMember", "presentation": [ "http://www.quidel.com/role/StockBasedCompensationNarrativeDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "RSUs", "label": "Restricted Stock Units (RSUs) [Member]", "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met." } } }, "auth_ref": [] }, "us-gaap_RevenueFromContractWithCustomerAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueFromContractWithCustomerAbstract", "lang": { "en-us": { "role": { "label": "Revenue from Contract with Customer [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax", "crdr": "credit", "calculation": { "http://www.quidel.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.quidel.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "terseLabel": "Changes in unrealized gains (losses) from investments, net of tax", "label": "OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax", "documentation": "Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale." } } }, "auth_ref": [ "r201", "r204", "r323" ] }, "us-gaap_RevenueFromContractWithCustomerTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueFromContractWithCustomerTextBlock", "presentation": [ "http://www.quidel.com/role/Revenue" ], "lang": { "en-us": { "role": { "terseLabel": "Revenue", "label": "Revenue from Contract with Customer [Text Block]", "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts." } } }, "auth_ref": [ "r178", "r405", "r406", "r407", "r408", "r409", "r410", "r411", "r412", "r424" ] }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInAccountsReceivable", "crdr": "credit", "calculation": { "http://www.quidel.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 9.0 } }, "presentation": [ "http://www.quidel.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Accounts receivable", "label": "Increase (Decrease) in Accounts Receivable", "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services." } } }, "auth_ref": [ "r14" ] }, "us-gaap_RevolvingCreditFacilityMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevolvingCreditFacilityMember", "presentation": [ "http://www.quidel.com/role/BorrowingsInterestExpenseDetails", "http://www.quidel.com/role/BorrowingsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Revolving Credit Facility", "label": "Revolving Credit Facility [Member]", "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount." } } }, "auth_ref": [] }, "qdel_MolecularDiagnosticsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.quidel.com/20231001", "localname": "MolecularDiagnosticsMember", "presentation": [ "http://www.quidel.com/role/RevenueDisaggregationofRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Molecular Diagnostics", "label": "Molecular Diagnostics [Member]", "documentation": "Molecular Diagnostics" } } }, "auth_ref": [] }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedOtherComprehensiveIncomeLossTable", "presentation": [ "http://www.quidel.com/role/AccumulatedOtherComprehensiveLossDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]", "label": "Accumulated Other Comprehensive Income (Loss) [Table]", "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss)." } } }, "auth_ref": [ "r213", "r214", "r527", "r529", "r530", "r531", "r532", "r533" ] }, "us-gaap_StatementLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementLineItems", "presentation": [ "http://www.quidel.com/role/ConsolidatedStatementsofStockholdersEquityStatement" ], "lang": { "en-us": { "role": { "terseLabel": "Statement [Line Items]", "label": "Statement [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r228", "r229", "r230", "r257", "r578", "r630", "r639", "r650", "r651", "r652", "r653", "r654", "r655", "r659", "r662", "r663", "r664", "r665", "r666", "r667", "r668", "r669", "r670", "r672", "r673", "r674", "r675", "r676", "r678", "r680", "r681", "r685", "r686", "r687", "r688", "r689", "r690", "r691", "r692", "r693", "r694", "r695", "r696", "r699", "r774" ] }, "us-gaap_OtherAssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherAssetsCurrent", "crdr": "debit", "calculation": { "http://www.quidel.com/role/BalanceSheetAccountDetailsPrepaidexpensesandothercurrentassetsDetails": { "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.quidel.com/role/BalanceSheetAccountDetailsPrepaidexpensesandothercurrentassetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other", "label": "Other Assets, Current", "documentation": "Amount of current assets classified as other." } } }, "auth_ref": [ "r196", "r768" ] }, "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable", "presentation": [ "http://www.quidel.com/role/StockBasedCompensationCompensationExpenseRelatedtoStockBasedCompensationPlansDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]", "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]", "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements." } } }, "auth_ref": [ "r74" ] }, "us-gaap_DepreciationDepletionAndAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DepreciationDepletionAndAmortization", "crdr": "debit", "calculation": { "http://www.quidel.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 2.0 }, "http://www.quidel.com/role/SegmentandGeographicInformationReconciliationtoIncomeDetails": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://www.quidel.com/role/ConsolidatedStatementsofCashFlows", "http://www.quidel.com/role/SegmentandGeographicInformationReconciliationtoIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Depreciation and amortization", "negatedTerseLabel": "Depreciation and amortization", "label": "Depreciation, Depletion and Amortization", "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets." } } }, "auth_ref": [ "r15", "r267" ] }, "us-gaap_CreditFacilityAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CreditFacilityAxis", "presentation": [ "http://www.quidel.com/role/BorrowingsInterestExpenseDetails", "http://www.quidel.com/role/BorrowingsNarrativeDetails", "http://www.quidel.com/role/BorrowingsScheduleofBorrowingsDetails", "http://www.quidel.com/role/FairValueMeasurementsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Credit Facility [Axis]", "label": "Credit Facility [Axis]", "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing." } } }, "auth_ref": [] }, "us-gaap_AssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsAbstract", "presentation": [ "http://www.quidel.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "ASSETS", "label": "Assets [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DeferredRevenueCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredRevenueCurrent", "crdr": "credit", "calculation": { "http://www.quidel.com/role/BalanceSheetAccountDetailsOtherCurrentLiabilitiesDetails": { "parentTag": "us-gaap_OtherLiabilitiesCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.quidel.com/role/BalanceSheetAccountDetailsOtherCurrentLiabilitiesDetails", "http://www.quidel.com/role/RevenueNarrativeDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Deferred revenue, current", "terseLabel": "Deferred revenue", "label": "Deferred Revenue, Current", "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current." } } }, "auth_ref": [ "r880" ] }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementsFairValueHierarchyDomain", "presentation": [ "http://www.quidel.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value Hierarchy and NAV [Domain]", "label": "Fair Value Hierarchy and NAV [Domain]", "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value." } } }, "auth_ref": [ "r385", "r426", "r427", "r428", "r429", "r430", "r431", "r549", "r550", "r551", "r748", "r749", "r760", "r761", "r762" ] }, "ecd_InsiderTradingArrLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTradingArrLineItems", "lang": { "en-us": { "role": { "label": "Insider Trading Arrangements [Line Items]" } } }, "auth_ref": [ "r852" ] }, "us-gaap_DeferredRevenueNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredRevenueNoncurrent", "crdr": "credit", "presentation": [ "http://www.quidel.com/role/RevenueNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred revenue, noncurrent", "label": "Deferred Revenue, Noncurrent", "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as noncurrent." } } }, "auth_ref": [ "r881" ] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://www.quidel.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Registrant Name", "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r785" ] }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "presentation": [ "http://www.quidel.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Changes in assets and liabilities:", "label": "Increase (Decrease) in Operating Capital [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract", "presentation": [ "http://www.quidel.com/role/SegmentandGeographicInformationTotalRevenuesbyReportableSegmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Abstract]", "label": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsCurrent", "crdr": "debit", "calculation": { "http://www.quidel.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.quidel.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total current assets", "label": "Assets, Current", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r184", "r197", "r225", "r325", "r362", "r363", "r364", "r365", "r366", "r367", "r368", "r369", "r370", "r501", "r504", "r525", "r768", "r927", "r928", "r943" ] }, "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "presentation": [ "http://www.quidel.com/role/StockBasedCompensationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Expense Related to Stock-Based Compensation Plans", "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]", "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement." } } }, "auth_ref": [ "r74" ] }, "us-gaap_IncreaseDecreaseInAccountsPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInAccountsPayable", "crdr": "debit", "calculation": { "http://www.quidel.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 12.0 } }, "presentation": [ "http://www.quidel.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts payable", "label": "Increase (Decrease) in Accounts Payable", "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business." } } }, "auth_ref": [ "r14" ] }, "us-gaap_FairValueInputsLevel2Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueInputsLevel2Member", "presentation": [ "http://www.quidel.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Level\u00a02", "label": "Fair Value, Inputs, Level 2 [Member]", "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets." } } }, "auth_ref": [ "r385", "r426", "r431", "r523", "r550", "r748", "r749", "r760", "r761", "r762" ] }, "us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementAndThirdPartyMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementAndThirdPartyMember", "presentation": [ "http://www.quidel.com/role/RevenueNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Collaborative Arrangement, Transaction with Party to Collaborative Arrangement and Third Party", "label": "Collaborative Arrangement, Transaction with Party to Collaborative Arrangement and Third Party [Member]", "documentation": "Collaborative arrangement transaction between party to collaborative arrangement and third party." } } }, "auth_ref": [ "r934" ] }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract", "presentation": [ "http://www.quidel.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "terseLabel": "Other comprehensive (loss) income", "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareBasic": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareBasic", "presentation": [ "http://www.quidel.com/role/ConsolidatedStatementsofIncome" ], "lang": { "en-us": { "role": { "terseLabel": "Basic (loss) earnings per share", "label": "Earnings Per Share, Basic", "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period." } } }, "auth_ref": [ "r219", "r233", "r234", "r235", "r236", "r237", "r243", "r245", "r250", "r251", "r252", "r256", "r520", "r521", "r582", "r602", "r741" ] }, "us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LineOfCreditFacilityRemainingBorrowingCapacity", "crdr": "credit", "presentation": [ "http://www.quidel.com/role/BorrowingsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Remaining borrowing capacity", "label": "Line of Credit Facility, Remaining Borrowing Capacity", "documentation": "Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding)." } } }, "auth_ref": [ "r30" ] }, "us-gaap_FairValueInputsLevel1Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueInputsLevel1Member", "presentation": [ "http://www.quidel.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Level 1", "label": "Fair Value, Inputs, Level 1 [Member]", "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date." } } }, "auth_ref": [ "r385", "r426", "r431", "r523", "r549", "r760", "r761", "r762" ] }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "crdr": "credit", "calculation": { "http://www.quidel.com/role/AccumulatedOtherComprehensiveLossDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.quidel.com/role/AccumulatedOtherComprehensiveLossDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Net change", "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent", "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity." } } }, "auth_ref": [ "r13", "r18", "r157", "r209", "r212" ] }, "us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember", "presentation": [ "http://www.quidel.com/role/RevenueNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Collaborative Arrangement, Transaction with Party to Collaborative Arrangement", "label": "Collaborative Arrangement, Transaction with Party to Collaborative Arrangement [Member]", "documentation": "Collaborative arrangement transaction between parties to collaborative arrangement." } } }, "auth_ref": [ "r934" ] }, "us-gaap_PreferredStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockValue", "crdr": "credit", "calculation": { "http://www.quidel.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.quidel.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred stock, $0.001 par value per share; 5.0 shares authorized; none issued or outstanding at October\u00a01, 2023 and January\u00a01, 2023", "label": "Preferred Stock, Value, Issued", "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r120", "r590", "r768" ] }, "us-gaap_AssetsCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsCurrentAbstract", "presentation": [ "http://www.quidel.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Current assets:", "label": "Assets, Current [Abstract]" } } }, "auth_ref": [] }, "ecd_PvpTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PvpTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Pay vs Performance Disclosure", "label": "Pay vs Performance Disclosure [Table]" } } }, "auth_ref": [ "r822" ] }, "us-gaap_StatementEquityComponentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementEquityComponentsAxis", "presentation": [ "http://www.quidel.com/role/AccumulatedOtherComprehensiveLossDetails", "http://www.quidel.com/role/ConsolidatedStatementsofStockholdersEquityStatement" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Components [Axis]", "label": "Equity Components [Axis]", "documentation": "Information by component of equity." } } }, "auth_ref": [ "r20", "r37", "r179", "r213", "r214", "r215", "r228", "r229", "r230", "r232", "r238", "r240", "r257", "r326", "r327", "r402", "r471", "r472", "r473", "r488", "r489", "r512", "r513", "r514", "r515", "r516", "r517", "r519", "r527", "r529", "r530", "r531", "r532", "r533", "r540", "r623", "r624", "r625", "r638", "r699" ] }, "us-gaap_FairValueInputsLevel3Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueInputsLevel3Member", "presentation": [ "http://www.quidel.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Level 3", "label": "Fair Value, Inputs, Level 3 [Member]", "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing." } } }, "auth_ref": [ "r385", "r426", "r427", "r428", "r429", "r430", "r431", "r523", "r551", "r748", "r749", "r760", "r761", "r762" ] }, "ecd_PvpTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PvpTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Pay vs Performance Disclosure, Table", "label": "Pay vs Performance [Table Text Block]" } } }, "auth_ref": [ "r822" ] }, "us-gaap_ScheduleOfGoodwillTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfGoodwillTextBlock", "presentation": [ "http://www.quidel.com/role/BalanceSheetAccountDetailsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Goodwill", "label": "Schedule of Goodwill [Table Text Block]", "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule." } } }, "auth_ref": [ "r746", "r912", "r913", "r914", "r915", "r916", "r917", "r918", "r919", "r920", "r921", "r922" ] }, "us-gaap_RetainedEarningsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetainedEarningsMember", "presentation": [ "http://www.quidel.com/role/ConsolidatedStatementsofStockholdersEquityStatement" ], "lang": { "en-us": { "role": { "terseLabel": "Retained earnings", "label": "Retained Earnings [Member]", "documentation": "Accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r179", "r228", "r229", "r230", "r232", "r238", "r240", "r326", "r327", "r471", "r472", "r473", "r488", "r489", "r512", "r514", "r515", "r517", "r519", "r623", "r625", "r638", "r959" ] }, "us-gaap_MarketableSecuritiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MarketableSecuritiesCurrent", "crdr": "debit", "calculation": { "http://www.quidel.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.quidel.com/role/BalanceSheetAccountDetailsMarketableSecuritiesDetails", "http://www.quidel.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Marketable securities", "label": "Marketable Securities, Current", "documentation": "Amount of investment in marketable security, classified as current." } } }, "auth_ref": [ "r879" ] }, "us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess", "crdr": "debit", "calculation": { "http://www.quidel.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.quidel.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Short-term borrowings, net", "label": "Proceeds from (Repayments of) Short-Term Debt, Maturing in Three Months or Less", "documentation": "The cash inflow from a borrowing net of the cash outflow from repayment of a borrowing having initial term of repayment within three months." } } }, "auth_ref": [ "r888", "r889", "r890" ] }, "us-gaap_OtherDebtSecuritiesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherDebtSecuritiesMember", "presentation": [ "http://www.quidel.com/role/BalanceSheetAccountDetailsMarketableSecuritiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign and other", "label": "Other Debt Obligations [Member]", "documentation": "Investments in debt securities classified as other." } } }, "auth_ref": [ "r911", "r931", "r939" ] }, "ecd_PeerGroupIssuersFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeerGroupIssuersFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Peer Group Issuers, Footnote", "label": "Peer Group Issuers, Footnote [Text Block]" } } }, "auth_ref": [ "r825" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://www.quidel.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Document Type", "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "ecd_NonPeoNeoAvgCompActuallyPaidAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonPeoNeoAvgCompActuallyPaidAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount", "label": "Non-PEO NEO Average Compensation Actually Paid Amount" } } }, "auth_ref": [ "r824" ] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.quidel.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Central Index Key", "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r785" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInFinancingActivities", "crdr": "debit", "calculation": { "http://www.quidel.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.quidel.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash (used for) provided by financing activities", "label": "Net Cash Provided by (Used in) Financing Activities", "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit." } } }, "auth_ref": [ "r222" ] }, "us-gaap_LineOfCreditMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LineOfCreditMember", "presentation": [ "http://www.quidel.com/role/BorrowingsInterestExpenseDetails", "http://www.quidel.com/role/BorrowingsNarrativeDetails", "http://www.quidel.com/role/BorrowingsScheduleofBorrowingsDetails", "http://www.quidel.com/role/FairValueMeasurementsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Line of Credit", "label": "Line of Credit [Member]", "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars." } } }, "auth_ref": [] }, "us-gaap_AccountsReceivableGrossCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsReceivableGrossCurrent", "crdr": "debit", "calculation": { "http://www.quidel.com/role/BalanceSheetAccountDetailsAccountsReceivableDetails": { "parentTag": "us-gaap_AccountsReceivableNetCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.quidel.com/role/BalanceSheetAccountDetailsAccountsReceivableDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts receivable", "label": "Accounts Receivable, before Allowance for Credit Loss, Current", "documentation": "Amount, before allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current." } } }, "auth_ref": [ "r192", "r291", "r292", "r734" ] }, "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasis", "crdr": "debit", "presentation": [ "http://www.quidel.com/role/BalanceSheetAccountDetailsMarketableSecuritiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt Securities, Available-for-sale, Amortized Cost", "label": "Debt Securities, Available-for-Sale, Amortized Cost", "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)." } } }, "auth_ref": [ "r294", "r333", "r585" ] }, "us-gaap_EarningsPerShareDiluted": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareDiluted", "presentation": [ "http://www.quidel.com/role/ConsolidatedStatementsofIncome" ], "lang": { "en-us": { "role": { "terseLabel": "Diluted (loss) earnings per share", "label": "Earnings Per Share, Diluted", "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period." } } }, "auth_ref": [ "r219", "r233", "r234", "r235", "r236", "r237", "r245", "r250", "r251", "r252", "r256", "r520", "r521", "r582", "r602", "r741" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "presentation": [ "http://www.quidel.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "FINANCING ACTIVITIES", "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInInvestingActivities", "crdr": "debit", "calculation": { "http://www.quidel.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.quidel.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash used for investing activities", "label": "Net Cash Provided by (Used in) Investing Activities", "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets." } } }, "auth_ref": [ "r222" ] }, "us-gaap_CommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockMember", "presentation": [ "http://www.quidel.com/role/ConsolidatedStatementsofStockholdersEquityStatement" ], "lang": { "en-us": { "role": { "terseLabel": "Common Stock", "label": "Common Stock [Member]", "documentation": "Stock that is subordinate to all other stock of the issuer." } } }, "auth_ref": [ "r771", "r772", "r773", "r775", "r776", "r777", "r780", "r895", "r896", "r938", "r956", "r959" ] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentQuarterlyReport", "presentation": [ "http://www.quidel.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Document Quarterly Report", "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r787" ] }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "presentation": [ "http://www.quidel.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "INVESTING ACTIVITIES", "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]" } } }, "auth_ref": [] }, "ecd_PeoTotalCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoTotalCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "PEO Total Compensation Amount", "label": "PEO Total Compensation Amount" } } }, "auth_ref": [ "r823" ] }, "us-gaap_OtherDeferredCompensationArrangementsLiabilityCurrentAndNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherDeferredCompensationArrangementsLiabilityCurrentAndNoncurrent", "crdr": "credit", "presentation": [ "http://www.quidel.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred consideration", "label": "Other Deferred Compensation Arrangements, Liability, Current and Noncurrent", "documentation": "Amount of the liabilities for deferred compensation arrangements classified as other." } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInOperatingActivities", "calculation": { "http://www.quidel.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.quidel.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash provided by operating activities", "label": "Net Cash Provided by (Used in) Operating Activities", "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities." } } }, "auth_ref": [ "r142", "r143", "r144" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://www.quidel.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity File Number", "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "us-gaap_LongtermDebtTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongtermDebtTypeDomain", "presentation": [ "http://www.quidel.com/role/BorrowingsInterestExpenseDetails", "http://www.quidel.com/role/BorrowingsNarrativeDetails", "http://www.quidel.com/role/BorrowingsScheduleofBorrowingsDetails", "http://www.quidel.com/role/FairValueMeasurementsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long-term Debt, Type [Domain]", "label": "Long-Term Debt, Type [Domain]", "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer." } } }, "auth_ref": [ "r34", "r68" ] }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://www.quidel.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "OPERATING ACTIVITIES", "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ArrangementsAndNonarrangementTransactionsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ArrangementsAndNonarrangementTransactionsMember", "presentation": [ "http://www.quidel.com/role/RevenueNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]", "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations." } } }, "auth_ref": [ "r500" ] }, "us-gaap_DerivativeInstrumentRiskAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeInstrumentRiskAxis", "presentation": [ "http://www.quidel.com/role/DerivativeInstrumentsandHedgingActivitiesNarrativeDetails", "http://www.quidel.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofCurrencyHedgingInstrumentsDetails", "http://www.quidel.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofFairValueDetails", "http://www.quidel.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofGainLossDetails", "http://www.quidel.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofInterestRateDerivativesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative Instrument [Axis]", "label": "Derivative Instrument [Axis]", "documentation": "Information by type of derivative contract." } } }, "auth_ref": [ "r91", "r93", "r95", "r98", "r647", "r649", "r664", "r665", "r666", "r667", "r668", "r669", "r670", "r672", "r673", "r674", "r675", "r687", "r688", "r689", "r690", "r693", "r694", "r695", "r696", "r708", "r709", "r714", "r716", "r740", "r771", "r773" ] }, "us-gaap_AllocatedShareBasedCompensationExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AllocatedShareBasedCompensationExpense", "crdr": "debit", "presentation": [ "http://www.quidel.com/role/StockBasedCompensationCompensationExpenseRelatedtoStockBasedCompensationPlansDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Total stock-based compensation expense", "label": "Share-Based Payment Arrangement, Expense", "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized." } } }, "auth_ref": [ "r466", "r474" ] }, "us-gaap_AccumulatedTranslationAdjustmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedTranslationAdjustmentMember", "presentation": [ "http://www.quidel.com/role/AccumulatedOtherComprehensiveLossDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unrealized Foreign Currency Translation Adjustments", "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]", "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent." } } }, "auth_ref": [ "r8", "r19", "r39", "r214", "r215", "r529", "r530", "r531", "r532", "r533", "r885" ] }, "ecd_NonPeoNeoAvgTotalCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonPeoNeoAvgTotalCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-PEO NEO Average Total Compensation Amount", "label": "Non-PEO NEO Average Total Compensation Amount" } } }, "auth_ref": [ "r823" ] }, "us-gaap_DeferredIncomeTaxAssetsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredIncomeTaxAssetsNet", "crdr": "debit", "calculation": { "http://www.quidel.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.quidel.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred tax asset", "label": "Deferred Income Tax Assets, Net", "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting." } } }, "auth_ref": [ "r478", "r479" ] }, "us-gaap_EquityComponentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityComponentDomain", "presentation": [ "http://www.quidel.com/role/AccumulatedOtherComprehensiveLossDetails", "http://www.quidel.com/role/ConsolidatedStatementsofStockholdersEquityStatement" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Component [Domain]", "label": "Equity Component [Domain]", "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "auth_ref": [ "r20", "r179", "r213", "r214", "r215", "r228", "r229", "r230", "r232", "r238", "r240", "r257", "r326", "r327", "r402", "r471", "r472", "r473", "r488", "r489", "r512", "r513", "r514", "r515", "r516", "r517", "r519", "r527", "r529", "r530", "r531", "r532", "r533", "r540", "r623", "r624", "r625", "r638", "r699" ] }, "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems", "presentation": [ "http://www.quidel.com/role/StockBasedCompensationCompensationExpenseRelatedtoStockBasedCompensationPlansDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]", "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://www.quidel.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Document Transition Report", "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r820" ] }, "ecd_PeoActuallyPaidCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoActuallyPaidCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "PEO Actually Paid Compensation Amount", "label": "PEO Actually Paid Compensation Amount" } } }, "auth_ref": [ "r824" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedOtherComprehensiveIncomeMember", "presentation": [ "http://www.quidel.com/role/ConsolidatedStatementsofStockholdersEquityStatement" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated other comprehensive (loss) income", "label": "AOCI Attributable to Parent [Member]", "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r6", "r19", "r39", "r513", "r516", "r540", "r623", "r624", "r885", "r886", "r887", "r895", "r896", "r897" ] }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://www.quidel.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustments to reconcile net (loss) income to net cash provided by operating activities:", "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]" } } }, "auth_ref": [] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://www.quidel.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Tax Identification Number", "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r785" ] }, "us-gaap_ShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensation", "crdr": "debit", "calculation": { "http://www.quidel.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.quidel.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Stock-based compensation expense", "label": "Share-Based Payment Arrangement, Noncash Expense", "documentation": "Amount of noncash expense for share-based payment arrangement." } } }, "auth_ref": [ "r14" ] }, "ecd_PeerGroupTotalShareholderRtnAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeerGroupTotalShareholderRtnAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Peer Group Total Shareholder Return Amount", "label": "Peer Group Total Shareholder Return Amount" } } }, "auth_ref": [ "r825" ] }, "us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember", "presentation": [ "http://www.quidel.com/role/AccumulatedOtherComprehensiveLossDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Available-for-Sale Investments", "label": "AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-Sale, Including Noncontrolling Interest [Member]", "documentation": "Accumulated unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), including portion attributable to noncontrolling interest." } } }, "auth_ref": [ "r201", "r202", "r203", "r206", "r213", "r886", "r887" ] }, "ecd_TotalShareholderRtnAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TotalShareholderRtnAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Total Shareholder Return Amount", "label": "Total Shareholder Return Amount" } } }, "auth_ref": [ "r825" ] }, "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember", "presentation": [ "http://www.quidel.com/role/AccumulatedOtherComprehensiveLossDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Pension and Other Post- Employment Benefits", "label": "Accumulated Defined Benefit Plans Adjustment Including Portion Attributable to Noncontrolling Interest [Member]", "documentation": "Accumulated other comprehensive (income) loss related to defined benefit plans including the portion attributable to the noncontrolling interest." } } }, "auth_ref": [ "r9", "r19", "r39", "r885", "r886", "r887" ] }, "us-gaap_RepaymentsOfDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RepaymentsOfDebt", "crdr": "credit", "presentation": [ "http://www.quidel.com/role/BorrowingsNarrativeDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Payments of term loan", "label": "Repayments of Debt", "documentation": "Amount of cash outflow for short-term and long-term debt. Excludes payment of lease obligation." } } }, "auth_ref": [ "r889" ] }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "calculation": { "http://www.quidel.com/role/ComputationofEarningsPerShareCalculationofBasicandDilutedEarningsPerShareDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.quidel.com/role/ComputationofEarningsPerShareCalculationofBasicandDilutedEarningsPerShareDetails", "http://www.quidel.com/role/ConsolidatedStatementsofIncome" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted-average shares outstanding - diluted", "totalLabel": "Diluted weighted-average shares of common stock outstanding", "label": "Weighted Average Number of Shares Outstanding, Diluted", "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period." } } }, "auth_ref": [ "r244", "r252" ] }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions", "crdr": "debit", "presentation": [ "http://www.quidel.com/role/StockBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unrecognized compensation expense", "label": "Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount", "documentation": "Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options." } } }, "auth_ref": [ "r932" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://www.quidel.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Incorporation, State or Country Code", "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "presentation": [ "http://www.quidel.com/role/StockBasedCompensationEstimatedFairValueofEachStockOptionAwardDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Expected option life (in years)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term", "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r461" ] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://www.quidel.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Interactive Data Current", "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r859" ] }, "srt_MajorCustomersAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MajorCustomersAxis", "presentation": [ "http://www.quidel.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails", "http://www.quidel.com/role/RevenueNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Customer [Axis]", "label": "Customer [Axis]" } } }, "auth_ref": [ "r290", "r755", "r930", "r953", "r954" ] }, "ecd_ChangedPeerGroupFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ChangedPeerGroupFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Changed Peer Group, Footnote", "label": "Changed Peer Group, Footnote [Text Block]" } } }, "auth_ref": [ "r825" ] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://www.quidel.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Current Fiscal Year End Date", "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "crdr": "credit", "presentation": [ "http://www.quidel.com/role/ConsolidatedStatementsofStockholdersEquityStatement" ], "lang": { "en-us": { "role": { "terseLabel": "Stock-based compensation expense", "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition", "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement." } } }, "auth_ref": [ "r75", "r76", "r436" ] }, "us-gaap_MarketableSecurities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MarketableSecurities", "crdr": "debit", "presentation": [ "http://www.quidel.com/role/BalanceSheetAccountDetailsMarketableSecuritiesDetails", "http://www.quidel.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Total marketable securities", "verboseLabel": "Marketable securities", "label": "Marketable Securities", "documentation": "Amount of investment in marketable security." } } }, "auth_ref": [ "r115", "r879" ] }, "us-gaap_RestrictedCashNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestrictedCashNoncurrent", "crdr": "debit", "calculation": { "http://www.quidel.com/role/BalanceSheetAccountDetailsCashCashEquivalentsandRestrictedCashDetails": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.quidel.com/role/BalanceSheetAccountDetailsCashCashEquivalentsandRestrictedCashDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Restricted Cash, Noncurrent", "label": "Restricted Cash, Noncurrent", "documentation": "Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits." } } }, "auth_ref": [ "r171", "r878", "r891" ] }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "calculation": { "http://www.quidel.com/role/ComputationofEarningsPerShareCalculationofBasicandDilutedEarningsPerShareDetails": { "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.quidel.com/role/ComputationofEarningsPerShareCalculationofBasicandDilutedEarningsPerShareDetails", "http://www.quidel.com/role/ConsolidatedStatementsofIncome" ], "lang": { "en-us": { "role": { "verboseLabel": "Weighted-average shares outstanding - basic", "terseLabel": "Basic weighted-average shares of common stock outstanding", "label": "Weighted Average Number of Shares Outstanding, Basic", "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period." } } }, "auth_ref": [ "r243", "r252" ] }, "us-gaap_CreditFacilityDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CreditFacilityDomain", "presentation": [ "http://www.quidel.com/role/BorrowingsInterestExpenseDetails", "http://www.quidel.com/role/BorrowingsNarrativeDetails", "http://www.quidel.com/role/BorrowingsScheduleofBorrowingsDetails", "http://www.quidel.com/role/FairValueMeasurementsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Credit Facility [Domain]", "label": "Credit Facility [Domain]", "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing." } } }, "auth_ref": [] }, "ecd_RestatementDeterminationDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RestatementDeterminationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Restatement Determination Date", "label": "Restatement Determination Date" } } }, "auth_ref": [ "r791", "r802", "r812", "r837" ] }, "ecd_TrdArrIndTitle": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrIndTitle", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Title", "label": "Trading Arrangement, Individual Title" } } }, "auth_ref": [ "r854" ] }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueByFairValueHierarchyLevelAxis", "presentation": [ "http://www.quidel.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value Hierarchy and NAV [Axis]", "label": "Fair Value Hierarchy and NAV [Axis]", "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient." } } }, "auth_ref": [ "r385", "r426", "r427", "r428", "r429", "r430", "r431", "r523", "r549", "r550", "r551", "r748", "r749", "r760", "r761", "r762" ] }, "us-gaap_DebtDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtDisclosureTextBlock", "presentation": [ "http://www.quidel.com/role/Borrowings" ], "lang": { "en-us": { "role": { "terseLabel": "Borrowings", "label": "Debt Disclosure [Text Block]", "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants." } } }, "auth_ref": [ "r150", "r224", "r371", "r377", "r378", "r379", "r380", "r381", "r382", "r387", "r394", "r395", "r397" ] }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "lang": { "en-us": { "role": { "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]", "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "auth_ref": [] }, "ecd_RestatementDateAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RestatementDateAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Restatement Determination Date:", "label": "Restatement Determination Date [Axis]" } } }, "auth_ref": [ "r790", "r801", "r811", "r836" ] }, "qdel_InterestRateSwapFourMember": { "xbrltype": "domainItemType", "nsuri": "http://www.quidel.com/20231001", "localname": "InterestRateSwapFourMember", "presentation": [ "http://www.quidel.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofInterestRateDerivativesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest Rate Swap Four", "label": "Interest Rate Swap Four [Member]", "documentation": "Interest Rate Swap Four" } } }, "auth_ref": [] }, "us-gaap_IncomeStatementAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementAbstract", "lang": { "en-us": { "role": { "terseLabel": "Income Statement [Abstract]", "label": "Income Statement [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax", "crdr": "credit", "calculation": { "http://www.quidel.com/role/AccumulatedOtherComprehensiveLossDetails": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.quidel.com/role/AccumulatedOtherComprehensiveLossDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Current period deferrals", "label": "Other Comprehensive Income (Loss), before Reclassifications, Net of Tax", "documentation": "Amount after tax, before reclassification adjustments of other comprehensive income (loss)." } } }, "auth_ref": [ "r25", "r39", "r214", "r527", "r530", "r533", "r885" ] }, "qdel_NorthAmericaSegmentMember": { "xbrltype": "domainItemType", "nsuri": "http://www.quidel.com/20231001", "localname": "NorthAmericaSegmentMember", "presentation": [ "http://www.quidel.com/role/BalanceSheetAccountDetailsGoodwillRollforwardDetails", "http://www.quidel.com/role/SegmentandGeographicInformationReconciliationtoIncomeDetails", "http://www.quidel.com/role/SegmentandGeographicInformationTotalRevenuesbyReportableSegmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "North America", "label": "North America Segment [Member]", "documentation": "North America Segment" } } }, "auth_ref": [] }, "us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PrepaidExpensesAndOtherCurrentAssetsMember", "presentation": [ "http://www.quidel.com/role/RevenueNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Prepaid expenses and other current assets", "label": "Prepaid Expenses and Other Current Assets [Member]", "documentation": "Primary financial statement caption encompassing prepaid expenses and other current assets." } } }, "auth_ref": [] }, "us-gaap_AccountingPoliciesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountingPoliciesAbstract", "lang": { "en-us": { "role": { "terseLabel": "Accounting Policies [Abstract]", "label": "Accounting Policies [Abstract]" } } }, "auth_ref": [] }, "ecd_AggtErrCompNotYetDeterminedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AggtErrCompNotYetDeterminedTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined", "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]" } } }, "auth_ref": [ "r795", "r806", "r816", "r841" ] }, "ecd_AggtErrCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AggtErrCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Erroneous Compensation Amount", "label": "Aggregate Erroneous Compensation Amount" } } }, "auth_ref": [ "r792", "r803", "r813", "r838" ] }, "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax", "crdr": "debit", "calculation": { "http://www.quidel.com/role/AccumulatedOtherComprehensiveLossDetails": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.quidel.com/role/AccumulatedOtherComprehensiveLossDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Amounts reclassified to net income", "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax", "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss)." } } }, "auth_ref": [ "r25", "r39", "r214", "r527", "r532", "r533", "r885" ] }, "qdel_EUMedicalDeviceRegulationTransitionCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://www.quidel.com/20231001", "localname": "EUMedicalDeviceRegulationTransitionCosts", "crdr": "debit", "calculation": { "http://www.quidel.com/role/SegmentandGeographicInformationReconciliationtoIncomeDetails": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0, "order": 9.0 } }, "presentation": [ "http://www.quidel.com/role/SegmentandGeographicInformationReconciliationtoIncomeDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "EU medical device regulation transition costs", "label": "EU medical device regulation transition costs", "documentation": "EU medical device regulation transition costs" } } }, "auth_ref": [] }, "us-gaap_Assets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Assets", "crdr": "debit", "calculation": { "http://www.quidel.com/role/ConsolidatedBalanceSheets": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.quidel.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total assets", "label": "Assets", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r160", "r189", "r225", "r262", "r277", "r283", "r325", "r362", "r363", "r364", "r365", "r366", "r367", "r368", "r369", "r370", "r501", "r504", "r525", "r586", "r671", "r768", "r783", "r927", "r928", "r943" ] }, "qdel_ChinaMember": { "xbrltype": "domainItemType", "nsuri": "http://www.quidel.com/20231001", "localname": "ChinaMember", "presentation": [ "http://www.quidel.com/role/BalanceSheetAccountDetailsGoodwillRollforwardDetails", "http://www.quidel.com/role/SegmentandGeographicInformationReconciliationtoIncomeDetails", "http://www.quidel.com/role/SegmentandGeographicInformationTotalRevenuesbyReportableSegmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "China", "label": "China [Member]", "documentation": "China" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesFairValueDisclosure", "crdr": "credit", "presentation": [ "http://www.quidel.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Total liabilities measured at fair value", "label": "Liabilities, Fair Value Disclosure", "documentation": "Fair value of financial and nonfinancial obligations." } } }, "auth_ref": [ "r103" ] }, "ecd_ErrCompAnalysisTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ErrCompAnalysisTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Erroneous Compensation Analysis", "label": "Erroneous Compensation Analysis [Text Block]" } } }, "auth_ref": [ "r792", "r803", "r813", "r838" ] }, "us-gaap_ReclassificationTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ReclassificationTable", "presentation": [ "http://www.quidel.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Reclassification [Table]", "label": "Reclassification [Table]", "documentation": "Disclosure of information about reclassification adjustment affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error." } } }, "auth_ref": [ "r181" ] }, "us-gaap_LiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.quidel.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.quidel.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total current liabilities", "label": "Liabilities, Current", "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer." } } }, "auth_ref": [ "r33", "r185", "r225", "r325", "r362", "r363", "r364", "r365", "r366", "r367", "r368", "r369", "r370", "r502", "r504", "r505", "r525", "r768", "r927", "r943", "r944" ] }, "us-gaap_CustomerConcentrationRiskMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CustomerConcentrationRiskMember", "presentation": [ "http://www.quidel.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails", "http://www.quidel.com/role/RevenueNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Customer Concentration Risk", "label": "Customer Concentration Risk [Member]", "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer." } } }, "auth_ref": [ "r51", "r290" ] }, "ecd_StkPrcOrTsrEstimationMethodTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "StkPrcOrTsrEstimationMethodTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Stock Price or TSR Estimation Method", "label": "Stock Price or TSR Estimation Method [Text Block]" } } }, "auth_ref": [ "r793", "r804", "r814", "r839" ] }, "us-gaap_DebtInstrumentCarryingAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentCarryingAmount", "crdr": "credit", "calculation": { "http://www.quidel.com/role/BorrowingsScheduleofBorrowingsDetails": { "parentTag": "us-gaap_LongTermDebtAndCapitalLeaseObligations", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.quidel.com/role/BorrowingsNarrativeDetails", "http://www.quidel.com/role/BorrowingsScheduleofBorrowingsDetails", "http://www.quidel.com/role/FairValueMeasurementsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Term Loan", "label": "Long-Term Debt, Gross", "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt." } } }, "auth_ref": [ "r26", "r163", "r398" ] }, "us-gaap_AssetsFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsFairValueDisclosure", "crdr": "debit", "presentation": [ "http://www.quidel.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Total assets measured at fair value", "label": "Assets, Fair Value Disclosure", "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r103" ] }, "us-gaap_ReclassificationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ReclassificationLineItems", "presentation": [ "http://www.quidel.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Reclassification [Line Items]", "label": "Reclassification [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r181" ] }, "us-gaap_SharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharesOutstanding", "presentation": [ "http://www.quidel.com/role/ConsolidatedStatementsofStockholdersEquityStatement" ], "lang": { "en-us": { "role": { "periodStartLabel": "Balance (in shares)", "periodEndLabel": "Balance (in shares)", "label": "Shares, Outstanding", "documentation": "Number of shares issued which are neither cancelled nor held in the treasury." } } }, "auth_ref": [] }, "us-gaap_CorporateDebtSecuritiesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CorporateDebtSecuritiesMember", "presentation": [ "http://www.quidel.com/role/BalanceSheetAccountDetailsMarketableSecuritiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Corporate bonds", "label": "Corporate Debt Securities [Member]", "documentation": "Debt securities issued by domestic or foreign corporate business, banks and other entities with a promise of repayment." } } }, "auth_ref": [ "r760", "r762", "r955" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsShareBasedLiabilitiesPaid": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsShareBasedLiabilitiesPaid", "crdr": "credit", "presentation": [ "http://www.quidel.com/role/StockBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share-based liabilities paid", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Share-Based Liabilities Paid", "documentation": "Amount of cash paid to settle liability for award under share-based payment arrangement." } } }, "auth_ref": [ "r458" ] }, "qdel_CustomersWithBalancesDueInExcessOf10OfAccountsReceivableMember": { "xbrltype": "domainItemType", "nsuri": "http://www.quidel.com/20231001", "localname": "CustomersWithBalancesDueInExcessOf10OfAccountsReceivableMember", "presentation": [ "http://www.quidel.com/role/RevenueNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Customers With Balances Due In Excess of 10% Of Accounts Receivable", "label": "Customers With Balances Due In Excess of 10% Of Accounts Receivable [Member]", "documentation": "Customers With Balances Due In Excess of 10% Of Accounts Receivable" } } }, "auth_ref": [] }, "ecd_OutstandingAggtErrCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OutstandingAggtErrCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount", "label": "Outstanding Aggregate Erroneous Compensation Amount" } } }, "auth_ref": [ "r794", "r805", "r815", "r840" ] }, "qdel_EndingAfterTheClosingDateOfTheCreditAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://www.quidel.com/20231001", "localname": "EndingAfterTheClosingDateOfTheCreditAgreementMember", "presentation": [ "http://www.quidel.com/role/BorrowingsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Ending after the closing date of the credit agreement", "label": "Ending After The Closing Date Of The Credit Agreement [Member]", "documentation": "Ending After The Closing Date Of The Credit Agreement" } } }, "auth_ref": [] }, "srt_ProductOrServiceAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ProductOrServiceAxis", "presentation": [ "http://www.quidel.com/role/RevenueNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Product and Service [Axis]", "label": "Product and Service [Axis]" } } }, "auth_ref": [ "r287", "r578", "r616", "r617", "r618", "r619", "r620", "r621", "r730", "r753", "r769", "r867", "r925", "r926", "r930", "r953" ] }, "srt_RangeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RangeAxis", "presentation": [ "http://www.quidel.com/role/StockBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Statistical Measurement [Axis]", "label": "Statistical Measurement [Axis]" } } }, "auth_ref": [ "r358", "r359", "r360", "r361", "r425", "r432", "r462", "r463", "r464", "r552", "r576", "r622", "r648", "r649", "r704", "r705", "r706", "r707", "r718", "r726", "r727", "r744", "r752", "r765", "r770", "r773", "r923", "r929", "r946", "r947", "r948", "r949", "r950" ] }, "qdel_InterestRateSwapFiveMember": { "xbrltype": "domainItemType", "nsuri": "http://www.quidel.com/20231001", "localname": "InterestRateSwapFiveMember", "presentation": [ "http://www.quidel.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofInterestRateDerivativesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest Rate Swap Five", "label": "Interest Rate Swap Five [Member]", "documentation": "Interest Rate Swap Five" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesCurrentAbstract", "presentation": [ "http://www.quidel.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Current liabilities:", "label": "Liabilities, Current [Abstract]" } } }, "auth_ref": [] }, "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Forgone Recovery, Explanation of Impracticability", "label": "Forgone Recovery, Explanation of Impracticability [Text Block]" } } }, "auth_ref": [ "r796", "r807", "r817", "r842" ] }, "ecd_NonNeosMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonNeosMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-NEOs", "label": "Non-NEOs [Member]" } } }, "auth_ref": [ "r796", "r807", "r817", "r834", "r842" ] }, "qdel_NoncashOfPartNoncashAcquisitionFixedAssetsTransferredFromInventories": { "xbrltype": "monetaryItemType", "nsuri": "http://www.quidel.com/20231001", "localname": "NoncashOfPartNoncashAcquisitionFixedAssetsTransferredFromInventories", "crdr": "debit", "presentation": [ "http://www.quidel.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Transfer of instrument inventories to fixed assets", "label": "Noncash of Part Noncash Acquisition, Fixed Assets transferred from inventories", "documentation": "Noncash of Part Noncash Acquisition, Fixed Assets transferred from inventories" } } }, "auth_ref": [] }, "us-gaap_StockCompensationPlanMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockCompensationPlanMember", "presentation": [ "http://www.quidel.com/role/ComputationofEarningsPerShareNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share-Based Payment Arrangement", "label": "Share-Based Payment Arrangement [Member]", "documentation": "Share-based payment arrangement in which award of equity shares are granted. Arrangement includes, but is not limited to, grantor incurring liability for product and service based on price of its shares." } } }, "auth_ref": [ "r900" ] }, "qdel_OtherMember": { "xbrltype": "domainItemType", "nsuri": "http://www.quidel.com/20231001", "localname": "OtherMember", "presentation": [ "http://www.quidel.com/role/BalanceSheetAccountDetailsGoodwillRollforwardDetails", "http://www.quidel.com/role/SegmentandGeographicInformationReconciliationtoIncomeDetails", "http://www.quidel.com/role/SegmentandGeographicInformationTotalRevenuesbyReportableSegmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other", "label": "Other [Member]", "documentation": "Other nonreportable segments" } } }, "auth_ref": [] }, "us-gaap_BusinessAcquisitionProFormaInformationNonrecurringAdjustmentLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionProFormaInformationNonrecurringAdjustmentLineItems", "presentation": [ "http://www.quidel.com/role/BusinessCombinationProFormaInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Business Acquisition, Pro Forma Information, Nonrecurring Adjustment [Line Items]", "label": "Business Acquisition, Pro Forma Information, Nonrecurring Adjustment [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "qdel_ExpectedValueContractCustomersMember": { "xbrltype": "domainItemType", "nsuri": "http://www.quidel.com/20231001", "localname": "ExpectedValueContractCustomersMember", "presentation": [ "http://www.quidel.com/role/RevenueNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Expected Value Contract Customers", "label": "Expected Value Contract Customers [Member]", "documentation": "Expected Value Contract Customers" } } }, "auth_ref": [] }, "srt_ProductsAndServicesDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ProductsAndServicesDomain", "presentation": [ "http://www.quidel.com/role/RevenueNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Product and Service [Domain]", "label": "Product and Service [Domain]" } } }, "auth_ref": [ "r287", "r578", "r616", "r617", "r618", "r619", "r620", "r621", "r730", "r753", "r769", "r867", "r925", "r926", "r930", "r953" ] }, "srt_MaximumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MaximumMember", "presentation": [ "http://www.quidel.com/role/StockBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Maximum", "label": "Maximum [Member]" } } }, "auth_ref": [ "r358", "r359", "r360", "r361", "r432", "r576", "r622", "r648", "r649", "r704", "r705", "r706", "r707", "r718", "r726", "r727", "r744", "r752", "r765", "r770", "r929", "r945", "r946", "r947", "r948", "r949", "r950" ] }, "us-gaap_RelatedPartyTransactionsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionsAbstract", "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AdditionalPaidInCapital": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdditionalPaidInCapital", "crdr": "credit", "calculation": { "http://www.quidel.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.quidel.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Additional paid-in capital", "label": "Additional Paid in Capital", "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock." } } }, "auth_ref": [ "r122", "r768", "r958" ] }, "qdel_GoodwillPurchaseAccountingAdjustmentDecreaseToDeferredTaxAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://www.quidel.com/20231001", "localname": "GoodwillPurchaseAccountingAdjustmentDecreaseToDeferredTaxAssets", "crdr": "debit", "presentation": [ "http://www.quidel.com/role/BusinessCombinationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Goodwill adjustment, decrease to deferred tax assets", "label": "Goodwill, Purchase Accounting Adjustment, DecreaseTo Deferred Tax Assets", "documentation": "Goodwill, Purchase Accounting Adjustment, DecreaseTo Deferred Tax Assets" } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationAndAssetAcquisitionAbstract", "lang": { "en-us": { "role": { "label": "Business Combination and Asset Acquisition [Abstract]" } } }, "auth_ref": [] }, "srt_RangeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RangeMember", "presentation": [ "http://www.quidel.com/role/StockBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Statistical Measurement [Domain]", "label": "Statistical Measurement [Domain]" } } }, "auth_ref": [ "r358", "r359", "r360", "r361", "r425", "r432", "r462", "r463", "r464", "r552", "r576", "r622", "r648", "r649", "r704", "r705", "r706", "r707", "r718", "r726", "r727", "r744", "r752", "r765", "r770", "r773", "r923", "r929", "r946", "r947", "r948", "r949", "r950" ] }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax", "crdr": "credit", "calculation": { "http://www.quidel.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.quidel.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "terseLabel": "Net unrealized gains on derivative instruments", "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax", "documentation": "Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness." } } }, "auth_ref": [ "r200", "r204" ] }, "qdel_Customer1Member": { "xbrltype": "domainItemType", "nsuri": "http://www.quidel.com/20231001", "localname": "Customer1Member", "presentation": [ "http://www.quidel.com/role/RevenueNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Customer 1", "label": "Customer 1 [Member]", "documentation": "Customer 1" } } }, "auth_ref": [] }, "us-gaap_BusinessAcquisitionProFormaInformationNonrecurringAdjustmentsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionProFormaInformationNonrecurringAdjustmentsTable", "presentation": [ "http://www.quidel.com/role/BusinessCombinationProFormaInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Business Acquisition, Pro Forma Information, Nonrecurring Adjustments [Table]", "label": "Business Acquisition, Pro Forma Information, Nonrecurring Adjustments [Table]", "documentation": "Schedule of the nature and amount of any material, nonrecurring adjustments directly attributable to the business combination(s) included in the reported pro forma revenue and earnings (supplemental pro forma information)." } } }, "auth_ref": [ "r22" ] }, "ecd_OutstandingRecoveryCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OutstandingRecoveryCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Amount", "label": "Outstanding Recovery Compensation Amount" } } }, "auth_ref": [ "r797", "r808", "r818", "r843" ] }, "qdel_DeferredConsiderationCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.quidel.com/20231001", "localname": "DeferredConsiderationCurrent", "crdr": "credit", "calculation": { "http://www.quidel.com/role/BalanceSheetAccountDetailsOtherCurrentLiabilitiesDetails": { "parentTag": "us-gaap_OtherLiabilitiesCurrent", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.quidel.com/role/BalanceSheetAccountDetailsOtherCurrentLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred consideration", "label": "Deferred Consideration, Current", "documentation": "Deferred Consideration, Current" } } }, "auth_ref": [] }, "srt_ScenarioForecastMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ScenarioForecastMember", "presentation": [ "http://www.quidel.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofInterestRateDerivativesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Forecast", "label": "Forecast [Member]" } } }, "auth_ref": [ "r433", "r898" ] }, "ecd_ForgoneRecoveryIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Forgone Recovery, Individual Name" } } }, "auth_ref": [ "r796", "r807", "r817", "r842" ] }, "qdel_ChangeInOperatingLeaseRightOfUseAssetsAndLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://www.quidel.com/20231001", "localname": "ChangeInOperatingLeaseRightOfUseAssetsAndLiabilities", "crdr": "debit", "calculation": { "http://www.quidel.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.quidel.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Net change in operating lease right-of-use assets and liabilities", "label": "Change in operating lease right-of-use assets and liabilities", "documentation": "Change in operating lease right-of-use assets and liabilities" } } }, "auth_ref": [] }, "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount", "label": "Forgone Recovery due to Expense of Enforcement, Amount" } } }, "auth_ref": [ "r796", "r807", "r817", "r842" ] }, "us-gaap_DerivativeLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeLiabilities", "crdr": "credit", "presentation": [ "http://www.quidel.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative liabilities", "label": "Derivative Liability", "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset." } } }, "auth_ref": [ "r198", "r199", "r524", "r640", "r641", "r642", "r643", "r645", "r646", "r647", "r648", "r649", "r672", "r674", "r675", "r709", "r710", "r711", "r714", "r715", "r716", "r717", "r740", "r957" ] }, "ecd_Rule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "Rule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Rule 10b5-1 Arrangement Terminated", "label": "Rule 10b5-1 Arrangement Terminated [Flag]" } } }, "auth_ref": [ "r853" ] }, "qdel_ReceivableForStockOptionExercises": { "xbrltype": "monetaryItemType", "nsuri": "http://www.quidel.com/20231001", "localname": "ReceivableForStockOptionExercises", "crdr": "debit", "presentation": [ "http://www.quidel.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Reduction of other current liabilities upon issuance of restricted share units", "label": "Receivable For Stock Option Exercises", "documentation": "Receivable For Stock Option Exercises" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfCashAndCashEquivalentsTableTextBlock", "presentation": [ "http://www.quidel.com/role/BalanceSheetAccountDetailsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Cash, Cash Equivalents and Restricted Cash", "label": "Schedule of Cash and Cash Equivalents [Table Text Block]", "documentation": "Tabular disclosure of the components of cash and cash equivalents." } } }, "auth_ref": [] }, "ecd_Rule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "Rule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Rule 10b5-1 Arrangement Adopted", "label": "Rule 10b5-1 Arrangement Adopted [Flag]" } } }, "auth_ref": [ "r853" ] }, "ecd_TrdArrIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Trading Arrangement, Individual Name" } } }, "auth_ref": [ "r854" ] }, "ecd_OutstandingRecoveryIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OutstandingRecoveryIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Outstanding Recovery, Individual Name" } } }, "auth_ref": [ "r797", "r808", "r818", "r843" ] }, "qdel_CorporateAdjustedEBITDA": { "xbrltype": "monetaryItemType", "nsuri": "http://www.quidel.com/20231001", "localname": "CorporateAdjustedEBITDA", "crdr": "credit", "calculation": { "http://www.quidel.com/role/SegmentandGeographicInformationReconciliationtoIncomeDetails": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.quidel.com/role/SegmentandGeographicInformationReconciliationtoIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Corporate", "label": "Corporate Adjusted EBITDA", "documentation": "Corporate Adjusted EBITDA" } } }, "auth_ref": [] }, "us-gaap_UseOfEstimates": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UseOfEstimates", "presentation": [ "http://www.quidel.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Use of Estimates", "label": "Use of Estimates, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles." } } }, "auth_ref": [ "r54", "r55", "r56", "r172", "r173", "r174", "r175" ] }, "qdel_GoodwillPurchaseAccountingAdjustmentDecreaseToIncomeTaxesPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://www.quidel.com/20231001", "localname": "GoodwillPurchaseAccountingAdjustmentDecreaseToIncomeTaxesPayable", "crdr": "credit", "presentation": [ "http://www.quidel.com/role/BusinessCombinationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Goodwill adjustment, decrease to income taxes payable", "label": "Goodwill, Purchase Accounting Adjustment, Decrease To Income Taxes Payable", "documentation": "Goodwill, Purchase Accounting Adjustment, Decrease To Income Taxes Payable" } } }, "auth_ref": [] }, "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount", "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount" } } }, "auth_ref": [ "r796", "r807", "r817", "r842" ] }, "qdel_LongTermInvestmentsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.quidel.com/20231001", "localname": "LongTermInvestmentsMember", "presentation": [ "http://www.quidel.com/role/BalanceSheetAccountDetailsMarketableSecuritiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long-Term Investments", "label": "Long-Term Investments [Member]", "documentation": "Long-Term Investments" } } }, "auth_ref": [] }, "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount", "label": "Forgone Recovery due to Violation of Home Country Law, Amount" } } }, "auth_ref": [ "r796", "r807", "r817", "r842" ] }, "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfInventoryCurrentTableTextBlock", "presentation": [ "http://www.quidel.com/role/BalanceSheetAccountDetailsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Inventories", "label": "Schedule of Inventory, Current [Table Text Block]", "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process." } } }, "auth_ref": [ "r27", "r127", "r128", "r129" ] }, "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInStockholdersEquityRollForward", "presentation": [ "http://www.quidel.com/role/ConsolidatedStatementsofStockholdersEquityStatement" ], "lang": { "en-us": { "role": { "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax", "crdr": "credit", "presentation": [ "http://www.quidel.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofGainLossDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amount of Loss (Gain) Recognized in OCI on Hedges", "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax", "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness." } } }, "auth_ref": [ "r200", "r204", "r507", "r508", "r511" ] }, "qdel_EMEASegmentMember": { "xbrltype": "domainItemType", "nsuri": "http://www.quidel.com/20231001", "localname": "EMEASegmentMember", "presentation": [ "http://www.quidel.com/role/BalanceSheetAccountDetailsGoodwillRollforwardDetails", "http://www.quidel.com/role/SegmentandGeographicInformationReconciliationtoIncomeDetails", "http://www.quidel.com/role/SegmentandGeographicInformationTotalRevenuesbyReportableSegmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "EMEA", "label": "EMEA Segment [Member]", "documentation": "EMEA Segment" } } }, "auth_ref": [] }, "us-gaap_AssetBackedSecuritiesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetBackedSecuritiesMember", "presentation": [ "http://www.quidel.com/role/BalanceSheetAccountDetailsMarketableSecuritiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Corporate asset-backed securities", "label": "Asset-Backed Securities [Member]", "documentation": "Securities that are primarily serviced by the cash flows of a discrete pool of receivables or other financial assets for example, but not limited to, credit card receivables, car loans, recreational vehicle loans, and mobile home loans." } } }, "auth_ref": [ "r760", "r902", "r903", "r904" ] }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax", "crdr": "debit", "presentation": [ "http://www.quidel.com/role/AccumulatedOtherComprehensiveLossDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Tax impact related to cash flow hedges", "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax", "documentation": "Amount, before reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness." } } }, "auth_ref": [ "r205" ] }, "qdel_InventoriesIncludingNoncurrentPortionNet": { "xbrltype": "monetaryItemType", "nsuri": "http://www.quidel.com/20231001", "localname": "InventoriesIncludingNoncurrentPortionNet", "crdr": "debit", "calculation": { "http://www.quidel.com/role/BalanceSheetAccountDetailsInventoriesDetails": { "parentTag": null, "weight": null, "order": null, "root": true }, "http://www.quidel.com/role/BalanceSheetAccountDetailsInventoriesDetails_1": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.quidel.com/role/BalanceSheetAccountDetailsInventoriesDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Inventories, including noncurrent portion, net", "label": "Inventories, including noncurrent portion, net", "documentation": "Inventories, including noncurrent portion, net" } } }, "auth_ref": [] }, "srt_ScenarioUnspecifiedDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ScenarioUnspecifiedDomain", "presentation": [ "http://www.quidel.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofInterestRateDerivativesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Scenario [Domain]", "label": "Scenario [Domain]" } } }, "auth_ref": [ "r241", "r433", "r860", "r898" ] }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax", "crdr": "credit", "calculation": { "http://www.quidel.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.quidel.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "totalLabel": "Total change in unrealized gains from cash flow hedges, net of tax", "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax", "documentation": "Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness." } } }, "auth_ref": [ "r200", "r204" ] }, "qdel_InterestRateSwapOneMember": { "xbrltype": "domainItemType", "nsuri": "http://www.quidel.com/20231001", "localname": "InterestRateSwapOneMember", "presentation": [ "http://www.quidel.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofInterestRateDerivativesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest Rate Swap One", "label": "Interest Rate Swap One [Member]", "documentation": "Interest Rate Swap One" } } }, "auth_ref": [] }, "us-gaap_SegmentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentDomain", "presentation": [ "http://www.quidel.com/role/BalanceSheetAccountDetailsGoodwillRollforwardDetails", "http://www.quidel.com/role/SegmentandGeographicInformationReconciliationtoIncomeDetails", "http://www.quidel.com/role/SegmentandGeographicInformationTotalRevenuesbyReportableSegmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Segments [Domain]", "label": "Segments [Domain]", "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity." } } }, "auth_ref": [ "r259", "r262", "r263", "r264", "r265", "r266", "r267", "r268", "r269", "r270", "r271", "r272", "r273", "r275", "r276", "r277", "r278", "r279", "r280", "r281", "r282", "r283", "r285", "r290", "r340", "r341", "r342", "r343", "r344", "r345", "r346", "r347", "r348", "r354", "r355", "r605", "r606", "r607", "r608", "r609", "r610", "r611", "r612", "r613", "r614", "r615", "r746", "r867", "r953" ] }, "us-gaap_StockRepurchasedDuringPeriodValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockRepurchasedDuringPeriodValue", "crdr": "debit", "presentation": [ "http://www.quidel.com/role/ConsolidatedStatementsofStockholdersEquityStatement" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Repurchases of common stock", "label": "Stock Repurchased During Period, Value", "documentation": "Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock." } } }, "auth_ref": [ "r20", "r120", "r121", "r153", "r638", "r699", "r722", "r782" ] }, "us-gaap_DerivativeAssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeAssetsCurrent", "crdr": "debit", "calculation": { "http://www.quidel.com/role/BalanceSheetAccountDetailsPrepaidexpensesandothercurrentassetsDetails": { "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.quidel.com/role/BalanceSheetAccountDetailsPrepaidexpensesandothercurrentassetsDetails", "http://www.quidel.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofFairValueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivatives", "verboseLabel": "Derivative Asset, Current", "label": "Derivative Asset, Current", "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset." } } }, "auth_ref": [ "r198" ] }, "us-gaap_LetterOfCreditMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LetterOfCreditMember", "presentation": [ "http://www.quidel.com/role/BorrowingsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Letter of Credit", "label": "Letter of Credit [Member]", "documentation": "A document typically issued by a financial institution which acts as a guarantee of payment to a beneficiary, or as the source of payment for a specific transaction (for example, wiring funds to a foreign exporter if and when specified merchandise is accepted pursuant to the terms of the letter of credit)." } } }, "auth_ref": [] }, "us-gaap_StatementBusinessSegmentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementBusinessSegmentsAxis", "presentation": [ "http://www.quidel.com/role/BalanceSheetAccountDetailsGoodwillRollforwardDetails", "http://www.quidel.com/role/SegmentandGeographicInformationReconciliationtoIncomeDetails", "http://www.quidel.com/role/SegmentandGeographicInformationTotalRevenuesbyReportableSegmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Segments [Axis]", "label": "Segments [Axis]", "documentation": "Information by business segments." } } }, "auth_ref": [ "r182", "r259", "r262", "r263", "r264", "r265", "r266", "r267", "r268", "r269", "r270", "r271", "r272", "r273", "r275", "r276", "r277", "r278", "r279", "r280", "r281", "r282", "r283", "r285", "r290", "r340", "r341", "r342", "r343", "r344", "r345", "r346", "r347", "r348", "r352", "r354", "r355", "r605", "r606", "r607", "r608", "r609", "r610", "r611", "r612", "r613", "r614", "r615", "r746", "r867", "r953" ] }, "ecd_PayVsPerformanceDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PayVsPerformanceDisclosureLineItems", "lang": { "en-us": { "role": { "label": "Pay vs Performance Disclosure [Line Items]" } } }, "auth_ref": [ "r822" ] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://www.quidel.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Amendment Flag", "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "us-gaap_IncomeTaxesReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxesReceivable", "crdr": "debit", "calculation": { "http://www.quidel.com/role/BalanceSheetAccountDetailsPrepaidexpensesandothercurrentassetsDetails": { "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.quidel.com/role/BalanceSheetAccountDetailsPrepaidexpensesandothercurrentassetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Income taxes and other tax receivables", "label": "Income Taxes Receivable, Current", "documentation": "Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes." } } }, "auth_ref": [ "r112", "r882" ] }, "us-gaap_FairValueDisclosuresTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueDisclosuresTextBlock", "presentation": [ "http://www.quidel.com/role/FairValueMeasurements" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value Measurements", "label": "Fair Value Disclosures [Text Block]", "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information." } } }, "auth_ref": [ "r522" ] }, "ecd_RestatementDoesNotRequireRecoveryTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RestatementDoesNotRequireRecoveryTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Restatement does not require Recovery", "label": "Restatement Does Not Require Recovery [Text Block]" } } }, "auth_ref": [ "r798", "r809", "r819", "r844" ] }, "ecd_AwardTmgDiscLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgDiscLineItems", "lang": { "en-us": { "role": { "label": "Award Timing Disclosures [Line Items]" } } }, "auth_ref": [ "r845" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum", "presentation": [ "http://www.quidel.com/role/StockBasedCompensationEstimatedFairValueofEachStockOptionAwardDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Volatility rate", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum", "documentation": "The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period." } } }, "auth_ref": [] }, "ecd_AwardsCloseToMnpiDiscIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardsCloseToMnpiDiscIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Awards Close in Time to MNPI Disclosures, Individual Name" } } }, "auth_ref": [ "r847" ] }, "us-gaap_DerivativeAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeAssets", "crdr": "debit", "presentation": [ "http://www.quidel.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative assets", "label": "Derivative Asset", "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset." } } }, "auth_ref": [ "r198", "r199", "r524", "r640", "r641", "r642", "r643", "r644", "r645", "r646", "r647", "r648", "r649", "r665", "r666", "r708", "r711", "r714", "r715", "r716", "r717", "r740", "r773", "r957" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum", "presentation": [ "http://www.quidel.com/role/StockBasedCompensationEstimatedFairValueofEachStockOptionAwardDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Risk-free interest rate", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum", "documentation": "The minimum risk-free interest rate assumption that is used in valuing an option on its own shares." } } }, "auth_ref": [] }, "us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestIncomeAndInterestExpenseDisclosureTableTextBlock", "presentation": [ "http://www.quidel.com/role/BorrowingsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Interest Expense", "label": "Interest Income and Interest Expense Disclosure [Table Text Block]", "documentation": "Tabular disclosure of interest income and expense, including, but not limited to, interest income and expense from investments, loans, and securities." } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://www.quidel.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, City or Town", "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://www.quidel.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, State or Province", "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "us-gaap_InterestIncomeOther": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestIncomeOther", "crdr": "credit", "calculation": { "http://www.quidel.com/role/BorrowingsInterestExpenseDetails": { "parentTag": "us-gaap_InterestIncomeExpenseNet", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.quidel.com/role/BorrowingsInterestExpenseDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Interest income", "label": "Interest Income, Other", "documentation": "Amount of interest income earned from interest bearing assets classified as other." } } }, "auth_ref": [] }, "us-gaap_UnrecognizedTaxBenefits": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UnrecognizedTaxBenefits", "crdr": "credit", "presentation": [ "http://www.quidel.com/role/IncomeTaxesDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Unrecognized tax benefits", "label": "Unrecognized Tax Benefits", "documentation": "Amount of unrecognized tax benefits." } } }, "auth_ref": [ "r477", "r484" ] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://www.quidel.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Document Fiscal Year Focus", "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInEmployeeRelatedLiabilities", "crdr": "debit", "calculation": { "http://www.quidel.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 13.0 } }, "presentation": [ "http://www.quidel.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued payroll and related expenses", "label": "Increase (Decrease) in Employee Related Liabilities", "documentation": "The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits." } } }, "auth_ref": [ "r14" ] }, "us-gaap_BusinessCombinationContingentConsiderationLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationContingentConsiderationLiability", "crdr": "credit", "presentation": [ "http://www.quidel.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Contingent consideration", "label": "Business Combination, Contingent Consideration, Liability", "documentation": "Amount of liability recognized arising from contingent consideration in a business combination." } } }, "auth_ref": [ "r4", "r82", "r499" ] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis", "presentation": [ "http://www.quidel.com/role/ComputationofEarningsPerShareNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Antidilutive Securities [Axis]", "label": "Antidilutive Securities [Axis]", "documentation": "Information by type of antidilutive security." } } }, "auth_ref": [ "r49" ] }, "ecd_AwardTmgMnpiDiscTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgMnpiDiscTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing MNPI Disclosure", "label": "Award Timing MNPI Disclosure [Text Block]" } } }, "auth_ref": [ "r845" ] }, "us-gaap_BusinessCombinationConsiderationTransferred1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationConsiderationTransferred1", "crdr": "credit", "presentation": [ "http://www.quidel.com/role/BusinessCombinationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Business Combination, Consideration Transferred", "label": "Business Combination, Consideration Transferred", "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer." } } }, "auth_ref": [ "r2", "r3", "r17" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://www.quidel.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Document Fiscal Period Focus (Q1,Q2,Q3,FY)", "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "us-gaap_OtherLongTermDebtNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherLongTermDebtNoncurrent", "crdr": "credit", "calculation": { "http://www.quidel.com/role/BorrowingsScheduleofBorrowingsDetails": { "parentTag": "us-gaap_LongTermDebtAndCapitalLeaseObligations", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.quidel.com/role/BorrowingsScheduleofBorrowingsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other long-term borrowings", "label": "Other Long-Term Debt, Noncurrent", "documentation": "Amount of long-term debt classified as other, payable after one year or the operating cycle, if longer." } } }, "auth_ref": [ "r34", "r656" ] }, "us-gaap_BalanceSheetLocationAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BalanceSheetLocationAxis", "presentation": [ "http://www.quidel.com/role/BalanceSheetAccountDetailsMarketableSecuritiesDetails", "http://www.quidel.com/role/RevenueNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Balance Sheet Location [Axis]", "label": "Balance Sheet Location [Axis]", "documentation": "Information by location on balance sheet (statement of financial position)." } } }, "auth_ref": [] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems", "presentation": [ "http://www.quidel.com/role/ComputationofEarningsPerShareNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Statement [Line Items]", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfDerivativeAssetsAtFairValueTableTextBlock", "presentation": [ "http://www.quidel.com/role/DerivativeInstrumentsandHedgingActivitiesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Derivative Assets at Fair Value", "label": "Schedule of Derivative Assets at Fair Value [Table Text Block]", "documentation": "Tabular disclosure of derivative assets at fair value." } } }, "auth_ref": [] }, "us-gaap_GrossProfit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GrossProfit", "crdr": "credit", "presentation": [ "http://www.quidel.com/role/RevenueNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Gross Profit", "label": "Gross Profit", "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity." } } }, "auth_ref": [ "r136", "r225", "r262", "r276", "r282", "r285", "r325", "r362", "r363", "r364", "r365", "r366", "r367", "r368", "r369", "r370", "r525", "r743", "r927" ] }, "us-gaap_EarningsPerShareTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareTextBlock", "presentation": [ "http://www.quidel.com/role/ComputationofEarningsPerShare" ], "lang": { "en-us": { "role": { "terseLabel": "Computation of Earnings Per Share", "label": "Earnings Per Share [Text Block]", "documentation": "The entire disclosure for earnings per share." } } }, "auth_ref": [ "r242", "r253", "r254", "r255" ] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://www.quidel.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Postal Zip Code", "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "ecd_AwardTmgMethodTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgMethodTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing Method", "label": "Award Timing Method [Text Block]" } } }, "auth_ref": [ "r845" ] }, "us-gaap_DerivativeAssetsNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeAssetsNoncurrent", "crdr": "debit", "presentation": [ "http://www.quidel.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofFairValueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative Asset, Noncurrent", "label": "Derivative Asset, Noncurrent", "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled after one year or the normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset." } } }, "auth_ref": [ "r198" ] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "presentation": [ "http://www.quidel.com/role/ComputationofEarningsPerShareCalculationofBasicandDilutedEarningsPerShareDetails", "http://www.quidel.com/role/ComputationofEarningsPerShareNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Potentially dilutive shares excluded from calculation due to anti-dilutive effect", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount", "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented." } } }, "auth_ref": [ "r253" ] }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "presentation": [ "http://www.quidel.com/role/ComputationofEarningsPerShareTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Earnings Per Share, Basic and Diluted", "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations." } } }, "auth_ref": [ "r899" ] }, "us-gaap_OtherAssetsNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherAssetsNoncurrent", "crdr": "debit", "calculation": { "http://www.quidel.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://www.quidel.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Other assets", "label": "Other Assets, Noncurrent", "documentation": "Amount of noncurrent assets classified as other." } } }, "auth_ref": [ "r188" ] }, "us-gaap_EarningsPerShareAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareAbstract", "lang": { "en-us": { "role": { "terseLabel": "Earnings Per Share [Abstract]", "label": "Earnings Per Share [Abstract]" } } }, "auth_ref": [] }, "us-gaap_InventoryNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryNoncurrent", "crdr": "debit", "calculation": { "http://www.quidel.com/role/BalanceSheetAccountDetailsInventoriesDetails": { "parentTag": "qdel_InventoriesIncludingNoncurrentPortionNet", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.quidel.com/role/BalanceSheetAccountDetailsInventoriesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Inventory, Noncurrent", "label": "Inventory, Noncurrent", "documentation": "Inventories not expected to be converted to cash, sold or exchanged within the normal operating cycle." } } }, "auth_ref": [ "r878" ] }, "us-gaap_GoodwillLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillLineItems", "presentation": [ "http://www.quidel.com/role/BalanceSheetAccountDetailsGoodwillRollforwardDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Goodwill [Line Items]", "label": "Goodwill [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r340", "r341", "r342", "r343", "r344", "r345", "r346", "r347", "r348", "r349", "r350", "r746" ] }, "ecd_AwardTmgPredtrmndFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgPredtrmndFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing Predetermined", "label": "Award Timing Predetermined [Flag]" } } }, "auth_ref": [ "r845" ] }, "us-gaap_IncreaseDecreaseInPrepaidExpensesOther": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInPrepaidExpensesOther", "crdr": "credit", "calculation": { "http://www.quidel.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 11.0 } }, "presentation": [ "http://www.quidel.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Prepaid expenses and other current and non-current assets", "label": "Increase (Decrease) in Prepaid Expenses, Other", "documentation": "Amount of increase (decrease) of consideration paid in advance for other costs that provide economic benefits in future periods." } } }, "auth_ref": [ "r14" ] }, "us-gaap_SegmentReportingDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentReportingDisclosureTextBlock", "presentation": [ "http://www.quidel.com/role/SegmentandGeographicInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Segment and Geographic Information", "label": "Segment Reporting Disclosure [Text Block]", "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments." } } }, "auth_ref": [ "r258", "r259", "r260", "r261", "r262", "r274", "r279", "r283", "r284", "r285", "r286", "r287", "r288", "r290" ] }, "us-gaap_OtherCostAndExpenseOperating": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherCostAndExpenseOperating", "crdr": "debit", "calculation": { "http://www.quidel.com/role/ConsolidatedStatementsofIncome": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 7.0 } }, "presentation": [ "http://www.quidel.com/role/ConsolidatedStatementsofIncome" ], "lang": { "en-us": { "role": { "terseLabel": "Other operating expenses", "label": "Other Cost and Expense, Operating", "documentation": "The total amount of other operating cost and expense items that are associated with the entity's normal revenue producing operation." } } }, "auth_ref": [ "r137", "r603" ] }, "us-gaap_BusinessCombinationDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationDisclosureTextBlock", "presentation": [ "http://www.quidel.com/role/BusinessCombination" ], "lang": { "en-us": { "role": { "terseLabel": "Business Combination", "label": "Business Combination Disclosure [Text Block]", "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable)." } } }, "auth_ref": [ "r156", "r498" ] }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "crdr": "credit", "presentation": [ "http://www.quidel.com/role/AccumulatedOtherComprehensiveLossDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Beginning balance", "periodEndLabel": "Ending balance", "label": "Equity, Including Portion Attributable to Noncontrolling Interest", "documentation": "Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity." } } }, "auth_ref": [ "r83", "r84", "r85", "r179", "r180", "r214", "r228", "r229", "r230", "r232", "r238", "r326", "r327", "r402", "r471", "r472", "r473", "r488", "r489", "r512", "r513", "r514", "r515", "r516", "r517", "r519", "r527", "r529", "r533", "r540", "r624", "r625", "r637", "r661", "r677", "r700", "r701", "r723", "r782", "r893", "r909", "r940", "r959" ] }, "us-gaap_DerivativeLiabilitiesNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeLiabilitiesNoncurrent", "crdr": "credit", "presentation": [ "http://www.quidel.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofFairValueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative Liability, Noncurrent", "label": "Derivative Liability, Noncurrent", "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled after one year or the normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset." } } }, "auth_ref": [ "r198" ] }, "ecd_AwardTmgMnpiCnsdrdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgMnpiCnsdrdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing MNPI Considered", "label": "Award Timing MNPI Considered [Flag]" } } }, "auth_ref": [ "r845" ] }, "us-gaap_Liabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Liabilities", "crdr": "credit", "calculation": { "http://www.quidel.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.quidel.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total liabilities", "label": "Liabilities", "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future." } } }, "auth_ref": [ "r31", "r225", "r325", "r362", "r363", "r364", "r365", "r366", "r367", "r368", "r369", "r370", "r502", "r504", "r505", "r525", "r657", "r742", "r783", "r927", "r943", "r944" ] }, "us-gaap_ScheduleOfGoodwillTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfGoodwillTable", "presentation": [ "http://www.quidel.com/role/BalanceSheetAccountDetailsGoodwillRollforwardDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Goodwill [Table]", "label": "Schedule of Goodwill [Table]", "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons." } } }, "auth_ref": [ "r340", "r341", "r342", "r343", "r344", "r345", "r346", "r347", "r348", "r349", "r350", "r746" ] }, "us-gaap_HedgingDesignationDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "HedgingDesignationDomain", "presentation": [ "http://www.quidel.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofCurrencyHedgingInstrumentsDetails", "http://www.quidel.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofFairValueDetails", "http://www.quidel.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofInterestRateDerivativesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Hedging Designation [Domain]", "label": "Hedging Designation [Domain]", "documentation": "Designation of purpose of derivative instrument." } } }, "auth_ref": [ "r21" ] }, "us-gaap_Revenues": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Revenues", "crdr": "credit", "calculation": { "http://www.quidel.com/role/ConsolidatedStatementsofIncome": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.quidel.com/role/ConsolidatedStatementsofIncome", "http://www.quidel.com/role/RevenueDisaggregationofRevenueDetails", "http://www.quidel.com/role/SegmentandGeographicInformationTotalRevenuesbyReportableSegmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Total revenues", "label": "Revenues", "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss)." } } }, "auth_ref": [ "r216", "r225", "r263", "r264", "r275", "r280", "r281", "r287", "r289", "r290", "r325", "r362", "r363", "r364", "r365", "r366", "r367", "r368", "r369", "r370", "r525", "r583", "r927" ] }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "presentation": [ "http://www.quidel.com/role/DerivativeInstrumentsandHedgingActivities" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative Instruments and Hedging Activities", "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]", "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts." } } }, "auth_ref": [ "r158", "r510", "r518" ] }, "us-gaap_AccruedIncomeTaxesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccruedIncomeTaxesCurrent", "crdr": "credit", "calculation": { "http://www.quidel.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.quidel.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Income tax payable", "label": "Accrued Income Taxes, Current", "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations." } } }, "auth_ref": [ "r119", "r162" ] }, "us-gaap_BusinessCombinationAcquisitionRelatedCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationAcquisitionRelatedCosts", "crdr": "debit", "calculation": { "http://www.quidel.com/role/SegmentandGeographicInformationReconciliationtoIncomeDetails": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0, "order": 5.0 }, "http://www.quidel.com/role/ConsolidatedStatementsofIncome": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 6.0 } }, "presentation": [ "http://www.quidel.com/role/ConsolidatedStatementsofIncome", "http://www.quidel.com/role/SegmentandGeographicInformationReconciliationtoIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Acquisition and integration costs", "negatedTerseLabel": "Acquisition and integration costs", "label": "Business Combination, Acquisition Related Costs", "documentation": "This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities." } } }, "auth_ref": [ "r79" ] }, "us-gaap_OperatingIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingIncomeLoss", "crdr": "credit", "calculation": { "http://www.quidel.com/role/ConsolidatedStatementsofIncome": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.quidel.com/role/ConsolidatedStatementsofIncome" ], "lang": { "en-us": { "role": { "totalLabel": "Operating income", "label": "Operating Income (Loss)", "documentation": "The net result for the period of deducting operating expenses from operating revenues." } } }, "auth_ref": [ "r262", "r276", "r282", "r285", "r743" ] }, "us-gaap_PreferredStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockSharesIssued", "presentation": [ "http://www.quidel.com/role/ConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred stock, shares issued (in shares)", "label": "Preferred Stock, Shares Issued", "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt." } } }, "auth_ref": [ "r120", "r400" ] }, "us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate", "crdr": "credit", "presentation": [ "http://www.quidel.com/role/IncomeTaxesDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Unrecognized tax benefits the could impact effective tax rate", "label": "Unrecognized Tax Benefits that Would Impact Effective Tax Rate", "documentation": "The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate." } } }, "auth_ref": [ "r485" ] }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock", "presentation": [ "http://www.quidel.com/role/SegmentandGeographicInformationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Segment Reporting Information, by Segment", "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]", "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss." } } }, "auth_ref": [ "r57", "r58", "r59", "r63" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://www.quidel.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "City Area Code", "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "ecd_AwardTmgHowMnpiCnsdrdTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgHowMnpiCnsdrdTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing, How MNPI Considered", "label": "Award Timing, How MNPI Considered [Text Block]" } } }, "auth_ref": [ "r845" ] }, "ecd_TrdArrSecuritiesAggAvailAmt": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrSecuritiesAggAvailAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Available", "label": "Trading Arrangement, Securities Aggregate Available Amount" } } }, "auth_ref": [ "r857" ] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://www.quidel.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Document Period End Date", "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet", "crdr": "credit", "presentation": [ "http://www.quidel.com/role/DerivativeInstrumentsandHedgingActivitiesNarrativeDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Fair value gain (loss) on derivative instruments not designated as hedging instruments", "label": "Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net", "documentation": "Amount of realized and unrealized gain (loss) of derivative instruments not designated or qualifying as hedging instruments." } } }, "auth_ref": [ "r97", "r866" ] }, "ecd_InsiderTradingPoliciesProcLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTradingPoliciesProcLineItems", "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures [Line Items]" } } }, "auth_ref": [ "r788", "r858" ] }, "us-gaap_InterestRateSwapMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestRateSwapMember", "presentation": [ "http://www.quidel.com/role/DerivativeInstrumentsandHedgingActivitiesNarrativeDetails", "http://www.quidel.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofFairValueDetails", "http://www.quidel.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofGainLossDetails", "http://www.quidel.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofInterestRateDerivativesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest Rate Swap", "label": "Interest Rate Swap [Member]", "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period." } } }, "auth_ref": [ "r729", "r778", "r779" ] }, "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation", "crdr": "credit", "calculation": { "http://www.quidel.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://www.quidel.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Payments of tax withholdings related to vesting of stock-based awards", "label": "Payment, Tax Withholding, Share-Based Payment Arrangement", "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement." } } }, "auth_ref": [ "r221" ] }, "us-gaap_GoodwillPurchaseAccountingAdjustments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillPurchaseAccountingAdjustments", "crdr": "debit", "presentation": [ "http://www.quidel.com/role/BalanceSheetAccountDetailsGoodwillRollforwardDetails", "http://www.quidel.com/role/BusinessCombinationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Measurement period adjustments of goodwill", "verboseLabel": "Purchase accounting adjustments", "label": "Goodwill, Purchase Accounting Adjustments", "documentation": "Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized." } } }, "auth_ref": [ "r1", "r919" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://www.quidel.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Local Phone Number", "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList": { "xbrltype": "enumerationSetItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList", "presentation": [ "http://www.quidel.com/role/BorrowingsScheduleofBorrowingsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]", "label": "Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]", "documentation": "Indicates line item in statement of financial position that includes noncurrent finance lease liability." } } }, "auth_ref": [ "r537" ] }, "ecd_AwardsCloseToMnpiDiscTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardsCloseToMnpiDiscTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Awards Close in Time to MNPI Disclosures, Table", "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]" } } }, "auth_ref": [ "r846" ] }, "us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentForContingentConsiderationLiabilityFinancingActivities", "crdr": "credit", "calculation": { "http://www.quidel.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 7.0 } }, "presentation": [ "http://www.quidel.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Principal payments of acquisition contingent consideration", "label": "Payment for Contingent Consideration Liability, Financing Activities", "documentation": "Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability up to amount recognized at acquisition date, including, but not limited to, measurement period adjustment and less amount paid soon after acquisition date." } } }, "auth_ref": [ "r11" ] }, "us-gaap_StockRepurchasedDuringPeriodShares": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockRepurchasedDuringPeriodShares", "presentation": [ "http://www.quidel.com/role/ConsolidatedStatementsofStockholdersEquityStatement" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Repurchases of common stock (in shares)", "label": "Stock Repurchased During Period, Shares", "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock." } } }, "auth_ref": [ "r20", "r120", "r121", "r153", "r631", "r699", "r722" ] }, "us-gaap_AcquisitionRelatedCostsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AcquisitionRelatedCostsMember", "presentation": [ "http://www.quidel.com/role/StockBasedCompensationCompensationExpenseRelatedtoStockBasedCompensationPlansDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Acquisition and integration costs", "label": "Acquisition-related Costs [Member]", "documentation": "Category of acquisition-related costs allocated to (included in) reported pro forma earnings (supplemental pro forma information)." } } }, "auth_ref": [] }, "us-gaap_GoodwillRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillRollForward", "presentation": [ "http://www.quidel.com/role/BalanceSheetAccountDetailsGoodwillRollforwardDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Goodwill [Roll Forward]", "label": "Goodwill [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "qdel_CustomerAMember": { "xbrltype": "domainItemType", "nsuri": "http://www.quidel.com/20231001", "localname": "CustomerAMember", "presentation": [ "http://www.quidel.com/role/RevenueNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Customer A", "label": "Customer A [Member]", "documentation": "Customer A" } } }, "auth_ref": [] }, "us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems", "presentation": [ "http://www.quidel.com/role/SegmentandGeographicInformationReconciliationtoIncomeDetails", "http://www.quidel.com/role/SegmentandGeographicInformationTotalRevenuesbyReportableSegmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]", "label": "Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_PreferredStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockSharesAuthorized", "presentation": [ "http://www.quidel.com/role/ConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred stock, shares authorized (in shares)", "label": "Preferred Stock, Shares Authorized", "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r120", "r659" ] }, "us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList": { "xbrltype": "enumerationSetItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList", "presentation": [ "http://www.quidel.com/role/BalanceSheetAccountDetailsOtherCurrentLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]", "label": "Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]", "documentation": "Indicates line item in statement of financial position that includes current operating lease liability." } } }, "auth_ref": [ "r537" ] }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable", "presentation": [ "http://www.quidel.com/role/ComputationofEarningsPerShareNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Statement [Table]", "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]", "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities." } } }, "auth_ref": [ "r49" ] }, "us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable", "presentation": [ "http://www.quidel.com/role/SegmentandGeographicInformationReconciliationtoIncomeDetails", "http://www.quidel.com/role/SegmentandGeographicInformationTotalRevenuesbyReportableSegmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table]", "label": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table]", "documentation": "Disclosure of information about the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment." } } }, "auth_ref": [ "r60", "r61" ] }, "us-gaap_PreferredStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockSharesOutstanding", "presentation": [ "http://www.quidel.com/role/ConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred stock, shares outstanding (in shares)", "label": "Preferred Stock, Shares Outstanding", "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased." } } }, "auth_ref": [ "r120", "r659", "r677", "r959", "r960" ] }, "us-gaap_DerivativeLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.quidel.com/role/BalanceSheetAccountDetailsOtherCurrentLiabilitiesDetails": { "parentTag": "us-gaap_OtherLiabilitiesCurrent", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.quidel.com/role/BalanceSheetAccountDetailsOtherCurrentLiabilitiesDetails", "http://www.quidel.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofFairValueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivatives", "verboseLabel": "Derivative Liability, Current", "label": "Derivative Liability, Current", "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset." } } }, "auth_ref": [ "r198" ] }, "us-gaap_DebtInstrumentNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentNameDomain", "presentation": [ "http://www.quidel.com/role/BorrowingsInterestExpenseDetails", "http://www.quidel.com/role/BorrowingsNarrativeDetails", "http://www.quidel.com/role/BorrowingsScheduleofBorrowingsDetails", "http://www.quidel.com/role/FairValueMeasurementsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt Instrument, Name [Domain]", "label": "Debt Instrument, Name [Domain]", "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities." } } }, "auth_ref": [ "r34", "r227", "r372", "r373", "r374", "r375", "r376", "r378", "r383", "r384", "r385", "r386", "r388", "r389", "r390", "r391", "r392", "r393", "r534", "r747", "r748", "r749", "r750", "r751", "r892" ] }, "us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInAccruedIncomeTaxesPayable", "crdr": "debit", "calculation": { "http://www.quidel.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 14.0 } }, "presentation": [ "http://www.quidel.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Income taxes payable", "label": "Increase (Decrease) in Income Taxes Payable", "documentation": "The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction." } } }, "auth_ref": [ "r14" ] }, "ecd_MnpiDiscTimedForCompValFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MnpiDiscTimedForCompValFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "MNPI Disclosure Timed for Compensation Value", "label": "MNPI Disclosure Timed for Compensation Value [Flag]" } } }, "auth_ref": [ "r845" ] }, "us-gaap_OtherNonoperatingIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherNonoperatingIncomeExpense", "crdr": "credit", "calculation": { "http://www.quidel.com/role/ConsolidatedStatementsofIncome": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.quidel.com/role/ConsolidatedStatementsofIncome" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Other expense (income), net", "label": "Other Nonoperating Income (Expense)", "documentation": "Amount of income (expense) related to nonoperating activities, classified as other." } } }, "auth_ref": [ "r140" ] }, "us-gaap_DerivativeLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeLineItems", "presentation": [ "http://www.quidel.com/role/DerivativeInstrumentsandHedgingActivitiesNarrativeDetails", "http://www.quidel.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofCurrencyHedgingInstrumentsDetails", "http://www.quidel.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofFairValueDetails", "http://www.quidel.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofInterestRateDerivativesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative [Line Items]", "label": "Derivative [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r518" ] }, "us-gaap_LiabilitiesAndStockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesAndStockholdersEquity", "crdr": "credit", "calculation": { "http://www.quidel.com/role/ConsolidatedBalanceSheets": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.quidel.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total liabilities and stockholders\u2019 equity", "label": "Liabilities and Equity", "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any." } } }, "auth_ref": [ "r126", "r164", "r594", "r768", "r893", "r909", "r940" ] }, "us-gaap_IncreaseDecreaseInInventories": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInInventories", "crdr": "credit", "calculation": { "http://www.quidel.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 10.0 } }, "presentation": [ "http://www.quidel.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Inventories", "label": "Increase (Decrease) in Inventories", "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities." } } }, "auth_ref": [ "r14" ] }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesAndStockholdersEquityAbstract", "presentation": [ "http://www.quidel.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY", "label": "Liabilities and Equity [Abstract]" } } }, "auth_ref": [] }, "ecd_AwardsCloseToMnpiDiscTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardsCloseToMnpiDiscTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Awards Close in Time to MNPI Disclosures", "label": "Awards Close in Time to MNPI Disclosures [Table]" } } }, "auth_ref": [ "r846" ] }, "us-gaap_DerivativeTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeTable", "presentation": [ "http://www.quidel.com/role/DerivativeInstrumentsandHedgingActivitiesNarrativeDetails", "http://www.quidel.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofCurrencyHedgingInstrumentsDetails", "http://www.quidel.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofFairValueDetails", "http://www.quidel.com/role/DerivativeInstrumentsandHedgingActivitiesScheduleofInterestRateDerivativesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative [Table]", "label": "Derivative [Table]", "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item." } } }, "auth_ref": [ "r21", "r86", "r87", "r88", "r89", "r92", "r95", "r99", "r100", "r101", "r518" ] }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock", "presentation": [ "http://www.quidel.com/role/FairValueMeasurementsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Assets and Liabilities Measured at Fair Value on Recurring Basis", "label": "Fair Value, Liabilities Measured on Recurring Basis [Table Text Block]", "documentation": "Tabular disclosure of liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3). Where the quoted price in an active market for the identical liability is not available, the Level 1 input is the quoted price of an identical liability when traded as an asset." } } }, "auth_ref": [ "r103", "r159" ] }, "us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization", "crdr": "debit", "calculation": { "http://www.quidel.com/role/ConsolidatedStatementsofIncome": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.quidel.com/role/ConsolidatedStatementsofIncome" ], "lang": { "en-us": { "role": { "terseLabel": "Cost of sales, excluding amortization of intangibles", "label": "Cost of Goods and Service, Excluding Depreciation, Depletion, and Amortization", "documentation": "Cost of product sold and service rendered, excluding depreciation, depletion, and amortization." } } }, "auth_ref": [ "r868", "r869" ] } } } }, "std_ref": { "r0": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "1", "SubTopic": "20", "Topic": "940", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481913/940-20-25-1" }, "r1": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "16", "SubTopic": "10", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479405/805-10-25-16" }, "r2": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "30", "Paragraph": "7", "SubTopic": "30", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479637/805-30-30-7" }, "r3": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "30", "Paragraph": "8", "SubTopic": "30", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479637/805-30-30-8" }, "r4": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "1", "Subparagraph": "(b)", "SubTopic": "30", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479613/805-30-35-1" }, "r5": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "SubTopic": "230", "Topic": "830", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1" }, "r6": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r7": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r8": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(a),(b),(c)", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r9": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(i),(j),(k)", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r10": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14" }, "r11": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "15", "Subparagraph": "(f)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r12": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "15", "Subparagraph": "(g)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r13": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-20" }, "r14": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r15": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r16": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "360", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r17": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "SubTopic": "30", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1" }, "r18": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c)(3)", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r19": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c),(3)", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r20": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "SubTopic": "10", "Topic": "505", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2" }, "r21": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "SubTopic": "10", "Topic": "815", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-2" }, "r22": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(4)", "SubTopic": "10", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2" }, "r23": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "a", "SubTopic": "10", "Topic": "280", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r24": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4D", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "815", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D" }, "r25": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482739/220-10-55-15" }, "r26": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22))", "SubTopic": "10", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r27": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483489/210-10-50-1" }, "r28": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19(a)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r29": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r30": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19(b),22(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r31": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19-26)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r32": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.20)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r33": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.21)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r34": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.22)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r35": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.24)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r36": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.25)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r37": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.29-31)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r38": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14" }, "r39": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "14A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14A" }, "r40": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-5" }, "r41": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12" }, "r42": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13" }, "r43": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14" }, "r44": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r45": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4" }, "r46": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-3" }, "r47": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-4" }, "r48": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-5" }, "r49": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r50": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18" }, "r51": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18" }, "r52": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "18", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18" }, "r53": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-20" }, "r54": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-4" }, "r55": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-8" }, "r56": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-9" }, "r57": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r58": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25" }, "r59": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "30", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r60": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "30", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r61": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31" }, "r62": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "330", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483080/330-10-50-1" }, "r63": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "20", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r64": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-1" }, "r65": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-2" }, "r66": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "2", "Subparagraph": "((a)(1),(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r67": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r68": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "10", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481544/470-10-50-5" }, "r69": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "50", "Section": "40", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481303/470-50-40-2" }, "r70": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "50", "Section": "40", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481303/470-50-40-4" }, "r71": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3" }, "r72": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-8" }, "r73": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r74": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r75": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "20", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-12" }, "r76": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "20", "Section": "55", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-13" }, "r77": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "720", "SubTopic": "30", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483384/720-30-45-1" }, "r78": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "740", "SubTopic": "10", "Section": "50", "Paragraph": "15", "Subparagraph": "(d)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15" }, "r79": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "25", "Paragraph": "23", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479405/805-10-25-23" }, "r80": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2" }, "r81": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-3" }, "r82": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "30", "Section": "25", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479668/805-30-25-6" }, "r83": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-15" }, "r84": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "45", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-16" }, "r85": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "55", "Paragraph": "4I", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4I" }, "r86": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1" }, "r87": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1A" }, "r88": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1B" }, "r89": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4" }, "r90": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A" }, "r91": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A" }, "r92": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B" }, "r93": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4B", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B" }, "r94": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B" }, "r95": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4C", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C" }, "r96": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4C", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C" }, "r97": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4C", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C" }, "r98": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4D", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D" }, "r99": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-5" }, "r100": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-8" }, "r101": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "25", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480238/815-25-50-1" }, "r102": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "30", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480870/815-30-50-1" }, "r103": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "820", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r104": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-11" }, "r105": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-12" }, "r106": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-20" }, "r107": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "21", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-21" }, "r108": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "45", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-1A" }, "r109": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-2" }, "r110": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-3" }, "r111": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482949/835-30-55-8" }, "r112": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "210", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03.10)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r113": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "210", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03.15(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r114": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "210", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03.17)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r115": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "210", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03.4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r116": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "470", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480848/942-470-50-3" }, "r117": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "985", "SubTopic": "20", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481283/985-20-50-1" }, "r118": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r119": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r120": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r121": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r122": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r123": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r124": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r125": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(31))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r126": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(32))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r127": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r128": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r129": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r130": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//220/tableOfContent" }, "r131": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-11" }, "r132": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r133": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r134": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r135": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r136": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.1,2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r137": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r138": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r139": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.8)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r140": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.9)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r141": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13" }, "r142": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24" }, "r143": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25" }, "r144": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r145": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "235", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//235/tableOfContent" }, "r146": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 4.E)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2" }, "r147": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "330", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.BB)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480581/330-10-S99-2" }, "r148": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482130/360-10-45-15" }, "r149": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "440", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//440/tableOfContent" }, "r150": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "470", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//470/tableOfContent" }, "r151": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-6" }, "r152": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-7" }, "r153": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r154": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "718", "SubTopic": "10", "Subparagraph": "(e)(2)", "Name": "Accounting Standards Codification", "Paragraph": "2", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r155": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "718", "SubTopic": "10", "Subparagraph": "(f)(2)", "Name": "Accounting Standards Codification", "Paragraph": "2", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r156": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "805", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//805/tableOfContent" }, "r157": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19" }, "r158": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "815", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//815/tableOfContent" }, "r159": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r160": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r161": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(13))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r162": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(15)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r163": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r164": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r165": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03.13,16)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r166": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(13)(f))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r167": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r168": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r169": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04.10)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r170": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Subparagraph": "(a)", "SubTopic": "20", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2" }, "r171": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "SubTopic": "210", "Topic": "954", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480632/954-210-45-5" }, "r172": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1" }, "r173": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1" }, "r174": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-11" }, "r175": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-12" }, "r176": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4C", "Subparagraph": "(c)", "SubTopic": "10", "Topic": "815", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C" }, "r177": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h))", "SubTopic": "10", "Topic": "235", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r178": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Topic": "606", "Publisher": "FASB", "URI": "https://asc.fasb.org//606/tableOfContent" }, "r179": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6" }, "r180": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6" }, "r181": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483504/205-10-50-1" }, "r182": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-1" }, "r183": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7" }, "r184": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r185": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-5" }, "r186": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r187": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r188": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r189": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r190": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r191": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r192": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(3)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r193": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r194": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r195": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r196": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r197": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r198": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-3" }, "r199": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-10" }, "r200": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r201": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r202": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r203": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r204": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-11" }, "r205": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-12" }, "r206": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14A" }, "r207": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-15" }, "r208": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r209": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r210": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r211": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B" }, "r212": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B" }, "r213": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4" }, "r214": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5" }, "r215": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6" }, "r216": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r217": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r218": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r219": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r220": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14" }, "r221": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "15", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r222": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24" }, "r223": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8" }, "r224": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r225": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r226": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r227": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-04(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3" }, "r228": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23" }, "r229": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24" }, "r230": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5" }, "r231": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r232": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r233": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r234": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r235": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3" }, "r236": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4" }, "r237": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r238": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r239": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8" }, "r240": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9" }, "r241": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SAB Topic 11.M.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480530/250-10-S99-5" }, "r242": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//260/tableOfContent" }, "r243": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10" }, "r244": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-16" }, "r245": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2" }, "r246": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-22" }, "r247": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-23" }, "r248": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-28A" }, "r249": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r250": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r251": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-7" }, "r252": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r253": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r254": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2" }, "r255": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-3" }, "r256": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-15" }, "r257": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1" }, "r258": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//280/tableOfContent" }, "r259": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-15" }, "r260": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-21" }, "r261": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-21" }, "r262": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r263": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r264": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r265": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r266": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r267": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r268": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r269": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r270": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r271": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(j)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r272": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25" }, "r273": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "25", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25" }, "r274": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "26", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-26" }, "r275": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r276": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r277": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r278": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r279": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31" }, "r280": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r281": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r282": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r283": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r284": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r285": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r286": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "34", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-34" }, "r287": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "40", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40" }, "r288": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r289": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r290": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "42", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42" }, "r291": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-2" }, "r292": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-9" }, "r293": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r294": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r295": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(aa)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r296": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(aaa)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r297": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r298": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r299": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r300": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3" }, "r301": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3" }, "r302": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3" }, "r303": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3" }, "r304": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3" }, "r305": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r306": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r307": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(aaa)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r308": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r309": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r310": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r311": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r312": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r313": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r314": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r315": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A" }, "r316": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A" }, "r317": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A" }, "r318": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B" }, "r319": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B" }, "r320": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B" }, "r321": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B" }, "r322": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B" }, "r323": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-9" }, "r324": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481664/323-10-45-1" }, "r325": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r326": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4" }, "r327": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5" }, "r328": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-11" }, "r329": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13" }, "r330": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-14" }, "r331": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-16" }, "r332": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-5" }, "r333": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479130/326-30-45-1" }, "r334": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-4" }, "r335": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-7" }, "r336": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-9" }, "r337": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "340", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "05", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482955/340-10-05-5" }, "r338": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "340", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483032/340-10-45-1" }, "r339": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482598/350-20-45-1" }, "r340": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r341": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r342": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r343": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r344": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r345": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r346": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r347": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r348": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r349": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1A" }, "r350": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-2" }, "r351": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3" }, "r352": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3" }, "r353": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r354": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r355": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2" }, "r356": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4" }, "r357": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4" }, "r358": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4" }, "r359": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9" }, "r360": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r361": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r362": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r363": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r364": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r365": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r366": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r367": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r368": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r369": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r370": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r371": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r372": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r373": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r374": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r375": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r376": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r377": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r378": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r379": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r380": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C" }, "r381": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C" }, "r382": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C" }, "r383": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r384": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r385": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r386": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r387": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r388": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r389": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r390": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r391": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r392": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r393": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r394": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r395": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r396": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r397": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r398": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-4" }, "r399": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-6" }, "r400": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r401": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r402": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r403": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479837/606-10-45-1" }, "r404": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479837/606-10-45-3" }, "r405": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-10" }, "r406": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12" }, "r407": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12" }, "r408": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12" }, "r409": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12" }, "r410": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12" }, "r411": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-13" }, "r412": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-15" }, "r413": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-17" }, "r414": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-18" }, "r415": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-18" }, "r416": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-19" }, "r417": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20" }, "r418": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20" }, "r419": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20" }, "r420": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20" }, "r421": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-4" }, "r422": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5" }, "r423": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-8" }, "r424": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-9" }, "r425": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r426": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r427": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r428": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(A)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r429": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(B)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r430": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(C)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r431": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r432": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5" }, "r433": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5" }, "r434": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//718/tableOfContent" }, "r435": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "1D", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-1D" }, "r436": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-2" }, "r437": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-3" }, "r438": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480454/718-10-45-1" }, "r439": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r440": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r441": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r442": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r443": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r444": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r445": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r446": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r447": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r448": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r449": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r450": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r451": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r452": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r453": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r454": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r455": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r456": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r457": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r458": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r459": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r460": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r461": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r462": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r463": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r464": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r465": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r466": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r467": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r468": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r469": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r470": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(l)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r471": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r472": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r473": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r474": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.F)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1" }, "r475": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "730", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482916/730-10-50-1" }, "r476": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//740/tableOfContent" }, "r477": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-10B" }, "r478": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-4" }, "r479": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-6" }, "r480": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-10" }, "r481": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12" }, "r482": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-14" }, "r483": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15" }, "r484": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15A" }, "r485": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15A" }, "r486": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "17", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-17" }, "r487": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-21" }, "r488": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r489": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r490": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r491": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB TOPIC 6.I.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r492": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 11.C)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-2" }, "r493": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "270", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482526/740-270-50-1" }, "r494": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482603/740-30-50-2" }, "r495": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2" }, "r496": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2" }, "r497": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-5" }, "r498": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-5" }, "r499": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1" }, "r500": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "808", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479402/808-10-50-1" }, "r501": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25" }, "r502": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25" }, "r503": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r504": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r505": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r506": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A" }, "r507": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4A", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A" }, "r508": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4C", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C" }, "r509": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4E", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4E" }, "r510": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5C", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-5C" }, "r511": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480627/815-20-45-3" }, "r512": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r513": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r514": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r515": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r516": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r517": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(i)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r518": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-5" }, "r519": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r520": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r521": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r522": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r523": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r524": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-10" }, "r525": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28" }, "r526": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "230", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1" }, "r527": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17" }, "r528": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r529": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r530": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r531": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r532": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r533": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1" }, "r534": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482900/835-30-50-1" }, "r535": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1" }, "r536": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1" }, "r537": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-2" }, "r538": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-5" }, "r539": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r540": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(3)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2" }, "r541": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//850/tableOfContent" }, "r542": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r543": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r544": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r545": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-6" }, "r546": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r547": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r548": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r549": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r550": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r551": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r552": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r553": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r554": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r555": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r556": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r557": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r558": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r559": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481444/860-30-45-1" }, "r560": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481420/860-30-50-7" }, "r561": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3" }, "r562": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3" }, "r563": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3" }, "r564": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(4)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3" }, "r565": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r566": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r567": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r568": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r569": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r570": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(6)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r571": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r572": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r573": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r574": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r575": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r576": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "910", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482546/910-10-50-6" }, "r577": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "912", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482312/912-310-45-2" }, "r578": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "924", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 11.L)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1" }, "r579": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(10)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r580": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r581": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(26))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r582": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(27))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r583": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-05(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1" }, "r584": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480842/942-360-50-1" }, "r585": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r586": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r587": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(15)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r588": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r589": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r590": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r591": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r592": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r593": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r594": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r595": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r596": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r597": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r598": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r599": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r600": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r601": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r602": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r603": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(7)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r604": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r605": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r606": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r607": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r608": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r609": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r610": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r611": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column G))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r612": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column H))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r613": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column I))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r614": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column J))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r615": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column K))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r616": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r617": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r618": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r619": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r620": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r621": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r622": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-7A" }, "r623": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r624": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r625": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r626": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r627": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r628": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r629": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "825", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B" }, "r630": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r631": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r632": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11" }, "r633": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-13" }, "r634": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-2" }, "r635": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-5" }, "r636": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-6" }, "r637": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3" }, "r638": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4" }, "r639": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4" }, "r640": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r641": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r642": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r643": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r644": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-12" }, "r645": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r646": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r647": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r648": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r649": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r650": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r651": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r652": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r653": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r654": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r655": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r656": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r657": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(14))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r658": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r659": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(16)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r660": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r661": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r662": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r663": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r664": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r665": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r666": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r667": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r668": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r669": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r670": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r671": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r672": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r673": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r674": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r675": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r676": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2" }, "r677": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2" }, "r678": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3" }, "r679": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7" }, "r680": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r681": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r682": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r683": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r684": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(g)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r685": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r686": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r687": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r688": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r689": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r690": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r691": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r692": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r693": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r694": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r695": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r696": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r697": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r698": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(1)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r699": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r700": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r701": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r702": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r703": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r704": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r705": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r706": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r707": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r708": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SX 210.12-13(Column A)(Footnote 3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5" }, "r709": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SX 210.12-13(Column G)(Footnote 8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5" }, "r710": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SX 210.12-13(Column G))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5" }, "r711": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5A", "Subparagraph": "(SX 210.12-13A(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5A" }, "r712": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5B", "Subparagraph": "(SX 210.12-13B(Column A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B" }, "r713": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5B", "Subparagraph": "(SX 210.12-13B(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B" }, "r714": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5B", "Subparagraph": "(SX 210.12-13B(Column E)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B" }, "r715": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5B", "Subparagraph": "(SX 210.12-13B(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B" }, "r716": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5C", "Subparagraph": "(SX 210.12-13C(Column H)(Footnote 7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C" }, "r717": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5C", "Subparagraph": "(SX 210.12-13C(Column H))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C" }, "r718": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r719": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "7", "Subparagraph": "(SX 210.12-15(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7" }, "r720": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "7", "Subparagraph": "(SX 210.12-15(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7" }, "r721": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "7", "Subparagraph": "(SX 210.12-15(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7" }, "r722": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r723": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-3" }, "r724": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481027/954-310-50-2" }, "r725": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "440", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480327/954-440-50-1" }, "r726": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "976", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482856/976-310-50-1" }, "r727": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "978", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482707/978-310-50-1" }, "r728": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)", "SubTopic": "10", "Topic": "235", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4" }, "r729": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4D", "Subparagraph": "(a)(1)", "SubTopic": "10", "Topic": "815", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D" }, "r730": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13H", "Subparagraph": "(a)", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H" }, "r731": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "7", "Subparagraph": "(SX 210.12-15(Column A))", "SubTopic": "320", "Topic": "946", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7" }, "r732": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r733": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r734": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r735": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r736": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "8", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-8" }, "r737": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r738": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r739": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r740": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-22" }, "r741": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "52", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52" }, "r742": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r743": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31" }, "r744": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481933/310-10-55-12A" }, "r745": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479081/326-30-55-8" }, "r746": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482548/350-20-55-24" }, "r747": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r748": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69B" }, "r749": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69C", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69C" }, "r750": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69E", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69E" }, "r751": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69F", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69F" }, "r752": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r753": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r754": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r755": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r756": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r757": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r758": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r759": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r760": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r761": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r762": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-17" }, "r763": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11" }, "r764": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-6" }, "r765": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480547/715-80-55-8" }, "r766": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r767": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4D", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D" }, "r768": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10" }, "r769": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479401/944-30-55-2" }, "r770": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "29F", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-29F" }, "r771": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r772": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r773": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1" }, "r774": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1" }, "r775": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r776": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r777": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r778": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5C", "Subparagraph": "(SX 210.12-13C(Column A)(Footnote 1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C" }, "r779": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5C", "Subparagraph": "(SX 210.12-13C(Column B)(Footnote 1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C" }, "r780": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r781": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10" }, "r782": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-11" }, "r783": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12" }, "r784": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r785": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r786": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r787": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r788": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16", "Subsection": "J", "Paragraph": "a" }, "r789": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1" }, "r790": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i" }, "r791": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "A" }, "r792": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "B" }, "r793": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "C" }, "r794": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "D" }, "r795": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "E" }, "r796": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "ii" }, "r797": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "iii" }, "r798": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "2" }, "r799": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Subsection": "F", "Paragraph": "1", "Subparagraph": "ii", "Section": "6" }, "r800": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a" }, "r801": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1" }, "r802": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "i" }, "r803": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "ii" }, "r804": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iii" }, "r805": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iv" }, "r806": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "v" }, "r807": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "2" }, "r808": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "3" }, "r809": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "b" }, "r810": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a" }, "r811": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1" }, "r812": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "i" }, "r813": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "ii" }, "r814": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iii" }, "r815": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iv" }, "r816": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "v" }, "r817": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "2" }, "r818": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "3" }, "r819": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "b" }, "r820": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r821": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v" }, "r822": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "1" }, "r823": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "ii" }, "r824": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii" }, "r825": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iv" }, "r826": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "vi" }, "r827": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "3" }, "r828": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "4" }, "r829": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "i" }, "r830": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "ii" }, "r831": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "iii" }, "r832": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "iv" }, "r833": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "6" }, "r834": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "6", "Subparagraph": "i" }, "r835": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1" }, "r836": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i" }, "r837": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "A" }, "r838": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "B" }, "r839": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "C" }, "r840": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "D" }, "r841": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "E" }, "r842": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "ii" }, "r843": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "iii" }, "r844": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "2" }, "r845": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "1" }, "r846": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2" }, "r847": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "A" }, "r848": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "C" }, "r849": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "D" }, "r850": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "E" }, "r851": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "F" }, "r852": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a" }, "r853": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "1" }, "r854": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "A" }, "r855": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "B" }, "r856": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "C" }, "r857": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "D" }, "r858": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "b", "Paragraph": "1" }, "r859": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r860": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-10" }, "r861": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-3" }, "r862": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18" }, "r863": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "SubTopic": "825", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B" }, "r864": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(2)", "SubTopic": "10", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2" }, "r865": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(3)", "SubTopic": "10", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2" }, "r866": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4CC", "SubTopic": "10", "Topic": "815", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4CC" }, "r867": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4H", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-4H" }, "r868": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(2)(a))", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r869": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(2)(d))", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r870": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(a)", "Publisher": "SEC" }, "r871": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(b)", "Subparagraph": "(1)", "Publisher": "SEC" }, "r872": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(b)", "Subparagraph": "(2)", "Publisher": "SEC" }, "r873": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(b)", "Subparagraph": "(3)", "Publisher": "SEC" }, "r874": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(c)", "Subparagraph": "(2)(i)", "Publisher": "SEC" }, "r875": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(c)", "Subparagraph": "(2)(ii)", "Publisher": "SEC" }, "r876": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(c)", "Subparagraph": "(2)(iii)", "Publisher": "SEC" }, "r877": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//210/tableOfContent" }, "r878": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r879": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r880": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r881": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(26)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r882": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(3)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r883": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r884": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r885": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4" }, "r886": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5" }, "r887": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6" }, "r888": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14" }, "r889": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "15", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r890": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "9", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-9" }, "r891": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8" }, "r892": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(f))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r893": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r894": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-04(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3" }, "r895": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23" }, "r896": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24" }, "r897": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5" }, "r898": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4" }, "r899": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r900": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r901": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481830/320-10-45-11" }, "r902": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3" }, "r903": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r904": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B" }, "r905": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-9" }, "r906": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "321", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3" }, "r907": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "321", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3" }, "r908": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "321", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3" }, "r909": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r910": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13" }, "r911": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-4" }, "r912": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r913": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r914": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r915": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r916": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r917": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r918": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r919": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r920": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r921": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1A" }, "r922": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-2" }, "r923": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "410", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10" }, "r924": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//450/tableOfContent" }, "r925": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9" }, "r926": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r927": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r928": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r929": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r930": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5" }, "r931": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r932": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r933": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15" }, "r934": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "808", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479402/808-10-50-1" }, "r935": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1A" }, "r936": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1B" }, "r937": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4A", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A" }, "r938": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r939": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r940": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28" }, "r941": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r942": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1" }, "r943": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7" }, "r944": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7" }, "r945": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r946": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r947": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r948": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r949": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r950": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r951": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "912", "SubTopic": "730", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482517/912-730-25-1" }, "r952": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "942", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480832/942-320-50-2" }, "r953": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479432/944-30-50-2B" }, "r954": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13H", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H" }, "r955": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480109/944-80-50-1" }, "r956": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4" }, "r957": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r958": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r959": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r960": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" } } } ZIP 83 0001906324-23-000058-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001906324-23-000058-xbrl.zip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Ǎ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�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end